FN Clarivate Analytics Web of Science
VR 1.0
PT J
AU Quirino-Teixeira, AC
   Rozini, SV
   Barbosa-Lima, G
   Coelho, DR
   Carneiro, PH
   Mohana-Borges, R
   Bozza, PT
   Hottz, ED
AF Quirino-Teixeira, Anna Cecillia
   Rozini, Stephane Vicente
   Barbosa-Lima, Giselle
   Coelho, Diego Rodrigues
   Carneiro, Pedro Henrique
   Mohana-Borges, Ronaldo
   Bozza, Patricia T.
   Hottz, Eugenio D.
TI Inflammatory signaling in dengue-infected platelets requires translation
   and secretion of nonstructural protein 1
SO BLOOD ADVANCES
LA English
DT Article
ID ACTIVATING-FACTOR; VIRUS-INFECTION; LIPOPOLYSACCHARIDE; PATHOGENESIS;
   COAGULATION; FIBRINOLYSIS; REPLICATION; MECHANISMS; EXPRESSION;
   CYTOKINES
AB Emerging evidence identifies major contributions of platelets to inflammatory amplification in dengue, but the mechanisms of infection-driven platelet activation are not completely understood. Dengue virus nonstructural protein-1 (DENV NS1) is a viral protein secreted by infected cells with recognized roles in dengue pathogenesis, but it remains unknown whether NS1 contributes to the inflammatory phenotype of infected platelets. This study shows that recombinant DENV NS1 activated platelets toward an inflammatory phenotype that partially reproduced DENV infection. NS1 stimulation induced translocation of a-granules and release of stored factors, but not of newly synthesized interleukin-1b (IL-1b). Even though both NS1 and DENV were able to induce pro-IL-1b synthesis, only DENV infection triggered caspase-1 activation and IL-1b release by platelets. A more complete thromboinflammatory phenotype was achieved by synergistic activation of NS1 with classic platelet agonists, enhancing a-granule translocation and inducing thromboxane A(2) synthesis (thrombin and platelet-activating factor), or activating caspase-1 for IL-1 beta processing and secretion (adenosine triphosphate). Also, platelet activation by NS1 partially depended on toll-like receptor-4 (TLR-4), but not TLR-2/6. Finally, the platelets sustained viral genome translation and replication, but did not support the release of viral progeny to the extracellular milieu, characterizing an abortive viral infection. Although DENV infection was not productive, translation of the DENV genome led to NS1 expression and release by platelets, contributing to the activation of infected platelets through an autocrine loop. These data reveal distinct, new mechanisms for platelet activation in dengue, involving DENV genome translation and NS1-induced platelet activation via platelet TLR4.
C1 [Quirino-Teixeira, Anna Cecillia; Rozini, Stephane Vicente; Hottz, Eugenio D.] Fed Univ Juiz de Fora UFJF, Dept Biochem, Lab Immunothrombosis, Juiz De Fora, Brazil.
   [Quirino-Teixeira, Anna Cecillia; Rozini, Stephane Vicente; Hottz, Eugenio D.] Fed Univ Juiz de Fora UFJF, Dept Biochem, Lab Glycoconjugates Anal, Juiz De Fora, Brazil.
   [Barbosa-Lima, Giselle; Bozza, Patricia T.] Fundacao Oswaldo Cruz, Oswaldo Cruz Inst, Lab Immunopharmacol, Rio De Janeiro, Brazil.
   [Coelho, Diego Rodrigues; Carneiro, Pedro Henrique; Mohana-Borges, Ronaldo] Univ Fed Rio de Janeiro, Inst Biophys Carlos Chagas Filho, Rio De Janeiro, Brazil.
RP Hottz, ED (corresponding author), Univ Fed Juiz de Fora, Inst Biol Sci, Dept Biochem, Rua Jose Lourenco Kelmer, BR-36036900 Juiz De Fora, Brazil.
EM eugenio.hottz@icb.ufjf.br
RI Borges, Ronaldo S Mohana/C-5575-2013
OI Bozza, Patricia/0000-0001-8349-9529; Mohana Borges,
   Ronaldo/0000-0002-1796-475X; Rozini, Stephane/0000-0003-3856-5210;
   Hottz, Eugenio/0000-0002-2201-1742
FU Fundacao de Amparo a Pesquisa fo Estado do Rio de Janeiro (FAPERJ)Carlos
   Chagas Filho Foundation for Research Support of the State of Rio de
   Janeiro (FAPERJ); Conselho Nacional de Desenvolvimento Cientifico e
   Tecnologico (CNPq)National Council for Scientific and Technological
   Development (CNPq); Coordenacao de Aperfeicoamento de Pessoal de Nivel
   Superior (CAPES)CAPES
FX This work was supported by grants from Fundacao de Amparo a Pesquisa fo
   Estado do Rio de Janeiro (FAPERJ), Conselho Nacional de Desenvolvimento
   Cientifico e Tecnologico (CNPq), and Coordenacao de Aperfeicoamento de
   Pessoal de Nivel Superior (CAPES) (E.D.H.).
CR Alayli F, 2016, VIROLOGY, V496, P227, DOI 10.1016/j.virol.2016.06.008
   Allonso D, 2011, J VIROL METHODS, V175, P109, DOI 10.1016/j.jviromet.2011.04.029
   Assuncao-Miranda I, 2010, FASEB J, V24, P218, DOI 10.1096/fj.09-139469
   Beatty PR, 2015, SCI TRANSL MED, V7, DOI 10.1126/scitranslmed.aaa3787
   Berthet J, 2012, CLIN IMMUNOL, V145, P189, DOI 10.1016/j.clim.2012.09.004
   Bozza FA, 2008, BMC INFECT DIS, V8, DOI 10.1186/1471-2334-8-86
   Brown GT, 2011, J IMMUNOL, V186, P5489, DOI 10.4049/jimmunol.1001623
   Chagan-Yasutan H, 2014, THROMB RES, V134, P449, DOI 10.1016/j.thromres.2014.05.003
   Chaloemwong Juthatip, 2018, BMC Hematol, V18, P20, DOI 10.1186/s12878-018-0116-1
   Chao CH, 2019, PLOS PATHOG, V15, DOI 10.1371/journal.ppat.1007625
   Chen HR, 2018, PLOS PATHOG, V14, DOI 10.1371/journal.ppat.1007033
   Chen HR, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004828
   Chen JC, 2015, PLOS PATHOG, V11, DOI 10.1371/journal.ppat.1005053
   Chen LC, 2006, AM J TROP MED HYG, V74, P142, DOI 10.4269/ajtmh.2006.74.142
   Conceicao TM, 2010, J INFECTION, V60, P65, DOI 10.1016/j.jinf.2009.10.003
   D'Atri LP, 2015, J THROMB HAEMOST, V13, P839, DOI 10.1111/jth.12842
   Damien P, 2015, BMC IMMUNOL, V16, DOI 10.1186/s12865-015-0067-2
   Trugilho MRD, 2017, PLOS PATHOG, V13, DOI 10.1371/journal.ppat.1006385
   Denis MM, 2005, CELL, V122, P379, DOI 10.1016/j.cell.2005.06.015
   Gastaminza P, 2010, J VIROL, V84, P10999, DOI 10.1128/JVI.00526-10
   Glasner DR, 2018, ANNU REV VIROL, V5, P227, DOI 10.1146/annurev-virology-101416-041848
   Glasner DR, 2017, PLOS PATHOG, V13, DOI 10.1371/journal.ppat.1006673
   Guzman MG, 2015, LANCET, V385, P453, DOI 10.1016/S0140-6736(14)60572-9
   Heijnen H, 2015, J THROMB HAEMOST, V13, P2141, DOI 10.1111/jth.13147
   Hottz ED, 2013, J THROMB HAEMOST, V11, P951, DOI 10.1111/jth.12178
   Hottz ED, 2018, FRONT MED-LAUSANNE, V5, DOI 10.3389/fmed.2018.00121
   Hottz ED, 2015, MEDIAT INFLAMM, V2015, DOI 10.1155/2015/435783
   Hottz ED, 2014, J IMMUNOL, V193, P1864, DOI 10.4049/jimmunol.1400091
   Hottz ED, 2013, BLOOD, V122, P3405, DOI 10.1182/blood-2013-05-504449
   Jayathilaka D, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-07667-z
   Jeewandara C, 2015, PLOS NEGLECT TROP D, V9, DOI 10.1371/journal.pntd.0003459
   Kamaladasa A, 2016, ANTIVIR RES, V133, P183, DOI 10.1016/j.antiviral.2016.07.016
   Kar M, 2017, OPEN FORUM INFECT DI, V4, DOI 10.1093/ofid/ofx051
   Koupenova M, 2019, NAT COMMUN, V10, DOI 10.1038/s41467-019-09607-x
   Koupenova M, 2014, BLOOD, V124, P791, DOI 10.1182/blood-2013-11-536003
   Kraemer BF, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002355
   Krishnamurti C, 2001, AM J TROP MED HYG, V65, P840, DOI 10.4269/ajtmh.2001.65.840
   Libraty DH, 2002, J INFECT DIS, V186, P1165, DOI 10.1086/343813
   Liu JY, 2016, NAT MICROBIOL, V1, DOI [10.1038/NMICROBIOL.2016.87, 10.1038/nmicrobiol.2016.87]
   Mariathasan S, 2007, NAT REV IMMUNOL, V7, P31, DOI 10.1038/nri1997
   Matsuura C, 2012, T ROY SOC TROP MED H, V106, P174, DOI 10.1016/j.trstmh.2011.10.009
   Michels M, 2014, THROMB HAEMOSTASIS, V112, P352, DOI 10.1160/TH14-01-0056
   Modhiran N, 2017, IMMUNOL CELL BIOL, V95, P491, DOI 10.1038/icb.2017.5
   Modhiran N, 2015, SCI TRANSL MED, V7, DOI 10.1126/scitranslmed.aaa3863
   Muller DA, 2013, ANTIVIR RES, V98, P192, DOI 10.1016/j.antiviral.2013.03.008
   Noisakran S, 2009, SE ASIAN J TROP MED, V40, P253
   Ojha A, 2017, SCI REP-UK, V7, DOI 10.1038/srep41697
   Pan P, 2019, J VIROL, V93, DOI 10.1128/JVI.00996-19
   Piccini A, 2008, P NATL ACAD SCI USA, V105, P8067, DOI 10.1073/pnas.0709684105
   Puerta-Guardo H, 2016, PLOS PATHOG, V12, DOI 10.1371/journal.ppat.1005738
   Qiao JL, 2018, HAEMATOLOGICA, V103, P1568, DOI 10.3324/haematol.2018.191700
   Sacramento CQ, 2017, SCI REP-UK, V7, DOI 10.1038/srep40920
   Samsa MM, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000632
   Schmid MA, 2016, PLOS PATHOG, V12, DOI 10.1371/journal.ppat.1005676
   Shashkin PN, 2008, J IMMUNOL, V181, P3495, DOI 10.4049/jimmunol.181.5.3495
   Simon AY, 2015, BLOOD, V126, P378, DOI 10.1182/blood-2014-09-598029
   Souza DG, 2009, P NATL ACAD SCI USA, V106, P14138, DOI 10.1073/pnas.0906467106
   Suharti C, 2002, THROMB HAEMOSTASIS, V87, P42
   Sung PS, 2019, NAT COMMUN, V10, DOI 10.1038/s41467-019-10360-4
   Thiemmeca S, 2016, J IMMUNOL, V197, P4053, DOI 10.4049/jimmunol.1600323
   Thisyakorn Usa, 2015, Southeast Asian J Trop Med Public Health, V46 Suppl 1, P3
   van de Weg CAM, 2013, PLOS NEGLECT TROP D, V7, DOI 10.1371/journal.pntd.0002236
   van Gorp ECM, 2002, J MED VIROL, V67, P549, DOI 10.1002/jmv.10137
   van Gorp ECM, 2001, BRIT J HAEMATOL, V113, P94, DOI 10.1046/j.1365-2141.2001.02710.x
   Vats R, 2020, AM J RESP CRIT CARE, V201, P33, DOI 10.1164/rccm.201807-1370OC
   Vogel S, 2018, BLOOD ADV, V2, P2672, DOI 10.1182/bloodadvances.2018021709
   World Health Organization, DENG CONTR WHAT IS D
   YANG KD, 1995, J INFECT DIS, V172, P604, DOI 10.1093/infdis/172.2.604
   Yeh TM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0055018
   Zhang GY, 2009, J IMMUNOL, V182, P7997, DOI 10.4049/jimmunol.0802884
   Zhao LZ, 2016, BMC INFECT DIS, V16, DOI 10.1186/s12879-016-1596-x
   2009, DENG GUID DIAGN TREA, P1
NR 72
TC 6
Z9 6
U1 2
U2 2
PU AMER SOC HEMATOLOGY
PI WASHINGTON
PA 2021 L ST NW, SUITE 900, WASHINGTON, DC 20036 USA
SN 2473-9529
EI 2473-9537
J9 BLOOD ADV
JI Blood Adv.
PD MAY 12
PY 2020
VL 4
IS 9
BP 2018
EP 2031
DI 10.1182/bloodadvances.2019001169
PG 14
WC Hematology
SC Hematology
GA LO2ZM
UT WOS:000533498800023
PM 32396616
OA Bronze, Green Published
DA 2020-12-17
ER

PT J
AU Conte, FD
   Tinoco, BC
   Chaves, TS
   de Oliveira, RC
   Mansur, JF
   Mohana-Borges, R
   de Lemos, ERS
   Neves, PCD
   Rodrigues-da-Silva, RN
AF Conte, Fernando de Paiva
   Tinoco, Bianca Correa
   Chaves, Thiago Santos
   de Oliveira, Renata Carvalho
   Mansur, Janaina Figueira
   Mohana-Borges, Ronaldo
   Sampaio de Lemos, Elba Regina
   da Costa Neves, Patricia Cristina
   Rodrigues-da-Silva, Rodrigo Nunes
TI Identification and validation of specific B-cell epitopes of
   hantaviruses associated to hemorrhagic fever and renal syndrome
SO PLOS NEGLECTED TROPICAL DISEASES
LA English
DT Article
ID PUUMALA VIRUS; CARDIOPULMONARY SYNDROME; SWISS-MODEL; PROTEIN; HANTAAN;
   ANTIGEN; HFRS; INFECTIONS; PREDICTION; ANTIBODIES
AB Background
   Orthohantavirus infection is a neglected global health problem affecting approximately 200,000 people/year, spread by rodent hosts and associated to fatal human diseases, such as hemorrhagic fever with renal syndrome (HFRS) and orthohantavirus cardiopulmonary syndrome (HCPS). Circulation of HFRS-associated orthohantaviruses, such as Seoul, Gou, Amur, Dobrava and Hantaan, are supposed to be restricted to Eurasian countries even though their hosts can be a worldwide distribution. Few confirmed HFRS orthohantavirus infections in humans have been reported in American countries, but due to lower medical awareness of the symptoms of this zoonosis, it could be associated to viral underreporting or to misdiagnosis with several tropical hemorrhagic diseases. Serological evidence of orthohantavirus infections, using enzyme-linked immunosorbent assay for the presence of immunoglobulin M and G against recombinant nucleoprotein protein, remains as an essential assay for viral surveillance. In this study, we aimed to identify in silico immunogenic B-cell linear epitopes present on orthohantavirus nucleoprotein that are exclusive to HFRS-related species.
   Methodology/Principal findings
   In silico analysis were performed using Seoul orthohantavirus nucleoprotein (SHNP) sequence as a model. Linear B-cell-epitopes on SHNP and its immunogenicity were predicted by BepiPred-2.0 and Vaxijen algorithms, respectively. The conservancy of predicted epitopes was compared with the most clinically relevant HFRS or HCPS-associated orthohantavirus, aiming to identify specific sequences from HFRS-orthohantavirus. Peptide validation was carried out by ELISA using Balb/c mice sera immunized with purified recombinant rSHNP. Peptides cross-reactivity against HCPS orthohantavirus were evaluated using immunized sera from mice injected with recombinant Juquitiba orthohantavirus nucleoprotein (rJHNP).
   Conclusion/Significance
   In silico analysis revealed nine potential immunogenic linear B-cell epitopes from SHNP; among them, SHNP(G72-D110) and SHNP(P251-D264) showed a high degree of sequence conservation among HFRS-related orthohantavirus and were experimentally validated against rSHNP-IMS and negatively validated against rJHNP-IMS. Taken together, we identified and validated two potential antigenic B-cell epitopes on SHNP, which were conserved among HFRS-associated orthohantavirus and could be applied to the development of novel immunodiagnostic tools for orthohantavirus surveillance.
C1 [Conte, Fernando de Paiva; Tinoco, Bianca Correa; Chaves, Thiago Santos; da Costa Neves, Patricia Cristina; Rodrigues-da-Silva, Rodrigo Nunes] Fiocruz MS, Immunobiol Technol Inst, Lab Monoclonal Antibodies Technol, Rio De Janeiro, Brazil.
   [de Oliveira, Renata Carvalho; Sampaio de Lemos, Elba Regina] Fiocruz MS, Inst Oswaldo Cruz, Lab Hantaviroses & Rickettsioses, Rio De Janeiro, Brazil.
   [Mansur, Janaina Figueira; Mohana-Borges, Ronaldo] Univ Fed Rio de Janeiro, UFRJ, Inst Biofis Carlos Chagas Filho IBCCF, Lab Genom Estrutural, Rio De Janeiro, Brazil.
RP Rodrigues-da-Silva, RN (corresponding author), Fiocruz MS, Immunobiol Technol Inst, Lab Monoclonal Antibodies Technol, Rio De Janeiro, Brazil.
EM Rodrigo.nunes@bio.fiocruz.br
RI Borges, Ronaldo S Mohana/C-5575-2013
OI Rodrigues-da-Silva, Rodrigo Nunes/0000-0002-9772-849X; Conte,
   Fernando/0000-0002-1754-5870; Chaves, Thiago Santos/0000-0002-9699-3320
FU Institute of Immunobiological Technology, Oswaldo Cruz Foundation
   (Fiocruz); Federal University of Rio de Janeiro (UFRJ); Conselho
   Nacional de Pesquisa e Desenvolvimento (CPNq) -Universal research grants
   [404762-20166]; FAPERJ technological initiation scholarshipCarlos Chagas
   Filho Foundation for Research Support of the State of Rio de Janeiro
   (FAPERJ) [E-26/260.041/2019]
FX This work was supported by Institute of Immunobiological Technology,
   Oswaldo Cruz Foundation (Fiocruz) and by Federal University of Rio de
   Janeiro (UFRJ). ERSL is recipient of Conselho Nacional de Pesquisa e
   Desenvolvimento (CPNq) -Universal research grants (404762-20166 -
   http://cnpq.br/). BCT is recipient of FAPERJ technological initiation
   scholarship (E-26/260.041/2019). The funders had no role in study
   design, data collection and analysis, decision to publish, or
   preparation of the manuscript.
CR Alexeyev OA, 1996, LANCET, V347, P1483, DOI 10.1016/S0140-6736(96)91717-1
   Arnada T, 2013, J VIROL METHODS, V193, P42, DOI 10.1016/j.jviromet.2013.04.021
   Bergmann-Leitner ES, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0071610
   Biasini M, 2014, NUCLEIC ACIDS RES, V42, pW252, DOI 10.1093/nar/gku340
   BOWIE JU, 1991, SCIENCE, V253, P164, DOI 10.1126/science.1853201
   Camacho C, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-421
   Chen VB, 2010, ACTA CRYSTALLOGR D, V66, P12, DOI 10.1107/S0907444909042073
   Clement J, 1999, LANCET, V354, P2003, DOI 10.1016/S0140-6736(05)76782-9
   Clement J, 2019, VIRUSES-BASEL, V11, DOI 10.3390/v11070652
   Costa F, 2014, VECTOR-BORNE ZOONOT, V14, P33, DOI 10.1089/vbz.2013.1378
   Cvetko L, 2005, J MED VIROL, V77, P290, DOI 10.1002/jmv.20448
   de Araujo J, 2015, J MED VIROL, V87, P725, DOI 10.1002/jmv.24118
   Doytchinova IA, 2007, BMC BIOINFORMATICS, V8, DOI 10.1186/1471-2105-8-4
   Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493
   GAUSEPOHL H, 1992, PEPTIDE RES, V5, P315
   Guex N, 2009, ELECTROPHORESIS, V30, pS162, DOI 10.1002/elps.200900140
   Guo Y, 2016, J VIROL, V90, P1048, DOI 10.1128/JVI.02523-15
   Hall TA., 1999, NUCL ACIDS S SER, V41, P95, DOI DOI 10.1021/BK-1999-0734.CH008
   Hjelle B, 1997, J CLIN MICROBIOL, V35, P600, DOI 10.1128/JCM.35.3.600-608.1997
   Hujakka H, 2003, J VIROL METHODS, V108, P117, DOI 10.1016/S0166-0934(02)00282-3
   Jespersen MC, 2017, NUCLEIC ACIDS RES, V45, pW24, DOI 10.1093/nar/gkx346
   Jiang H, 2017, VIROL SIN, V32, P32, DOI 10.1007/s12250-016-3899-x
   Jiang W, 2014, J VIROL METHODS, V196, P145, DOI 10.1016/j.jviromet.2013.11.004
   Kalaiselvan S, 2017, J CELL BIOCHEM, V118, P2320, DOI 10.1002/jcb.25887
   Kalaiselvan S, 2017, J CELL BIOCHEM, V118, P1182, DOI 10.1002/jcb.25765
   Koma T, 2010, J CLIN MICROBIOL, V48, P1635, DOI 10.1128/JCM.00072-10
   Krautkramer E, 2016, BMC INFECT DIS, V16, DOI 10.1186/s12879-016-2012-2
   LEDUC JW, 1985, AM J TROP MED HYG, V34, P810, DOI 10.4269/ajtmh.1985.34.810
   LEE HW, 1982, SCAND J INFECT DIS, P82
   Lima RN, 2016, BMC BIOINFORMATICS, V17, DOI 10.1186/s12859-016-1339-4
   LUTHY R, 1992, NATURE, V356, P83, DOI 10.1038/356083a0
   Luu T, 1996, INT J PEPT PROT RES, V47, P91
   Manigold T, 2014, SWISS MED WKLY, V144, DOI 10.4414/smw.2014.13937
   Figueiredo LTM, 2014, VIRUS RES, V187, P43, DOI 10.1016/j.virusres.2014.01.015
   Olal D, 2016, CELL REP, V14, P2092, DOI 10.1016/j.celrep.2016.02.005
   Remmert M, 2012, NAT METHODS, V9, P173, DOI [10.1038/NMETH.1818, 10.1038/nmeth.1818]
   Rezende CMF, 2018, MOL IMMUNOL, V101, P29, DOI 10.1016/j.molimm.2018.05.019
   Rodrigues-da-Silva RN, 2019, VACCINE, V37, P306, DOI 10.1016/j.vaccine.2018.10.016
   SALI A, 1993, J MOL BIOL, V234, P779, DOI 10.1006/jmbi.1993.1626
   Ti JF, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0181177
   Vaheri A, 2013, NAT REV MICROBIOL, V11, P539, DOI 10.1038/nrmicro3066
   VAPALAHTI O, 1995, J MED VIROL, V46, P293, DOI 10.1002/jmv.1890460402
   Vollmar P, 2016, J CLIN VIROL, V84, P42, DOI 10.1016/j.jcv.2016.10.004
   Yoshimatsu K, 2014, VIRUS RES, V187, P77, DOI 10.1016/j.virusres.2013.12.040
NR 44
TC 0
Z9 0
U1 0
U2 0
PU PUBLIC LIBRARY SCIENCE
PI SAN FRANCISCO
PA 1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA
SN 1935-2735
J9 PLOS NEGLECT TROP D
JI Plos Neglect. Trop. Dis.
PD DEC
PY 2019
VL 13
IS 12
AR e0007915
DI 10.1371/journal.pntd.0007915
PG 15
WC Infectious Diseases; Parasitology; Tropical Medicine
SC Infectious Diseases; Parasitology; Tropical Medicine
GA MZ7OY
UT WOS:000559317800039
PM 31841521
OA DOAJ Gold, Green Published
DA 2020-12-17
ER

PT J
AU Amorim, JFS
   Azevedo, AS
   Costa, SM
   Trindade, GF
   Basilio-de-Oliveira, CA
   Goncalves, AJS
   Salomao, NG
   Rabelo, K
   Amaral, R
   Geraldo, LHM
   Lima, FRS
   Mohana-Borges, R
   Paes, MV
   Alves, AMB
AF Amorim, J. F. S.
   Azevedo, A. S.
   Costa, S. M.
   Trindade, G. F.
   Basilio-de-Oliveira, C. A.
   Goncalves, A. J. S.
   Salomao, N. G.
   Rabelo, K.
   Amaral, R.
   Geraldo, L. H. M.
   Lima, F. R. S.
   Mohana-Borges, R.
   Paes, M. V.
   Alves, A. M. B.
TI Dengue infection in mice inoculated by the intracerebral route:
   neuropathological effects and identification of target cells for virus
   replication
SO SCIENTIFIC REPORTS
LA English
DT Article
ID CENTRAL-NERVOUS-SYSTEM; GUILLAIN-BARRE-SYNDROME; MICROGLIA; BRAIN;
   ENCEPHALITIS; PATHOGENESIS; PROTECTION; DAMAGE; CNS
AB Dengue is an important arboviral infection, causing a broad range symptom that varies from life-threatening mild illness to severe clinical manifestations. Recent studies reported the impairment of the central nervous system (CNS) after dengue infection, a characteristic previously considered as atypical and underreported. However, little is known about the neuropathology associated to dengue. Since animal models are important tools for helping to understand the dengue pathogenesis, including neurological damages, the aim of this work was to investigate the effects of intracerebral inoculation of a neuroadapted dengue serotype 2 virus (DENV2) in immunocompetent BALB/c mice, mimicking some aspects of the viral encephalitis. Mice presented neurological morbidity after the 7th day post infection. At the same time, histopathological analysis revealed that DENV2 led to damages in the CNS, such as hemorrhage, reactive gliosis, hyperplastic and hypertrophied microglia, astrocyte proliferation, Purkinje neurons retraction and cellular infiltration around vessels in the pia mater and in neuropil. Viral tropism and replication were detected in resident cells of the brain and cerebellum, such as neurons, astrocyte, microglia and oligodendrocytes. Results suggest that this classical mice model might be useful for analyzing the neurotropic effect of DENV with similarities to what occurs in human.
C1 [Amorim, J. F. S.; Azevedo, A. S.; Costa, S. M.; Goncalves, A. J. S.; Salomao, N. G.; Rabelo, K.; Paes, M. V.; Alves, A. M. B.] Fundacao Oswaldo Cruz, Inst Oswaldo Cruz, Lab Biotechnol & Physiol Viral Infect, Rio De Janeiro, Brazil.
   [Trindade, G. F.] Fundacao Oswaldo Cruz, Inst Technol Immunobiol Biomanguinhos, Lab Virol Technol, Rio De Janeiro, Brazil.
   [Basilio-de-Oliveira, C. A.] Fed Univ State Rio de Janeiro UNIRIO, Gaffree & Guinle Univ Hosp, Rio De Janeiro, Brazil.
   [Salomao, N. G.; Paes, M. V.] Fundacao Oswaldo Cruz, Inst Oswaldo Cruz, Interdisciplinary Lab Med Res, Rio De Janeiro, Brazil.
   [Amaral, R.; Geraldo, L. H. M.; Lima, F. R. S.] Univ Fed Rio de Janeiro, Inst Biomed Sci, Lab Glial Cell Biol, Rio De Janeiro, Brazil.
   [Mohana-Borges, R.] Univ Fed Rio de Janeiro, Inst Biophys Carlos Chagas Filho, Lab Struct Genom, Rio De Janeiro, RJ, Brazil.
RP Paes, MV; Alves, AMB (corresponding author), Fundacao Oswaldo Cruz, Inst Oswaldo Cruz, Lab Biotechnol & Physiol Viral Infect, Rio De Janeiro, Brazil.; Paes, MV (corresponding author), Fundacao Oswaldo Cruz, Inst Oswaldo Cruz, Interdisciplinary Lab Med Res, Rio De Janeiro, Brazil.
EM marciano@ioc.fiocruz.br; ada@ioc.fiocruz.br
RI Borges, Ronaldo S Mohana/C-5575-2013
OI Rabelo, Kissila/0000-0001-7579-7788; Paes, Marciano/0000-0002-2266-2801;
   Trindade, Gisela/0000-0002-1630-4143; Geraldo, Luiz
   Henrique/0000-0003-3318-4697; Souza Lima, Flavia
   Regina/0000-0003-0799-9235
FU Brazilian National Research Council (CNPq)National Council for
   Scientific and Technological Development (CNPq) [443712/2014-0]; Carlos
   Chagas Filho Foundation for Research Support of the State of Rio de
   Janeiro (FAPERJ)Carlos Chagas Filho Foundation for Research Support of
   the State of Rio de Janeiro (FAPERJ) [E-26/110.519/2010]; Research
   Program for the Unified Health System (PPSUS) [E-26/110.271/2014];
   National Institute of Science and Technology in Vaccines (INCTV)
   [573547/2013]
FX lWe thank the significant help of Geraldo C. Wagner from the Federal
   University of the State of Rio de Janeiro (UNIRIO) with tissue slides
   production. We thank Dr. Sheila Maria Barbosa de Lima, head of the
   Laboratory of Virological Technology (BioManguinhos-Fiocruz), for
   collaborating in the development of qPCR and also kindly donating
   reagents for extraction and reverse transcription of viral RNA. We also
   give recognition to Dr. Grasiella Ventura Matioszek, responsible for the
   Multiuser Unit of Confocal Microscopy ICB/FCM at Federal University of
   Rio de Janeiro (UFRJ) that assisted us in the acquisition of
   immunofluorescence images. The work was supported by the Brazilian
   National Research Council (CNPq) (Grant Number: 443712/2014-0), Carlos
   Chagas Filho Foundation for Research Support of the State of Rio de
   Janeiro (FAPERJ) (grant number: E-26/110.519/2010), Research Program for
   the Unified Health System (PPSUS) (Grant Number: E-26/110.271/2014) and
   National Institute of Science and Technology in Vaccines (INCTV) (Grant
   Number: 573547/2013).
CR Aguirre S, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002934
   Amaral DCG, 2011, J NEUROINFLAMM, V8, DOI 10.1186/1742-2094-8-23
   Araujo FMC, 2012, NEUROLOGY, V78, P736, DOI 10.1212/WNL.0b013e31824b94e9
   Araujo F, 2012, EMERG INFECT DIS, V18, P677, DOI [10.3201/eid1804.111522, 10.3201/eid1804.111552]
   Ashour J, 2010, CELL HOST MICROBE, V8, P410, DOI 10.1016/j.chom.2010.10.007
   Aspelund A, 2015, J EXP MED, V212, P991, DOI 10.1084/jem.20142290
   Atrasheuskaya A, 2003, FEMS IMMUNOL MED MIC, V35, P33, DOI 10.1111/j.1574-695X.2003.tb00646.x
   Azevedo AS, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0058357
   Azevedo AS, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020528
   Bhatt S, 2013, NATURE, V496, P504, DOI 10.1038/nature12060
   Bhoopat L, 1996, ASIAN PAC J ALLERGY, V14, P107
   Chambers TJ, 2003, J VIROL, V77, P3655, DOI 10.1128/JVI.77.6.3655-3668.2003
   Chen HC, 2004, J MED VIROL, V73, P419, DOI 10.1002/jmv.20108
   Costa SM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025685
   Costa SM, 2006, VACCINE, V24, P195, DOI 10.1016/j.vaccine.2005.07.059
   Dhenni R, 2018, PLOS NEGLECT TROP D, V12, DOI 10.1371/journal.pntd.0006198
   ERHARDT W, 1984, RES EXP MED, V184, P159, DOI 10.1007/BF01852390
   FALGOUT B, 1990, J VIROL, V64, P4356, DOI 10.1128/JVI.64.9.4356-4363.1990
   Gabel S, 2016, MOL NEUROBIOL, V53, P5041, DOI 10.1007/s12035-015-9428-3
   Goldmann T, 2015, EMBO J, V34, P1612, DOI 10.15252/embj.201490791
   Guabiraba R, 2014, IMMUNOLOGY, V141, P143, DOI 10.1111/imm.12188
   Gupta M, 2013, J NEUROL SCI, V335, P216, DOI 10.1016/j.jns.2013.08.029
   HENDARTO S K, 1992, Acta Paediatrica Japonica, V34, P350
   Herath H M M, 2018, J Med Case Rep, V12, P100, DOI 10.1186/s13256-018-1627-x
   IRIE K, 1989, GENE, V75, P197, DOI 10.1016/0378-1119(89)90266-7
   Carod-Artal FJ, 2013, LANCET NEUROL, V12, P906, DOI 10.1016/S1474-4422(13)70150-9
   Jensen CJ, 2013, J NEUROIMMUNE PHARM, V8, P824, DOI 10.1007/s11481-013-9480-6
   Jhan MK, 2018, J LEUKOCYTE BIOL, V104, P961, DOI 10.1002/JLB.MA1217-484R
   Laman JD, 2013, J NEUROIMMUNE PHARM, V8, P840, DOI 10.1007/s11481-013-9470-8
   Lana-Peixoto MA, 2018, J NEUROIMMUNOL, V318, P53, DOI 10.1016/j.jneuroim.2018.02.003
   Landais A., 2018, MED MALADIES INFECT, V49, P270
   Lauretti F, 2016, HUM VACC IMMUNOTHER, V12, P2327, DOI 10.1080/21645515.2016.1183857
   Li GH, 2017, FRONT CELL INFECT MI, V7, DOI 10.3389/fcimb.2017.00449
   London A, 2013, FRONT CELL NEUROSCI, V7, DOI 10.3389/fncel.2013.00034
   Martina BEE, 2009, CLIN MICROBIOL REV, V22, P564, DOI 10.1128/CMR.00035-09
   MEIKLEJOHN G, 1952, AM J TROP MED HYG, V1, P51, DOI 10.4269/ajtmh.1952.1.51
   Miagostovich MP, 1997, CLIN NEUROPATHOL, V16, P204
   Mittelbronn M, 2001, ACTA NEUROPATHOL, V101, P249
   Oliveira ERA, 2016, VIROLOGY, V489, P95, DOI 10.1016/j.virol.2015.12.006
   Paes MV, 2009, LAB INVEST, V89, P1140, DOI 10.1038/labinvest.2009.83
   Pandey S, 2018, ANN INDIAN ACAD NEUR, V21, P315, DOI 10.4103/aian.AIAN_454_17
   Puccioni-Sohler M, 2015, ARQ NEURO-PSIQUIAT, V73, P698, DOI 10.1590/0004-282X20150074
   Puccioni-Sohler M, 2012, NEUROL INT, V4, P65, DOI 10.4081/ni.2012.e15
   Qureshi N. K., 2012, Journal of Medicine, V13, P246
   Ramos C, 1998, J NEUROVIROL, V4, P465, DOI 10.3109/13550289809114548
   Ramos JM, 2015, J TRAVEL MED, V22, P133, DOI 10.1111/jtm.12157
   Rothman AL, 2004, J CLIN INVEST, V113, P946, DOI 10.1172/JCI21512
   Rothman Alan L, 2014, Curr Trop Med Rep, V1, P13
   Salomao NG, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-28137-y
   Sanguansermsri T., 1976, BANGKOK SEAMEO TROPM, V10
   Shao Q, 2017, DEVELOPMENT, V144, P4114, DOI 10.1242/dev.156752
   Shresta S, 2004, VIROLOGY, V319, P262, DOI 10.1016/j.virol.2003.09.048
   Simon O, 2016, J CLIN VIROL, V77, P29, DOI 10.1016/j.jcv.2016.01.016
   Soares CN, 2010, INT J INFECT DIS, V14, pE150, DOI 10.1016/j.ijid.2009.03.016
   Stowell RD, 2018, DEV NEUROBIOL, V78, P627, DOI 10.1002/dneu.22572
   Tay TL, 2017, NAT NEUROSCI, V20, P793, DOI 10.1038/nn.4547
   Tsai TT, 2016, SCI REP-UK, V6, DOI 10.1038/srep27670
   Wasay M, 2008, CLIN NEUROL NEUROSUR, V110, P635, DOI 10.1016/j.clineuro.2008.03.011
   Weller RO, 1996, BRAIN PATHOL, V6, P275, DOI 10.1111/j.1750-3639.1996.tb00855.x
   Whitehorn J, 2011, VACCINE, V29, P7221, DOI 10.1016/j.vaccine.2011.07.022
   Withana Milinda, 2014, BMC Res Notes, V7, P125, DOI 10.1186/1756-0500-7-125
   World Health Organization, 1997, DENG HAEM FEV DIAGN
   Zellweger RM, 2014, FRONT IMMUNOL, V5, DOI 10.3389/fimmu.2014.00151
NR 63
TC 3
Z9 3
U1 0
U2 1
PU NATURE PUBLISHING GROUP
PI LONDON
PA MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND
SN 2045-2322
J9 SCI REP-UK
JI Sci Rep
PD NOV 29
PY 2019
VL 9
AR 17926
DI 10.1038/s41598-019-54474-7
PG 15
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA JR9DI
UT WOS:000499916600001
PM 31784616
OA DOAJ Gold, Green Published
DA 2020-12-17
ER

PT J
AU Allonso, D
   Pereira, IB
   Alves, AMB
   Kurtenbach, E
   Mohana-Borges, R
AF Allonso, Diego
   Pereira, Iuri B.
   Alves, Ada M. B.
   Kurtenbach, Eleonora
   Mohana-Borges, Ronaldo
TI Expression of soluble, glycosylated and correctly folded dengue virus
   NS1 protein in Pichia pastoris
SO PROTEIN EXPRESSION AND PURIFICATION
LA English
DT Article
DE Dengue virus; NSI protein; Pichia pastoris; Glycosylation
ID NONSTRUCTURAL GLYCOPROTEIN NS1; DNA VACCINE; YEAST; SECRETION;
   ANTIBODIES; HEXAMER; ANTIGEN; SURFACE; CELLS; MICE
AB The dengue virus (DENV) non structural protein 1 (NS1) is a 46-55 kDa protein that exists as homodimer inside cells and as hexamer in the extracellular milieu. Several lines of evidence have demonstrated that the biochemical and structural properties of recombinant NS1 (rNS1) vary depending on the protein expression system used. Aiming to improve current tools for studying NS1 multiple roles, a recombinant tag-free NS1 protein was expressed and purified from P. pastoris yeast cells. The best expression condition was achieved using GS115 strain and induction for 72 h with 0.7% methanol addition every 24 h. Total secreted rNS1 reached 2.18 mg in 1 L culture and the final yield of the purified protein was 1 mg per liter of culture (recovery yield of approximately 45.9%). Size-exclusion chromatography and treatment with EndoH and PNGase indicate that it exists as an N-glycosylated homodimer. Moreover, an ELISA assay with specific DENV anti-NS1 antibody that recognizes conformational epitopes revealed that rNS1 has most of its conformational epitopes preserved. The expression of rNS1 in its native conformation is an important tool for further studies of its role in DENV pathogenesis and replication.
C1 [Allonso, Diego] Univ Fed Rio de Janeiro, Fac Pharm, Dept Pharmaceut Biotechnol, Rio De Janeiro, Brazil.
   [Pereira, Iuri B.; Kurtenbach, Eleonora] Univ Fed Rio de Janeiro, Biophys Inst Carlos Chagas Filho, Lab Biochem & Mol Biol Proteins, Rio De Janeiro, Brazil.
   [Alves, Ada M. B.] Fundacao Oswaldo Cruz, Oswaldo Cruz Inst, Lab Biotechnol & Physiol Virus Infect, Rio De Janeiro, Brazil.
   [Allonso, Diego; Mohana-Borges, Ronaldo] Univ Fed Rio de Janeiro, Biophys Inst Carlos Chagas Filho, Lab Biotechnol & Struct Bioengn, Rio De Janeiro, Brazil.
RP Mohana-Borges, R (corresponding author), Univ Fed Rio de Janeiro, Inst Biofis Carlos Chagas Filho, Lab Biotecnol & Bioengn Estrutural, Edificio Ctr Ciencias Saude,, BR-21941902 Rio de Janeiro, RJ, Brazil.
EM mohana@biof.ufrj.br
RI Borges, Ronaldo S Mohana/C-5575-2013; Allonso, Diego/Y-3446-2018;
   Pereira, Iuri Bastos/Y-3677-2019
OI Allonso, Diego/0000-0002-1410-480X; Pereira, Iuri
   Bastos/0000-0002-6323-2883; Mohana Borges, Ronaldo/0000-0002-1796-475X
FU Brazilian Health Ministry; Conselho Nacional de Desenvolvimento
   Cientifico e TecnologicoNational Council for Scientific and
   Technological Development (CNPq); Fundacao Carlos Chagas Filho de Amparo
   a Pesquisa do Estado do Rio de JaneiroCarlos Chagas Filho Foundation for
   Research Support of the State of Rio de Janeiro (FAPERJ); Financiadora
   de Inovacao e Pesquisa (FINEP - Chamada GENOPROT Dengue); National
   Institutes of Science and Technology in Structural Biology and
   Bioimaging (INCT-INBEB); Coordenacao de Aperfeicoamento de Pessoal de
   Nivel Superior - Brasil (CAPES)CAPES [001]
FX This work was supported by the following funding agencies: Brazilian
   Health Ministry, Conselho Nacional de Desenvolvimento Cientifico e
   Tecnologico, Fundacao Carlos Chagas Filho de Amparo a Pesquisa do Estado
   do Rio de Janeiro, Financiadora de Inovacao e Pesquisa (FINEP - Chamada
   GENOPROT Dengue) and the National Institutes of Science and Technology
   in Structural Biology and Bioimaging (INCT-INBEB). This study was also
   financed in part by the Coordenacao de Aperfeicoamento de Pessoal de
   Nivel Superior - Brasil (CAPES) - Finance Code 001. We would also like
   to thank the Genomic Platform for the DNA sequencing of PDTIS/FIOCRUZ.
CR Akey DL, 2014, SCIENCE, V343, P881, DOI 10.1126/science.1247749
   Alcon S, 2002, J CLIN MICROBIOL, V40, P376, DOI 10.1128/JCM.40.02.376-381.2002
   Allonso D, 2015, J VIROL, V89, P11871, DOI 10.1128/JVI.01342-15
   Allonso D, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0113634
   Allonso D, 2011, J VIROL METHODS, V175, P109, DOI 10.1016/j.jviromet.2011.04.029
   Angelo MA, 2017, J VIROL, V91, DOI 10.1128/JVI.02147-16
   Athmaram T. N., 2012, VIRUS GENES, V46, P219, DOI [10.1099/0022-1317-68-3-853, DOI 10.1099/0022-1317-68-3-853]
   Avirutnan P, 2007, PLOS PATHOG, V3, P1798, DOI 10.1371/journal.ppat.0030183
   Avirutnan P, 2011, J IMMUNOL, V187, P424, DOI 10.4049/jimmunol.1100750
   Avirutnan P, 2010, J EXP MED, V207, P793, DOI 10.1084/jem.20092545
   Batra G, 2010, J BIOSCI BIOENG, V110, P408, DOI 10.1016/j.jbiosc.2010.05.001
   Batra G, 2010, J VIROL METHODS, V167, P10, DOI 10.1016/j.jviromet.2010.03.002
   Beatty PR, 2015, SCI TRANSL MED, V7, DOI 10.1126/scitranslmed.aaa3787
   Bhatt S, 2013, NATURE, V496, P504, DOI 10.1038/nature12060
   Cereghino JL, 2000, FEMS MICROBIOL REV, V24, P45, DOI 10.1016/S0168-6445(99)00029-7
   Conde JN, 2016, J VIROL, V90, P9570, DOI 10.1128/JVI.00912-16
   Costa SM, 2006, VACCINE, V24, P4562, DOI 10.1016/j.vaccine.2005.08.022
   Cregg JM, 2009, METHOD ENZYMOL, V463, P169, DOI 10.1016/S0076-6879(09)63013-5
   Das D, 2009, PROTEIN EXPRES PURIF, V66, P66, DOI 10.1016/j.pep.2009.02.003
   Dorigatti I, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-06006-6
   FALGOUT B, 1995, J VIROL, V69, P7232, DOI 10.1128/JVI.69.11.7232-7243.1995
   Figueira-Mansur J, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-019-39185-3
   Flamand M, 1999, J VIROL, V73, P6104, DOI 10.1128/JVI.73.7.6104-6110.1999
   Gellissen G, 2000, APPL MICROBIOL BIOT, V54, P741, DOI 10.1007/s002530000464
   Glasner DR, 2018, ANNU REV VIROL, V5, P227, DOI 10.1146/annurev-virology-101416-041848
   Gubler DJ, 1998, CLIN MICROBIOL REV, V11, P480, DOI 10.1128/CMR.11.3.480
   Gutsche I, 2011, P NATL ACAD SCI USA, V108, P8003, DOI 10.1073/pnas.1017338108
   Guy B, 2015, VACCINE, V33, P7100, DOI 10.1016/j.vaccine.2015.09.108
   HENCHAL EA, 1988, J GEN VIROL, V69, P2101, DOI 10.1099/0022-1317-69-8-2101
   Hollenberg CP, 1997, CURR OPIN BIOTECH, V8, P554, DOI 10.1016/S0958-1669(97)80028-6
   Lei HY, 2001, J BIOMED SCI, V8, P377, DOI 10.1007/BF02255946
   Libraty DH, 2002, J INFECT DIS, V186, P1165, DOI 10.1086/343813
   Mackenzie JM, 1996, VIROLOGY, V220, P232, DOI 10.1006/viro.1996.0307
   Modhiran N, 2015, SCI TRANSL MED, V7, DOI 10.1126/scitranslmed.aaa3863
   Muller DA, 2012, J GEN VIROL, V93, P771, DOI 10.1099/vir.0.039321-0
   PRYOR MJ, 1994, J GEN VIROL, V75, P1183, DOI 10.1099/0022-1317-75-5-1183
   PRYOR MJ, 1993, VIROLOGY, V194, P769, DOI 10.1006/viro.1993.1318
   ROMANOS MA, 1992, YEAST, V8, P423, DOI 10.1002/yea.320080602
   Saez-Llorens X, 2017, LANCET INFECT DIS, V17, P615, DOI 10.1016/S1473-3099(17)30166-4
   Sankar S. G., 2013, BIOMED RES INT, V2013, P1, DOI [10.1128/jb.177.14.4121-4130.1995, DOI 10.1128/JB.177.14.4121-4130.1995]
   SCHLESINGER JJ, 1987, J GEN VIROL, V68, P853, DOI 10.1099/0022-1317-68-3-853
   Silva EM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057514
   Somnuke P, 2011, VIROLOGY, V413, P253, DOI 10.1016/j.virol.2011.02.022
   Sreekrishna K, 1997, GENE, V190, P55, DOI 10.1016/S0378-1119(96)00672-5
   Wallis TP, 2004, J BIOL CHEM, V279, P20729, DOI 10.1074/jbc.M312907200
   Wan SB, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0089545
   Weiskopf D, 2015, J VIROL, V89, P120, DOI 10.1128/JVI.02129-14
   Wilder-Smith A., 2018, LANCET INFECT DIS, P1, DOI [10.1016/51473-3099(18)30494-8, DOI 10.1016/51473-3099(18)30494-8]
   WINKLER G, 1988, VIROLOGY, V162, P187, DOI 10.1016/0042-6822(88)90408-4
   WINKLER G, 1989, VIROLOGY, V171, P302, DOI 10.1016/0042-6822(89)90544-8
   Wu SF, 2003, VACCINE, V21, P3919, DOI 10.1016/S0264-410X(03)00310-4
   Yohan B, 2017, PROTEIN EXPRES PURIF, V129, P53, DOI 10.1016/j.pep.2016.09.007
   Young PR, 2000, J CLIN MICROBIOL, V38, P1053, DOI 10.1128/JCM.38.3.1053-1057.2000
   Zhou JM, 2006, VIRUS GENES, V33, P27, DOI 10.1007/s11262-005-0036-6
NR 54
TC 4
Z9 4
U1 1
U2 20
PU ACADEMIC PRESS INC ELSEVIER SCIENCE
PI SAN DIEGO
PA 525 B ST, STE 1900, SAN DIEGO, CA 92101-4495 USA
SN 1046-5928
EI 1096-0279
J9 PROTEIN EXPRES PURIF
JI Protein Expr. Purif.
PD OCT
PY 2019
VL 162
BP 9
EP 17
DI 10.1016/j.pep.2019.05.003
PG 9
WC Biochemical Research Methods; Biochemistry & Molecular Biology;
   Biotechnology & Applied Microbiology
SC Biochemistry & Molecular Biology; Biotechnology & Applied Microbiology
GA IF3MU
UT WOS:000472985700002
PM 31077812
DA 2020-12-17
ER

PT J
AU Conci, J
   Alvarez-Paggi, D
   de Oliveira, GAP
   Pagani, TD
   Esperante, SA
   Borkosky, SS
   Aran, M
   Alonso, LG
   Mohana-Borges, R
   de Prat-Gay, G
AF Conci, Julieta
   Alvarez-Paggi, Damian
   de Oliveira, Guilherme A. P.
   Pagani, Talita D.
   Esperante, Sebastian A.
   Borkosky, Silvina S.
   Aran, Martin
   Alonso, Leonardo G.
   Mohana-Borges, Ronaldo
   de Prat-Gay, Gonzalo
TI Conformational Isomerization Involving Conserved Proline Residues
   Modulates Oligomerization of the NS1 Interferon Response Inhibitor from
   the Syncytial Respiratory Virus
SO BIOCHEMISTRY
LA English
DT Article
ID NONSTRUCTURAL PROTEINS; MOLECULAR-DYNAMICS; TRANSCRIPTION; SUPPRESSION;
   ALPHA; BETA
AB Interferon response suppression by the respiratory syncytial virus relies on two unique nonstructural proteins, NS1 and NS2, that interact with cellular partners through high-order complexes. We hypothesized that two conserved proline residues, P81 and P67, participate in the conformational change leading to oligomerization. We found that the molecular dynamics of NS1 show a highly mobile C-terminal helix, which becomes rigid upon in silico replacement of P81. A soluble oligomerization pathway into regular spherical structures at low ionic strengths competes with an aggregation pathway at high ionic strengths with an increase in temperature. P81A requires higher temperatures to oligomerize and has a small positive effect on aggregation, while P67A is largely prone to aggregation. Chemical denaturation shows a first transition, involving a high fluorescence and ellipticity change corresponding to both a conformational change and substantial effects on the environment of its single tryptophan, that is strongly destabilized by P67A but stabilized by P81A. The subsequent global cooperative unfolding corresponding to the main beta-sheet core is not affected by the proline mutations. Thus, a clear link exists between the effect of P81 and P67 on the stability of the first transition and oligomerization/aggregation. Interestingly, both P67 and P81 are located far away in space and sequence from the C-terminal helix, indicating a marked global structural dynamics. This provides a mechanism for modulating the oligomerization of NS1 by unfolding of a weak helix that exposes hydrophobic surfaces, linked to the participation of NS1 in multiprotein complexes.
C1 [Conci, Julieta; Alvarez-Paggi, Damian; Esperante, Sebastian A.; Borkosky, Silvina S.; Aran, Martin; Alonso, Leonardo G.; de Prat-Gay, Gonzalo] Fdn Inst Leloir, Prot Struct Funct & Engn Lab, Ave Patricias Argentinas 435, RA-1405 Buenos Aires, DF, Argentina.
   [Conci, Julieta; Alvarez-Paggi, Damian; Esperante, Sebastian A.; Borkosky, Silvina S.; Aran, Martin; Alonso, Leonardo G.; de Prat-Gay, Gonzalo] Consejo Nacl Invest Cient & Tecn, IIBBA, Ave Patricias Argentinas 435, RA-1405 Buenos Aires, DF, Argentina.
   [de Oliveira, Guilherme A. P.] Univ Fed Rio de Janeiro, Inst Nacl Ciencia & Tecnol Biol Estrutural & Bioi, Ctr Nacl Ressonancia Magnet Nucl Jiri Jonas, Inst Bioquim Med Leopoldo de Meis,Programa Biol E, BR-21941902 Rio De Janeiro, Brazil.
   [Pagani, Talita D.; Mohana-Borges, Ronaldo] Univ Fed Rio de Janeiro, Inst Biofis Carlos Chagas Filho, BR-21941902 Rio De Janeiro, Brazil.
   [Alonso, Leonardo G.] Univ Buenos Aires, CONICET, Inst Nanobiotecnol NANOBIOTEC, Junin 956, RA-1113 Buenos Aires, DF, Argentina.
   [Alvarez-Paggi, Damian] Consejo Nacl Invest Cient & Tecn, INFANT Fdn, Gavilan 94, Buenos Aires, DF, Argentina.
RP de Prat-Gay, G (corresponding author), Fdn Inst Leloir, Prot Struct Funct & Engn Lab, Ave Patricias Argentinas 435, RA-1405 Buenos Aires, DF, Argentina.; de Prat-Gay, G (corresponding author), Consejo Nacl Invest Cient & Tecn, IIBBA, Ave Patricias Argentinas 435, RA-1405 Buenos Aires, DF, Argentina.
EM gpg@leloir.org.ar
RI Borges, Ronaldo S Mohana/C-5575-2013; de Oliveira, Guilherme A.
   P./O-1192-2013; Alvarez Paggi, Damian/N-7549-2018
OI de Oliveira, Guilherme A. P./0000-0002-0063-5888; Duarte Pagani,
   Talita/0000-0002-6936-0608; Alvarez Paggi, Damian/0000-0002-1507-9685;
   Prat Gay, Gonzalo/0000-0001-5748-6863
FU Agencia Nacional de Promocion Cientifica y Tecnologica (ANPCyT)ANPCyT
   [PICT 2015-1135]; CONICETConsejo Nacional de Investigaciones Cientificas
   y Tecnicas (CONICET)
FX This work was supported by Agencia Nacional de Promocion Cientifica y
   Tecnologica (ANPCyT, PICT 2015-1135). J.C. holds a Ph.D. fellowship from
   CONICET. D.A.-P., S.A.E., S.S.B., M.A., L.G.A., and G.d.P.-G. are career
   investigators from CONICET.
CR Afonso CL, 2016, ARCH VIROL, V161, P2351, DOI 10.1007/s00705-016-2880-1
   Atreya PL, 1998, J VIROL, V72, P1452, DOI 10.1128/JVI.72.2.1452-1461.1998
   BERENDSEN HJC, 1984, J CHEM PHYS, V81, P3684, DOI 10.1063/1.448118
   Bernado P, 2006, BIOPHYS J, V91, P4536, DOI 10.1529/biophysj.106.087528
   Boyapalle S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0029386
   Chatterjee S, 2017, NAT MICROBIOL, V2, DOI 10.1038/nmicrobiol.2017.101
   Chemes LB, 2013, J BIOL CHEM, V288, P18923, DOI 10.1074/jbc.M113.467316
   Collins P. L, 2011, HUMAN RESP SYNCYTIAL
   DELAGLIO F, 1995, J BIOMOL NMR, V6, P277, DOI 10.1007/BF00197809
   Fearns R, 1999, J VIROL, V73, P5852, DOI 10.1128/JVI.73.7.5852-5864.1999
   Goswami R, 2013, CELL RES, V23, P1025, DOI 10.1038/cr.2013.98
   Gotoh B, 2001, MICROBIOL IMMUNOL, V45, P787, DOI 10.1111/j.1348-0421.2001.tb01315.x
   Humphrey W, 1996, J MOL GRAPH MODEL, V14, P33, DOI 10.1016/0263-7855(96)00018-5
   Lamb RA, 2007, FIELDS VIROLOGY
   Ling Z, 2008, PROTEIN EXPRES PURIF, V57, P261, DOI 10.1016/j.pep.2007.09.017
   Lovell SC, 2003, PROTEINS, V50, P437, DOI 10.1002/prot.10286
   Maier JA, 2015, J CHEM THEORY COMPUT, V11, P3696, DOI 10.1021/acs.jctc.5b00255
   Ollins P. L., 2007, FIELDS VIROLOGY
   Parks GD, 2013, J MOL BIOL, V425, P4872, DOI 10.1016/j.jmb.2013.09.015
   PLATEAU P, 1982, J AM CHEM SOC, V104, P7310, DOI 10.1021/ja00389a067
   Pretel E, 2015, BIOCHEMISTRY-US, V54, P5136, DOI 10.1021/acs.biochem.5b00615
   Pretel E, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0074338
   Ren JP, 2011, J GEN VIROL, V92, P2153, DOI 10.1099/vir.0.032987-0
   Roe DR, 2013, J CHEM THEORY COMPUT, V9, P3084, DOI 10.1021/ct400341p
   Salomon-Ferrer R, 2013, WIRES COMPUT MOL SCI, V3, P198, DOI 10.1002/wcms.1121
   SANCHEZRUIZ JM, 1992, BIOPHYS J, V61, P921, DOI 10.1016/S0006-3495(92)81899-4
   Schymkowitz J, 2005, NUCLEIC ACIDS RES, V33, pW382, DOI 10.1093/nar/gki387
   Spann KM, 2004, J VIROL, V78, P4363, DOI 10.1128/JVI.78.8.4363-4369.2004
   Swedan S, 2011, J VIROL, V85, P10090, DOI 10.1128/JVI.00413-11
   Swedan S, 2009, J VIROL, V83, P9682, DOI 10.1128/JVI.00715-09
   Taler-Vercic A, 2017, INT J MOL SCI, V18, DOI 10.3390/ijms18030549
   Tremino L, 2017, FEBS LETT, V591, P3431, DOI 10.1002/1873-3468.12841
   Wu WN, 2012, J VIROL, V86, P7777, DOI 10.1128/JVI.00460-12
NR 33
TC 0
Z9 0
U1 0
U2 2
PU AMER CHEMICAL SOC
PI WASHINGTON
PA 1155 16TH ST, NW, WASHINGTON, DC 20036 USA
SN 0006-2960
J9 BIOCHEMISTRY-US
JI Biochemistry
PD JUL 2
PY 2019
VL 58
IS 26
BP 2883
EP 2892
DI 10.1021/acs.biochem.8b01288
PG 10
WC Biochemistry & Molecular Biology
SC Biochemistry & Molecular Biology
GA IH4RE
UT WOS:000474479000004
PM 31243994
OA Green Published
DA 2020-12-17
ER

PT J
AU dos Santos, NA
   de Souza, LM
   Pinto, FE
   Macrino, CD
   de Almeida, CM
   Merlo, BB
   Filgueiras, PR
   Ortiz, RS
   Mohana-Borges, R
   Romao, W
AF dos Santos, Nayara A.
   de Souza, Lindamara M.
   Pinto, Fernanda E.
   Macrino, Clebson de J.
   de Almeida, Camila M.
   Merlo, Bianca B.
   Filgueiras, Paulo R.
   Ortiz, Rafael S.
   Mohana-Borges, Ronaldo
   Romao, Wanderson
TI LDI and MALDI-FT-ICR imaging MS in Cannabis leaves: optimization and
   study of spatial distribution of cannabinoids
SO ANALYTICAL METHODS
LA English
DT Article
ID DESORPTION/IONIZATION MASS-SPECTROMETRY; METABOLITES; TISSUE; BRAIN;
   EXPRESSION; DESORPTION; MARIJUANA; COCAINE; LIPIDS; SEEDS
AB A matrix-assisted laser desorption/ionization imaging mass spectrometry (MALDI IMS) technique is considered a powerful analytical tool to determine the chemical identity and spatial distribution of several molecules in a single analysis, conserving its natural histology. However, there are no specific studies by MALDI IMS on the spatial distribution of cannabinoids in the extension of Cannabis leaves. Therefore, the LDI, MALDI MS, and IMS techniques have been employed to detect and determine the distribution of cannabinoid compounds on the surface of fresh and aged Cannabis leaves, evaluating the ionization efficiency of three matrices: a-cyano-4-hydroxycinnamic acid (CHCA), 2.5-dihydroxybenzoic acid (DHB), and 2-mercaptobenzothiazole (MBT), in different concentrations (from 0.1 to 25 mg mL(-1)). The results of MALDI(-) MS and IMS showed a better ionization efficiency of cannabinoids at low concentrations (0.1 and 0.5 mg mL(-1)) of the matrices. In the analyzes of whole Cannabis leaves, in comparison to LDI, MALDI provided a better detection and spatial distribution of the cannabinoids with an MBT matrix. The sensitivity of the IMS technique was also evaluated on the surface of the Jatropha curca L. leaves using different concentrations of cannabinol (CBN) standard (from 1.0 to 15.0 mg mL(-1)). The spatial distribution of CBN, m/z 309, on physic nut leaves proved the excellent sensitivity of the IMS technique (LOD < 1.0 mg mL(-1)).
C1 [dos Santos, Nayara A.; de Souza, Lindamara M.; Pinto, Fernanda E.; Macrino, Clebson de J.; de Almeida, Camila M.; Filgueiras, Paulo R.; Romao, Wanderson] Univ Fed Espirito Santo, Lab Petrole & Forense, Ave Fernando Ferrari 514, BR-29075910 Vitoria, ES, Brazil.
   [dos Santos, Nayara A.; de Souza, Lindamara M.; Pinto, Fernanda E.; Macrino, Clebson de J.; de Almeida, Camila M.; Ortiz, Rafael S.; Romao, Wanderson] Inst Nacl Ciencia & Tecnol Forense INCT Forense, Porto Alegre, RS, Brazil.
   [Merlo, Bianca B.] Superintendencia Policia Tecnicocient Estado Espi, BR-29045402 Vitoria, ES, Brazil.
   [Ortiz, Rafael S.] Superintendencia Policia Fed Rio Grande Sul, Porto Alegre, RS, Brazil.
   [Mohana-Borges, Ronaldo] Univ Fed Rio de Janeiro, Inst Biofis Carlos Chagas Filho, Rio De Janeiro, RJ, Brazil.
   [Romao, Wanderson] IFES, Av Ministro Salgado Filho, BR-29106010 Vila Velha, ES, Brazil.
RP Romao, W (corresponding author), Univ Fed Espirito Santo, Lab Petrole & Forense, Ave Fernando Ferrari 514, BR-29075910 Vitoria, ES, Brazil.; Romao, W (corresponding author), Inst Nacl Ciencia & Tecnol Forense INCT Forense, Porto Alegre, RS, Brazil.; Romao, W (corresponding author), IFES, Av Ministro Salgado Filho, BR-29106010 Vila Velha, ES, Brazil.
EM wandersonromao@gmail.com
RI Pinto, Fernanda Endringer/AAD-5436-2019; Borges, Ronaldo S
   Mohana/C-5575-2013; Filgueiras, Paulo/E-2482-2018
OI Romao, Wanderson/0000-0002-2254-6683; Filgueiras,
   Paulo/0000-0003-2617-1601; Endringer Pinto, Fernanda/0000-0002-2300-8481
FU CAPESCAPES [23038.007083/2014-40]; FAPES [73309516/16]; CNPqNational
   Council for Scientific and Technological Development (CNPq)
   [445987/2014-6, 465450/2014-8]; Coordenacao de Aperfeicoamento De
   Pessoal De Nivel Superior - Brasil (CAPES)CAPES [1]
FX The authors thank CAPES (23038.007083/2014-40), FAPES (73309516/16), and
   CNPq (445987/2014-6, and 465450/2014-8) for financial support. The
   authors would also like to thank the Nucleo de Competencias em Quimica
   do Petroleo and LabPetro for the use of their installations and the
   Civil Police of Espirito Santo and Federal Police of Rio Grande do Sul
   for providing the samples. "This study was financed in part by the
   CoordenacAo de Aperfeicoamento De Pessoal De Nivel Superior - Brasil
   (CAPES) - Finance Code 1".
CR Aichler M, 2015, LAB INVEST, V95, P422, DOI 10.1038/labinvest.2014.156
   Astigarraga E, 2008, ANAL CHEM, V80, P9105, DOI 10.1021/ac801662n
   Bjarnholt N, 2014, NAT PROD REP, V31, P818, DOI 10.1039/c3np70100j
   Borille BT, 2017, ANAL METHODS-UK, V9, P4070, DOI 10.1039/c7ay01294b
   Bradshaw R, 2017, ANALYST, V142, P1581, DOI 10.1039/c7an00218a
   Broseus J, 2010, FORENSIC SCI INT, V200, P87, DOI 10.1016/j.forsciint.2010.03.034
   Chandra S., 2017, BOT BIOTECHNOLOGY
   Cornett DS, 2007, NAT METHODS, V4, P828, DOI 10.1038/NMETH1094
   Correa DN, 2016, ANAL CHEM, V88, P2515, DOI 10.1021/acs.analchem.5b02397
   Cramer Rainer, 2016, ADV MALDI LASER INDU
   De Backer B, 2009, J CHROMATOGR B, V877, P4115, DOI 10.1016/j.jchromb.2009.11.004
   dos Santos NA, 2019, J BRAZIL CHEM SOC, V30, P60, DOI 10.21577/0103-5053.20180152
   ElSohly MA, 2005, LIFE SCI, V78, P539, DOI 10.1016/j.lfs.2005.09.011
   Elsohly MA, 2007, MARIJUANA CANNABINOI
   Eriksson Cecilia, 2013, Mass Spectrom (Tokyo), V2, pS0022, DOI 10.5702/massspectrometry.S0022
   Esquenazi E, 2009, NAT PROD REP, V26, P1521, DOI 10.1039/b915674g
   Fiehn O., 2002, METABOLOMICSTHE LINK
   Gottardo R, 2012, J MASS SPECTROM, V47, P141, DOI 10.1002/jms.2036
   Grassl J, 2011, PLANT METHODS, V7, DOI 10.1186/1746-4811-7-21
   Groeneveld G, 2015, SCI REP-UK, V5, DOI 10.1038/srep11716
   Hillenkamp F, 2013, MALDI MS PRACTICAL G
   Horn PJ, 2013, PLANT J, V76, P138, DOI 10.1111/tpj.12278
   Horn PJ, 2013, PLANT PHYSIOL, V162, P1926, DOI 10.1104/pp.113.222455
   Hsieh Yunsheng, 2007, Journal of Pharmacological and Toxicological Methods, V55, P193, DOI 10.1016/j.vascn.2006.06.004
   Hunt NJ, 2016, J PROTEOMICS, V138, P48, DOI 10.1016/j.jprot.2016.02.022
   KARAS M, 1987, INT J MASS SPECTROM, V78, P53, DOI 10.1016/0168-1176(87)87041-6
   Kaspar S, 2011, PROTEOMICS, V11, P1840, DOI 10.1002/pmic.201000756
   Kuwayama K, 2014, ANAL BIOANAL CHEM, V406, P4789, DOI 10.1007/s00216-014-7881-x
   Lee YJ, 2012, PLANT J, V70, P81, DOI 10.1111/j.1365-313X.2012.04899.x
   Li C, 2014, ANAL BIOANAL CHEM, V406, P171, DOI 10.1007/s00216-013-7444-6
   Lindholst C, 2010, AUST J FORENSIC SCI, V42, P181, DOI 10.1080/00450610903258144
   Lopes AA, 2013, CHEM COMMUN, V49, P9989, DOI 10.1039/c3cc46213g
   LYDON J, 1987, PHOTOCHEM PHOTOBIOL, V46, P201, DOI 10.1111/j.1751-1097.1987.tb04757.x
   Mariotti KD, 2016, SCI JUSTICE, V56, P35, DOI 10.1016/j.scijus.2015.09.002
   Musshoff F, 2013, DRUG TEST ANAL, V5, P361, DOI 10.1002/dta.1453
   Paolino MC, 2016, EXPERT REV NEUROTHER, V16, P17, DOI 10.1586/14737175.2016.1121098
   Pirman DA, 2013, ANAL CHEM, V85, P1090, DOI 10.1021/ac3029618
   Pirman DA, 2013, ANAL CHEM, V85, P1081, DOI 10.1021/ac302960j
   Radwan MM, 2015, J NAT PROD, V78, P1271, DOI 10.1021/acs.jnatprod.5b00065
   Raharjo T. J., 2014, J BIOMOL TECH, V15, P97
   Rompp A, 2013, HISTOCHEM CELL BIOL, V139, P759, DOI 10.1007/s00418-013-1097-6
   Schwartz SA, 2003, J MASS SPECTROM, V38, P699, DOI 10.1002/jms.505
   Silva R, 2016, PLANTA MED, V82, P671, DOI 10.1055/s-0042-104800
   Sirikantaramas S, 2004, J BIOL CHEM, V279, P39767, DOI 10.1074/jbc.M403693200
   Takats Z, 2004, SCIENCE, V306, P471, DOI 10.1126/science.1104404
   Thakur GA, 2005, LIFE SCI, V78, P454, DOI 10.1016/j.lfs.2005.09.014
   Vanhove W, 2011, FORENSIC SCI INT, V212, P158, DOI 10.1016/j.forsciint.2011.06.006
   Weyermann C, 2006, J AM SOC MASS SPECTR, V17, P297, DOI 10.1016/j.jasms.2005.11.010
   Zaima N, 2010, RAPID COMMUN MASS SP, V24, P2723, DOI 10.1002/rcm.4693
NR 49
TC 1
Z9 1
U1 1
U2 18
PU ROYAL SOC CHEMISTRY
PI CAMBRIDGE
PA THOMAS GRAHAM HOUSE, SCIENCE PARK, MILTON RD, CAMBRIDGE CB4 0WF, CAMBS,
   ENGLAND
SN 1759-9660
EI 1759-9679
J9 ANAL METHODS-UK
JI Anal. Methods
PD APR 7
PY 2019
VL 11
IS 13
BP 1757
EP 1764
DI 10.1039/c9ay00226j
PG 8
WC Chemistry, Analytical; Food Science & Technology; Spectroscopy
SC Chemistry; Food Science & Technology; Spectroscopy
GA HR1EC
UT WOS:000462870500004
DA 2020-12-17
ER

PT J
AU Oliveira, IA
   Pol-Fachin, L
   de Carvalho, ST
   Lins, RD
   Soares, TA
   Mohana-Borges, R
   Neves, JL
   Todeschini, AR
AF Oliveira, Isadora A.
   Pol-Fachin, Laercio
   de Carvalho, Sebastiao T.
   Lins, Roberto D.
   Soares, Thereza A.
   Mohana-Borges, Ronaldo
   Neves, Jorge L.
   Todeschini, Adriane R.
TI Duffy binding-like 1 alpha adhesin from Plasmodium falciparum recognizes
   ABH histo-blood group saccharide in a type specific manner
SO CARBOHYDRATE POLYMERS
LA English
DT Article
DE DBL1 alpha; Malaria; ABH histo-blood group antigens; PfEMP1;
   Glycoconjugate
ID MEMBRANE PROTEIN-1 PFEMP1; TRANSFER DIFFERENCE NMR; CEREBRAL MALARIA;
   MEDIATES BINDING; LIGAND; DOCKING; DOMAIN; CYTOADHERENCE; INFECTION;
   CHILDREN
AB The ability of erythrocytes, infected by Plasmodium falciparum, to adhere to endothelial cells (cytoadherence) and to capture uninfected erythrocyte (rosetting) is the leading cause of death by severe malaria. Evidences link the binding of the adhesin Duffy Binding Like1-alpha (DBL1 alpha) domain to the ABH histo-blood antigens with formation of rosettes. Inspired by this very close relationship between the disease susceptibility and individual blood type, here we investigate the structural requirements involved in the interaction of DBL1 alpha with A, B and H histo-blood determinants and their subtypes. Our results evidence the high preference of DBL1 alpha to A epitopes, in comparison to B and H epitopes. DBL1 alpha interacts with ABH epitopes in subtype specific manner, presenting a remarkable affinity for type 2 structures, Fuc alpha 1-2Gal beta 1-4GlcNAc beta 1, particularly the A2 epitope. The contacts made by DBL1 alpha binding pocket and the ABH histo-blood groups were mapped by theoretical methods and supported by NMR experiments.
C1 [Oliveira, Isadora A.; de Carvalho, Sebastiao T.; Todeschini, Adriane R.] Univ Fed Rio de Janeiro, Inst Biofis Carlos Chagas Filho, Lab Glicobiol Estrutural & Func, BR-21941902 Rio De Janeiro, RJ, Brazil.
   [Pol-Fachin, Laercio; Soares, Thereza A.; Neves, Jorge L.] Univ Fed Pernambuco, Dept Quim Fundamental, BR-50740560 Recife, PE, Brazil.
   [Pol-Fachin, Laercio; Lins, Roberto D.] Fundacao Oswaldo Cruz, Inst Aggeu Magalhaes, BR-50740465 Recife, PE, Brazil.
   [Mohana-Borges, Ronaldo] Univ Fed Rio de Janeiro, Inst Biofis Carlos Chagas Filho, Lab Genom Estrutural, BR-21941902 Rio De Janeiro, RJ, Brazil.
RP Todeschini, AR (corresponding author), Univ Fed Rio de Janeiro, Inst Biofis Carlos Chagas Filho, Bloco D Sala 03 CCS, BR-21941902 Rio de Janeiro, RJ, Brazil.
EM adrianet@biof.ufrj.br
RI Todeschini, Adriane/AAG-8128-2020; Lins, Roberto D/J-7511-2012; Soares,
   Thereza A./M-9962-2019; Soares, Thereza A./G-1065-2010; Borges, Ronaldo
   S Mohana/C-5575-2013; Neves, Jorge Luiz JL/F-8393-2010; Todeschini,
   Adriane Regina/ABC-9165-2020
OI Lins, Roberto D/0000-0002-3983-8025; Soares, Thereza
   A./0000-0002-5891-6906; Soares, Thereza A./0000-0002-5891-6906; Neves,
   Jorge Luiz JL/0000-0003-3853-4529; Todeschini, Adriane
   Regina/0000-0002-6049-2751; Oliveira, Isadora/0000-0003-0269-1450
FU Fundacao de Amparo a Ciencia e Tecnologia do Estado de Pernambuco
   [APQ-0398-1.06/13]; Coordenacao de Aperfeicoamento de Pessoal de Nivel
   SuperiorCAPES; Conselho Nacional de Desenvolvimento Cientifico e
   TecnologicoNational Council for Scientific and Technological Development
   (CNPq); Fundacao Carlos Chagas Filho de Amparo a Pesquisa do Estado do
   Rio de Janeiro
FX This work was supported by grants from Conselho Nacional de
   Desenvolvimento Cientifico e Tecnologico, Fundacao Carlos Chagas Filho
   de Amparo a Pesquisa do Estado do Rio de Janeiro, Fundacao de Amparo a
   Ciencia e Tecnologia do Estado de Pernambuco (APQ-0398-1.06/13) and
   Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior. We thank
   Centro Nacional de Ressonancia Magnetica Nuclear (Rio de Janeiro,
   Brazil) for the use of the NMR faciliteis and Plataforma de Expressao e
   Purificacao de Proteinas com Interesse Biotecnologico (PEPIBiotec,
   UFRJ).
CR Ahuja S, 2006, MALARIA J, V5, DOI 10.1186/1475-2875-5-52
   Arda A, 2018, CHEM COMMUN, V54, P4761, DOI 10.1039/c8cc01444b
   Assrir N, 2014, BIOCHIMIE, V97, P39, DOI 10.1016/j.biochi.2013.09.011
   ATHREYA BH, 1967, AM J EPIDEMIOL, V86, P292, DOI 10.1093/oxfordjournals.aje.a120739
   Barragan A, 2000, BLOOD, V95, P3594, DOI 10.1182/blood.V95.11.3594.011k21_3594_3599
   Chen Q, 1998, J EXP MED, V187, P15, DOI 10.1084/jem.187.1.15
   Chen QJ, 2000, J EXP MED, V192, P1, DOI 10.1084/jem.192.1.1
   Chung WY, 2005, MOL BIOCHEM PARASIT, V144, P128, DOI 10.1016/j.molbiopara.2005.08.004
   CLAUSEN H, 1989, VOX SANG, V56, P1, DOI 10.1111/j.1423-0410.1989.tb03040.x
   Clausen TM, 2012, J BIOL CHEM, V287, P23332, DOI 10.1074/jbc.M112.348839
   Cohen M, 2009, BLOOD, V114, P3668, DOI 10.1182/blood-2009-06-227041
   Cooling L, 2015, CLIN MICROBIOL REV, V28, P801, DOI 10.1128/CMR.00109-14
   Cserti CM, 2007, BLOOD, V110, P2250, DOI 10.1182/blood-2007-03-077602
   Dahlback M, 2010, TRENDS PARASITOL, V26, P230, DOI 10.1016/j.pt.2010.02.002
   Dai MX, 2010, MICROBES INFECT, V12, P1198, DOI 10.1016/j.micinf.2010.08.006
   DAVID PH, 1988, AM J TROP MED HYG, V38, P289, DOI 10.4269/ajtmh.1988.38.289
   Fodjo BAY, 2016, MALARIA J, V15, DOI 10.1186/s12936-016-1585-y
   GOODFORD PJ, 1985, J MED CHEM, V28, P849, DOI 10.1021/jm00145a002
   Hackett MJ, 2012, ACS CHEM NEUROSCI, V3, P1017, DOI 10.1021/cn300093g
   Hakomori S, 1999, BBA-GEN SUBJECTS, V1473, P247, DOI 10.1016/S0304-4165(99)00183-X
   Idro R, 2010, PEDIATR RES, V68, P267, DOI 10.1203/00006450-201011001-00524
   Idro Richard, 2010, BMC Res Notes, V3, P104, DOI 10.1186/1756-0500-3-104
   Idro R, 2010, J CHILD NEUROL, V25, P518, DOI 10.1177/0883073809357792
   John CC, 2008, PEDIATRICS, V122, pE92, DOI 10.1542/peds.2007-3709
   Juillerat A, 2011, P NATL ACAD SCI USA, V108, P5243, DOI 10.1073/pnas.1018692108
   Juillerat A, 2010, MOL BIOCHEM PARASIT, V170, P84, DOI 10.1016/j.molbiopara.2009.12.008
   Koscielak J, 2001, TRANSFUSION MED, V11, P267, DOI 10.1046/j.1365-3148.2001.00317.x
   Kraemer SM, 2006, CURR OPIN MICROBIOL, V9, P374, DOI 10.1016/j.mib.2006.06.006
   Kyriacou HM, 2006, MOL BIOCHEM PARASIT, V150, P211, DOI 10.1016/j.molbiopara.2006.08.005
   LASKOWSKI RA, 1993, J APPL CRYSTALLOGR, V26, P283, DOI 10.1107/S0021889892009944
   Lepre CA, 2004, CHEM REV, V104, P3641, DOI 10.1021/cr030409h
   Lin WL, 2017, IMMUNOL CELL BIOL, V95, P372, DOI 10.1038/icb.2016.110
   Mayer M, 2001, J AM CHEM SOC, V123, P6108, DOI 10.1021/ja0100120
   Moll K, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0145120
   Morris GM, 2009, J COMPUT CHEM, V30, P2785, DOI 10.1002/jcc.21256
   Morris GM, 1998, J COMPUT CHEM, V19, P1639, DOI 10.1002/(SICI)1096-987X(19981115)19:14<1639::AID-JCC10>3.0.CO;2-B
   Mung'Ala-Odera V, 2004, AM J TROP MED HYG, V71, P64, DOI 10.4269/ajtmh.2004.71.64
   Olsson MHM, 2011, J CHEM THEORY COMPUT, V7, P525, DOI 10.1021/ct100578z
   Ravn V, 2000, APMIS, V108, P1, DOI 10.1034/j.1600-0463.2000.d01-1.x
   ROWE A, 1995, INFECT IMMUN, V63, P2323, DOI 10.1128/IAI.63.6.2323-2326.1995
   Sanchez R, 2000, NUCLEIC ACIDS RES, V28, P250, DOI 10.1093/nar/28.1.250
   Sanner MF, 1999, J MOL GRAPH MODEL, V17, P57
   Shi CS, 2008, BLOOD, V112, P3661, DOI 10.1182/blood-2008-03-142760
   Siriwardhana C, 2017, MALARIA J, V16, DOI 10.1186/s12936-017-2041-3
   Soares TA, 2000, J MOL RECOGNIT, V13, P146, DOI 10.1002/1099-1352(200005/06)13:3<146::AID-JMR497>3.0.CO;2-4
   Soares TA, 1999, BIOPOLYMERS, V50, P319, DOI 10.1002/(SICI)1097-0282(199909)50:3<319::AID-BIP7>3.0.CO;2-8
   SU XZ, 1995, CELL, V82, P89, DOI 10.1016/0092-8674(95)90055-1
   SZULMAN AE, 1960, J EXP MED, V111, P785, DOI 10.1084/jem.111.6.785
   Todeschini AR, 2004, J BIOL CHEM, V279, P5323, DOI 10.1074/jbc.M310663200
   UDOMSANGPETCH R, 1993, AM J TROP MED HYG, V48, P149, DOI 10.4269/ajtmh.1993.48.149
   Uneke CJ, 2007, PARASITOL RES, V100, P759, DOI 10.1007/s00436-006-0342-5
   Vigan-Womas I, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002781
   WALLACE AC, 1995, PROTEIN ENG, V8, P127, DOI 10.1093/protein/8.2.127
   Wang MM, 2013, NEUROREPORT, V24, P79, DOI 10.1097/WNR.0b013e32835c93a2
   WEINER SJ, 1986, J COMPUT CHEM, V7, P230, DOI 10.1002/jcc.540070216
   Whitmore L, 2004, NUCLEIC ACIDS RES, V32, pW668, DOI 10.1093/nar/gkh371
   [WHO] World Health Organization, 2016, WORLD MALARIA REPORT
   Wolofsky KT, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002942
NR 58
TC 0
Z9 0
U1 0
U2 8
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 0144-8617
EI 1879-1344
J9 CARBOHYD POLYM
JI Carbohydr. Polym.
PD MAR 1
PY 2019
VL 207
BP 266
EP 275
DI 10.1016/j.carbpol.2018.11.082
PG 10
WC Chemistry, Applied; Chemistry, Organic; Polymer Science
SC Chemistry; Polymer Science
GA HF9BW
UT WOS:000454537500029
PM 30600009
DA 2020-12-17
ER

PT J
AU Figueira-Mansur, J
   Aguilera, EA
   Stoque, RM
   Ventura, GT
   Mohana-Borges, R
AF Figueira-Mansur, Janaina
   Aguilera, Estefania A.
   Stoque, Rafael M.
   Ventura, Gustavo T.
   Mohana-Borges, Ronaldo
TI Mutations in the dimer interfaces of the dengue virus capsid protein
   affect structural stability and impair RNA-capsid interaction
SO SCIENTIFIC REPORTS
LA English
DT Article
ID BINDING
AB The dengue virus 2 capsid protein (DENV2C) plays a primary structural role in the protection of the viral genome and is crucial for nucleocapsid assembly. In this study, we generated single mutants of DENV2C at L50 and L54 residues of the alpha 2 helix, which was shown to interfere with the integration of the capsid into lipid droplets, and at residues L81 and I88 located in the alpha 4 helix, which was shown to affect viral assembly. We demonstrated that the oligomeric states of DENV2C and its mutants exist primarily in the dimeric state in solution. All single-point mutations introduced in DENV2C promoted reduction in protein stability, an effect that was more pronounced for the L81N and I88N mutants, but not protein unfolding. All the single-point mutations affected the ability of DEN2C to interact with RNA. We concluded that mutations in the alpha 2-alpha 2' and alpha 4-alpha 4' dimer interfaces of DENV2C affect the structural stability of the protein and impair RNA-capsid interaction. These effects were more pronounced for mutations at the L81 and I88 residues in the alpha 4 helix. These results indicate the importance of the alpha 4-alpha 4' dimer interface, which could be studied as a potential target for drug design in the future.
C1 [Figueira-Mansur, Janaina; Aguilera, Estefania A.; Stoque, Rafael M.; Ventura, Gustavo T.; Mohana-Borges, Ronaldo] Univ Fed Rio de Janeiro, Inst Biofis Carlos Chagas Filho, Lab Genom Estrutural, Rio De Janeiro, Brazil.
RP Mohana-Borges, R (corresponding author), Univ Fed Rio de Janeiro, Inst Biofis Carlos Chagas Filho, Lab Genom Estrutural, Rio De Janeiro, Brazil.
EM mohana@biof.ufrj.br
RI Borges, Ronaldo S Mohana/C-5575-2013
FU Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq,
   Brazil)National Council for Scientific and Technological Development
   (CNPq); Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior
   (CAPES, Brazil)CAPES [001]; Fundacao Carlos Chagas Filho de Amparo a
   Pesquisa do Estado do Rio de Janeiro (FAPERJ, Brazil)Carlos Chagas Filho
   Foundation for Research Support of the State of Rio de Janeiro (FAPERJ);
   International Centre for Genetic Engineering and Biotechnology (ICGEB,
   Triste, Italy)
FX Studies were supported by Conselho Nacional de Desenvolvimento
   Cientifico e Tecnologico (CNPq, Brazil), Coordenacao de Aperfeicoamento
   de Pessoal de Nivel Superior, Finance Code 001 (CAPES, Brazil), Fundacao
   Carlos Chagas Filho de Amparo a Pesquisa do Estado do Rio de Janeiro
   (FAPERJ, Brazil) and International Centre for Genetic Engineering and
   Biotechnology (ICGEB, Triste, Italy). The NMR experiments were carried
   out at the National Center for Bioimaging (CENABIO-UFRJ).
CR Belgrano FS, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0079572
   Bhatt S, 2013, NATURE, V496, P504, DOI 10.1038/nature12060
   Brady OJ, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001760
   Carvalho FA, 2012, J VIROL, V86, P2096, DOI 10.1128/JVI.06796-11
   Diamond MS, 2015, CELL, V162, P488, DOI 10.1016/j.cell.2015.07.005
   Faustino AF, 2015, ACS CHEM BIOL, V10, P517, DOI 10.1021/cb500640t
   Faustino AF, 2014, NANOMED-NANOTECHNOL, V10, P247, DOI 10.1016/j.nano.2013.06.004
   Fischl W, 2011, CURR OPIN MICROBIOL, V14, P470, DOI 10.1016/j.mib.2011.07.012
   Freire J. M., 2005, J VIROL, V282, P6631
   Jones CT, 2003, J VIROL, V77, P7143, DOI 10.1128/JVI.77.12.7143-7149.2003
   Kuhn RJ, 2002, CELL, V108, P717, DOI 10.1016/S0092-8674(02)00660-8
   Kuno G, 1998, J VIROL, V72, P73, DOI 10.1128/JVI.72.1.73-83.1998
   Lakowicz J. R., 2013, FLUORESCENCE POLARIZ, P111
   Lindenbach B., 2013, FIELDS VIROLOGY, V1, P712
   Ma LX, 2004, P NATL ACAD SCI USA, V101, P3414, DOI 10.1073/pnas.0305892101
   Markoff L, 1997, VIROLOGY, V233, P105, DOI 10.1006/viro.1997.8608
   Martins IC, 2012, BIOCHEM J, V444, P405, DOI 10.1042/BJ20112219
   Mohana-Borges R, 2004, J MOL BIOL, V340, P1131, DOI 10.1016/j.jmb.2004.05.022
   Oliveira ERA, 2017, VIRUS RES, V227, P115, DOI 10.1016/j.virusres.2016.10.005
   Pace CN, 2000, PROTEINS, P1
   Patkar CG, 2007, J VIROL, V81, P6471, DOI 10.1128/JVI.02120-06
   Pong WL, 2011, FEBS LETT, V585, P2575, DOI 10.1016/j.febslet.2011.06.038
   Samsa MM, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000632
   Schwarzinger S, 2002, BIOCHEMISTRY-US, V41, P12681, DOI 10.1021/bi020381o
   Ventura GT, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0115941
   Willows S, 2013, FUTURE VIROL, V8, P435, DOI 10.2217/FVL.13.32
   World Health Organisation, 2016, DRAFT GLOB HLTH SECT, P1
   Zhan CY, 2013, BIOORGAN MED CHEM, V21, P3443, DOI 10.1016/j.bmc.2013.04.035
NR 28
TC 2
Z9 2
U1 0
U2 2
PU NATURE PUBLISHING GROUP
PI LONDON
PA MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND
SN 2045-2322
J9 SCI REP-UK
JI Sci Rep
PD FEB 26
PY 2019
VL 9
AR 2829
DI 10.1038/s41598-019-39185-3
PG 14
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA HM7ZT
UT WOS:000459698900090
PM 30808916
OA DOAJ Gold, Green Published
DA 2020-12-17
ER

PT J
AU Silva, EM
   Conde, JN
   Allonso, D
   Ventura, GT
   Coelho, DR
   Carneiro, PH
   Silva, ML
   Paes, MV
   Rabelo, K
   Weissmuller, G
   Bisch, PM
   Mohana-Borges, R
AF Silva, Emiliana M.
   Conde, Jonas N.
   Allonso, Diego
   Ventura, Gustavo T.
   Coelho, Diego R.
   Carneiro, Pedro Henrique
   Silva, Manuela L.
   Paes, Marciano, V
   Rabelo, Kissila
   Weissmuller, Gilberto
   Bisch, Paulo Mascarello
   Mohana-Borges, Ronaldo
TI Dengue virus nonstructural 3 protein interacts directly with human
   glyceraldehyde-3-phosphate dehydrogenase (GAPDH) and reduces its
   glycolytic activity
SO SCIENTIFIC REPORTS
LA English
DT Article
ID NS3 PROTEIN; MEMBRANE TOPOLOGY; SECONDARY STRUCTURE; MESSENGER-RNA;
   EXPRESSION; PREDICTION; BINDING; CELLS; FLAVIVIRUSES; INHIBITORS
AB Dengue is an important mosquito-borne disease and a global public health problem. The disease is caused by dengue virus (DENV), which is a member of the Flaviviridae family and contains a positive single-stranded RNA genome that encodes a single precursor polyprotein that is further cleaved into structural and non-structural proteins. Among these proteins, the non-structural 3 (NS3) protein is very important because it forms a non-covalent complex with the NS2B cofactor, thereby forming the functional viral protease. NS3 also contains a C-terminal ATPase/helicase domain that is essential for RNA replication. Here, we identified 47 NS3-interacting partners using the yeast two-hybrid system. Among those partners, we highlight several proteins involved in host energy metabolism, such as apolipoprotein H, aldolase B, cytochrome C oxidase and glyceraldehyde-3-phosphate dehydrogenase (GAPDH). GAPDH directly binds full-length NS3 and its isolated helicase and protease domains. Moreover, we observed an intense colocalization between the GAPDH and NS3 proteins in DENV2-infected Huh7.5.1 cells, in NS3-transfected BHK-21 cells and in hepatic tissue from a fatal dengue case. Taken together, these results suggest that the human GAPDH-DENV NS3 interaction is involved in hepatic metabolic alterations, which may contribute to the appearance of steatosis in dengue-infected patients. The interaction between GAPDH and full-length NS3 or its helicase domain in vitro as well as in NS3-transfected cells resulted in decreased GAPDH glycolytic activity. Reduced GAPDH glycolytic activity may lead to the accumulation of metabolic intermediates, shifting metabolism to alternative, non-glycolytic pathways. This report is the first to identify the interaction of the DENV2 NS3 protein with the GAPDH protein and to demonstrate that this interaction may play an important role in the molecular mechanism that triggers hepatic alterations.
C1 [Silva, Emiliana M.; Conde, Jonas N.; Ventura, Gustavo T.; Coelho, Diego R.; Carneiro, Pedro Henrique; Mohana-Borges, Ronaldo] Univ Fed Rio de Janeiro, Inst Biofis Carlos Chagas Filho, Lab Genom Estrut, BR-21941590 Rio De Janeiro, RJ, Brazil.
   [Allonso, Diego] Univ Fed Rio de Janeiro, Fac Farm, Dept Biotecnol Farmaceut, Rio De Janeiro, RJ, Brazil.
   [Silva, Manuela L.] Univ Fed Rio de Janeiro, Inst Biodiversidade & Sustentabilidade NUPEM UFR, Macae, RJ, Brazil.
   [Paes, Marciano, V] Fundacao Oswaldo Cruz, Lab Interdisciplinar Pesquisa Med, Inst Oswaldo Cruz, Rio De Janeiro, RJ, Brazil.
   [Rabelo, Kissila] Univ Estado Rio De Janeiro, Lab Ultraestrut & Biol Tecidual, Rio De Janeiro, RJ, Brazil.
   [Weissmuller, Gilberto; Bisch, Paulo Mascarello] Univ Fed Rio de Janeiro, Inst Biofis Carlos Chagas Filho, Lab Fis Biol, BR-21941590 Rio De Janeiro, RJ, Brazil.
RP Mohana-Borges, R (corresponding author), Univ Fed Rio de Janeiro, Inst Biofis Carlos Chagas Filho, Lab Genom Estrut, BR-21941590 Rio De Janeiro, RJ, Brazil.
EM mohana@biof.ufrj.br
RI da Silva, Manuela Leal/AAK-8760-2020; Allonso, Diego/Y-3446-2018;
   Borges, Ronaldo S Mohana/C-5575-2013
OI da Silva, Manuela Leal/0000-0003-4844-7138; Allonso,
   Diego/0000-0002-1410-480X; Rabelo, Kissila/0000-0001-7579-7788;
   Weissmuller, Gilberto/0000-0002-0345-7335; Paes,
   Marciano/0000-0002-2266-2801
FU Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq,
   Brazil)National Council for Scientific and Technological Development
   (CNPq); Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior
   (CAPES, Brazil)CAPES [001]; Fundacao Carlos Chagas Filho de Amparo a
   Pesquisa do Estado do Rio de Janeiro (FAPERJ, Brazil)Carlos Chagas Filho
   Foundation for Research Support of the State of Rio de Janeiro (FAPERJ);
   National Institutes of Science and Technology in Structural Biology and
   Bioimaging (INCT-INBEB); FINEP (GENOPROT Dengue)Ciencia Tecnologia e
   Inovacao (FINEP); International Centre for Genetic Engineering and
   Biotechnology (ICGEB, Triste, Italy)
FX This work was supported by the following funding agencies: Conselho
   Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq, Brazil),
   Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior, Finance
   Code 001 (CAPES, Brazil), Fundacao Carlos Chagas Filho de Amparo a
   Pesquisa do Estado do Rio de Janeiro (FAPERJ, Brazil), the National
   Institutes of Science and Technology in Structural Biology and
   Bioimaging (INCT-INBEB), FINEP (GENOPROT Dengue), and International
   Centre for Genetic Engineering and Biotechnology (ICGEB, Triste, Italy).
   The funders had no role in study design, data collection and analysis,
   publishing decisions, or manuscript preparation. We thank Grasiela for
   her technical assistance and Iamara S. Andrade for her assistance with
   cell culture. We would also like to thank the Genomic Platform for DNA
   sequencing of PDTIS/FIOCRUZ.
CR Allonso D, 2015, J VIROL, V89, P11871, DOI 10.1128/JVI.01342-15
   Belon CA, 2009, FUTURE VIROL, V4, P277, DOI 10.2217/FVL.09.7
   Bente Dennis A, 2006, Drug Discov Today Dis Models, V3, P97, DOI 10.1016/j.ddmod.2006.03.014
   Bhatt S, 2013, NATURE, V496, P504, DOI 10.1038/nature12060
   Bonafe N, 2005, CANCER RES, V65, P3762, DOI 10.1158/0008-5472.CAN-04-3954
   CHAMBERS TJ, 1990, ANNU REV MICROBIOL, V44, P649, DOI 10.1146/annurev.mi.44.100190.003245
   Chua JJE, 2004, VIRUS RES, V102, P151, DOI 10.1016/j.virusres.2004.01.025
   Comeau SR, 2004, BIOINFORMATICS, V20, P45, DOI 10.1093/bioinformatics/btg371
   Comeau SR, 2004, NUCLEIC ACIDS RES, V32, pW96, DOI 10.1093/nar/gkh354
   Cui TA, 1998, VIROLOGY, V246, P409, DOI 10.1006/viro.1998.9213
   da Costa ECB, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0082504
   Dastoor Z, 2001, J CELL SCI, V114, P1643
   De BP, 1996, J BIOL CHEM, V271, P24728, DOI 10.1074/jbc.271.40.24728
   DeLano W. L, 2002, PYMOL MOL GRAPHICS S
   El-Bacha T, 2007, BBA-MOL BASIS DIS, V1772, P1158, DOI 10.1016/j.bbadis.2007.08.003
   Eswar Narayanan, 2008, V426, P145, DOI 10.1007/978-1-60327-058-8_8
   Fiske CH, 1925, J BIOL CHEM, V66, P375
   Fontaine KA, 2015, J VIROL, V89, P2358, DOI 10.1128/JVI.02309-14
   Freire MS, 2007, MEM I OSWALDO CRUZ, V102, P203, DOI 10.1590/S0074-02762007005000011
   Gubler DJ, 1998, CLIN MICROBIOL REV, V11, P480, DOI 10.1128/CMR.11.3.480
   Gubler DJ, 2011, EXPERT REV VACCINES, V10, P563, DOI [10.1586/ERV.11.35, 10.1586/erv.11.35]
   Guy B, 2016, NAT REV MICROBIOL, V14, P45, DOI 10.1038/nrmicro.2015.2
   Guy B, 2011, VACCINE, V29, P7229, DOI 10.1016/j.vaccine.2011.06.094
   Guzman MG, 2015, LANCET, V385, P453, DOI 10.1016/S0140-6736(14)60572-9
   Hannibal L, 2012, BIOCHEMISTRY-US, V51, P8514, DOI 10.1021/bi300863a
   Hara MR, 2006, CELL MOL NEUROBIOL, V26, P527, DOI 10.1007/s10571-006-9011-6
   Heaton NS, 2010, P NATL ACAD SCI USA, V107, P17345, DOI 10.1073/pnas.1010811107
   Ikeda Y, 2012, ARCH BIOCHEM BIOPHYS, V528, P141, DOI 10.1016/j.abb.2012.09.004
   Ishitani R, 1996, P NATL ACAD SCI USA, V93, P9937, DOI 10.1073/pnas.93.18.9937
   Ishitani R, 1998, MOL PHARMACOL, V53, P701
   KARPEL RL, 1981, BIOCHIM BIOPHYS ACTA, V654, P256, DOI 10.1016/0005-2787(81)90180-5
   Khadka S, 2011, MOL CELL PROTEOMICS, V10, DOI [10.1074/mcp.M111.012187-1, 10.1074/mcp.M111.012187]
   Kondo S, 2011, BIOCHEM BIOPH RES CO, V405, P382, DOI 10.1016/j.bbrc.2011.01.034
   Kozakov D, 2006, PROTEINS, V65, P392, DOI 10.1002/prot.21117
   Kozakov D, 2013, PROTEINS, V81, P2159, DOI 10.1002/prot.24403
   Lamarre D, 2003, NATURE, V426, P186, DOI 10.1038/nature02099
   LASKOWSKI RA, 1993, J MOL BIOL, V231, P1049, DOI 10.1006/jmbi.1993.1351
   LASKOWSKI RA, 1993, J APPL CRYSTALLOGR, V26, P283, DOI 10.1107/S0021889892009944
   Lee D, 2007, NAT REV MOL CELL BIO, V8, P995, DOI 10.1038/nrm2281
   Lescar J, 2008, ANTIVIR RES, V80, P94, DOI 10.1016/j.antiviral.2008.07.001
   Leung D, 2001, J BIOL CHEM, V276, P45762, DOI 10.1074/jbc.M107360200
   Li Y., 2016, ANGEW CHEM INT EDIT, V128, P12247
   Li Y, 2018, BBA-BIOMEMBRANES, V1860, P442, DOI 10.1016/j.bbamem.2017.10.016
   Li Y, 2015, BBA-BIOMEMBRANES, V1848, P3150, DOI 10.1016/j.bbamem.2015.09.016
   Li Y, 2015, BBA-BIOMEMBRANES, V1848, P2244, DOI 10.1016/j.bbamem.2015.06.010
   Lindenbach B., 2013, FIELDS VIROLOGY, V1, P712
   Lindenbach BD, 2007, FIELDS VIROLOGY, P1101
   Luo D, 2008, J VIROL, V82, P173, DOI 10.1128/JVI.01788-07
   Luo DH, 2008, EMBO J, V27, P3209, DOI 10.1038/emboj.2008.232
   Marti-Renom MA, 2002, STRUCTURE, V10, P435, DOI 10.1016/S0969-2126(02)00731-1
   Martina BEE, 2009, CLIN MICROBIOL REV, V22, P564, DOI 10.1128/CMR.00035-09
   McGuffin LJ, 2000, BIOINFORMATICS, V16, P404, DOI 10.1093/bioinformatics/16.4.404
   Negi SS, 2007, BIOINFORMATICS, V23, P3397, DOI 10.1093/bioinformatics/btm474
   Ozbabacan SEA, 2011, PROTEIN ENG DES SEL, V24, P635, DOI 10.1093/protein/gzr025
   Perera R, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002584
   Povoa TF, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0083386
   Rabelo K, 2017, DATA BRIEF, V10, P248, DOI 10.1016/j.dib.2016.11.083
   Raj M, 2017, J GEN VIROL, V98, P977, DOI 10.1099/jgv.0.000754
   Ramirez R, 2014, VIRUS GENES, V49, P185, DOI 10.1007/s11262-014-1087-3
   SALI A, 1993, J MOL BIOL, V234, P779, DOI 10.1006/jmbi.1993.1626
   Schultz DE, 1996, J BIOL CHEM, V271, P14134, DOI 10.1074/jbc.271.24.14134
   Sirover MA, 1999, BBA-PROTEIN STRUCT M, V1432, P159, DOI 10.1016/S0167-4838(99)00119-3
   Sirover MA, 2014, INT J BIOCHEM CELL B, V57, P20, DOI 10.1016/j.biocel.2014.09.026
   Sirover MA, 2012, J CELL BIOCHEM, V113, P2193, DOI 10.1002/jcb.24113
   Tisdale EJ, 2001, J BIOL CHEM, V276, P2480, DOI 10.1074/jbc.M007567200
   Tristan C, 2011, CELL SIGNAL, V23, P317, DOI 10.1016/j.cellsig.2010.08.003
   WENGLER G, 1993, VIROLOGY, V197, P265, DOI 10.1006/viro.1993.1587
   WHO, 2009, WHO TECH REP SER, V958, P1
   Yang SH, 2009, J BIOMED SCI, V16, DOI 10.1186/1423-0127-16-40
NR 69
TC 6
Z9 6
U1 2
U2 4
PU NATURE PUBLISHING GROUP
PI LONDON
PA MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND
SN 2045-2322
J9 SCI REP-UK
JI Sci Rep
PD FEB 25
PY 2019
VL 9
AR 2651
DI 10.1038/s41598-019-39157-7
PG 19
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA HM6GC
UT WOS:000459571100015
PM 30804377
OA DOAJ Gold, Green Published
DA 2020-12-17
ER

PT J
AU da Silva, ICD
   Vicentino, ARR
   dos Santos, RC
   da Fonseca, RN
   Amarante, AD
   Carneiro, VC
   Pinto, MD
   Aguilera, EA
   Mohana-Borges, R
   Bisch, PM
   da Silva-Neto, MAC
   Fantappie, MR
AF de Abreu da Silva, Isabel Caetano
   Revoredo Vicentino, Amanda Roberta
   dos Santos, Renata Coutinho
   da Fonseca, Rodrigo Nunes
   Amarante, Anderson de Mendonca
   Carneiro, Vitor Coutinho
   Pinto, Marcia de Amorim
   Aguilera, Estefania Anahi
   Mohana-Borges, Ronaldo
   Bisch, Paulo Mascarello
   Cardoso da Silva-Neto, Mario Alberto
   Fantappie, Marcelo Rosado
TI Molecular and functional characterization of single-box high-mobility
   group B (HMGB) chromosomal protein from Aedes aegypti
SO GENE
LA English
DT Article
DE Aedes aegypti; HMG-box proteins; Embryogenesis; Nucleic acid binding;
   Phosphorylation
ID DNA-BINDING PROPERTIES; STRUCTURAL BASIS; ACIDIC TAIL; DOMAIN;
   CHROMATIN; GENE; DSP1
AB High-mobility group B (HMGB) proteins have highly conserved, unique DNA-binding domains, HMG boxes, that can bind non-B-type DNA structures, such as bent, kinked and unwound structures, with high affinity. HMGB proteins also promote DNA bending, looping and unwinding. In this study, we determined the role of the Aedes aegypti single HMG-box domain protein A alpha HMGB; characterized its structure, spatiotemporal expression levels, subcellular localization, and nucleic acid binding activities; and compared these properties with those of its double-HMG-box counterpart protein, A alpha HMGB1. Via qRT-PCR, we showed that A alpha HMGB is expressed at much higher levels than A alpha HMGB1 throughout mosquito development. In situ hybridization results suggested a role for A alpha HMGB and A alpha HMGB1 during embryogenesis. Immunolocalization in the midgut revealed that A alpha HMGB is exclusively nuclear. Circular dichroism and fluorescence spectroscopy analyses showed that A alpha HMGB exhibits common features of alpha-helical structures and is more stably folded than A alpha HMGB1, likely due to the presence of one or two HMG boxes. Using several DNA substrates or single-stranded RNAs as probes, we observed significant differences between A alpha HMGB and A alpha HMGB1 in terms of their binding patterns, activity and/or specificity. Importantly, we showed that the phosphorylation of A alpha HMGB plays a critical role in its DNA-binding activity. Our study provides additional insight into the roles of single- versus double-HMG-box-containing proteins in nucleic acid interactions for better understanding of mosquito development, physiology and homeostasis.
C1 [de Abreu da Silva, Isabel Caetano; Revoredo Vicentino, Amanda Roberta; Amarante, Anderson de Mendonca; Carneiro, Vitor Coutinho; Pinto, Marcia de Amorim; Cardoso da Silva-Neto, Mario Alberto; Fantappie, Marcelo Rosado] INCT EM, Inst Bioquim Med Leopoldo de Meis, Brasilia, DF, Brazil.
   [dos Santos, Renata Coutinho; da Fonseca, Rodrigo Nunes] Nucleo Ecol & Desenvolvimento Socio Ambiental Mac, Macae, RJ, Brazil.
   [Aguilera, Estefania Anahi; Mohana-Borges, Ronaldo; Bisch, Paulo Mascarello] Univ Fed Rio de Janeiro, Inst Biofis Carlos Chagas Filho, Rio De Janeiro, RJ, Brazil.
RP Fantappie, MR (corresponding author), Univ Fed Rio de Janeiro, Inst Bioquim Med Leopoldo de Meis, CCS, BR-21941902 Rio De Janeiro, RJ, Brazil.
EM fantappie@bioqmed.ufrj.br
RI Borges, Ronaldo S Mohana/C-5575-2013; Nunes-da-Fonseca,
   Rodrigo/S-3964-2018
OI Carneiro, Vitor/0000-0003-1518-7667; Nunes-da-Fonseca,
   Rodrigo/0000-0001-9576-2849
FU Conselho Nacional de Desenvolvimento Cientifico e TecnologicoNational
   Council for Scientific and Technological Development (CNPq)
   [470099/20143]; Fundacao de Amparo a Pesquisa do Estado do Rio de
   JaneiroCarlos Chagas Filho Foundation for Research Support of the State
   of Rio de Janeiro (FAPERJ) [E-26/202990/2015]; Instituto Nacional de
   Ciencia e Tecnologia em Entomologia Molecular [573959/2008-0]
FX This work was supported by Conselho Nacional de Desenvolvimento
   Cientifico e Tecnologico (grant number 470099/20143), Fundacao de Amparo
   a Pesquisa do Estado do Rio de Janeiro (grant number E-26/202990/2015)
   and Instituto Nacional de Ciencia e Tecnologia em Entomologia Molecular
   (grant number 573959/2008-0).
CR Amarante AD, 2017, INSECT BIOCHEM MOLEC, V80, P32, DOI 10.1016/j.ibmb.2016.11.006
   Ba ANN, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-202
   de Oliveira FMB, 2006, GENE, V377, P33, DOI 10.1016/j.gene.2006.03.001
   Belgrano F. S., 2013, PLOS ONE, V8, DOI [10.1371/JOUMAL.PONE.0079572, DOI 10.1371/JOUMAL.PONE.0079572]
   Bianchi ME, 2005, CURR OPIN GENET DEV, V15, P496, DOI 10.1016/j.gde.2005.08.007
   Bustin M, 1999, MOL CELL BIOL, V19, P5237
   Bustin M, 1996, PROG NUCLEIC ACID RE, V54, P35, DOI 10.1016/S0079-6603(08)60360-8
   Calogero S, 1999, NAT GENET, V22, P276, DOI 10.1038/10338
   Celona B, 2011, PLOS BIOL, V9, DOI 10.1371/journal.pbio.1001086
   da Fonseca RN, 2008, DEV CELL, V14, P605, DOI 10.1016/j.devcel.2008.02.011
   Grasser KD, 2007, BBA-GENE STRUCT EXPR, V1769, P346, DOI 10.1016/j.bbaexp.2006.12.004
   Hardman CH, 1995, BIOCHEMISTRY-US, V34, P16596, DOI 10.1021/bi00051a007
   Haugen Morgan, 2010, Cold Spring Harb Protoc, V2010, DOI 10.1101/pdb.prot5509
   Janke C, 2003, J BIOCHEM, V133, P533, DOI 10.1093/jb/mvg063
   Lakowicz J. R., 2006, PRINCIPLES FLUORESCE, DOI 10.1007/978-0-387-46312-4
   Li YP, 2005, J BIOL CHEM, V280, P11869, DOI 10.1074/jbc.M413944200
   LOVE JJ, 1995, NATURE, V376, P791, DOI 10.1038/376791a0
   Lynch JA, 2010, CURR BIOL, V20, P1042, DOI 10.1016/j.cub.2010.04.023
   Masse JE, 2002, J MOL BIOL, V323, P263, DOI 10.1016/S0022-2836(02)00938-5
   Mosrin-Huaman C, 1998, DEV GENET, V23, P324
   Murphy EC, 2001, J MOL BIOL, V312, P481, DOI 10.1006/jmbi.2001.4977
   Murphy FV, 1999, ACTA CRYSTALLOGR D, V55, P1594, DOI 10.1107/S0907444999008240
   NER SS, 1994, EMBO J, V13, P1817, DOI 10.1002/j.1460-2075.1994.tb06450.x
   Ohndorf UM, 1999, NATURE, V399, P708, DOI 10.1038/21460
   Payet D, 1997, J MOL BIOL, V266, P66, DOI 10.1006/jmbi.1996.0782
   RAMINANI L N, 1975, International Journal of Insect Morphology and Embryology, V4, P517, DOI 10.1016/0020-7322(75)90028-8
   READ CM, 1993, NUCLEIC ACIDS RES, V21, P3427, DOI 10.1093/nar/21.15.3427
   Ribeiro FS, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040192
   Rowell JP, 2012, STRUCTURE, V20, P2014, DOI 10.1016/j.str.2012.09.004
   Sim S, 2013, PLOS NEGLECT TROP D, V7, DOI 10.1371/journal.pntd.0002295
   Stott K, 2014, J BIOL CHEM, V289, P29817, DOI 10.1074/jbc.M114.591115
   Stros M, 1998, EUR J BIOCHEM, V251, P427, DOI 10.1046/j.1432-1327.1998.2510427.x
   Stros M, 2007, CELL MOL LIFE SCI, V64, P2590, DOI 10.1007/s00018-007-7162-3
   Stros M, 1998, J BIOL CHEM, V273, P10355
   Stros M, 2000, J BIOL CHEM, V275, P35699, DOI 10.1074/jbc.M007167200
   Stros M, 2010, BBA-GENE REGUL MECH, V1799, P101, DOI 10.1016/j.bbagrm.2009.09.008
   Thomas JO, 2001, TRENDS BIOCHEM SCI, V26, P167, DOI 10.1016/S0968-0004(01)01801-1
   TRPIS M, 1970, CAN J ZOOLOG, V48, P892, DOI 10.1139/z70-158
   Vital W, 2010, BMC DEV BIOL, V10, DOI 10.1186/1471-213X-10-25
   WAGNER CR, 1992, MOL CELL BIOL, V12, P1915, DOI 10.1128/MCB.12.5.1915
   Watson M, 2007, J MOL BIOL, V374, P1286, DOI 10.1016/j.jmb.2007.09.075
   WEIR HM, 1993, EMBO J, V12, P1311, DOI 10.1002/j.1460-2075.1993.tb05776.x
   Wisniewski JR, 1999, J BIOL CHEM, V274, P20116
   WISNIEWSKI JR, 1994, EUR J BIOCHEM, V225, P687, DOI 10.1111/j.1432-1033.1994.00687.x
NR 44
TC 0
Z9 0
U1 0
U2 10
PU ELSEVIER
PI AMSTERDAM
PA RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS
SN 0378-1119
EI 1879-0038
J9 GENE
JI Gene
PD SEP 10
PY 2018
VL 671
BP 152
EP 160
DI 10.1016/j.gene.2018.05.103
PG 9
WC Genetics & Heredity
SC Genetics & Heredity
GA GO0YK
UT WOS:000439672400018
PM 29859286
DA 2020-12-17
ER

PT J
AU Joao, EAC
   Ferreira, OD
   Gouvea, MI
   Teixeira, MDB
   Tanuri, A
   Higa, LM
   Costa, DA
   Mohana-Borges, R
   Arruda, MB
   Matos, HJ
   Cruz, ML
   Mendes-Silva, W
   Read, JS
AF Joao, Esau A. C.
   Ferreira, Orlando da C., Jr.
   Gouvea, Maria Isabel
   Teixeira, Maria de Lourdes B.
   Tanuri, Amilcar
   Higa, Luiza M.
   Costa, Deise A.
   Mohana-Borges, Ronaldo
   Arruda, Monica B.
   Matos, Haroldo J.
   Cruz, Maria Leticia
   Mendes-Silva, Wallace
   Read, Jennifer S.
TI Pregnant women co-infected with HIV and Zika: Outcomes and birth defects
   in infants according to maternal symptomatology
SO PLOS ONE
LA English
DT Article
ID RIO-DE-JANEIRO; VIRUS-INFECTION; BRAZIL
AB Background
   Zika virus (ZIKV) was first isolated in Uganda in 1947. In Brazil, the first reported case of ZIKV infection was in May 2015. Additionally, dengue (DENV) is endemic and there has been a recent outbreak of chikungunya (CHIKV). Since the clinical manifestations of different arboviral infections (AI) can be similar, definitive diagnosis requires laboratory testing.
   Objectives
   To determine the prevalence of ZIKV, DENV, and CHIKV infections in a Brazilian cohort of HIV-infected pregnant women, to assess clinical/immunological characteristics and pregnancy outcomes of women with evidence of recent AI.
   Study design
   Laboratory diagnosis of ZIKV, DENV and CHIKV infections utilized serological assays, RT-PCR and PRNT. The tests were performed at the first visit, 34-36 weeks of gestation and at any time if a woman had symptoms suggestive of AI. Mann-Whitney tests were used for comparison of medians, Chi-square or Fisher's to compare proportions; p<0.05 was considered statistically significant. Poisson regression was used to analyze risk factors for central nervous system (CNS) malformations in the infant according to maternal symptomatology.
   Results
   Of 219 HIV-infected pregnant women enrolled, 92% were DENV IgG+; 47(22%) had laboratory evidence of recent AI. Of these, 34 (72%) were ZIKV+, nine (19%) CHIKV+, and two (4%) DENV+. Symptoms consistent with AI were observed in 23 (10%) women, of whom 10 (43%) were ZIKV+, eight (35%) CHIKV+. No CNS abnormalities were observed among infants of DENV+ or CHIKV+ women; four infants with CNS abnormalities were born to ZIKV+ women (three symptomatic). Infants born to ZIKV+ women had a higher risk of CNS malformations if the mother was symptomatic (RR = 7.20), albeit not statistically significant (p = 0.066).
   Conclusions
   Among HIV-infected pregnant women with laboratory evidence of a recent AI, 72% were ZIKV-infected. In this cohort, CNS malformations occurred among infants born to both symptomatic and asymptomatic pregnant women with Zika infection.
C1 [Joao, Esau A. C.; Gouvea, Maria Isabel; Teixeira, Maria de Lourdes B.; Cruz, Maria Leticia] Hosp Fed Servidores Estado, Dept Infect Dis, Rio De Janeiro, RJ, Brazil.
   [Ferreira, Orlando da C., Jr.; Tanuri, Amilcar; Higa, Luiza M.; Arruda, Monica B.] Univ Fed Rio de Janeiro, Inst Biol, Dept Genet, Lab Biol Mol, Rio De Janeiro, RJ, Brazil.
   [Gouvea, Maria Isabel; Teixeira, Maria de Lourdes B.] Fundacao Oswaldo Cruz, Inst Nacl Infectol Evandro Chagas, Rio De Janeiro, RJ, Brazil.
   [Costa, Deise A.; Mohana-Borges, Ronaldo] Univ Fed Rio de Janeiro, Inst Biofis Carlos Chagas Filho, Lab Genom Estrutural, Rio De Janeiro, RJ, Brazil.
   [Matos, Haroldo J.] Inst Evandro Chagas, Dept Epidemiol, Belem, Para, Brazil.
   [Mendes-Silva, Wallace] Hosp Fed Servidores Estado, Maternal Fetal Unit, Rio De Janeiro, RJ, Brazil.
   [Read, Jennifer S.] Univ Calif San Francisco, Dept Epidemiol & Biostat, San Francisco, CA 94143 USA.
RP Joao, EAC (corresponding author), Hosp Fed Servidores Estado, Dept Infect Dis, Rio De Janeiro, RJ, Brazil.
EM esaujoao@gmail.com
RI Higa, Luiza/W-2698-2019; Borges, Ronaldo S Mohana/C-5575-2013; amsalu,
   ribka/G-8780-2019; Cruz, Maria Leticia/Y-5632-2019
OI Joao, Esau/0000-0002-2412-0627; /0000-0002-6896-0089; Mendes da Silva,
   Wallace/0000-0002-5195-4061
CR Abushouk AI, 2016, J CLIN VIROL, V84, P53, DOI 10.1016/j.jcv.2016.09.012
   Adams L, 2017, 2017 ANN M AM SOC TR
   Adebanjo T, 2017, MMWR-MORBID MORTAL W, V66, P1089, DOI 10.15585/mmwr.mm6641a1
   [Anonymous], 2017, ZIK VIR GUID US LAB
   Blohm GM, 2018, CLIN INFECT DIS, V66, P1120, DOI 10.1093/cid/cix968
   Brasil P, 2016, NEW ENGL J MED, V375, P2321, DOI 10.1056/NEJMoa1602412
   Calvet GA, 2016, J CLIN VIROL, V74, P1, DOI 10.1016/j.jcv.2015.11.014
   Cao-Lormeau VM, 2016, LANCET, V387, P1531, DOI 10.1016/S0140-6736(16)00562-6
   Castanha PMS, 2013, EPIDEMIOL INFECT, V141, P1080, DOI 10.1017/S0950268812001367
   Melo ASD, 2016, JAMA NEUROL, V73, P1407, DOI 10.1001/jamaneurol.2016.3720
   Gabaglia CR, 2017, CURR OPIN PEDIATR, V29, P107, DOI 10.1097/MOP.0000000000000446
   Honein MA, 2017, JAMA-J AM MED ASSOC, V317, P59, DOI 10.1001/jama.2016.19006
   Joao EC, 2012, INT J STD AIDS, V23, P44, DOI 10.1258/ijsa.2011.010545
   Joao Esau Custodio, 2017, Pediatr Infect Dis J, V36, P500, DOI 10.1097/INF.0000000000001482
   Lanciotti RS, 2008, EMERG INFECT DIS, V14, P1232, DOI 10.3201/eid1408.080287
   Lanciotti RS, 2007, EMERG INFECT DIS, V13, P764, DOI 10.3201/eid1305.070015
   MACNAMARA FN, 1954, T ROY SOC TROP MED H, V48, P139, DOI 10.1016/0035-9203(54)90006-1
   Menting S, 2011, ADV VIROL, V2011, DOI 10.1155/2011/514681
   Moore CA, 2017, JAMA PEDIATR, V171, P288, DOI 10.1001/jamapediatrics.2016.3982
   Musso D, 2016, CLIN MICROBIOL REV, V29, P487, DOI 10.1128/CMR.00072-15
   Petersen E, 2016, INT J INFECT DIS, V44, P11, DOI 10.1016/j.ijid.2016.02.001
   Petersen LR, 2016, NEW ENGL J MED, V374, P1552, DOI 10.1056/NEJMra1602113
   Rothan HA, 2018, J AUTOIMMUN, V89, P11, DOI 10.1016/j.jaut.2018.01.002
   SELVIN S, 1998, MODERN APPL BIOSTATI
   Shapiro-Mendoza CK, 2017, MMWR-MORBID MORTAL W, V66, P615, DOI 10.15585/mmwr.mm6623e1
NR 25
TC 3
Z9 3
U1 0
U2 4
PU PUBLIC LIBRARY SCIENCE
PI SAN FRANCISCO
PA 1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA
SN 1932-6203
J9 PLOS ONE
JI PLoS One
PD JUL 6
PY 2018
VL 13
IS 7
AR e0200168
DI 10.1371/journal.pone.0200168
PG 12
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA GM1FJ
UT WOS:000437809500071
PM 29979796
OA DOAJ Gold, Green Published
DA 2020-12-17
ER

PT J
AU Salomao, NG
   Rabelo, K
   Povoa, TF
   Alves, AMB
   da Costa, SM
   Goncalves, AJS
   Amorim, JF
   Azevedo, AS
   Nunes, PCG
   Basilio-de-Oliveira, CA
   Basilio-de-Oliveira, RP
   Geraldo, LHM
   Fonseca, CG
   Lima, FRS
   Mohana-Borges, R
   Silva, EM
   dos Santos, FB
   Oliveira, ERA
   Paes, MV
AF Salomao, Natalia G.
   Rabelo, Kissila
   Povoa, Tiago F.
   Alves, Ada M. B.
   da Costa, Simone M.
   Goncalves, Antonio J. S.
   Amorim, Juliana F.
   Azevedo, Adriana S.
   Nunes, Priscilla C. G.
   Basilio-de-Oliveira, Carlos A.
   Basilio-de-Oliveira, Rodrigo P.
   Geraldo, Luiz H. M.
   Fonseca, Celina G.
   Lima, Flavia R. S.
   Mohana-Borges, Ronaldo
   Silva, Emiliana M.
   dos Santos, Flavia B.
   Oliveira, Edson R. A.
   Paes, Marciano V.
TI BALB/c mice infected with DENV-2 strain 66985 by the intravenous route
   display injury in the central nervous system
SO SCIENTIFIC REPORTS
LA English
DT Article
ID DENGUE VIRUS-INFECTION; RIO-DE-JANEIRO; NEUROLOGICAL COMPLICATIONS;
   ELECTRON MICROSCOPY; MULTIPLE-SCLEROSIS; CELL-DEATH; MICROGLIA; FEVER;
   BRAIN; APOPTOSIS
AB Dengue is a mild flu-like arboviral illness caused by dengue virus (DENV) that occurs in tropical and subtropical countries. An increasing number of reports have been indicating that dengue is also associated to neurological manifestations, however, little is known regarding the neuropathogenesis of the disease. Here, using BALB/c mice intravenously infected with DENV-2 strain 66985, we demonstrated that the virus is capable of invading and damaging the host's central nervous system (CNS). Brain and cerebellum of infected animals revealed histological alterations such as the presence of inflammatory infiltrates, thickening of pia matter and disorganization of white matter. Additionally, it was also seen that infection lead to altered morphology of neuroglial cells and apoptotic cell death. Such observations highlighted possible alterations that DENV may promote in the host's CNS during a natural infection, hence, helping us to better understand the neuropathological component of the disease.
C1 [Salomao, Natalia G.; Goncalves, Antonio J. S.; Paes, Marciano V.] Fundacao Oswaldo Cruz, Inst Oswaldo Cruz, Lab Interdisciplinar Pesquisas Med, Rio De Janeiro, Brazil.
   [Rabelo, Kissila] Univ Estado Rio de Janeiro, Lab Ultraestrutura & Biol Tecidual, Rio De Janeiro, Brazil.
   [Povoa, Tiago F.] Inst Criminalist, Tocantins, Brazil.
   [Alves, Ada M. B.; da Costa, Simone M.] Fundacao Oswaldo Cruz, Inst Oswaldo Cruz, Lab Biotecnol & Fisiol Infeccoes Virais, Rio De Janeiro, Brazil.
   [Amorim, Juliana F.; Azevedo, Adriana S.] Fundacao Oswaldo Cruz, Inst Tecnol Imunobiol, Lab Tecnol Virol, Rio De Janeiro, Brazil.
   [Nunes, Priscilla C. G.] Fundacao Oswaldo Cruz, Inst Oswaldo Cruz, Lab Imunol Viral, Rio De Janeiro, Brazil.
   [Basilio-de-Oliveira, Carlos A.; Basilio-de-Oliveira, Rodrigo P.] Univ Fed Estado Rio de Janeiro, Hosp Gaffree Guinle, Anat Patol, Rio De Janeiro, Brazil.
   [Geraldo, Luiz H. M.; Fonseca, Celina G.; Lima, Flavia R. S.] Univ Fed Rio de Janeiro, Inst Ciencias Biomed, Lab Biol Celulas Gliais, Rio De Janeiro, Brazil.
   [Mohana-Borges, Ronaldo; Silva, Emiliana M.] Univ Fed Rio de Janeiro, Inst Biofis Carlos Chagas Filho, Lab Genom Estrutural, Rio De Janeiro, Brazil.
   [dos Santos, Flavia B.] Fundacao Oswaldo Cruz, Inst Oswaldo Cruz, Lab Imunol Viral, Rio De Janeiro, Brazil.
   [Oliveira, Edson R. A.] Univ Fed Rio de Janeiro, Inst Quim Organ, Lab Modelagem Mol, Rio De Janeiro, Brazil.
RP Paes, MV (corresponding author), Fundacao Oswaldo Cruz, Inst Oswaldo Cruz, Lab Interdisciplinar Pesquisas Med, Rio De Janeiro, Brazil.; Oliveira, ERA (corresponding author), Univ Fed Rio de Janeiro, Inst Quim Organ, Lab Modelagem Mol, Rio De Janeiro, Brazil.
EM edsonrao@gmail.com; marciano@ioc.fiocruz.br
RI Borges, Ronaldo S Mohana/C-5575-2013
OI Santos, Flavia/0000-0002-1309-5366; Rabelo, Kissila/0000-0001-7579-7788;
   Paes, Marciano/0000-0002-2266-2801; Geraldo, Luiz
   Henrique/0000-0003-3318-4697; Souza Lima, Flavia
   Regina/0000-0003-0799-9235; Oliveira, Edson RA/0000-0002-8606-7454
FU Brazilian foundation FAPERJ [E-26/110.511/2014, E-26/202.003/2016];
   CNPqNational Council for Scientific and Technological Development (CNPq)
   [30382202015-5]
FX We thank the Brazilian foundation FAPERJ (grant number:
   E-26/110.511/2014 and E-26/202.003/2016) and CNPq (grant number:
   30382202015-5) for the financial support and Geraldo C. Wagner from
   Universidade Federal do Estado do Rio de Janeiro (UNIRIO) for the help
   with slides production. We also acknowledge the Laboratory of
   Flaviviruses, Fiocruz, Rio de Janeiro, Brazil, for kindly providing us
   the DENV-2 samples isolated from patient.
CR Aguirre S, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002934
   Amaral DCG, 2011, J NEUROINFLAMM, V8, DOI 10.1186/1742-2094-8-23
   Angibaud G, 2001, J CLIN NEUROSCI, V8, P63, DOI 10.1054/jocn.2000.0735
   Araujo FMC, 2011, J VIROL METHODS, V177, P128, DOI 10.1016/j.jviromet.2011.07.003
   Ashour J, 2010, CELL HOST MICROBE, V8, P410, DOI 10.1016/j.chom.2010.10.007
   Ashour J, 2009, J VIROL, V83, P5408, DOI 10.1128/JVI.02188-08
   Bhatt S, 2013, NATURE, V496, P504, DOI 10.1038/nature12060
   Boche D, 2013, NEUROPATH APPL NEURO, V39, P3, DOI 10.1111/nan.12011
   Cam BV, 2001, AM J TROP MED HYG, V65, P848, DOI 10.4269/ajtmh.2001.65.848
   Castellanos JE, 2016, BIOMEDICA, V36, P156, DOI 10.7705/biomedica.v36i0.2984
   Chatterjee D, 2013, CLIN DEV IMMUNOL, DOI 10.1155/2013/510396
   Chen HC, 2004, J MED VIROL, V73, P419, DOI 10.1002/jmv.20108
   Chen HC, 2007, J VIROL, V81, P5518, DOI 10.1128/JVI.02575-06
   Courageot MP, 2003, ADV VIRUS RES, V60, P157, DOI 10.1016/S0065-3527(03)60005-9
   Diamond MS, 2000, J VIROL, V74, P4957, DOI 10.1128/JVI.74.11.4957-4966.2000
   Diamond MS, 2001, VIROLOGY, V289, P297, DOI 10.1006/viro.2001.1114
   Domingues RB, 2008, J NEUROL SCI, V267, P36, DOI 10.1016/j.jns.2007.09.040
   El-Bacha T, 2007, BBA-MOL BASIS DIS, V1772, P1158, DOI 10.1016/j.bbadis.2007.08.003
   ERHARDT W, 1984, RES EXP MED, V184, P159, DOI 10.1007/BF01852390
   Everett H, 2001, VIROLOGY, V288, P1, DOI 10.1006/viro.2001.1081
   Garcia-Rivera EJ, 2002, LANCET, V360, P261, DOI 10.1016/S0140-6736(02)09481-3
   Garman RH, 2011, TOXICOL PATHOL, V39, P22, DOI 10.1177/0192623310389621
   Giovannoni G, 1998, MULT SCLER J, V4, P212, DOI 10.1177/135245859800400323
   Gubler DJ, 2012, AM J TROP MED HYG, V86, P743, DOI 10.4269/ajtmh.2012.12-0157
   Nunes PCG, 2016, J MED VIROL, V88, P1130, DOI 10.1002/jmv.24464
   HOFMAN FM, 1989, J EXP MED, V170, P607, DOI 10.1084/jem.170.2.607
   Carod-Artal FJ, 2013, LANCET NEUROL, V12, P906, DOI 10.1016/S1474-4422(13)70150-9
   Jensen CJ, 2013, J NEUROIMMUNE PHARM, V8, P824, DOI 10.1007/s11481-013-9480-6
   Jessen KR, 2005, NAT REV NEUROSCI, V6, P671, DOI 10.1038/nrn1746
   Johnson BW, 2005, J CLIN MICROBIOL, V43, P4977, DOI 10.1128/JCM.43.10.4977-4983.2005
   Jones M, 2005, J VIROL, V79, P5414, DOI 10.1128/JVI.79.9.5414-5420.2005
   Katzelnick Leah C, 2017, Lancet Infect Dis, V17, pe88, DOI 10.1016/S1473-3099(16)30473-X
   Kettenmann H, 2011, PHYSIOL REV, V91, P461, DOI 10.1152/physrev.00011.2010
   Lima DM, 2011, VACCINE, V29, P831, DOI 10.1016/j.vaccine.2010.10.078
   Liu Y, 2014, VIROLOGY, V448, P15, DOI 10.1016/j.virol.2013.09.016
   Mamdouh KH, 2013, J GLOB INFECT DIS, V5, P183, DOI 10.4103/0974-777X.122021
   Mazzon M, 2009, J INFECT DIS, V200, P1261, DOI 10.1086/605847
   MCGEER PL, 1988, ANN NEUROL, V24, P574, DOI 10.1002/ana.410240415
   Miagostovich MP, 1997, CLIN NEUROPATHOL, V16, P204
   Miagostovich MP, 1997, MEM I OSWALDO CRUZ, V92, P595, DOI 10.1590/S0074-02761997000500006
   Michell-Robinson MA, 2015, BRAIN, V138, P1138, DOI 10.1093/brain/awv066
   Morrison J, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003265
   Morrison J, 2012, VIRUSES-BASEL, V4, P397, DOI 10.3390/v4030397
   Munoz-Jordan JL, 2005, J VIROL, V79, P8004, DOI 10.1128/JVI.79.13.8004-8013.2005
   Munoz-Jordan JL, 2003, P NATL ACAD SCI USA, V100, P14333, DOI 10.1073/pnas.2335168100
   Murthy JMK, 2010, NEUROL INDIA, V58, P581, DOI 10.4103/0028-3886.68654
   Nayak D, 2014, ANNU REV IMMUNOL, V32, P367, DOI 10.1146/annurev-immunol-032713-120240
   Newman EA, 2003, TRENDS NEUROSCI, V26, P536, DOI 10.1016/S0166-2236(03)00237-6
   Huy NT, 2013, PLOS NEGLECT TROP D, V7, DOI 10.1371/journal.pntd.0002412
   NOGUEIRA RMR, 1993, EPIDEMIOL INFECT, V111, P163, DOI 10.1017/S0950268800056788
   Oliveira ERA, 2016, VIROLOGY, V489, P95, DOI 10.1016/j.virol.2015.12.006
   Paes MV, 2009, LAB INVEST, V89, P1140, DOI 10.1038/labinvest.2009.83
   Paes MV, 2005, VIROLOGY, V338, P236, DOI 10.1016/j.virol.2005.04.042
   Pancharoen Chitsanu, 2001, Southeast Asian Journal of Tropical Medicine and Public Health, V32, P341
   PATEY O, 1993, AM J TROP MED HYG, V48, P793, DOI 10.4269/ajtmh.1993.48.793
   Piccoli C, 2006, BBA-BIOENERGETICS, V1757, P1429, DOI 10.1016/j.bbabio.2006.05.018
   Povoa TF, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0083386
   Puccioni-Sohler M, 2009, NEUROLOGY, V73, P1413, DOI 10.1212/WNL.0b013e3181bd8258
   Ramos C, 1998, J NEUROVIROL, V4, P465, DOI 10.3109/13550289809114548
   REED L. J., 1938, AMER JOUR HYG, V27, P493
   REYNOLDS ES, 1963, J CELL BIOL, V17, P208, DOI 10.1083/jcb.17.1.208
   ROGERS J, 1988, NEUROBIOL AGING, V9, P339, DOI 10.1016/S0197-4580(88)80079-4
   Sahu R, 2014, NEUROLOGY, V83, P1601, DOI 10.1212/WNL.0000000000000935
   Saini L, 2017, NEUROL INDIA, V65, P636, DOI [10.4103/neuroindia.NI_1367_15, 10.4103/neuroindia.ni_1367_15]
   Sanguansermsri T., 1976, BANGKOK SEAMEO TROPM, P10
   Sofroniew MV, 2009, TRENDS NEUROSCI, V32, P638, DOI 10.1016/j.tins.2009.08.002
   Sofroniew MV, 2005, NEUROSCIENTIST, V11, P400, DOI 10.1177/1073858405278321
   Solomon T, 2000, LANCET, V355, P1053, DOI 10.1016/S0140-6736(00)02036-5
   Thisyakorn Usa, 1999, Southeast Asian Journal of Tropical Medicine and Public Health, V30, P504
   Thisyakorn Usa, 1994, Journal of the Medical Association of Thailand, V77, P410
   Thongtan T, 2012, J MED VIROL, V84, P615, DOI 10.1002/jmv.23248
   Torrentes-Carvalho A, 2009, MEM I OSWALDO CRUZ, V104, P1091, DOI 10.1590/S0074-02762009000800005
   Tsai TT, 2016, SCI REP-UK, V6, DOI 10.1038/srep27670
   WATSON ML, 1958, J BIOPHYS BIOCHEM CY, V4, P475, DOI 10.1083/jcb.4.4.475
   WHO, 2009, WHO LIB CAT IN PUBL
   Yu CY, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002780
NR 76
TC 6
Z9 8
U1 0
U2 2
PU NATURE PUBLISHING GROUP
PI LONDON
PA MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND
SN 2045-2322
J9 SCI REP-UK
JI Sci Rep
PD JUN 27
PY 2018
VL 8
AR 9754
DI 10.1038/s41598-018-28137-y
PG 13
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA GK7OQ
UT WOS:000436397000003
PM 29950590
OA DOAJ Gold, Green Published
DA 2020-12-17
ER

PT J
AU Oliveira, ERA
   Povoa, TF
   Nuovo, GJ
   Allonso, D
   Salomao, NG
   Basilio-de-Oliveira, CA
   Geraldo, LHM
   Fonseca, CG
   Lima, FRS
   Mohana-Borges, R
   Paes, MV
AF Oliveira, Edson R. A.
   Povoa, Tiago F.
   Nuovo, Gerard J.
   Allonso, Diego
   Salomao, Natalia G.
   Basilio-de-Oliveira, Carlos A.
   Geraldo, Luiz H. M.
   Fonseca, Celina G.
   Lima, Flavia R. S.
   Mohana-Borges, Ronaldo
   Paes, Marciano V.
TI Dengue fatal cases present virus-specific HMGB1 response in peripheral
   organs
SO SCIENTIFIC REPORTS
LA English
DT Article
ID MOBILITY GROUP BOX-1; ORIGINAL ANTIGENIC SIN; ACUTE LIVER-FAILURE;
   MURINE MODEL; 1 PROTEIN; IMMUNE; INFLAMMATION; INFECTION; DISEASE;
   ENHANCEMENT
AB Dengue is an important infectious disease that presents high incidence and yields a relevant number of fatal cases (about 20,000) every year worldwide. Despite its epidemiological relevance, there are many knowledge gaps concerning dengue pathogenesis, especially with regards to the circumstances that drive a mild clinical course to a severe disease. In this work, we investigated the participation of high mobility group box 1 (HMGB1), an important modulator of inflammation, in dengue fatal cases. Histopathological and ultrastructural analyses revealed that liver, lung and heart post-mortem samples were marked by tissue abnormalities, such as necrosis and apoptotic cell death. These observations go in line with an HMGB1-mediated response and raised concerns regarding the participation of this cytokine in promoting/perpetuating inflammation in severe dengue. Further experiments of immunohistochemistry (IHC) showed increased expression of cytoplasmic HMGB1 in dengue-extracted tissues when compared to non-dengue controls. Co-staining of DENV RNA and HMGB1 in the host cell cytoplasm, as found by in situ hybridization and IHC, confirmed the virus specific induction of the HMGB1-mediated response in these peripheral tissues. This report brings the first in-situ evidence of the participation of HMGB1 in severe dengue and highlights novel considerations in the development of dengue immunopathogenesis.
C1 [Oliveira, Edson R. A.] Univ Fed Rio de Janeiro, Inst Quim Organ, Lab Modelagem Mol, Rio De Janeiro, Brazil.
   [Povoa, Tiago F.] Inst Criminalist, Tocantins, Brazil.
   [Nuovo, Gerard J.] Ohio State Univ, Ctr Comprehens Canc, Columbus, OH 43210 USA.
   [Nuovo, Gerard J.] Phylogeny Inc, Powell, OH USA.
   [Allonso, Diego; Mohana-Borges, Ronaldo] Univ Fed Rio de Janeiro, Inst Biofis Carlos Chagas Filho, Lab Genom Estrutural, Rio De Janeiro, Brazil.
   [Salomao, Natalia G.; Paes, Marciano V.] Fundacao Oswaldo Cruz, Inst Oswaldo Cruz, Lab Interdisciplinar Pesquisas Med, Rio De Janeiro, RJ, Brazil.
   [Basilio-de-Oliveira, Carlos A.] Univ Fed Estado Rio de Janeiro, Hosp Gaffree Guinle, Anat Patol, Rio De Janeiro, Brazil.
   [Geraldo, Luiz H. M.; Fonseca, Celina G.; Lima, Flavia R. S.] Univ Fed Rio de Janeiro, Inst Ciencias Biomed, Lab Biol Celulas Gliais, Rio De Janeiro, Brazil.
RP Oliveira, ERA (corresponding author), Univ Fed Rio de Janeiro, Inst Quim Organ, Lab Modelagem Mol, Rio De Janeiro, Brazil.; Paes, MV (corresponding author), Fundacao Oswaldo Cruz, Inst Oswaldo Cruz, Lab Interdisciplinar Pesquisas Med, Rio De Janeiro, RJ, Brazil.
EM edsonrao@gmail.com; marciano@ioc.fiocruz.br
RI Borges, Ronaldo S Mohana/C-5575-2013; Allonso, Diego/Y-3446-2018
OI Allonso, Diego/0000-0002-1410-480X; Oliveira, Edson
   RA/0000-0002-8606-7454; Paes, Marciano/0000-0002-2266-2801; Geraldo,
   Luiz Henrique/0000-0003-3318-4697; Souza Lima, Flavia
   Regina/0000-0003-0799-9235
FU Brazilian foundation FAPERJ [E-26/110.511/2014]
FX We thank the Brazilian foundation FAPERJ for the financial support
   (grant number: E-26/110.511/2014), Geraldo C. Wagner from Universidade
   Federal do Estado do Rio de Janeiro (UNIRIO) for the help with slides
   production, Kissila Rabelo from Laboratoio de Ultraestrutura e Biologia
   Tecidual/UERJ for the assistance with confocal microscopy, Vera L. A.
   Chagas from the Hospital Universitario Clementino Fraga Filho for
   providing us samples from the dengue case number 2 and Rene Branquinho
   for the technical revision.
CR Allonso D, 2013, AM J TROP MED HYG, V88, P506, DOI 10.4269/ajtmh.2012.12-0619
   Allonso D, 2012, J CLIN VIROL, V55, P214, DOI 10.1016/j.jcv.2012.07.010
   Andersson U, 2011, ANNU REV IMMUNOL, V29, P139, DOI 10.1146/annurev-immunol-030409-101323
   Anggayasti WL, 2017, FEBS LETT, V591, P282, DOI 10.1002/1873-3468.12545
   Arora Shalabh, 2015, BMJ Case Rep, V2015, DOI 10.1136/bcr-2015-209443
   Bangert A, 2016, P NATL ACAD SCI USA, V113, pE155, DOI 10.1073/pnas.1522288113
   Bell CW, 2006, AM J PHYSIOL-CELL PH, V291, pC1318, DOI 10.1152/ajpcell.00616.2005
   Bhatt S, 2013, NATURE, V496, P504, DOI 10.1038/nature12060
   Chen GQ, 2004, MED HYPOTHESES, V63, P691, DOI 10.1016/j.mehy.2004.01.037
   Cheng Y, 2017, MOL BIOL CELL, V28, P201, DOI 10.1091/mbc.E16-02-0126
   Chung S, 2015, INT J DISTRIB SENS N, DOI 10.1155/2015/510516
   Fraisier C, 2015, VIRUS RES, V195, P9, DOI 10.1016/j.virusres.2014.08.017
   Green S, 2006, CURR OPIN INFECT DIS, V19, P429, DOI 10.1097/01.qco.0000244047.31135.fa
   HALSTEAD SB, 1973, J INFECT DIS, V128, P15, DOI 10.1093/infdis/128.1.15
   HALSTEAD SB, 1976, P SOC EXP BIOL MED, V151, P136, DOI 10.3181/00379727-151-39160
   HALSTEAD SB, 1977, J EXP MED, V146, P218, DOI 10.1084/jem.146.1.218
   HALSTEAD SB, 1973, NATURE-NEW BIOL, V243, P24
   HALSTEAD SB, 1979, J INFECT DIS, V140, P527, DOI 10.1093/infdis/140.4.527
   Halstead SB, 2007, LANCET, V370, P1644, DOI 10.1016/S0140-6736(07)61687-0
   Harris HE, 2012, NAT REV RHEUMATOL, V8, P195, DOI 10.1038/nrrheum.2011.222
   Hayakawa K, 2010, ANN NY ACAD SCI, V1207, P50, DOI 10.1111/j.1749-6632.2010.05728.x
   Her Z, 2017, J INFECT DIS, V215, P42, DOI 10.1093/infdis/jiw494
   Huang WC, 2012, INFLAMMATION, V35, P350, DOI 10.1007/s10753-011-9325-5
   HUMPHREY CD, 1974, STAIN TECHNOL, V49, P9, DOI 10.3109/10520297409116929
   Kamau E, 2009, J GEN VIROL, V90, P1827, DOI 10.1099/vir.0.009027-0
   Kang R, 2014, MOL ASPECTS MED, V40, P1, DOI 10.1016/j.mam.2014.05.001
   Kim S, 2013, MOL MED, V19, P88, DOI 10.2119/molmed.2012.00306
   La Braga E, 2001, MEM I OSWALDO CRUZ, V96, P229, DOI 10.1590/S0074-02762001000200015
   Lan KC, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-12285-8
   Lee CH, 2009, INT J CARDIOL, V136, pE69, DOI 10.1016/j.ijcard.2008.05.023
   Lee LC, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0115809
   Lee YR, 2006, J GEN VIROL, V87, P3623, DOI 10.1099/vir.0.82093-0
   Lu B, 2014, EXPERT REV CLIN IMMU, V10, P713, DOI 10.1586/1744666X.2014.909730
   Mackow ER, 2015, FRONT MICROBIOL, V5, DOI 10.3389/fmicb.2014.00733
   Majumdar M, 2013, LIVER INT, V33, P1341, DOI 10.1111/liv.12197
   Mandavilli A, 2004, NAT MED, V10, P1268, DOI 10.1038/nm1204-1268a
   Mathew A, 1998, J VIROL, V72, P3999, DOI 10.1128/JVI.72.5.3999-4004.1998
   Mittal D, 2010, EMBO J, V29, P2242, DOI 10.1038/emboj.2010.94
   Mon KK, 2016, AM J TROP MED HYG, V95, P1338, DOI 10.4269/ajtmh.16-0374
   Mongkolsapaya J, 2003, NAT MED, V9, P921, DOI 10.1038/nm887
   Oliveira ERA, 2016, VIROLOGY, V489, P95, DOI 10.1016/j.virol.2015.12.006
   Ong SP, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041932
   Paes MV, 2009, LAB INVEST, V89, P1140, DOI 10.1038/labinvest.2009.83
   Pang T, 2007, IMMUNOL CELL BIOL, V85, P43, DOI 10.1038/sj.icb.7100008
   Pang Tikki, 2017, Lancet Infect Dis, V17, pe79, DOI 10.1016/S1473-3099(16)30471-6
   Park JS, 2004, J BIOL CHEM, V279, P7370, DOI 10.1074/jbc.M306793200
   Pawitan Jeanne A, 2011, Acta Med Indones, V43, P129
   Povoa TF, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0168973
   Povoa TF, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0083386
   Puerta-Guardo H, 2016, PLOS PATHOG, V12, DOI 10.1371/journal.ppat.1005738
   REYNOLDS ES, 1963, J CELL BIOL, V17, P208, DOI 10.1083/jcb.17.1.208
   Rider P, 2017, J IMMUNOL, V198, P1395, DOI 10.4049/jimmunol.1601342
   Rodrigues RS, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0096313
   Rothman AL, 1999, VIROLOGY, V257, P1, DOI 10.1006/viro.1999.9656
   Rothman AL, 2011, NAT REV IMMUNOL, V11, P532, DOI 10.1038/nri3014
   Rothman AL, 2010, CURR TOP MICROBIOL, V338, P83, DOI 10.1007/978-3-642-02215-9_7
   Rouhiainen A., 2012, METHOD MOL BIOL, P239
   Rovere-Querini P, 2004, EMBO REP, V5, P825, DOI 10.1038/sj.embor.7400205
   Rus KR, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004804
   Sachdev U, 2013, J VASC SURG, V58, P460, DOI 10.1016/j.jvs.2012.11.071
   Sam SS, 2013, PLOS NEGLECT TROP D, V7, DOI 10.1371/journal.pntd.0002194
   Samanta J, 2015, WORLD J CLIN CASES, V3, P125, DOI 10.12998/wjcc.v3.i2.125
   Shresta S, 2006, J VIROL, V80, P10208, DOI 10.1128/JVI.00062-06
   Sims GP, 2010, ANNU REV IMMUNOL, V28, P367, DOI 10.1146/annurev.immunol.021908.132603
   Srikiatkhachorn A, 2010, CURR TOP MICROBIOL, V338, P67, DOI 10.1007/978-3-642-02215-9_6
   Stros M, 2010, BBA-GENE REGUL MECH, V1799, P101, DOI 10.1016/j.bbagrm.2009.09.008
   Thomas JO, 2012, BIOCHEM SOC T, V40, P341, DOI 10.1042/BST20120014
   Venereau E, 2012, J EXP MED, V209, P1519, DOI 10.1084/jem.20120189
   Wang LW, 2010, HEPATOB PANCREAT DIS, V9, P499
   Yamamoto T., 2017, EXPERT REV GASTROENT
   Yang H, 2010, BBA-GENE REGUL MECH, V1799, P149, DOI 10.1016/j.bbagrm.2009.11.019
   Yu R, 2016, J VIROL, V90, P2332, DOI 10.1128/JVI.02795-15
   Zhang JH, 2000, CELL RES, V10, P205, DOI 10.1038/sj.cr.7290049
   Zhao LZ, 2016, BMC INFECT DIS, V16, DOI 10.1186/s12879-016-1596-x
   Zheng WK, 2017, MEDICINE, V96, DOI 10.1097/MD.0000000000006764
NR 75
TC 5
Z9 6
U1 0
U2 2
PU NATURE PUBLISHING GROUP
PI LONDON
PA MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND
SN 2045-2322
J9 SCI REP-UK
JI Sci Rep
PD NOV 22
PY 2017
VL 7
AR 16011
DI 10.1038/s41598-017-16197-5
PG 14
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA FN6IT
UT WOS:000416118300035
PM 29167501
OA DOAJ Gold, Green Published
DA 2020-12-17
ER

PT J
AU de Souza, LJ
   de Azevedo, J
   Kohler, LIA
   Barros, LD
   Lima, MA
   Silva, EM
   Mohana-Borges, R
   Nunes, PCG
   Paes, MV
AF de Souza, Luiz Jose
   de Azevedo, Joao
   Acha Kohler, Liza Ingride
   Barros, Lorena de Freitas
   Lima, Mariana Aredes
   Silva, Emiliana Mandarano
   Mohana-Borges, Ronaldo
   Guerra Nunes, Priscila Conrado
   Paes, Marciano Viana
TI Evidence of dengue virus replication in a non-traumatic spleen rupture
   case
SO ARCHIVES OF VIROLOGY
LA English
DT Article
DE Splenic rupture; Dengue; NS3 detection; Acute abdomen
ID SPONTANEOUS SPLENIC RUPTURE; FEVER
AB The present report describes a case of splenic rupture due to dengue, a rare complication of dengue that should be considered in any patient with suspected dengue disease who started with left upper quadrant abdominal pain and hypotension. The pathophysiology of this entity is not yet well elucidated, but one of the theories present in the literature is that it is due to a depletion of coagulation factors and platelets leading to intra-splenic hemorrhage and rupture. The RT-PCR technique detected serotype 1 and histopathological studies of the spleen revealed significant atrophy of lymphoid follicles and extensive hemorrhage areas. Besides histopathological observations, virus replication was investigated by detection of dengue antigens, especially the non-structural 3 protein (NS3) in endothelial cells and splenic macrophages. This important complication has serious clinical repercussions and high mortality, due to the diagnostic difficulty and many factors that usually confuse or delay its diagnosis. Therefore, it is of the utmost importance to recognize their manifestations and their management to try to best minimize their consequences and mortality.
C1 [de Souza, Luiz Jose] Ctr Referncia Doencas Imunoinfecciosas, Campos Dos Goytacazes, RJ, Brazil.
   [de Souza, Luiz Jose] Hosp Plantadores Cana, Campos Dos Goytacazes, RJ, Brazil.
   [de Azevedo, Joao; Acha Kohler, Liza Ingride; Barros, Lorena de Freitas; Lima, Mariana Aredes] Fac Med Campos, Campos Dos Goytacazes, RJ, Brazil.
   [Silva, Emiliana Mandarano; Mohana-Borges, Ronaldo] Univ Fed Rio de Janeiro, Inst Biofis Carlos Chagas Filho, Lab Genom Estrutural, Rio De Janeiro, RJ, Brazil.
   [Guerra Nunes, Priscila Conrado] Fundacao Oswaldo Cruz, Lab Imunologia Viral, Inst Oswaldo Cruz, Rio De Janeiro, Brazil.
   [Paes, Marciano Viana] Fundacao Oswaldo Cruz, Lab Interdisciplinar Pesquisa Med, Inst Oswaldo Cruz, Rio De Janeiro, Brazil.
RP Paes, MV (corresponding author), Fundacao Oswaldo Cruz, Lab Interdisciplinar Pesquisa Med, Inst Oswaldo Cruz, Rio De Janeiro, Brazil.
EM marciano@ioc.fiocruz.br
RI Borges, Ronaldo S Mohana/C-5575-2013
OI Paes, Marciano/0000-0002-2266-2801
FU FAPERJCarlos Chagas Filho Foundation for Research Support of the State
   of Rio de Janeiro (FAPERJ) [18/2015]
FX This study was funded by FAPERJ (grant number 18/2015).
CR [Anonymous], 2009, DENG GUID DIAGN TREA
   Aubrey-Bassler FK, 2012, BMC EMERG MED, V12, DOI 10.1186/1471-227X-12-11
   Bhaskar E, 2012, J INFECT DEV COUNTR, V6, P369
   Coutard B, 2014, ANTIVIR RES, V106, P61, DOI 10.1016/j.antiviral.2014.03.013
   Mendonca LSD, 2011, JPN J INFECT DIS, V64, P330
   de Silva W T T, 2015, BMC Res Notes, V8, P286, DOI 10.1186/s13104-015-1234-5
   Deen JL, 2006, LANCET, V368, P170, DOI 10.1016/S0140-6736(06)69006-5
   FALGOUT B, 1991, J VIROL, V65, P2467, DOI 10.1128/JVI.65.5.2467-2475.1991
   Gedik E, 2008, WORLD J GASTROENTERO, V14, P6711, DOI 10.3748/wjg.14.6711
   Giagounidis AAN, 1996, ANN HEMATOL, V73, P297, DOI 10.1007/s002770050245
   Gopie P, 2012, Trop Gastroenterol, V33, P154
   Gorg C, 2003, BRIT J RADIOL, V76, P704, DOI 10.1259/bjr/69247894
   Keelapang P, 2004, J VIROL, V78, P2367, DOI 10.1128/JVI.78.5.2367-2381.2004
   LANCIOTTI RS, 1992, J CLIN MICROBIOL, V30, P545, DOI 10.1128/JCM.30.3.545-551.1992
   LIEBERMAN ME, 1989, AM J EMERG MED, V7, P28, DOI 10.1016/0735-6757(89)90079-X
   Martina BEE, 2009, CLIN MICROBIOL REV, V22, P564, DOI 10.1128/CMR.00035-09
   Miller N, 2010, CURR OPIN MOL THER, V12, P31
   Narvaez F, 2011, PLOS NEGLECT TROP D, V5, DOI 10.1371/journal.pntd.0001397
   Povoa TF, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0083386
   Teixeira MG, 2013, PLOS NEGLECT TROP D, V7, DOI 10.1371/journal.pntd.0002520
   Veronesi R, 2009, TRATADO INFECTOLOGIA
NR 21
TC 3
Z9 3
U1 0
U2 1
PU SPRINGER WIEN
PI WIEN
PA SACHSENPLATZ 4-6, PO BOX 89, A-1201 WIEN, AUSTRIA
SN 0304-8608
EI 1432-8798
J9 ARCH VIROL
JI Arch. Virol.
PD NOV
PY 2017
VL 162
IS 11
BP 3535
EP 3539
DI 10.1007/s00705-017-3527-6
PG 5
WC Virology
SC Virology
GA FJ7OK
UT WOS:000412948400033
PM 28808809
OA Green Published
DA 2020-12-17
ER

PT J
AU Portela, AC
   Barros, TG
   Lima, CHD
   Dias, LRS
   Azevedo, PHRD
   Dantas, ASCL
   Mohana-Borges, R
   Ventura, GT
   Pinheiro, S
   Muri, EMF
AF Portela, Aline C.
   Barros, Thalita G.
   Lima, Camilo H. da S.
   Dias, Luiza R. S.
   Azevedo, Pedro H. R. de A.
   Dantas, Anna Sophia C. L.
   Mohana-Borges, Ronaldo
   Ventura, Gustavo T.
   Pinheiro, Sergio
   Muri, Estela M. F.
TI Isosorbide-based peptidomimetics as inhibitors of hepatitis C virus
   serine protease
SO BIOORGANIC & MEDICINAL CHEMISTRY LETTERS
LA English
DT Article
DE Peptidomimetics; Isosorbide; HCV; Serine proteases; Molecular docking;
   Molecular dynamic simulation; MMPBSA
ID PEPTIDE MIMETICS; ISOMANNIDE; DISCOVERY; DERIVATIVES
AB Hepatitis C infection is a cause of chronic liver diseases such as cirrhosis and carcinoma. The current therapy for hepatitis C has limited efficacy and low tolerance. The HCV encodes a serine protease which is critical for viral replication, and few protease inhibitors are currently on the market. In this paper, we describe the synthesis and screening of novel isosorbide-based peptidomimetic inhibitors, in which the compounds 1d, 1e, and 1i showed significant inhibition of the protease activity in vitro at 100 mu M. The compound le also showed dose-response (IC50= 36 +/- 3 mu M) and inhibited the protease mutants D168A and V170A at 100 mu M, indicating it as a promising inhibitor of the HCV NS3/4A protease. Our molecular modeling studies suggest that the activity of le is associated with a change in the interactions of S2 and S4 subsites, since that the increased flexibility favors a decrease in activity against D168A, whereas the appearance of a hydrophobic cavity in the S4 subsite increase the inhibition against V170A strain. (C) 2017 Elsevier Ltd. All rights reserved.
C1 [Portela, Aline C.; Barros, Thalita G.; Lima, Camilo H. da S.; Dias, Luiza R. S.; Azevedo, Pedro H. R. de A.; Dantas, Anna Sophia C. L.; Muri, Estela M. F.] Univ Fed Fluminense, Fac Farm, Dept Tecnol Farmaceut, Lab Quim Med, Rua Mario Viana 523, BR-24241000 Niteroi, RJ, Brazil.
   [Mohana-Borges, Ronaldo] Univ Fed Rio de Janeiro, Inst Biofis Carlos Chagas Filho, Lab Genom Estrutural, Rio De Janeiro, RJ, Brazil.
   [Ventura, Gustavo T.] Univ Fed Rio de Janeiro, Inst Biofis Carlos Chagas Filho, Lab Glicobiol Estrutural & Func, Rio De Janeiro, RJ, Brazil.
   [Pinheiro, Sergio] Univ Fed Fluminense, Inst Quim, Dept Quim Organ, Niteroi, RJ, Brazil.
RP Muri, EMF (corresponding author), Univ Fed Fluminense, Fac Farm, Dept Tecnol Farmaceut, Lab Quim Med, Rua Mario Viana 523, BR-24241000 Niteroi, RJ, Brazil.
EM estelamuri@yahoo.com.br
RI Muri, Estela/AAG-4930-2019; Pinheiro, Sergio/AAU-6419-2020; lima, camilo
   HS/J-2434-2018; Dias, Luiza R S/X-2847-2018; lima, camilo/ABE-8956-2020;
   Borges, Ronaldo S Mohana/C-5575-2013
OI Muri, Estela/0000-0001-8489-1848; lima, camilo HS/0000-0002-5579-7809;
   Pinheiro, Sergio/0000-0003-2725-1769; Dias, Luiza R.
   S./0000-0001-5809-5602
FU Coordination for the Improvement of Higher Education Personnel - Brazil
   (Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior/CAPES);
   National Council for Scientific and Technological Development - Brazil
   (Conselho Nacional de Desenvolvimento Cientifico e Tecnologico/CNPq);
   Carlos Chagas Filho Foundation of Research of the State of Rio de
   Janeiro - Brazil (Fundacao Carlos Chagas Filho de Amparo a Pesquisa do
   Estado do Rio de Janeiro/FAPERJ)
FX We gratefully acknowledge financial support from Coordination for the
   Improvement of Higher Education Personnel - Brazil (Coordenacao de
   Aperfeicoamento de Pessoal de Nivel Superior/CAPES), National Council
   for Scientific and Technological Development - Brazil (Conselho Nacional
   de Desenvolvimento Cientifico e Tecnologico/CNPq), and the Carlos Chagas
   Filho Foundation for Support of Research of the State of Rio de Janeiro
   - Brazil (Fundacao Carlos Chagas Filho de Amparo a Pesquisa do Estado do
   Rio de Janeiro/FAPERJ). This work was development with the assistance of
   Laboratorio de Modelagem Molecular (LabMMol), localized at Chemistry
   Institute of Federal University of Rio de Janeiro (IQ-UFRJ).
CR ABENHAIM D, 1994, CARBOHYD RES, V261, P255, DOI 10.1016/0008-6215(94)84022-9
   Abrahim-Vieira B, 2014, MED CHEM RES, V23, P5305, DOI 10.1007/s00044-014-1058-1
   Alexandre FR, 2015, BIOORG MED CHEM LETT, V25, P3984, DOI 10.1016/j.bmcl.2015.07.020
   Bachmann F, 1998, MACROMOL RAPID COMM, V19, P21, DOI 10.1002/(SICI)1521-3927(19980101)19:1<21::AID-MARC21>3.0.CO;2-T
   Barros TG, 2012, LETT ORG CHEM, V9, P239, DOI 10.2174/157017812800233787
   Barros TG, 2010, AMINO ACIDS, V38, P701, DOI 10.1007/s00726-009-0273-4
   Barros TG, 2009, SYNTHESIS-STUTTGART, P620, DOI 10.1055/s-0028-1083332
   Chen Stephen L, 2006, Int J Med Sci, V3, P47
   De Luca A, 2014, CURR OPIN PHARMACOL, V18, P9, DOI 10.1016/j.coph.2014.07.016
   Forestier N, 2012, EXPERT OPIN PHARMACO, V13, P593, DOI 10.1517/14656566.2012.660524
   Freitas RF, 2012, BIOORG MED CHEM LETT, V22, P6072, DOI 10.1016/j.bmcl.2012.08.047
   Halfon P, 2011, J HEPATOL, V55, P192, DOI 10.1016/j.jhep.2011.01.011
   He Y, 2008, ANTIMICROB AGENTS CH, V52, P1101, DOI 10.1128/AAC.01149-07
   Janvier M, 2016, EUR J ORG CHEM, V2016, P2308, DOI 10.1002/ejoc.201600186
   Huynh KD, 2011, NEW J CHEM, V35, P2622, DOI 10.1039/c1nj20588a
   KITAZAWA M, 1995, J PHYS CHEM-US, V99, P14784, DOI 10.1021/j100040a031
   Kumar S, 2005, TETRAHEDRON, V61, P4141, DOI 10.1016/j.tet.2005.02.010
   Kurochkina GI, 2004, RUSS J GEN CHEM+, V74, P1616, DOI 10.1007/s11176-005-0067-7
   Mesaik MA, 2004, BIOORGAN MED CHEM, V12, P2049, DOI 10.1016/j.bmc.2004.02.034
   Oliveira JPC, 2014, ACS MED CHEM LETT, V5, P128, DOI 10.1021/ml4003698
   Parsy CC, 2015, BIOORG MED CHEM LETT, V25, P5427, DOI 10.1016/j.bmcl.2015.09.009
   Prongay AJ, 2007, J MED CHEM, V50, P2310, DOI 10.1021/jm060173k
   Raboisson P, 2008, BIOORG MED CHEM LETT, V18, P4853, DOI 10.1016/j.bmcl.2008.07.088
   Rizza SA, 2011, DRUG TODAY, V47, P743, DOI 10.1358/dot.2011.47.10.1656503
   Romano KP, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002832
   Rosenquist A, 2014, J MED CHEM, V57, P1673, DOI 10.1021/jm401507s
   TAMION R, 1993, TETRAHEDRON-ASYMMETR, V4, P1879, DOI 10.1016/S0957-4166(00)80428-0
   Zeuzem S, 2010, CURR MED RES OPIN, V26, P1733, DOI 10.1185/03007995.2010.487038
NR 28
TC 4
Z9 4
U1 0
U2 10
PU PERGAMON-ELSEVIER SCIENCE LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND
SN 0960-894X
EI 1464-3405
J9 BIOORG MED CHEM LETT
JI Bioorg. Med. Chem. Lett.
PD AUG 15
PY 2017
VL 27
IS 16
BP 3661
EP 3665
DI 10.1016/j.bmcl.2017.07.027
PG 5
WC Chemistry, Medicinal; Chemistry, Organic
SC Pharmacology & Pharmacy; Chemistry
GA FD4WM
UT WOS:000407532900008
PM 28729054
DA 2020-12-17
ER

PT J
AU Vidotto, A
   Morais, ATS
   Ribeiro, MR
   Pacca, CC
   Terzian, ACB
   Gil, LHVG
   Mohana-Borges, R
   Gallay, P
   Nogueira, ML
AF Vidotto, Alessandra
   Morais, Ana T. S.
   Ribeiro, Milene R.
   Pacca, Carolina C.
   Terzian, Ana C. B.
   Gil, Laura H. V. G.
   Mohana-Borges, Ronaldo
   Gallay, Philippe
   Nogueira, Mauricio L.
TI Systems Biology Reveals NS4B-Cyclophilin A Interaction: A New Target to
   Inhibit YFV Replication
SO JOURNAL OF PROTEOME RESEARCH
LA English
DT Article
DE yellow fever virus; NS4B; proteomics; protein interactions; systems
   biology; cyclophilin A; cyclosporine A; sirolimus
ID HEPATITIS-C VIRUS; YELLOW-FEVER VIRUS; QUANTITATIVE PROTEOMIC ANALYSIS;
   NONSTRUCTURAL PROTEINS NS1; DENGUE VIRUS; HOST PROTEINS; NS4B PROTEIN;
   RNA-BINDING; IN-VITRO; NUCLEOTIDE-SEQUENCE
AB Yellow fever virus (YFV) replication is highly dependent on host cell factors. YFV NS4B is reported to be involved in viral replication and immune evasion. Here interactions between NS4B and human proteins were determined using a GST pull-down assay and analyzed using 1-DE and LC-MS/MS. We present a total of 207 proteins confirmed using Scaffold 3 Software. Cyclophilin A (CypA), a protein that has been shown to be necessary for the positive regulation of flavivirus replication, was identified as a possible NS4B partner. 59 proteins were found to be significantly increased when compared with a negative control, and CypA exhibited the greatest difference, with a 22-fold change. Fisher's exact test was significant for 58 proteins, and the p value of CypA was the most significant (0.000000019). The Ingenuity Systems software identified 16 pathways, and this analysis indicated sirolimus, an mTOR pathway inhibitor, as a potential inhibitor of CypA. Immunofluorescence and viral plaque assays showed a significant reduction in YFV replication using sirolimus and cyclosporine A (CsA) as inhibitors. Furthermore, YFV replication was strongly inhibited in treated with both inhibitors using reporter BHK-21-rep-YFV17DLucNeolres cells. Taken together, these data suggest that CypA-NS4B interaction regulates YFV replication. Finally, we present the first evidence that YFV inhibition may depend on NS4B-CypA interaction.
C1 [Vidotto, Alessandra; Morais, Ana T. S.; Ribeiro, Milene R.; Pacca, Carolina C.; Terzian, Ana C. B.; Nogueira, Mauricio L.] Fac Med Jose do Rio Preto, Lab Virol, BR-15090000 Sao Jose Do Rio Preto, SP, Brazil.
   [Gil, Laura H. V. G.] Fundacao Oswaldo Cruz FIOCRUZ, Dept Virol, Ctr Pesquisa Aggeu Magalhaes, BR-50740465 Recife, PE, Brazil.
   [Mohana-Borges, Ronaldo] Univ Fed Rio de Janeiro, Inst Biofis Carlos Chagas Filho, Lab Genom Estrutural, BR-21941902 Rio de Janeiro, RJ, Brazil.
   [Gallay, Philippe] Scripps Res Inst La Jolla, Dept Immunol & Microbial Sci, San Diego, CA 92037 USA.
RP Nogueira, ML (corresponding author), Fac Med Jose do Rio Preto, Lab Virol, BR-15090000 Sao Jose Do Rio Preto, SP, Brazil.
EM mnogueira@famerp.br
RI Nogueira, Mauricio L/B-7599-2012; Borges, Ronaldo S Mohana/C-5575-2013
OI Nogueira, Mauricio L/0000-0003-1102-2419; 
FU Fundacao de Amparo a Pesquisa do Estado de sao Paulo, or FAPESP
   [2010/05043-1, 2009/01400-7]; Conselho Nacional de Pesquisa, or CNPq
   [566289/2008-3]; CNPq fellowshipNational Council for Scientific and
   Technological Development (CNPq); Rede Proteoma do Estado de sao Paulo;
   Financiadora de Estudes e Projetos, or FINEP [2004/14846-0,
   01.07.0290.00]; Coordenagao de Aperfeicoamento de Pessoal de Nivel
   Superior (CAPES); FAPESPFundacao de Amparo a Pesquisa do Estado de Sao
   Paulo (FAPESP)
FX We thank the Mass Spectrometry at Brazilian Biosciences National
   Laboratory (LNBio), CNPEM, Campinas, sao Paulo, Brazil for their support
   with the use of NanoAcquity Ultra Performance LC coupled with
   nanoelectrospray source on a Q-TOF Ultima mass spectrometer (Waters
   Corporation, Milford, MA). This work was supported by Grants from the
   Fundacao de Amparo a Pesquisa do Estado de sao Paulo, or FAPESP (no.
   2010/05043-1 and no. 2009/01400-7 to M.L.N.), and by Conselho Nacional
   de Pesquisa, or CNPq (no. 566289/2008-3 to M.L.N.). M.L.N. is supported
   by a CNPq fellowship. We also thank FAPESP, the Rede Proteoma do Estado
   de sao Paulo, the Financiadora de Estudes e Projetos, or FINEP (FAPESP
   grant number 2004/14846-0 and FINEP grant number 01.07.0290.00), and the
   Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES) for
   the financial support and fellowships.
CR Abraham R, 2015, J PROTEOMICS, V120, P126, DOI 10.1016/j.jprot.2015.03.007
   Albarnaz JD, 2014, ANTIVIR RES, V111, P82, DOI 10.1016/j.antiviral.2014.09.004
   Albuquerque LM, 2009, J PROTEOME RES, V8, P5431, DOI 10.1021/pr900236f
   Allaya N, 2015, TUMOR BIOL, V36, P3807, DOI 10.1007/s13277-014-3022-6
   Ambagala AP, 2009, J VIROL, V83, P200, DOI 10.1128/JVI.00645-08
   [Anonymous], 2016, PROTEIN
   [Anonymous], 2016, GENE
   [Anonymous], 2016, UNIPROT
   Antrobus R, 2009, PROTEOMICS, V9, P3913, DOI 10.1002/pmic.200900207
   Ashford P, 2016, MOL CELL PROTEOMICS, V15, P2939, DOI 10.1074/mcp.M116.058552
   Barrero CA, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0068376
   Bassett JD, 2012, MOL THER, V20, P860, DOI 10.1038/mt.2011.281
   BEAUD G, 1994, J GEN VIROL, V75, P283, DOI 10.1099/0022-1317-75-2-283
   Blazquez AB, 2014, FRONT MICROBIOL, V5, DOI [10.3389/fmicb.2014.00797, 10.3389/fmicb.2014.00266]
   Bobardt M, 2013, J HEPATOL, V58, P16, DOI 10.1016/j.jhep.2012.08.007
   Bosco DA, 2010, J MOL BIOL, V403, P723, DOI 10.1016/j.jmb.2010.08.001
   BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3
   Brown RE, 2012, ANN CLIN LAB SCI, V42, P243
   Burgener A, 2008, J PROTEOME RES, V7, P4446, DOI 10.1021/pr800406r
   Byron A., 2011, SCI SIGNALING 2, V4
   Byron A, 2012, PROTEOMICS, V12, P2107, DOI 10.1002/pmic.201100487
   Cao WP, 2008, NAT IMMUNOL, V9, P1157, DOI 10.1038/ni.1645
   Carpp LN, 2014, MOL CELL PROTEOMICS, V13, P2836, DOI 10.1074/mcp.M114.038984
   Caruso MB, 2017, J PROTEOMICS, V151, P106, DOI 10.1016/j.jprot.2016.07.011
   Castello A, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000562
   Chai F, 2015, BBA-PROTEINS PROTEOM, V1854, P967, DOI 10.1016/j.bbapap.2015.04.016
   Chatterji U, 2015, ANTIMICROB AGENTS CH, V59, P2496, DOI 10.1128/AAC.04958-14
   Chatterji U, 2010, J HEPATOL, V53, P50, DOI 10.1016/j.jhep.2010.01.041
   Chatterji U, 2010, J GEN VIROL, V91, P1189, DOI 10.1099/vir.0.018531-0
   Chen SP, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027551
   Chen Z, 2010, IMMUNOL LETT, V131, P11, DOI 10.1016/j.imlet.2010.04.003
   Cheng S, 2012, J PROTEOMICS, V75, P3258, DOI 10.1016/j.jprot.2012.03.039
   Chiu HC, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0093305
   Ciborowski P, 2007, VIROLOGY, V363, P198, DOI 10.1016/j.virol.2007.01.013
   Coombs KM, 2010, J VIROL, V84, P10888, DOI 10.1128/JVI.00431-10
   Courtney SC, 2012, J VIROL, V86, P3647, DOI 10.1128/JVI.06549-11
   De Iaco A, 2014, RETROVIROLOGY, V11, DOI 10.1186/1742-4690-11-11
   Munoz MD, 2013, BIOMED RES INT, V2013, DOI 10.1155/2013/875958
   Deighton RF, 2010, PROTEOMICS, V10, P1307, DOI 10.1002/pmic.200900112
   Dhanwani R, 2011, PROTEOMICS, V11, P1936, DOI 10.1002/pmic.201000500
   Ding XM, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0156017
   Doolittle JM, 2011, PLOS NEGLECT TROP D, V5, DOI 10.1371/journal.pntd.0000954
   DOSSANTOS CND, 1995, VIRUS RES, V35, P35
   Egger D, 2002, J VIROL, V76, P5974, DOI 10.1128/JVI.76.12.5974-5984.2002
   Einav S, 2008, NAT BIOTECHNOL, V26, P1019, DOI 10.1038/nbt.1490
   Emmott E, 2010, J PROTEOME RES, V9, P5335, DOI 10.1021/pr100593g
   Eng JK, 2011, MOL CELL PROTEOMICS, V10, DOI 10.1074/mcp.R111.009522
   Evans JD, 2007, J VIROL, V81, P11809, DOI 10.1128/JVI.00791-07
   Fania C, 2009, ELECTROPHORESIS, V30, P2193, DOI 10.1002/elps.200800800
   Felciano Ramon M, 2013, Pac Symp Biocomput, P17
   Fonseca B.A.L., 2005, TRATADO INFECTOLOGIA, P343
   Foster TL, 2011, J VIROL, V85, P7460, DOI 10.1128/JVI.00393-11
   Fragnoud R, 2015, BMC INFECT DIS, V15, DOI 10.1186/s12879-015-1271-7
   Friedrich S, 2014, J VIROL, V88, P11586, DOI 10.1128/JVI.01283-14
   Gagne JP, 2008, NUCLEIC ACIDS RES, V36, P6959, DOI 10.1093/nar/gkn771
   Gerold G, 2015, CELL REP, V12, P864, DOI 10.1016/j.celrep.2015.06.063
   Gould EA, 2008, LANCET, V371, P500, DOI 10.1016/S0140-6736(08)60238-X
   Gregan J, 2007, NAT PROTOC, V2, P1145, DOI 10.1038/nprot.2007.172
   Gretton SN, 2005, J GEN VIROL, V86, P1415, DOI 10.1099/vir.0.80768-0
   Higa LM, 2008, BBA-PROTEINS PROTEOM, V1784, P1607, DOI 10.1016/j.bbapap.2008.06.015
   Hojlund K, 2009, J PROTEOME RES, V8, P4954, DOI 10.1021/pr9007267
   Holmes B, 2016, J BIOL CHEM, V291, P14146, DOI 10.1074/jbc.M116.726927
   Hopkins S, 2012, ANTIMICROB AGENTS CH, V56, P3888, DOI 10.1128/AAC.00693-12
   Hoque M, 2009, RETROVIROLOGY, V6, DOI 10.1186/1742-4690-6-90
   Humphries JD, 2009, SCI SIGNAL, V2, DOI 10.1126/scisignal.2000396
   Ikezoe T, 2007, LEUKEMIA RES, V31, P673, DOI 10.1016/j.leukres.2006.08.001
   Ingenuity, 2016, INGENUITY
   Issac THK, 2014, J PROTEOMICS, V108, P445, DOI 10.1016/j.jprot.2014.06.003
   Ji WT, 2009, J GEN VIROL, V90, P3002, DOI 10.1099/vir.0.013953-0
   Ji WT, 2009, BIOCHEM BIOPH RES CO, V384, P301, DOI 10.1016/j.bbrc.2009.04.116
   Kadam SD, 2012, ARCH DERMATOL RES, V304, P229, DOI 10.1007/s00403-012-1210-z
   Kalia M, 2013, J VIROL, V87, P148, DOI 10.1128/JVI.01399-12
   Kang SM, 2005, PROTEOMICS, V5, P2227, DOI 10.1002/pmic.200401093
   Karsani SA, 2014, PROTEOME SCI, V12, DOI 10.1186/1477-5956-12-3
   Keshamouni VG, 2009, J PROTEOME RES, V8, P35, DOI 10.1021/pr8006478
   Keyes LR, 2012, J GEN VIROL, V93, P722, DOI 10.1099/vir.0.037309-0
   Kozak SL, 2006, J BIOL CHEM, V281, P29105, DOI 10.1074/jbc.M601901200
   Kroeker AL, 2012, J PROTEOME RES, V11, P4132, DOI 10.1021/pr300239r
   Kudchodkar SB, 2004, J VIROL, V78, P11030, DOI 10.1128/JVI.78.20.11030-11039.2004
   Labudova M, 2009, J VIROL, V83, P7842, DOI 10.1128/JVI.00309-09
   Lahaye X, 2016, CELL REP, V15, P879, DOI 10.1016/j.celrep.2016.03.074
   Lam YW, 2010, MOL CELL PROTEOMICS, V9, P117, DOI 10.1074/mcp.M900338-MCP200
   Lee N, 2012, RNA, V18, P2073, DOI 10.1261/rna.034900.112
   Lee RCH, 2013, PLOS NEGLECT TROP D, V7, DOI 10.1371/journal.pntd.0002050
   Li F, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021977
   Li YJ, 2012, AM J TRANSPLANT, V12, P2348, DOI 10.1111/j.1600-6143.2012.04116.x
   Li ZJ, 2011, ACTA PHARMACOL SIN, V32, P1116, DOI 10.1038/aps.2011.86
   Liang QM, 2016, CELL STEM CELL, V19, P663, DOI 10.1016/j.stem.2016.07.019
   Lietzen N, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1001340
   Lim PJ, 2012, J BIOL CHEM, V287, P30861, DOI 10.1074/jbc.M112.376822
   Lin AE, 2013, MOL CELL PROTEOMICS, V12, P3237, DOI 10.1074/mcp.M113.030866
   Lindenbach BD, 1999, J VIROL, V73, P4611, DOI 10.1128/JVI.73.6.4611-4621.1999
   Liu C, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms10714
   Liu JF, 2011, J NEUROIMMUNE PHARM, V6, P308, DOI 10.1007/s11481-011-9265-8
   Liu JO, 2009, IMMUNOL REV, V228, P184, DOI 10.1111/j.1600-065X.2008.00756.x
   Liu L, 2006, ONCOGENE, V25, P7029, DOI 10.1038/sj.onc.1209691
   Liu Q, 2012, EVID-BASED COMPL ALT, V2012, DOI 10.1155/2012/278652
   Liu XL, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037277
   Liu XY, 2008, PROTEOMICS, V8, P582, DOI 10.1002/pmic.200700514
   Lloyd RE, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002741
   Lu MM, 2015, P NATL ACAD SCI USA, V112, P14617, DOI 10.1073/pnas.1516920112
   Lund N, 2012, NUCLEIC ACIDS RES, V40, P3663, DOI 10.1093/nar/gkr1238
   Madan V, 2014, GASTROENTEROLOGY, V146, P1361, DOI 10.1053/j.gastro.2014.01.055
   Mairiang D, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0053535
   Martin-Liberal J, 2014, BRIT J CANCER, V111, P858, DOI 10.1038/bjc.2014.370
   McNulty S, 2013, J VIROL, V87, P912, DOI 10.1128/JVI.02415-12
   Mohankumar V, 2011, BIOCHEM BIOPH RES CO, V406, P262, DOI 10.1016/j.bbrc.2011.02.030
   Munday DC, 2010, MOL CELL PROTEOMICS, V9, P2438, DOI 10.1074/mcp.M110.001859
   Munoz-Jordan JL, 2005, J VIROL, V79, P8004, DOI 10.1128/JVI.79.13.8004-8013.2005
   Munoz-Jordan JL, 2010, CURR TOP MICROBIOL, V338, P35, DOI 10.1007/978-3-642-02215-9_3
   Muraoka T, 2012, MOL MED REP, V5, P331, DOI 10.3892/mmr.2011.662
   Nag A, 2012, J VIROL, V86, P12616, DOI 10.1128/JVI.01351-12
   Ngwa Julius S, 2011, BMC Proc, V5 Suppl 9, pS18, DOI 10.1186/1753-6561-5-S9-S18
   Nichols LA, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0014535
   Pacca C, 2009, VIRUS GENES, V38, P224, DOI 10.1007/s11262-009-0328-3
   Paek KY, 2008, J VIROL, V82, P12082, DOI 10.1128/JVI.01405-08
   Paingankar MS, 2010, ARCH VIROL, V155, P1453, DOI 10.1007/s00705-010-0728-7
   Pando-Robles V, 2014, J PROTEOMICS, V111, P16, DOI 10.1016/j.jprot.2014.06.029
   Pang XD, 2011, EUR J MED CHEM, V46, P1701, DOI 10.1016/j.ejmech.2011.02.023
   Park JS, 2000, BIOCHEM BIOPH RES CO, V267, P581, DOI 10.1006/bbrc.1999.1999
   Pastorino B, 2010, ANTIVIR RES, V87, P281, DOI 10.1016/j.antiviral.2010.04.014
   Paudel N, 2012, J VIROL, V86, P1589, DOI 10.1128/JVI.05754-11
   Peng H, 2010, P NATL ACAD SCI USA, V107, P2461, DOI 10.1073/pnas.0911128107
   Piccininni S, 2002, J BIOL CHEM, V277, P45670, DOI 10.1074/jbc.M204124200
   Pike L, 2006, J GENE MED, V8, P804, DOI 10.1002/jgm.909
   Poenisch M, 2010, SEMIN LIVER DIS, V30, P333, DOI 10.1055/s-0030-1267535
   Qing J, 2014, PLOS PATHOG, V10, DOI 10.1371/journal.ppat.1004422
   Qing M, 2009, ANTIMICROB AGENTS CH, V53, P3226, DOI 10.1128/AAC.00189-09
   Queiroz SRA, 2013, AN ACAD BRAS CIENC, V85, P159, DOI 10.1590/S0001-37652013005000008
   Rehman S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030071
   RICE CM, 1985, SCIENCE, V229, P726, DOI 10.1126/science.4023707
   Roland K, 2013, AQUAT TOXICOL, V128, P43, DOI 10.1016/j.aquatox.2012.10.016
   Rosnoblet C, 2012, J BIOL CHEM, V287, P44249, DOI 10.1074/jbc.M112.392209
   Ross-Thriepland D, 2013, J GEN VIROL, V94, P1009, DOI 10.1099/vir.0.050633-0
   Satoh JI, 2009, MULT SCLER J, V15, P531, DOI 10.1177/1352458508101943
   Saxena V, 2012, J VIROL, V86, P4139, DOI 10.1128/JVI.06327-11
   Shah VB, 2013, J VIROL, V87, P422, DOI 10.1128/JVI.07177-11
   Shih YT, 2010, VIROL J, V7, DOI 10.1186/1743-422X-7-214
   Shoemaker JE, 2012, BMC SYST BIOL, V6, DOI 10.1186/1752-0509-6-117
   Silvestri E, 2010, MOL BIOSYST, V6, P2256, DOI 10.1039/c0mb00040j
   Sin SH, 2007, BLOOD, V109, P2165, DOI 10.1182/blood-2006-06-028092
   Soderholm S, 2016, MOL CELL PROTEOMICS, V15, P3203, DOI 10.1074/mcp.M116.057984
   Solbak SM, 2010, BMC STRUCT BIOL, V10, DOI 10.1186/1472-6807-10-31
   Solbak SMO, 2012, BBA-PROTEINS PROTEOM, V1824, P667, DOI 10.1016/j.bbapap.2012.02.002
   Solbak SMO, 2011, BMC STRUCT BIOL, V11, DOI 10.1186/1472-6807-11-49
   Spoden G, 2013, J VIROL, V87, P7765, DOI 10.1128/JVI.00370-13
   Stelzer MK, 2010, CANCER PREV RES, V3, P1542, DOI 10.1158/1940-6207.CAPR-10-0228
   Tawaratsumida K, 2014, J VIROL, V88, P9038, DOI 10.1128/JVI.00830-14
   Tian YS, 2013, J MOL MODEL, V19, P465, DOI 10.1007/s00894-012-1560-7
   Tong AP, 2008, PROTEOMICS, V8, P2012, DOI 10.1002/pmic.200700849
   Tong WY, 2002, BIOCHEM BIOPH RES CO, V299, P366, DOI 10.1016/S0006-291X(02)02638-4
   Trinh Hung V, 2013, Int J Proteomics, V2013, P581862, DOI 10.1155/2013/581862
   Umareddy I, 2006, J GEN VIROL, V87, P2605, DOI 10.1099/vir.0.81844-0
   Vanheel A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035544
   Veillette M, 2013, RETROVIROLOGY, V10, DOI 10.1186/1742-4690-10-25
   Verdegem D, 2011, J BIOL CHEM, V286, P20441, DOI 10.1074/jbc.M110.182436
   Vester D, 2009, PROTEOMICS, V9, P3316, DOI 10.1002/pmic.200800893
   von Hahn T, 2012, GASTROENTEROLOGY, V143, P439, DOI 10.1053/j.gastro.2012.04.053
   Wagner D, 2010, INT IMMUNOPHARMACOL, V10, P990, DOI 10.1016/j.intimp.2010.05.006
   Wang S, 2013, GENE, V512, P89, DOI 10.1016/j.gene.2012.10.006
   Wang XJ, 2012, J PROTEOMICS, V75, P1411, DOI 10.1016/j.jprot.2011.11.011
   Wang YD, 2015, INT J CLIN EXP MED, V8, P10723
   Welsch C, 2007, J MOL GRAPH MODEL, V26, P546, DOI 10.1016/j.jmgm.2007.03.012
   Weng LY, 2012, BBA-GEN SUBJECTS, V1820, P1886, DOI 10.1016/j.bbagen.2012.08.017
   Wikan N, 2014, J TRANSL MED, V12, DOI 10.1186/1479-5876-12-96
   Woodham AW, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043519
   Wright C, 2009, ANN RHEUM DIS, V68, P1626, DOI 10.1136/ard.2008.097204
   Wu JH, 2005, J VIROL, V79, P10268, DOI 10.1128/JVI.79.16.10268-10277.2005
   Xie XP, 2011, J VIROL, V85, P11183, DOI 10.1128/JVI.05468-11
   Yang F, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1001118
   Yang S, 2015, J MED CHEM, V58, P9546, DOI 10.1021/acs.jmedchem.5b01064
   Zhao DM, 2012, PROTEOMICS, V12, P1970, DOI 10.1002/pmic.201100619
NR 172
TC 6
Z9 6
U1 1
U2 12
PU AMER CHEMICAL SOC
PI WASHINGTON
PA 1155 16TH ST, NW, WASHINGTON, DC 20036 USA
SN 1535-3893
EI 1535-3907
J9 J PROTEOME RES
JI J. Proteome Res.
PD APR
PY 2017
VL 16
IS 4
BP 1542
EP 1555
DI 10.1021/acs.jproteome.6b00933
PG 14
WC Biochemical Research Methods
SC Biochemistry & Molecular Biology
GA ER7IO
UT WOS:000398985700016
PM 28317380
DA 2020-12-17
ER

PT J
AU Vasconcelos-dos-Santos, A
   Loponte, HFBR
   Mantuano, NR
   Oliveira, IA
   de Paula, IF
   Teixeira, LK
   de-Freitas, JCM
   Gondim, KC
   Heise, N
   Mohana-Borges, R
   Morgado-Diaz, JA
   Dias, WB
   Todeschini, AR
AF Vasconcelos-dos-Santos, A.
   Loponte, H. F. B. R.
   Mantuano, N. R.
   Oliveira, I. A.
   de Paula, I. F.
   Teixeira, L. K.
   de-Freitas-Junior, J. C. M.
   Gondim, K. C.
   Heise, N.
   Mohana-Borges, R.
   Morgado-Diaz, J. A.
   Dias, W. B.
   Todeschini, A. R.
TI Hyperglycemia exacerbates colon cancer malignancy through hexosamine
   biosynthetic pathway
SO ONCOGENESIS
LA English
DT Article
ID BETA-N-ACETYLGLUCOSAMINE; GLUCOSE-TRANSPORT SYSTEM; IX GNT-IX;
   COLORECTAL-CANCER; ABERRANT GLYCOSYLATION; O-GLCNAC; CELL-LINES;
   EPIGENETIC REGULATION; INSULIN-RESISTANCE; DIABETES-MELLITUS
AB Hyperglycemia is a common feature of diabetes mellitus, considered as a risk factor for cancer. However, its direct effects in cancer cell behavior are relatively unexplored. Herein we show that high glucose concentration induces aberrant glycosylation, increased cell proliferation, invasion and tumor progression of colon cancer. By modulating the activity of the rate-limiting enzyme, glutamine-fructose-6-phosphate amidotransferase (GFAT), we demonstrate that hexosamine biosynthetic pathway (HBP) is involved in those processes. Biopsies from patients with colon carcinoma show increased levels of GFAT and consequently aberrant glycans' expression suggesting an increase of HBP flow in human colon cancer. All together, our results open the possibility that HBP links hyperglycemia, aberrant glycosylation and tumor malignancy, and suggest this pathway as a potential therapeutic target for colorectal cancer.
C1 [Vasconcelos-dos-Santos, A.; Loponte, H. F. B. R.; Mantuano, N. R.; Oliveira, I. A.; Heise, N.; Mohana-Borges, R.; Dias, W. B.; Todeschini, A. R.] Inst Biofis Carlos Chagas Filho, Rio De Janeiro, Brazil.
   [de Paula, I. F.; de-Freitas-Junior, J. C. M.; Gondim, K. C.; Morgado-Diaz, J. A.] Univ Fed Rio de Janeiro, Inst Bioquim Med Leopoldo Meis, Rio De Janeiro, Brazil.
   [Teixeira, L. K.] Inst Nacl Canc INCA, Programa Biol Celular, Rio De Janeiro, Brazil.
RP Todeschini, AR (corresponding author), Univ Fed Rio de Janeiro, Inst Biofis Carlos Chagas Filho, Bloco D Sala 03 CCS, BR-21941902 Rio De Janeiro, Brazil.
EM adrianet@biof.ufrj.br
RI Gondim, Katia C./AAN-4059-2020; de Freitas Junior, Julio
   Cesar/M-5754-2013; Teixeira, Leonardo Karam/S-8773-2016; Dias,
   Wagner/B-1401-2016; Todeschini, Adriane/AAG-8128-2020; Morgado-Diaz,
   Jose A./A-9649-2010; Borges, Ronaldo S Mohana/C-5575-2013; Todeschini,
   Adriane Regina/ABC-9165-2020
OI de Freitas Junior, Julio Cesar/0000-0002-2070-1432; Teixeira, Leonardo
   Karam/0000-0001-6117-423X; Todeschini, Adriane
   Regina/0000-0002-6049-2751; Heise, Norton/0000-0003-0154-7406; Oliveira,
   Isadora/0000-0003-0269-1450; Dias, Wagner/0000-0002-8378-8846
FU Conselho Nacional de Desenvolvimento Cientifico e Tecnologico
   (CNPq)National Council for Scientific and Technological Development
   (CNPq); Fundacao Carlos Chagas Filho de Amparo a Pesquisa do Estado do
   Rio de Janeiro (FAPERJ)Carlos Chagas Filho Foundation for Research
   Support of the State of Rio de Janeiro (FAPERJ); Coordenacao de
   Aperfeicoamento de Pessoal de Nivel Superior (CAPES)CAPES
FX We are grateful to the Centro Nacional de Biologia Estrutural e
   Bioimagem (CENABIO), to Centro de Espectrometria de Massas de
   Biomoleculas (CEMBIO) (Rio de Janeiro, Brazil) and Plataforma de
   Imuno-analise (PIA). This work was supported by grants from Conselho
   Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq), Fundacao
   Carlos Chagas Filho de Amparo a Pesquisa do Estado do Rio de Janeiro
   (FAPERJ), and Coordenacao de Aperfeicoamento de Pessoal de Nivel
   Superior (CAPES).
CR Algire C, 2010, ENDOCR-RELAT CANCER, V17, P351, DOI 10.1677/ERC-09-0252
   Alisson-Silva F, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0060471
   Almuhaideb A, 2011, ANN SAUDI MED, V31, P3, DOI 10.4103/0256-4947.75771
   Amoedo N. D., 2013, BIOSCI REP, V33
   Aurer I, 2007, COLLEGIUM ANTROPOL, V31, P247
   Barone BB, 2008, JAMA-J AM MED ASSOC, V300, P2754, DOI 10.1001/jama.2008.824
   BAUMANN H, 1979, CANCER RES, V39, P2637
   Bennmann D, 2016, FEBS J, V283, P2285, DOI 10.1111/febs.13729
   BERG EL, 1991, J BIOL CHEM, V266, P14869
   Borsig L, 2002, P NATL ACAD SCI USA, V99, P2193, DOI 10.1073/pnas.261704098
   Buck A, 2015, J PATHOL, V237, P123, DOI 10.1002/path.4560
   Burns MJ, 2005, BMC BIOTECHNOL, V5, DOI 10.1186/1472-6750-5-31
   Buzzai M, 2007, CANCER RES, V67, P6745, DOI 10.1158/0008-5472.CAN-06-4447
   Cencioni C, 2014, INT J BIOCHEM CELL B, V51, P155, DOI 10.1016/j.biocel.2014.04.014
   de Queirozl RM, 2014, FRONT ONCOL, V4, DOI 10.3389/fonc.2014.00132
   Dehennaut V, 2014, FRONT ENDOCRINOL, V5, DOI 10.3389/fendo.2014.00155
   Dennis JW, 2009, CELL, V139, P1229, DOI 10.1016/j.cell.2009.12.008
   Devaraj S, 2005, DIABETES, V54, P85, DOI 10.2337/diabetes.54.1.85
   Ding MX, 2012, ASIAN PAC J CANCER P, V13, P5653, DOI 10.7314/APJCP.2012.13.11.5653
   Duan WX, 2014, BIOMED RES INT, V2014, DOI 10.1155/2014/461917
   Durning SP, 2016, J BIOL CHEM, V291, P2107, DOI 10.1074/jbc.M115.693580
   Garcia-Jimenez C, 2014, J MOL ENDOCRINOL, V52, pR51, DOI 10.1530/JME-13-0152
   Giouleme O, 2011, WORLD J GASTROENTERO, V17, P444, DOI 10.3748/wjg.v17.i4.444
   Giovannucci E, 2010, CA-CANCER J CLIN, V60, P207, DOI 10.3322/caac.20078
   Giuffre G, 1996, VIRCHOWS ARCH, V429, P345
   Gonzalez Y, 2012, BMC IMMUNOL, V13, DOI 10.1186/1471-2172-13-19
   Greville G, 2016, EPIGENETICS-US, V11, P845, DOI 10.1080/15592294.2016.1241932
   Guo HB, 2014, J BIOL CHEM, V289, P31534, DOI 10.1074/jbc.M114.602680
   Guo JM, 2004, ONCOLOGY-BASEL, V67, P271, DOI 10.1159/000081328
   Gupta C, 2014, EXP CELL RES, V324, P75, DOI 10.1016/j.yexcr.2014.03.019
   Hahn T, 1998, INT J CANCER, V78, P353, DOI 10.1002/(SICI)1097-0215(19981029)78:3<353::AID-IJC16>3.0.CO;2-7
   Hanover JA, 2012, NAT REV MOL CELL BIO, V13, P312, DOI 10.1038/nrm3334
   HARRIS RD, 1991, KIDNEY INT, V40, P107, DOI 10.1038/ki.1991.187
   Hart GW, 2007, NATURE, V446, P1017, DOI 10.1038/nature05815
   HEILIG CW, 1995, J CLIN INVEST, V96, P1802, DOI 10.1172/JCI118226
   Heimburg-Molinaro J, 2011, VACCINE, V29, P8802, DOI 10.1016/j.vaccine.2011.09.009
   Hirabayashi J, 2002, BBA-GEN SUBJECTS, V1572, P232, DOI 10.1016/S0304-4165(02)00311-2
   Holmes K, 2001, Curr Protoc Immunol, VChapter 5, DOI 10.1002/0471142735.im0503s44
   Holst S, 2015, ADV CANCER RES, V126, P203, DOI 10.1016/bs.acr.2014.11.004
   Holst S, 2013, MOL CELL PROTEOMICS, V12, P3081, DOI 10.1074/mcp.M113.030387
   Itkonen HM, 2013, CANCER RES, V73, P5277, DOI 10.1158/0008-5472.CAN-13-0549
   ITZKOWITZ SH, 1989, CANCER RES, V49, P197
   Jiang XM, 2015, ONCOTARGET, V6, P3178, DOI 10.18632/oncotarget.3063
   Johnson JA, 2012, DIABETOLOGIA, V55, P1607, DOI 10.1007/s00125-012-2525-1
   Kemmner W, 2003, BBA-GEN SUBJECTS, V1621, P272, DOI 10.1016/S0304-4165(03)00079-5
   Kizuka Y, 2014, J BIOL CHEM, V289, P11253, DOI 10.1074/jbc.M114.554311
   Kizuka Y, 2011, J BIOL CHEM, V286, P31875, DOI 10.1074/jbc.M111.251173
   Krechler T, 2004, Cas Lek Cesk, V143, P97
   Lau KS, 2007, CELL, V129, P123, DOI 10.1016/j.cell.2007.01.049
   Li W, 2012, FRONT BIOSCI-LANDMRK, V17, P1761, DOI 10.2741/4017
   Libby G, 2009, DIABETES CARE, V32, P1620, DOI 10.2337/dc08-2175
   Lin CY, 2015, WORLD J GASTROENTERO, V21, P2047, DOI 10.3748/wjg.v21.i7.2047
   Liu BL, 2009, CELL CYCLE, V8, P2031, DOI 10.4161/cc.8.13.8814
   Liu FT, 2005, NAT REV CANCER, V5, P29, DOI 10.1038/nrc1527
   Liu J, 2011, MOL MED REP, V4, P1299, DOI 10.3892/mmr.2011.569
   Lopez R, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0079708
   Lucena MC, 2016, J BIOL CHEM, V291, P12917, DOI 10.1074/jbc.M116.729236
   de-Freitas JCM, 2016, ONCOTARGET, V7, P19395, DOI 10.18632/oncotarget.6283
   MARSHALL S, 1991, J BIOL CHEM, V266, P4706
   Mascini NE, 2016, ANAL CHEM, V88, P3107, DOI 10.1021/acs.analchem.5b04032
   Masur K, 2011, BRIT J CANCER, V104, P345, DOI 10.1038/sj.bjc.6606050
   Mills KT, 2013, DIS COLON RECTUM, V56, P1304, DOI 10.1097/DCR.0b013e3182a479f9
   Moriwaki K, 2010, WORLD J HEPATOL, V2, P151, DOI 10.4254/wjh.v2.i4.151
   Moriwaki K, 2009, GASTROENTEROLOGY, V137, P188, DOI 10.1053/j.gastro.2009.04.002
   Nakayama K, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0070298
   Nordgard O, 2006, ANAL BIOCHEM, V356, P182, DOI 10.1016/j.ab.2006.06.020
   Oki T, 1999, GENOMICS, V57, P227, DOI 10.1006/geno.1999.5785
   Onitsuka K, 2003, CANCER SCI, V94, P32, DOI 10.1111/j.1349-7006.2003.tb01348.x
   Onodera Y, 2014, J CLIN INVEST, V124, P367, DOI 10.1172/JCI63146
   Park JJ, 2013, GUT LIVER, V7, P629, DOI 10.5009/gnl.2013.7.6.629
   Pavlova NN, 2016, CELL METAB, V23, P27, DOI 10.1016/j.cmet.2015.12.006
   Pinho SS, 2015, NAT REV CANCER, V15, P540, DOI 10.1038/nrc3982
   Plass C, 2013, NAT REV GENET, V14, P765, DOI 10.1038/nrg3554
   Qiu YH, 2008, J PROTEOME RES, V7, P1693, DOI 10.1021/pr700706s
   Rajaram S, 1997, ENDOCR REV, V18, P801, DOI 10.1210/er.18.6.801
   Rozen S, 2000, Methods Mol Biol, V132, P365
   Ryu TY, 2014, DIABETES METAB J, V38, P330, DOI 10.4093/dmj.2014.38.5.330
   Saengboonmee C, 2016, SCI REP-UK, V6, DOI 10.1038/srep18995
   Saldova R, 2011, EPIGENETICS-US, V6, P1362, DOI 10.4161/epi.6.11.17977
   Seales EC, 2005, CANCER RES, V65, P4645, DOI 10.1158/0008-5472.CAN-04-3117
   Sethi MK, 2014, J PROTEOME RES, V13, P277, DOI 10.1021/pr400861m
   Siegel R, 2014, CA-CANCER J CLIN, V64, P104, DOI 10.3322/caac.21220
   Srinivasan V, 2007, CLIN BIOCHEM, V40, P952, DOI 10.1016/j.clinbiochem.2007.05.002
   Suh S, 2011, DIABETES METAB J, V35, P193, DOI 10.4093/dmj.2011.35.3.193
   Swindall AF, 2013, CANCER RES, V73, P2368, DOI 10.1158/0008-5472.CAN-12-3424
   Tolboom Tanja C. A., 2007, V135, P413
   Vasconcelos-dos-Santos A, 2015, FRONT ONCOL, V5, DOI 10.3389/fonc.2015.00138
   VAVASSEUR F, 1994, EUR J BIOCHEM, V222, P415, DOI 10.1111/j.1432-1033.1994.tb18880.x
   Vigneri P, 2009, ENDOCR-RELAT CANCER, V16, P1103, DOI 10.1677/ERC-09-0087
   Vojta A, 2016, BBA-GEN SUBJECTS, V1860, P1776, DOI 10.1016/j.bbagen.2016.01.002
   Wellen KE, 2012, NAT REV MOL CELL BIO, V13, P270, DOI 10.1038/nrm3305
   Wojciechowska J, 2016, EXP CLIN ENDOCR DIAB, V124, P263, DOI 10.1055/s-0042-100910
   Zachara NE, 2004, BBA-GEN SUBJECTS, V1673, P13, DOI 10.1016/j.bbagen.2004.03.016
   Zhang W, 2013, DIABETES, V62, P4192, DOI 10.2337/db13-0312
   Zhang ZJ, 2011, DIABETES CARE, V34, P2323, DOI 10.2337/dc11-0512
NR 95
TC 38
Z9 41
U1 1
U2 5
PU NATURE PUBLISHING GROUP
PI NEW YORK
PA 75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA
SN 2157-9024
J9 ONCOGENESIS
JI Oncogenesis
PD MAR
PY 2017
VL 6
AR e306
DI 10.1038/oncsis.2017.2
PG 13
WC Oncology
SC Oncology
GA EP2RZ
UT WOS:000397232200005
PM 28319096
OA DOAJ Gold, Green Published
DA 2020-12-17
ER

PT J
AU Conde, JN
   Silva, EM
   Barbosa, AS
   Mohana-Borges, R
AF Conde, Jonas N.
   Silva, Emiliana M.
   Barbosa, Angela S.
   Mohana-Borges, Ronaldo
TI The Complement System in Flavivirus Infections
SO FRONTIERS IN MICROBIOLOGY
LA English
DT Review
DE complement system; flavivirus; dengue; NS1 protein; immune evasion
ID WEST-NILE-VIRUS; NONSTRUCTURAL PROTEIN NS1; ANTIBODY-MEDIATED
   NEUTRALIZATION; BORNE ENCEPHALITIS-VIRUS; DENGUE HEMORRHAGIC-FEVER;
   MANNOSE-BINDING LECTIN; YELLOW-FEVER; GLYCOPROTEIN NS1; RNA REPLICATION;
   FACTOR-H
AB The incidence of flavivirus infections has increased dramatically in recent decades in tropical and sub-tropical climates worldwide, affecting hundreds of millions of people each year. The Flaviviridae family includes dengue, West Nile, Zika, Japanese encephalitis, and yellow fever viruses that are typically transmitted by mosquitoes or ticks, and cause a wide range of symptoms, such as fever, shock, meningitis, paralysis, birth defects, and death. The flavivirus genome is composed of a single positive-sense RNA molecule encoding a single viral polyprotein. This polyprotein is further processed by viral and host proteases into three structural proteins (C, prM/M, E) and seven nonstructural proteins (NS1, NS2A, NS2B, NS3, NS4A, NS4B, NS5) that are involved in viral replication and pathogenicity. The complement system has been described to play an important role in flavivirus infection either by protecting the host and/or by influencing disease pathogenesis. In this mini-review, we will explore the role of complement system inhibition and/or activation against infection by the Flavivirus genus, with an emphasis on dengue and West Nile viruses.
C1 [Conde, Jonas N.; Silva, Emiliana M.; Mohana-Borges, Ronaldo] Univ Fed Rio de Janeiro, Inst Biofis Carlos Chagas Filho, Lab Genom Estrutural, Rio De Janeiro, Brazil.
   [Barbosa, Angela S.] Inst Butantan, Bacteriol Lab, Sao Paulo, Brazil.
RP Conde, JN; Mohana-Borges, R (corresponding author), Univ Fed Rio de Janeiro, Inst Biofis Carlos Chagas Filho, Lab Genom Estrutural, Rio De Janeiro, Brazil.
EM jonasconde@biof.ufrj.br; mohana@biof.ufrj.br
RI Barbosa, Angela S/I-3518-2013; Borges, Ronaldo S Mohana/C-5575-2013;
   Nascimento conde, Jonas/D-4481-2019
OI Barbosa, Angela S/0000-0002-6458-9489; 
FU ICGEB [CRP/BRA15-02]
FX We want to thank the ICGEB grant (project CRP/BRA15-02).
CR Akey DL, 2015, BIOESSAYS, V37, P489, DOI 10.1002/bies.201400182
   Akey DL, 2014, SCIENCE, V343, P881, DOI 10.1126/science.1247749
   Alcon S, 2002, J CLIN MICROBIOL, V40, P376, DOI 10.1128/JCM.40.02.376-381.2002
   Avirutnan P, 2006, J INFECT DIS, V193, P1078, DOI 10.1086/500949
   Avirutnan P, 1998, J IMMUNOL, V161, P6338
   Avirutnan P, 2011, MBIO, V2, DOI 10.1128/mBio.00276-11
   Avirutnan P, 2011, J IMMUNOL, V187, P424, DOI 10.4049/jimmunol.1100750
   Avirutnan P, 2010, J EXP MED, V207, P793, DOI 10.1084/jem.20092545
   Balsitis SJ, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000790
   Basu A, 2008, FEMS IMMUNOL MED MIC, V53, P287, DOI 10.1111/j.1574-695X.2008.00420.x
   Beatty PR, 2015, SCI TRANSL MED, V7, DOI 10.1126/scitranslmed.aaa3787
   Bennett SN, 2003, MOL BIOL EVOL, V20, P1650, DOI 10.1093/molbev/msg182
   Bhatt S, 2013, NATURE, V496, P504, DOI 10.1038/nature12060
   Bhattacharjee A, 2013, J BIOL CHEM, V288, P18685, DOI 10.1074/jbc.M113.459040
   BOKISCH VA, 1973, NEW ENGL J MED, V289, P996, DOI 10.1056/NEJM197311082891902
   BRANDT WE, 1970, J IMMUNOL, V105, P1565
   CARDOSA MJ, 1986, J VIROL, V57, P952, DOI 10.1128/JVI.57.3.952-959.1986
   CARDOSA MJ, 1983, J EXP MED, V158, P258, DOI 10.1084/jem.158.1.258
   Chan M, 2016, LANCET, V387, P2165, DOI 10.1016/S0140-6736(16)30620-1
   Chung KM, 2006, P NATL ACAD SCI USA, V103, P19111, DOI 10.1073/pnas.0605668103
   Conde JN, 2016, J VIROL, V90, P9570, DOI 10.1128/JVI.00912-16
   CROOKS AJ, 1990, J CHROMATOGR, V502, P59, DOI 10.1016/S0021-9673(01)89563-7
   CROOKS AJ, 1994, J GEN VIROL, V75, P3453, DOI 10.1099/0022-1317-75-12-3453
   Dalrymple NA, 2015, MBIO, V6, DOI 10.1128/mBio.00553-15
   Douradinha B, 2014, VIRUS RES, V179, P231, DOI 10.1016/j.virusres.2013.11.007
   FALGOUT B, 1995, J VIROL, V69, P7232, DOI 10.1128/JVI.69.11.7232-7243.1995
   Flamand M, 1999, J VIROL, V73, P6104, DOI 10.1128/JVI.73.7.6104-6110.1999
   Fragnoud R, 2015, BMC INFECT DIS, V15, DOI 10.1186/s12879-015-1271-7
   Fuchs A, 2011, VIROLOGY, V412, P101, DOI 10.1016/j.virol.2011.01.003
   Fuchs A, 2010, CELL HOST MICROBE, V8, P186, DOI 10.1016/j.chom.2010.07.007
   Gould EA, 2008, LANCET, V371, P500, DOI 10.1016/S0140-6736(08)60238-X
   Granwehr BP, 2004, LANCET INFECT DIS, V4, P547, DOI 10.1016/S1473-3099(04)01128-4
   Gubler DJ, 1998, CLIN MICROBIOL REV, V11, P480, DOI 10.1128/CMR.11.3.480
   Gubler DJ, 2002, ARCH MED RES, V33, P330, DOI 10.1016/S0188-4409(02)00378-8
   Gubler DJ, 2007, CLIN INFECT DIS, V45, P1039, DOI 10.1086/521911
   Gutsche I, 2011, P NATL ACAD SCI USA, V108, P8003, DOI 10.1073/pnas.1017338108
   Halstead Scott B, 2005, Vaccine, V23, P849, DOI 10.1016/j.vaccine.2004.03.069
   Huerta V, 2016, J PROTEOMICS, V131, P205, DOI 10.1016/j.jprot.2015.11.003
   Jacobs MG, 2000, FASEB J, V14, P1603, DOI 10.1096/fj.14.11.1603
   Khromykh AA, 1999, J VIROL, V73, P10272, DOI 10.1128/JVI.73.12.10272-10280.1999
   Kuno G, 2005, CLIN MICROBIOL REV, V18, P608, DOI 10.1128/CMR.18.4.608-637.2005
   Kurosu T, 2007, BIOCHEM BIOPH RES CO, V362, P1051, DOI 10.1016/j.bbrc.2007.08.137
   Lindenbach BD, 2003, ADV VIRUS RES, V59, P23, DOI 10.1016/S0065-3527(03)59002-9
   Lindenbach BD, 1997, J VIROL, V71, P9608, DOI 10.1128/JVI.71.12.9608-9617.1997
   Mackenzie JM, 1996, VIROLOGY, V220, P232, DOI 10.1006/viro.1996.0307
   MCCLOUD T G, 1970, Virology, V41, P569
   Mehlhop E, 2005, J VIROL, V79, P7466, DOI 10.1128/JVI.79.12.7466-7477.2005
   Mehlhop E, 2007, CELL HOST MICROBE, V2, P417, DOI 10.1016/j.chom.2007.09.015
   Mehlhop E, 2006, J EXP MED, V203, P1371, DOI 10.1084/jem.20052388
   Mehlhop E, 2009, CELL HOST MICROBE, V6, P381, DOI 10.1016/j.chom.2009.09.003
   Mehlhop E, 2009, VIROLOGY, V393, P11, DOI 10.1016/j.virol.2009.08.019
   Merle NS, 2015, FRONT IMMUNOL, V6, DOI 10.3389/fimmu.2015.00262
   Merle NS, 2015, FRONT IMMUNOL, V6, DOI 10.3389/fimmu.2015.00257
   Modhiran N, 2015, SCI TRANSL MED, V7, DOI 10.1126/scitranslmed.aaa3863
   Monath TP, 2003, ADV VIRUS RES, V60, P343, DOI 10.1016/S0065-3527(03)60009-6
   Mukhopadhyay S, 2005, NAT REV MICROBIOL, V3, P13, DOI 10.1038/nrmicro1067
   Muller DA, 2013, ANTIVIR RES, V98, P192, DOI 10.1016/j.antiviral.2013.03.008
   Murphy BR, 2011, ANNU REV IMMUNOL, V29, P587, DOI 10.1146/annurev-immunol-031210-101315
   Musso D, 2016, CLIN MICROBIOL REV, V29, P487, DOI 10.1128/CMR.00072-15
   Nascimento EJM, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006782
   Neal JW, 2014, J INFECTION, V69, P203, DOI 10.1016/j.jinf.2014.05.010
   Nishioka K., 1974, ALLERG IMMUNOL, V2, P385
   Persson BD, 2007, NAT STRUCT MOL BIOL, V14, P164, DOI 10.1038/nsmb1190
   Pierson TC, 2007, CELL HOST MICROBE, V1, P135, DOI 10.1016/j.chom.2007.03.002
   Pinto AK, 2014, PLOS PATHOG, V10, DOI 10.1371/journal.ppat.1004086
   PRYOR MJ, 1994, J GEN VIROL, V75, P1183, DOI 10.1099/0022-1317-75-5-1183
   Rothman AL, 2011, NAT REV IMMUNOL, V11, P532, DOI 10.1038/nri3014
   RUSSELL PK, 1970, J IMMUNOL, V105, P838
   SCHLESINGER JJ, 1990, J GEN VIROL, V71, P593, DOI 10.1099/0022-1317-71-3-593
   Schneider MC, 2009, NATURE, V458, P890, DOI 10.1038/nature07769
   Shresta S, 2012, MBIO, V3, DOI 10.1128/mBio.00003-12
   Silva EM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057514
   Simmons CP, 2012, NEW ENGL J MED, V366, P1423, DOI 10.1056/NEJMra1110265
   Steel A, 2010, VIROLOGY, V405, P505, DOI 10.1016/j.virol.2010.05.033
   Stoermer KA, 2011, VIROLOGY, V411, P362, DOI 10.1016/j.virol.2010.12.045
   Thielens NM, 2002, IMMUNOBIOLOGY, V205, P563, DOI 10.1078/0171-2985-00155
   Thiemmeca S, 2016, J IMMUNOL, V197, P4053, DOI 10.4049/jimmunol.1600323
   Ubol S, 2008, J INFECT DIS, V197, P1459, DOI 10.1086/587699
   Vasek MJ, 2016, NATURE, V534, P538, DOI 10.1038/nature18283
   Watterson D, 2016, ANTIVIR RES, V130, P7, DOI 10.1016/j.antiviral.2016.02.014
   Weaver SC, 2010, ANTIVIR RES, V85, P328, DOI 10.1016/j.antiviral.2009.10.008
   WINKLER G, 1989, VIROLOGY, V171, P302, DOI 10.1016/0042-6822(89)90544-8
   Yamanaka A, 2008, J VIROL, V82, P927, DOI 10.1128/JVI.00992-07
   Zellweger RM, 2010, CELL HOST MICROBE, V7, P128, DOI 10.1016/j.chom.2010.01.004
   Zhang R, 2016, NATURE, V535, P164, DOI 10.1038/nature18625
NR 85
TC 18
Z9 18
U1 0
U2 32
PU FRONTIERS MEDIA SA
PI LAUSANNE
PA PO BOX 110, EPFL INNOVATION PARK, BUILDING I, LAUSANNE, 1015,
   SWITZERLAND
SN 1664-302X
J9 FRONT MICROBIOL
JI Front. Microbiol.
PD FEB 14
PY 2017
VL 8
AR 213
DI 10.3389/fmicb.2017.00213
PG 7
WC Microbiology
SC Microbiology
GA EK3PI
UT WOS:000393837900001
PM 28261172
OA DOAJ Gold, Green Published
DA 2020-12-17
ER

PT J
AU Oliveira, ERA
   Mohana-Borges, R
   de Alencastro, RB
   Horta, BAC
AF Oliveira, Edson R. A.
   Mohana-Borges, Ronaldo
   de Alencastro, Ricardo B.
   Horta, Bruno A. C.
TI The flavivirus capsid protein: Structure, function and perspectives
   towards drug design
SO VIRUS RESEARCH
LA English
DT Article
DE Flavivirus; Capsid protein; Drug design; Antiviral; Review
ID VIRUS CORE PROTEIN; YELLOW-FEVER VIRUS; JAPANESE ENCEPHALITIS-VIRUS;
   PUBLIC-HEALTH PREPAREDNESS; STRUCTURE-BASED DISCOVERY; N-TERMINAL
   REGION; DENGUE-VIRUS; ZIKA VIRUS; IN-VITRO; NONSTRUCTURAL PROTEINS
AB Flaviviruses, such as dengue and zika viruses, are etiologic agents transmitted to humans mainly by arthropods and are of great epidemiological interest. The flavivirus capsid protein is a structural element required for the viral nucleocapsid assembly that presents the classical function of sheltering the viral genome. After decades of research, many reports have shown its different functionalities and influence over cell normal functioning. The subcellular distribution of this protein, which involves accumulation around lipid droplets and nuclear localization, also corroborates with its multi-functional characteristic. As flavivirus diseases are still in need of global control and in view of the possible key functionalities that the capsid protein promotes over flavivirus biology, novel considerations arise towards anti-flavivirus drug research. This review covers the main aspects concerning structural and functional features of the flavivirus C protein, ultimately, highlighting prospects in drug discovery based on this viral target. (C) 2016 Elsevier B.V. All rights reserved.
C1 [Oliveira, Edson R. A.; de Alencastro, Ricardo B.; Horta, Bruno A. C.] Univ Fed Rio de Janeiro, Inst Quim Organ, Lab Modelagem Mol, Rio De Janeiro, RJ, Brazil.
   [Mohana-Borges, Ronaldo] Univ Fed Rio de Janeiro, Inst Biofis Carlos Chagas Filho, Lab Genom Estrutural, Rio De Janeiro, RJ, Brazil.
RP Oliveira, ERA (corresponding author), Univ Fed Rio de Janeiro, Inst Quim, Ctr Tecnol, Ave Athos da Silveira Ramos 149,Bloco A,Sala 609, BR-21941909 Rio De Janeiro, RJ, Brazil.
EM edsonrao@gmail.com
RI Horta, Bruno AC/L-5079-2013; Borges, Ronaldo S Mohana/C-5575-2013
OI Horta, Bruno AC/0000-0002-3952-1474; Oliveira, Edson
   RA/0000-0002-8606-7454
FU CAPESCAPES; CNPqNational Council for Scientific and Technological
   Development (CNPq); FAPERJCarlos Chagas Filho Foundation for Research
   Support of the State of Rio de Janeiro (FAPERJ)
FX This work was supported by the Brazilian foundations CAPES, CNPq and
   FAPERJ. ERAO also acknowledges CAPES for his postdoctoral fellowship.
CR Acosta EG, 2011, VIRUS RES, V160, P173, DOI 10.1016/j.virusres.2011.06.008
   Alen MMF, 2012, J TROP MED-US, V2012, DOI 10.1155/2012/628475
   AMBERG SM, 1994, J VIROL, V68, P3794, DOI 10.1128/JVI.68.6.3794-3802.1994
   Amberg SM, 1999, J VIROL, V73, P8083, DOI 10.1128/JVI.73.10.8083-8094.1999
   Araujo AQC, 2016, BRAIN, V139, P2122, DOI 10.1093/brain/aww158
   Balinsky CA, 2013, J VIROL, V87, P13094, DOI 10.1128/JVI.00704-13
   Barrows NJ, 2016, CELL HOST MICROBE, V20, P259, DOI 10.1016/j.chom.2016.07.004
   Beesetti H., 2016, EXPERT OPIN INV DRUG, V24, P1
   Bhatt S, 2013, NATURE, V496, P504, DOI 10.1038/nature12060
   Bhuvanakantham R, 2009, BIOCHEM BIOPH RES CO, V389, P63, DOI 10.1016/j.bbrc.2009.08.108
   BIEDRZYCKA A, 1987, J GEN VIROL, V68, P1317, DOI 10.1099/0022-1317-68-5-1317
   Bodenreider C, 2009, ANAL BIOCHEM, V395, P195, DOI 10.1016/j.ab.2009.08.013
   Bogoch II, 2016, LANCET, V387, P335, DOI 10.1016/S0140-6736(16)00080-5
   Bose S, 2004, J VIROL, V78, P8146, DOI 10.1128/JVI.78.15.8146-8158.2004
   BULICH R, 1992, J GEN VIROL, V73, P2999, DOI 10.1099/0022-1317-73-11-2999
   Butler D, 2016, NATURE, V532, P155, DOI 10.1038/532155a
   Byk LA, 2016, MBIO, V7, DOI 10.1128/mBio.00804-16
   Byrd CM, 2013, ANTIMICROB AGENTS CH, V57, P1902, DOI 10.1128/AAC.02251-12
   Byrd CM, 2013, ANTIMICROB AGENTS CH, V57, P15, DOI 10.1128/AAC.01429-12
   Campbell GL, 2011, B WORLD HEALTH ORGAN, V89, P766, DOI 10.2471/BLT.10.085233
   Carvalho FA, 2012, J VIROL, V86, P2096, DOI 10.1128/JVI.06796-11
   Castro JEZ, 2011, CLIN DEV IMMUNOL, DOI 10.1155/2011/370872
   CHAMBERS TJ, 1991, J VIROL, V65, P6042, DOI 10.1128/JVI.65.11.6042-6050.1991
   CHAMBERS TJ, 1990, P NATL ACAD SCI USA, V87, P8898, DOI 10.1073/pnas.87.22.8898
   Chang CJ, 2001, DNA CELL BIOL, V20, P569, DOI 10.1089/104454901317094981
   Clyde K, 2006, J VIROL, V80, P2170, DOI 10.1128/JVI.80.5.2170-2182.2006
   Clyde K, 2008, VIROLOGY, V379, P314, DOI 10.1016/j.virol.2008.06.034
   Colpitts TM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024365
   Cregar-Hernandez Lynne, 2011, Antiviral Chemistry & Chemotherapy, V21, P209, DOI 10.3851/IMP1767
   Cronican JJ, 2010, ACS CHEM BIOL, V5, P747, DOI 10.1021/cb1001153
   de Wispelaere M, 2013, J VIROL, V87, P7367, DOI 10.1128/JVI.00632-13
   Dokland T, 2004, STRUCTURE, V12, P1157, DOI 10.1016/j.str.2004.04.024
   Durbin AP, 2016, CELL, V166, P1, DOI 10.1016/j.cell.2016.06.036
   Elachola H, 2016, LANCET, V387, P630, DOI 10.1016/S0140-6736(16)00274-9
   Fajardo E., 2016, J BIOMOL STRUCT DYN, V35, P1
   FALGOUT B, 1989, J VIROL, V63, P1852, DOI 10.1128/JVI.63.5.1852-1860.1989
   FALGOUT B, 1991, J VIROL, V65, P2467, DOI 10.1128/JVI.65.5.2467-2475.1991
   Faria NR, 2016, SCIENCE, V352, P345, DOI 10.1126/science.aaf5036
   Fassati A, 2012, VIRUS RES, V170, P15, DOI 10.1016/j.virusres.2012.09.012
   Ferlenghi I, 2001, MOL CELL, V7, P593, DOI 10.1016/S1097-2765(01)00206-4
   Freire JM, 2015, FEBS J, V282, P2267, DOI 10.1111/febs.13274
   Freire JM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0081450
   Freire JM, 2013, BIOPOLYMERS, V100, P325, DOI 10.1002/bip.22266
   Garcez PP, 2016, SCIENCE, V352, P816, DOI 10.1126/science.aaf6116
   Gubler DJ, 2007, FIELDS VIROLOGY, P1153
   Guzman MG, 2015, LANCET, V385, P453, DOI 10.1016/S0140-6736(14)60572-9
   Harrison SC, 2008, NAT STRUCT MOL BIOL, V15, P690, DOI 10.1038/nsmb.1456
   Hayakawa M, 2015, BIOCHEM BIOPH RES CO, V463, P1165, DOI 10.1016/j.bbrc.2015.06.077
   HEINZ FX, 1994, VIROLOGY, V198, P109, DOI 10.1006/viro.1994.1013
   Ho JY, 2016, J ANTIMICROB CHEMOTH, V71, P1922, DOI 10.1093/jac/dkw101
   Hovanessian AG, 2006, CELL RES, V16, P174, DOI 10.1038/sj.cr.7310024
   Iglesias NG, 2015, TRAFFIC, V16, P962, DOI 10.1111/tra.12305
   Jones CT, 2003, J VIROL, V77, P7143, DOI 10.1128/JVI.77.12.7143-7149.2003
   Kaiser R, 2016, NERVENARZT, V87, P667, DOI 10.1007/s00115-016-0134-9
   Kaiser R, 2012, WIEN MED WOCHENSCHR, V162, P229, DOI 10.1007/s10354-012-0119-7
   Kampmann T, 2009, ANTIVIR RES, V84, P234, DOI 10.1016/j.antiviral.2009.09.007
   Kielian M, 2006, NAT REV MICROBIOL, V4, P67, DOI 10.1038/nrmicro1326
   Kiermayr S, 2004, J VIROL, V78, P8078, DOI 10.1128/JVI.78.15.8078-8084.2004
   Klumpp K, 2014, CURR OPIN VIROL, V5, P63, DOI 10.1016/j.coviro.2014.02.002
   Kofler RM, 2002, J VIROL, V76, P3534, DOI 10.1128/JVI.76.7.3534-3543.2002
   Kok WM, 2016, EXPERT OPIN DRUG DIS, V11, P433, DOI 10.1517/17460441.2016.1160887
   Kuhn RJ, 2002, CELL, V108, P717, DOI 10.1016/S0092-8674(02)00660-8
   Kunze Ursula, 2008, Travel Med Infect Dis, V6, P380, DOI 10.1016/j.tmaid.2008.06.004
   Kunze U, 2016, TICKS TICK-BORNE DIS, V7, P399, DOI 10.1016/j.ttbdis.2015.12.018
   Larocca R. A., 2016, NATURE IN PRESS
   Lessler J, 2016, SCIENCE, V353, DOI 10.1126/science.aaf8160
   Li JL, 2012, BIOCHEM BIOPH RES CO, V418, P622, DOI 10.1016/j.bbrc.2012.01.050
   Li L, 2008, SCIENCE, V319, P1830, DOI 10.1126/science.1153263
   Lim SP, 2011, J BIOL CHEM, V286, P6233, DOI 10.1074/jbc.M110.179184
   Limjindaporn T, 2007, BIOCHEM BIOPH RES CO, V362, P334, DOI 10.1016/j.bbrc.2007.07.194
   Lindenbach BD, 2003, ADV VIRUS RES, V59, P23, DOI 10.1016/S0065-3527(03)59002-9
   Lo SJ, 2006, CELL RES, V16, P530, DOI 10.1038/sj.cr.7310070
   Lorenz IC, 2003, J VIROL, V77, P4370, DOI 10.1128/JVI.77.7.4370-4382.2003
   Lowe R, 2015, T ROY SOC TROP MED H, V109, P607, DOI 10.1093/trstmh/trv068
   Lucey D, 2016, JAMA-J AM MED ASSOC, V315, P2661, DOI 10.1001/jama.2016.6606
   Ma LX, 2004, P NATL ACAD SCI USA, V101, P3414, DOI 10.1073/pnas.0305892101
   Makarov VA, 2015, CHEMMEDCHEM, V10, P1629, DOI 10.1002/cmdc.201500304
   MAKINO Y, 1989, J GEN VIROL, V70, P1417, DOI 10.1099/0022-1317-70-6-1417
   Malkki H, 2016, NAT REV NEUROL, V12, DOI [10.1038/nrneurol.2016.139, 10.1038/nrneurol.2016.22, 10.1038/nrneurol.2016.117, 10.1038/nrneurol.2016.78, 10.1038/nrneurol.2016.58, 10.1038/nrneurol.2016.175, 10.1038/nrneurol.2016.79, 10.1038/nrneurol.2016.151, 10.1038/nrneurol.2016.30, 10.1038/nrneurol.2016.52]
   Mandl CW, 2004, VIRAL IMMUNOL, V17, P461, DOI 10.1089/vim.2004.17.461
   Markoff L, 1997, VIROLOGY, V233, P105, DOI 10.1006/viro.1997.8608
   MARKOFF L, 1994, VIROLOGY, V204, P526, DOI 10.1006/viro.1994.1566
   Martins IC, 2012, BIOCHEM J, V444, P405, DOI 10.1042/BJ20112219
   Mastrangelo E, 2012, J ANTIMICROB CHEMOTH, V67, P1884, DOI 10.1093/jac/dks147
   McNaughton BR, 2009, P NATL ACAD SCI USA, V106, P6111, DOI 10.1073/pnas.0807883106
   Modis Y, 2003, P NATL ACAD SCI USA, V100, P6986, DOI 10.1073/pnas.0832193100
   Mongelard F, 2007, TRENDS CELL BIOL, V17, P80, DOI 10.1016/j.tcb.2006.11.010
   Mori Y, 2005, J VIROL, V79, P3448, DOI 10.1128/JVI.79.6.3448-3458.2005
   Mori Y, 2007, J VIROL, V81, P8477, DOI 10.1128/JVI.00477-07
   Mosso C, 2008, VIROLOGY, V378, P193, DOI 10.1016/j.virol.2008.05.012
   Mukhopadhyay S, 2005, NAT REV MICROBIOL, V3, P13, DOI 10.1038/nrmicro1067
   Nayak V, 2009, J VIROL, V83, P4338, DOI 10.1128/JVI.02574-08
   Nemesio H, 2013, MOL MEMBR BIOL, V30, P273, DOI 10.3109/09687688.2013.805835
   Netsawang J, 2010, VIRUS RES, V147, P275, DOI 10.1016/j.virusres.2009.11.012
   Nguyen NM, 2013, J INFECT DIS, V207, P1442, DOI 10.1093/infdis/jis470
   Ni P, 2013, VIROLOGY, V446, P123, DOI 10.1016/j.virol.2013.07.023
   Nisole S, 1999, J BIOL CHEM, V274, P27875, DOI 10.1074/jbc.274.39.27875
   Niyomrattanakit P, 2011, J BIOMOL SCREEN, V16, P201, DOI 10.1177/1087057110389323
   Niyomrattanakit P, 2010, J VIROL, V84, P5678, DOI 10.1128/JVI.02451-09
   Noble CG, 2013, J VIROL, V87, P5291, DOI 10.1128/JVI.00045-13
   Noble CG, 2010, ANTIVIR RES, V85, P450, DOI 10.1016/j.antiviral.2009.12.011
   Noda M, 2012, BIOL-TARGETS THER, V6, P409, DOI 10.2147/BTT.S37792
   NOWAK T, 1989, VIROLOGY, V169, P365, DOI 10.1016/0042-6822(89)90162-1
   Oh WK, 2006, BIOCHEM BIOPH RES CO, V347, P994, DOI 10.1016/j.bbrc.2006.06.190
   Oh W, 2006, J BIOL CHEM, V281, P30166, DOI 10.1074/jbc.M602651200
   Patkar CG, 2007, J VIROL, V81, P6471, DOI 10.1128/JVI.02120-06
   Perilla JR, 2016, J PHYS CHEM LETT, V7, P1836, DOI 10.1021/acs.jpclett.6b00517
   Petersen E, 2016, INT J INFECT DIS, V44, P11, DOI 10.1016/j.ijid.2016.02.001
   Petersen LR, 2016, NEW ENGL J MED, V374, P1552, DOI 10.1056/NEJMra1602113
   Piccini LE, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0140824
   Poh MK, 2009, ANTIVIR RES, V84, P260, DOI 10.1016/j.antiviral.2009.09.011
   Potisopon S, 2016, NUCLEIC ACIDS RES, V44, P2974, DOI 10.1093/nar/gkv1294
   PREUGSCHAT F, 1990, J VIROL, V64, P4364, DOI 10.1128/JVI.64.9.4364-4374.1990
   RANDOLPH VB, 1990, VIROLOGY, V174, P450, DOI 10.1016/0042-6822(90)90099-D
   Roby JA, 2014, J GEN VIROL, V95, P2176, DOI 10.1099/vir.0.064121-0
   RUIZLINARES A, 1989, J VIROL, V63, P4199, DOI 10.1128/JVI.63.10.4199-4209.1989
   Said EA, 2005, FEBS J, V272, P4646, DOI 10.1111/j.1742-4658.2005.04870.x
   Salgado D, 2012, PEDIATR INFECT DIS J, V31, P771, DOI 10.1097/INF.0b013e3182575e6a
   Samsa MM, 2012, J VIROL, V86, P1046, DOI 10.1128/JVI.05431-11
   Samsa MM, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000632
   Scaturro P, 2014, J VIROL, V88, P11540, DOI 10.1128/JVI.01745-14
   Schlick P, 2010, VACCINE, V28, P5903, DOI 10.1016/j.vaccine.2010.06.045
   Sejvar JJ, 2016, MICROBIOL SPECTR, V4, DOI 10.1128/microbiolspec.EI10-0021-2016
   Smithburn K.C., 1940, AM J TROP MED HYG, V20, P471, DOI [10.4269/ajtmh.1940.s1-20.471, DOI 10.4269/AJTMH.1940.S1-20.471]
   Soto-Acosta R, 2014, ANTIVIR RES, V109, P132, DOI 10.1016/j.antiviral.2014.07.002
   SPEIGHT G, 1988, J GEN VIROL, V69, P23, DOI 10.1099/0022-1317-69-1-23
   Steffen R, 2016, J TRAVEL MED, V23, P1, DOI 10.1093/jtm/taw018
   Suksanpaisan L, 2009, J BIOMED SCI, V16, DOI 10.1186/1423-0127-16-17
   Tadano M., 1989, J GEN VIROL, V70
   Tajrishi Marjan M, 2011, Commun Integr Biol, V4, P267, DOI 10.4161/cib.4.3.14884
   Tam DTH, 2012, CLIN INFECT DIS, V55, P1216, DOI 10.1093/cid/cis655
   Tayyari F, 2011, NAT MED, V17, P1132, DOI 10.1038/nm.2444
   Thenin-Houssier S, 2016, ANTIMICROB AGENTS CH, V60, P2195, DOI 10.1128/AAC.02574-15
   Thomas SJ, 2015, VACCINE, V33, pD24, DOI 10.1016/j.vaccine.2015.05.095
   Thompson DB, 2012, METHOD ENZYMOL, V503, P293, DOI 10.1016/B978-0-12-396962-0.00012-4
   Thongtan T, 2012, J MED VIROL, V84, P615, DOI 10.1002/jmv.23248
   Tomlinson S. M., 2009, Infectious Disorders - Drug Targets, V9, P327
   Tomlinson SM, 2012, ANTIVIR RES, V93, P245, DOI 10.1016/j.antiviral.2011.12.003
   Tomlinson SM, 2011, ANTIVIR RES, V89, P127, DOI 10.1016/j.antiviral.2010.12.006
   Tomlinson SM, 2009, ANTIVIR RES, V82, P110, DOI 10.1016/j.antiviral.2009.02.190
   Tsuda Y, 2006, MICROBIOL IMMUNOL, V50, P225, DOI 10.1111/j.1348-0421.2006.tb03789.x
   van Cleef KWR, 2013, ANTIVIR RES, V99, P165, DOI 10.1016/j.antiviral.2013.05.011
   Vasconcelos PFC, 2016, VECTOR-BORNE ZOONOT, V16, P566, DOI 10.1089/vbz.2016.2031
   Ventura CV, 2016, LANCET, V387, P228, DOI 10.1016/S0140-6736(16)00006-4
   Verma R, 2014, HUM VACC IMMUNOTHER, V10, P126, DOI 10.4161/hv.26549
   Wang HY, 2015, THER CLIN RISK MANAG, V11, P435, DOI 10.2147/TCRM.S51168
   Wang QY, 2009, ANTIMICROB AGENTS CH, V53, P1823, DOI 10.1128/AAC.01148-08
   Wang SH, 2004, J GEN VIROL, V85, P2307, DOI 10.1099/vir.0.80067-0
   Wang SH, 2002, J GEN VIROL, V83, P3093, DOI 10.1099/0022-1317-83-12-3093
   Watanabe S, 2012, ANTIVIR RES, V96, P32, DOI 10.1016/j.antiviral.2012.07.008
   Watrin L, 2016, MEDICINE, V95, DOI 10.1097/MD.0000000000003257
   Weaver SC, 2016, ANTIVIR RES, V130, P69, DOI 10.1016/j.antiviral.2016.03.010
   Westaway EG, 1997, VIROLOGY, V234, P31, DOI 10.1006/viro.1997.8629
   Whitehorn J, 2016, CLIN INFECT DIS, V62, P468, DOI 10.1093/cid/civ949
   Whitehorn J, 2012, TRIALS, V13, DOI 10.1186/1745-6215-13-203
   WRIGHT PJ, 1989, VIROLOGY, V171, P61, DOI 10.1016/0042-6822(89)90510-2
   Xiao XD, 2011, BIOCHEM BIOPH RES CO, V411, P253, DOI 10.1016/j.bbrc.2011.06.109
   YAMSHCHIKOV VF, 1995, J VIROL, V69, P1995, DOI 10.1128/JVI.69.4.1995-2003.1995
   YAMSHCHIKOV VF, 1994, J VIROL, V68, P5765, DOI 10.1128/JVI.68.9.5765-5771.1994
   Yang CC, 2011, ANTIMICROB AGENTS CH, V55, P229, DOI 10.1128/AAC.00855-10
   Yang JS, 2003, EMERG INFECT DIS, V9, P406
   Yang L, 2016, ANTIVIR RES, V125, P25, DOI 10.1016/j.antiviral.2015.11.004
   Yin Z, 2009, J MED CHEM, V52, P7934, DOI 10.1021/jm901044z
   Yin Z, 2009, P NATL ACAD SCI USA, V106, P20435, DOI 10.1073/pnas.0907010106
   Yu IM, 2008, SCIENCE, V319, P1834, DOI 10.1126/science.1153264
   Yun SI, 2014, HUM VACC IMMUNOTHER, V10, P263, DOI 10.4161/hv.26902
   Zaitseva E, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1001131
   Zhang Y, 2007, J VIROL, V81, P6141, DOI 10.1128/JVI.00037-07
   Zhou ZG, 2008, ACS CHEM BIOL, V3, P765, DOI 10.1021/cb800176t
NR 169
TC 34
Z9 35
U1 1
U2 86
PU ELSEVIER
PI AMSTERDAM
PA RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS
SN 0168-1702
EI 1872-7492
J9 VIRUS RES
JI Virus Res.
PD JAN 2
PY 2017
VL 227
BP 115
EP 123
DI 10.1016/j.virusres.2016.10.005
PG 9
WC Virology
SC Virology
GA EE6NO
UT WOS:000389729700015
PM 27751882
DA 2020-12-17
ER

PT J
AU Oliveira, IA
   Pol-Fachin, L
   Carvalho, ST
   Lins, RD
   Soares, TA
   Mohana-Borges, R
   Neves, JL
   Todeschini, AR
AF Oliveira, Isadora A.
   Pol-Fachin, Laercio
   Carvalho, Sebastiao T.
   Lins, Roberto D.
   Soares, Thereza A.
   Mohana-Borges, Ronaldo
   Neves, Jorge L.
   Todeschini, Adriane R.
TI Plasmodium falciparum rosetting domain recognizes ABH histo-blood group
   antigens in a type specific manner
SO GLYCOBIOLOGY
LA English
DT Meeting Abstract
CT Annual Meeting of the Society-for-Glycobiology
CY NOV 19-22, 2016
CL New Orleans, LA
SP Soc Glycobiol
C1 [Oliveira, Isadora A.; Carvalho, Sebastiao T.; Mohana-Borges, Ronaldo; Todeschini, Adriane R.] Univ Fed Rio de Janeiro, Inst Biofis Carlos Chagas Filho, Rio De Janeiro, RJ, Brazil.
   [Pol-Fachin, Laercio; Soares, Thereza A.; Neves, Jorge L.] Univ Fed Pernambuco, Dept Quim Fundamental, Recife, PE, Brazil.
   [Pol-Fachin, Laercio; Lins, Roberto D.] Fundacao Oswaldo Cruz, Ctr Pesquisas Aggeu Magalhaes, Recife, PE, Brazil.
RI Soares, Thereza A./M-9962-2019; Todeschini, Adriane
   Regina/ABC-9165-2020; Borges, Ronaldo S Mohana/C-5575-2013; Soares,
   Thereza A./G-1065-2010; Todeschini, Adriane/AAG-8128-2020
OI Soares, Thereza A./0000-0002-5891-6906; Todeschini, Adriane
   Regina/0000-0002-6049-2751; Soares, Thereza A./0000-0002-5891-6906; 
NR 0
TC 0
Z9 0
U1 0
U2 0
PU OXFORD UNIV PRESS INC
PI CARY
PA JOURNALS DEPT, 2001 EVANS RD, CARY, NC 27513 USA
SN 0959-6658
EI 1460-2423
J9 GLYCOBIOLOGY
JI Glycobiology
PD DEC
PY 2016
VL 26
IS 12
MA 82
BP 1407
EP 1407
PG 1
WC Biochemistry & Molecular Biology
SC Biochemistry & Molecular Biology
GA EJ0XX
UT WOS:000392935600085
DA 2020-12-17
ER

PT J
AU Conde, JN
   da Silva, EM
   Allonso, D
   Coelho, DR
   Andrade, ID
   de Medeiros, LN
   Menezes, JL
   Barbosa, AS
   Mohana-Borges, R
AF Conde, Jonas Nascimento
   da Silva, Emiliana Mandarano
   Allonso, Diego
   Coelho, Diego Rodrigues
   Andrade, Iamara da Silva
   de Medeiros, Luciano Neves
   Menezes, Joice Lima
   Barbosa, Angela Silva
   Mohana-Borges, Ronaldo
TI Inhibition of the Membrane Attack Complex by Dengue Virus NS1 through
   Interaction with Vitronectin and Terminal Complement Proteins
SO JOURNAL OF VIROLOGY
LA English
DT Article
ID PLASMINOGEN-ACTIVATOR INHIBITOR-1; HEPARIN-BINDING DOMAINS;
   HEMORRHAGIC-FEVER; ESCHERICHIA-COLI; RNA REPLICATION; FACTOR-H; REVEALS;
   IDENTIFICATION; GLYCOPROTEIN; PURIFICATION
AB Dengue virus (DENV) infects millions of people worldwide and is a major public health problem. DENV nonstructural protein 1 (NS1) is a conserved glycoprotein that associates with membranes and is also secreted into the plasma in DENV-infected patients. The present study describes a novel mechanism by which NS1 inhibits the terminal complement pathway. We first identified the terminal complement regulator vitronectin (VN) as a novel DENV2 NS1 binding partner by using a yeast two-hybrid system. This interaction was further assessed by enzyme-linked immunosorbent assay (ELISA) and surface plasmon resonance (SPR) assay. The NS1-VN complex was also detected in plasmas from DENV-infected patients, suggesting that this interaction occurs during DENV infection. We also demonstrated that the DENV2 NS1 protein, either by itself or by interacting with VN, hinders the formation of the membrane attack complex (MAC) and C9 polymerization. Finally, we showed that DENV2, West Nile virus (WNV), and Zika virus (ZIKV) NS1 proteins produced in mammalian cells inhibited C9 polymerization. Taken together, our results points to a role for NS1 as a terminal pathway inhibitor of the complement system.
C1 [Conde, Jonas Nascimento; da Silva, Emiliana Mandarano; Allonso, Diego; Coelho, Diego Rodrigues; Andrade, Iamara da Silva; Menezes, Joice Lima; Mohana-Borges, Ronaldo] Univ Fed Rio de Janeiro, Inst Biofis Carlos Chagas Filho, Lab Genom Estrutural, Rio De Janeiro, RJ, Brazil.
   [de Medeiros, Luciano Neves] Univ Fed Rio de Janeiro, Inst Biofis Carlos Chagas Filho, Lab Biol Mol & Bioquim Prot, Rio De Janeiro, RJ, Brazil.
   [Barbosa, Angela Silva] Inst Butantan, Bacteriol Lab, Sao Paulo, SP, Brazil.
   [Andrade, Iamara da Silva] Fac Educ Tecnol Estado Rio De Janeiro FAETERJ FAE, Paracambi, RJ, Brazil.
RP Mohana-Borges, R (corresponding author), Univ Fed Rio de Janeiro, Inst Biofis Carlos Chagas Filho, Lab Genom Estrutural, Rio De Janeiro, RJ, Brazil.
EM mohana@biof.ufrj.br
RI Borges, Ronaldo S Mohana/C-5575-2013; Nascimento conde,
   Jonas/D-4481-2019; Barbosa, Angela S/I-3518-2013; Allonso,
   Diego/Y-3446-2018
OI Barbosa, Angela S/0000-0002-6458-9489; Allonso,
   Diego/0000-0002-1410-480X
FU International Centre for Genetic Engineering and Biotechnology (ICGEB)
   [CRP/BRA15-02]; Fundacao Carlos Chagas Filho de Amparo a Pesquisa do
   Estado do Rio de Janeiro (FAPERJ)Carlos Chagas Filho Foundation for
   Research Support of the State of Rio de Janeiro (FAPERJ) [475104/2012-9]
FX This work, including the efforts of Ronaldo Mohana-Borges, was funded by
   International Centre for Genetic Engineering and Biotechnology (ICGEB)
   (CRP/BRA15-02). This work, including the efforts of Ronaldo
   Mohana-Borges, was funded by Fundacao Carlos Chagas Filho de Amparo a
   Pesquisa do Estado do Rio de Janeiro (FAPERJ) (475104/2012-9).
CR Akey DL, 2014, SCIENCE, V343, P881, DOI 10.1126/science.1247749
   Alcon S, 2002, J CLIN MICROBIOL, V40, P376, DOI 10.1128/JCM.40.02.376-381.2002
   Allonso D, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0113634
   Allonso D, 2011, J VIROL METHODS, V175, P109, DOI 10.1016/j.jviromet.2011.04.029
   [Anonymous], 2009, DENG GUID DIAGN TREA
   Avirutnan P, 2011, J IMMUNOL, V187, P424, DOI 10.4049/jimmunol.1100750
   Avirutnan P, 2010, J EXP MED, V207, P793, DOI 10.1084/jem.20092545
   Bhatt S, 2013, NATURE, V496, P504, DOI 10.1038/nature12060
   Bozzini S, 1998, J MED VIROL, V54, P44, DOI 10.1002/(SICI)1096-9071(199801)54:1&lt;44::AID-JMV7&gt;3.0.CO;2-P
   Chung KM, 2006, P NATL ACAD SCI USA, V103, P19111, DOI 10.1073/pnas.0605668103
   Cunha CSE, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000911
   da Silva LB, 2015, INFECT IMMUN, V83, P888, DOI 10.1128/IAI.02844-14
   DECLERCK PJ, 1988, J BIOL CHEM, V263, P15454
   Djamiatun K, 2011, J TROP PEDIATRICS, V57, P424, DOI 10.1093/tropej/fmq122
   Gutsche I, 2011, P NATL ACAD SCI USA, V108, P8003, DOI 10.1073/pnas.1017338108
   Hallstrom T, 2009, J IMMUNOL, V183, P2593, DOI 10.4049/jimmunol.0803226
   Hansen M, 2001, EUR J BIOCHEM, V268, P6274, DOI 10.1046/j.0014-2956.2001.02582.x
   Huang YP, 2005, WORLD J GASTROENTERO, V11, P5659, DOI 10.3748/wjg.v11.i36.5659
   Kohler S, 2015, THROMB HAEMOSTASIS, V113, P125, DOI 10.1160/TH14-06-0561
   KOST C, 1992, J BIOL CHEM, V267, P12098
   LANE DA, 1987, J BIOL CHEM, V262, P16343
   LAWRENCE D, 1989, EUR J BIOCHEM, V186, P523, DOI 10.1111/j.1432-1033.1989.tb15238.x
   Liang OD, 1997, BIOCHEM BIOPH RES CO, V234, P445, DOI 10.1006/bbrc.1997.6663
   Liang OD, 1997, FEBS LETT, V407, P169, DOI 10.1016/S0014-5793(97)00330-X
   Libraty DH, 2002, J INFECT DIS, V186, P1165, DOI 10.1086/343813
   Lindenbach BD, 2003, ADV VIRUS RES, V59, P23, DOI 10.1016/S0065-3527(03)59002-9
   Lindenbach BD, 1997, J VIROL, V71, P9608, DOI 10.1128/JVI.71.12.9608-9617.1997
   Mackenzie JM, 1996, VIROLOGY, V220, P232, DOI 10.1006/viro.1996.0307
   Mairuhu ATA, 2005, THROMB J, V3, DOI 10.1186/1477-9560-3-17
   MILIS L, 1993, CLIN EXP IMMUNOL, V92, P114
   Miner JJ, 2016, CELL, V165, P1080, DOI 10.1016/j.cell.2016.05.008
   Modhiran N, 2015, SCI TRANSL MED, V7, DOI 10.1126/scitranslmed.aaa3863
   Muller DA, 2013, ANTIVIR RES, V98, P192, DOI 10.1016/j.antiviral.2013.03.008
   PODACK ER, 1984, ACTA PATH MICRO IM C, V92, P89
   PREISSNER KT, 1990, BIOCHEM BIOPH RES CO, V168, P966, DOI 10.1016/0006-291X(90)91123-A
   Schar CR, 2008, J BIOL CHEM, V283, P28487, DOI 10.1074/jbc.M804257200
   SHEEHAN M, 1995, CLIN EXP IMMUNOL, V101, P136
   Shyu HW, 2010, THROMB HAEMOSTASIS, V104, P1219, DOI 10.1160/TH10-05-0302
   Silva EM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057514
   Singh B, 2010, MOL MICROBIOL, V78, P545, DOI 10.1111/j.1365-2958.2010.07373.x
   SU HR, 1994, INT ARCH ALLERGY IMM, V105, P238, DOI 10.1159/000236763
   Su YC, 2013, MOL MICROBIOL, V87, P1245, DOI 10.1111/mmi.12164
   Veerhuis R, 2011, MOL IMMUNOL, V48, P1592, DOI 10.1016/j.molimm.2011.04.003
   Wills BA, 2002, CLIN INFECT DIS, V35, P277, DOI 10.1086/341410
   Xu D, 2001, PROTEINS, V44, P312, DOI 10.1002/prot.1096
   YASUMITSU H, 1993, IN VITRO CELL DEV-AN, V29A, P403
   Zhang ZF, 2011, PLOS NEGLECT TROP D, V5, DOI 10.1371/journal.pntd.0001225
   Zhou AW, 2001, J BIOL CHEM, V276, P27541, DOI 10.1074/jbc.M102594200
NR 48
TC 26
Z9 26
U1 0
U2 30
PU AMER SOC MICROBIOLOGY
PI WASHINGTON
PA 1752 N ST NW, WASHINGTON, DC 20036-2904 USA
SN 0022-538X
EI 1098-5514
J9 J VIROL
JI J. Virol.
PD NOV
PY 2016
VL 90
IS 21
BP 9570
EP 9581
DI 10.1128/JVI.00912-16
PG 12
WC Virology
SC Virology
GA DZ0JW
UT WOS:000385525700002
PM 27512066
OA Green Published, Bronze
DA 2020-12-17
ER

PT J
AU da Silva, ICD
   Carneiro, VC
   Vicentino, ARR
   Aguilera, EA
   Mohana-Borges, R
   Thiengo, S
   Fernandez, MA
   Fantappie, MR
AF de Abreu da Silva, Isabel Caetano
   Carneiro, Vitor Coutinho
   Revoredo Vicentino, Amanda Roberta
   Aguilera, Estefania Anahi
   Mohana-Borges, Ronaldo
   Thiengo, Silvana
   Fernandez, Monica Ammon
   Fantappie, Marcelo Rosado
TI The distinct C-terminal acidic domains of HMGB proteins are functionally
   relevant in Schistosoma mansoni
SO INTERNATIONAL JOURNAL FOR PARASITOLOGY
LA English
DT Article
DE Schistosoma mansoni; HMGB proteins; DNA binding proteins; DNA
   transactions
ID DNA-BINDING PROPERTIES; CHROMATIN-STRUCTURE; TAIL; NUCLEOSOME; BOX;
   TRANSCRIPTION; ACETYLATION; INFECTION; VACCINES; CLONING
AB The Schistosoma mansoni High Mobility Group Box (HMGB) proteins SmHMGB1, SmHMGB2 and SmHMGB3 share highly conserved HMG box DNA binding domains but have significantly different C-terminal acidic tails. Here, we used three full-length and tailless forms of the S. mansoni HMGB proteins to examine the functional roles of their acidic tails. DNA binding assays revealed that the different lengths of the acidic tails among the three SmHMGB proteins significantly and distinctively influenced their DNA transactions. Spectroscopic analyses indicated that the longest acidic tail of SmHMGB3 contributes to the structural stabilisation of this protein. Using immunohistochemical analysis, we showed distinct patterns of SmHMGB1, SmHMGB2 and SmHMGB3 expression in different tissues of adult worms. RNA interference approaches indicated a role for SmHMGB2 and SmHMGB3 in the reproductive system of female worms, whereas for SmHMGB1 no clear phenotype was observed. Schistosome HMGB proteins can be phosphorylated, acetylated and methylated. Importantly, the acetylation and methylation of schistosome HMGBs were greatly enhanced upon removal of the acidic tail. These data support the notion that the C-terminal acidic tails dictate the differences in the structure, expression and function of schistosome HMGB proteins. (C) 2016 Australian Society for Parasitology Inc. Published by Elsevier Ltd. All rights reserved.
C1 [de Abreu da Silva, Isabel Caetano; Carneiro, Vitor Coutinho; Revoredo Vicentino, Amanda Roberta; Fantappie, Marcelo Rosado] Univ Fed Rio de Janeiro, Program Mol Biol & Biotechnol, Inst Bioquim Med Leopoldo Meis, BR-21941902 Rio De Janeiro, Brazil.
   [Aguilera, Estefania Anahi; Mohana-Borges, Ronaldo] Univ Fed Rio de Janeiro, Inst Biofis Carlos Chagas Filho, BR-21941902 Rio De Janeiro, Brazil.
   [Thiengo, Silvana; Fernandez, Monica Ammon] Inst Oswaldo Cruz, Lab Malacol, Fdn Oswaldo Cruz, Rio De Janeiro, Brazil.
RP Fantappie, MR (corresponding author), Univ Fed Rio de Janeiro, Inst Bioquim Med Leopoldo Meis, CCS, Ilha Fdn, BR-21941902 Rio De Janeiro, Brazil.
EM fantappie@bioqmed.ufrj.br
RI Borges, Ronaldo S Mohana/C-5575-2013
OI Thiengo, Silvana/0000-0002-5547-206X; Carneiro,
   Vitor/0000-0003-1518-7667
FU Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq),
   BrasilNational Council for Scientific and Technological Development
   (CNPq) [470099/20143]; Fundacao Carlos Chagas Filho de Amparo a Pesquisa
   do Estado do Rio de Janeiro (FAPERJ), BrasilCarlos Chagas Filho
   Foundation for Research Support of the State of Rio de Janeiro (FAPERJ)
   [E-26/010.001554/2014]
FX We thank Mr. Paulo Cesar dos Santos (Fiocruz, Rio de Janeiro, Brasil)
   for providing S. mansoni cercariae. This work was financially supported
   through grants from the Conselho Nacional de Desenvolvimento Cientifico
   e Tecnologico (CNPq - grant number 470099/20143), Brasil and Fundacao
   Carlos Chagas Filho de Amparo a Pesquisa do Estado do Rio de Janeiro
   (FAPERJ - grant number: E-26/010.001554/2014), Brasil to MRF.
CR Agresti A, 2003, CURR OPIN GENET DEV, V13, P170, DOI 10.1016/S0959-437X(03)00023-6
   de Oliveira FMB, 2006, GENE, V377, P33, DOI 10.1016/j.gene.2006.03.001
   Belgrano FS, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0079572
   BIANCHI ME, 1989, SCIENCE, V243, P1056, DOI 10.1126/science.2922595
   Carneiro VC, 2014, PLOS PATHOG, V10, DOI 10.1371/journal.ppat.1004116
   Carneiro VC, 2009, BIOCHEM BIOPH RES CO, V390, P1245, DOI 10.1016/j.bbrc.2009.10.129
   Catena R, 2009, BIOL REPROD, V80, P358, DOI 10.1095/biolreprod.108.070243
   da Silva ICD, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023572
   DeMarco R, 2009, DRUG DISCOV TODAY, V14, P472, DOI 10.1016/j.drudis.2009.01.011
   El-Ansary A, 2005, MED SCI MONITOR, V11, pRA94
   Fantappie MR, 2008, ACTA TROP, V108, P186, DOI 10.1016/j.actatropica.2007.11.006
   GROSSCHEDL R, 1994, TRENDS GENET, V10, P94, DOI 10.1016/0168-9525(94)90232-1
   Groth A, 2007, CELL, V128, P721, DOI 10.1016/j.cell.2007.01.030
   Happel N, 2009, GENE, V431, P1, DOI 10.1016/j.gene.2008.11.003
   Hotez PJ, 2010, NAT REV MICROBIOL, V8, P814, DOI 10.1038/nrmicro2438
   Jaouen S, 2005, J MOL BIOL, V353, P822, DOI 10.1016/j.jmb.2005.08.073
   Kornberg RD, 1999, CELL, V98, P285, DOI 10.1016/S0092-8674(00)81958-3
   KORNBERG RD, 1974, SCIENCE, V184, P865, DOI 10.1126/science.184.4139.865
   Lee KB, 2000, J MOL BIOL, V304, P135, DOI 10.1006/jmbi.2000.4206
   Li B, 2007, CELL, V128, P707, DOI 10.1016/j.cell.2007.01.015
   Maciel RD, 2004, MOL BIOCHEM PARASIT, V133, P131, DOI 10.1016/j.molbiopara.2003.09.005
   Malarkey CS, 2012, TRENDS BIOCHEM SCI, V37, P553, DOI 10.1016/j.tibs.2012.09.003
   Mansure JJ, 2005, BIOCHEM BIOPH RES CO, V335, P1163, DOI 10.1016/j.bbrc.2005.07.192
   Nemeth MJ, 2006, P NATL ACAD SCI USA, V103, P13783, DOI 10.1073/pnas.0604006103
   Park S, 2012, BIOCHEMISTRY-US, V51, P6728, DOI 10.1021/bi300649v
   Pasheva E, 2004, BIOCHEMISTRY-US, V43, P2935, DOI 10.1021/bi035615y
   Pasheva EA, 1998, J BIOL CHEM, V273, P24730, DOI 10.1074/jbc.273.38.24730
   Pierce RJ, 2012, CURR PHARM DESIGN, V18, P3567, DOI 10.2174/138161212801327248
   PIL PM, 1992, SCIENCE, V256, P234, DOI 10.1126/science.1566071
   Pinlaor P, 2009, PLOS NEGLECT TROP D, V3, DOI 10.1371/journal.pntd.0000398
   Ramstein J, 1999, EUR J BIOCHEM, V260, P692, DOI 10.1046/j.1432-1327.1999.00185.x
   Ribeiro FS, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040192
   Ronfani L, 2001, DEVELOPMENT, V128, P1265
   SHEFLIN LG, 1993, BIOCHEMISTRY-US, V32, P3238, DOI 10.1021/bi00064a005
   SMITHERS SR, 1965, PARASITOLOGY, V55, P695, DOI 10.1017/S0031182000086248
   Stott K, 2010, J MOL BIOL, V403, P706, DOI 10.1016/j.jmb.2010.07.045
   Stros M, 2007, CELL MOL LIFE SCI, V64, P2590, DOI 10.1007/s00018-007-7162-3
   Stros M, 1998, J BIOL CHEM, V273, P10355
   Stros M, 2004, BIOCHEMISTRY-US, V43, P7215, DOI 10.1021/bi049928k
   STROS M, 1994, NUCLEIC ACIDS RES, V22, P1044, DOI 10.1093/nar/22.6.1044
   Stros M, 2010, BBA-GENE REGUL MECH, V1799, P101, DOI 10.1016/j.bbagrm.2009.09.008
   Stros M, 2009, NUCLEIC ACIDS RES, V37, P2070, DOI 10.1093/nar/gkp067
   Thomas JO, 2012, BIOCHEM SOC T, V40, P341, DOI 10.1042/BST20120014
   Thomas JO, 2001, TRENDS BIOCHEM SCI, V26, P167, DOI 10.1016/S0968-0004(01)01801-1
   Travers AA, 2003, EMBO REP, V4, P131, DOI 10.1038/sj.embor.embor741
   Ueda T, 2004, BIOCHEMISTRY-US, V43, P9901, DOI 10.1021/bi035975l
   Wang Q, 2007, BIOCHEM BIOPH RES CO, V360, P14, DOI 10.1016/j.bbrc.2007.05.130
   Watson M, 2007, J MOL BIOL, V374, P1286, DOI 10.1016/j.jmb.2007.09.075
   Watson M, 2014, NUCLEIC ACIDS RES, V42, P848, DOI 10.1093/nar/gkt950
   World Health Organization, 2002, WHO ANT CAR RAND TRI, P1
NR 50
TC 2
Z9 2
U1 0
U2 4
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 0020-7519
EI 1879-0135
J9 INT J PARASITOL
JI Int. J. Parasit.
PD APR
PY 2016
VL 46
IS 4
BP 253
EP 262
DI 10.1016/j.ijpara.2015.12.007
PG 10
WC Parasitology
SC Parasitology
GA DJ3BM
UT WOS:000374079800004
PM 26820302
DA 2020-12-17
ER

PT J
AU Allonso, D
   Andrade, IS
   Conde, JN
   Coelho, DR
   Rocha, DCP
   da Silva, ML
   Ventura, GT
   Silva, EM
   Mohana-Borges, R
AF Allonso, Diego
   Andrade, Iamara S.
   Conde, Jonas N.
   Coelho, Diego R.
   Rocha, Daniele C. P.
   da Silva, Manuela L.
   Ventura, Gustavo T.
   Silva, Emiliana M.
   Mohana-Borges, Ronaldo
TI Dengue Virus NS1 Protein Modulates Cellular Energy Metabolism by
   Increasing Glyceraldehyde-3-Phosphate Dehydrogenase Activity
SO JOURNAL OF VIROLOGY
LA English
DT Article
ID WEST-NILE-VIRUS; NONSTRUCTURAL GLYCOPROTEIN NS1; COMPLEMENT ACTIVATION;
   RNA REPLICATION; DNA VACCINE; DOCKING; CELLS; PATHOGENESIS; INFECTIONS;
   MICE
AB Dengue is one of the main public health concerns worldwide. Recent estimates indicate that over 390 million people are infected annually with the dengue virus (DENV), resulting in thousands of deaths. Among the DENV nonstructural proteins, the NS1 protein is the only one whose function during replication is still unknown. NS1 is a 46- to 55-kDa glycoprotein commonly found as both a membrane-associated homodimer and a soluble hexameric barrel-shaped lipoprotein. Despite its role in the pathogenic process, NS1 is essential for proper RNA accumulation and virus production. In the present study, we identified that glyceraldehyde-3-phosphate dehydrogenase (GAPDH) interacts with intracellular NS1. Molecular docking revealed that this interaction occurs through the hydrophobic protrusion of NS1 and the hydrophobic residues located at the opposite side of the catalytic site. Moreover, addition of purified recombinant NS1 enhanced the glycolytic activity of GAPDH in vitro. Interestingly, we observed that DENV infection promoted the relocalization of GAPDH to the perinuclear region, where NS1 is commonly found. Both DENV infection and expression of NS1 itself resulted in increased GAPDH activity. Our findings indicate that the NS1 protein acts to increase glycolytic flux and, consequently, energy production, which is consistent with the recent finding that DENV induces and requires glycolysis for proper replication. This is the first report to propose that NS1 is an important modulator of cellular energy metabolism. The data presented here provide new insights that may be useful for further drug design and the development of alternative antiviral therapies against DENV.
   IMPORTANCE
   Dengue represents a serious public health problem worldwide and is caused by infection with dengue virus (DENV). Estimates indicate that half of the global population is at risk of infection, with almost 400 million cases occurring per year. The NS1 glycoprotein is found in both the intracellular and the extracellular milieus. Despite the fact that NS1 has been commonly associated with DENV pathogenesis, it plays a pivotal but unknown role in the replication process. In an effort to understand the role of intracellular NS1, we demonstrate that glyceraldehyde-3-phosphate dehydrogenase (GAPDH) interacts with NS1. Our results indicate that NS1 increases the glycolytic activity of GAPDH in vitro. Interestingly, the GAPDH activity was increased during DENV infection, and NS1 expression alone was sufficient to enhance intracellular GAPDH activity in BHK-21 cells. Overall, our findings suggest that NS1 is an important modulator of cellular energy metabolism by increasing glycolytic flux.
C1 [Allonso, Diego; Andrade, Iamara S.; Conde, Jonas N.; Coelho, Diego R.; Rocha, Daniele C. P.; Ventura, Gustavo T.; Silva, Emiliana M.; Mohana-Borges, Ronaldo] Univ Fed Rio de Janeiro, Inst Biofis Carlos Chagas Filho, Lab Genom Estrutural, Rio De Janeiro, RJ, Brazil.
   [Andrade, Iamara S.] Fac Educ Tecnol Estado Rio de Janeiro FAETERJ FAE, Paracambi, RJ, Brazil.
   [da Silva, Manuela L.] Inst Nacl Metrol Qualidade & Tecnol INMETRO, Lab Biol Computac, Xerem, RJ, Brazil.
RP Silva, EM (corresponding author), Univ Fed Rio de Janeiro, Inst Biofis Carlos Chagas Filho, Lab Genom Estrutural, Rio De Janeiro, RJ, Brazil.
EM emilisilva@biof.ufrj.br; mohana@biof.ufrj.br
RI Nascimento conde, Jonas/D-4481-2019; Borges, Ronaldo S
   Mohana/C-5575-2013; Allonso, Diego/Y-3446-2018; da Silva, Manuela
   Leal/AAK-8760-2020
OI Allonso, Diego/0000-0002-1410-480X; da Silva, Manuela
   Leal/0000-0003-4844-7138; Rocha, Daniele/0000-0002-1923-5796
FU INCT-INBEB; CAPESCAPES; CNPqNational Council for Scientific and
   Technological Development (CNPq); FAPERJCarlos Chagas Filho Foundation
   for Research Support of the State of Rio de Janeiro (FAPERJ)
FX We thank the following Brazilian funding agencies for financial support:
   INCT-INBEB, CAPES, CNPq, and FAPERJ.
CR Abrantes JL, 2012, BBA-MOL BASIS DIS, V1822, P1198, DOI 10.1016/j.bbadis.2012.04.011
   Akey DL, 2015, BIOESSAYS, V37, P489, DOI 10.1002/bies.201400182
   Akey DL, 2014, SCIENCE, V343, P881, DOI 10.1126/science.1247749
   Alcon S, 2002, J CLIN MICROBIOL, V40, P376, DOI 10.1128/JCM.40.02.376-381.2002
   Allonso D, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0113634
   Allonso D, 2011, J VIROL METHODS, V175, P109, DOI 10.1016/j.jviromet.2011.04.029
   Avirutnan P, 2006, J INFECT DIS, V193, P1078, DOI 10.1086/500949
   Avirutnan P, 2011, J IMMUNOL, V187, P424, DOI 10.4049/jimmunol.1100750
   Avirutnan P, 2010, J EXP MED, V207, P793, DOI 10.1084/jem.20092545
   Bhatt S, 2013, NATURE, V496, P504, DOI 10.1038/nature12060
   Chung KM, 2006, P NATL ACAD SCI USA, V103, P19111, DOI 10.1073/pnas.0605668103
   Comeau SR, 2004, BIOINFORMATICS, V20, P45, DOI 10.1093/bioinformatics/btg371
   Comeau SR, 2004, NUCLEIC ACIDS RES, V32, pW96, DOI 10.1093/nar/gkh354
   Costa SM, 2006, VACCINE, V24, P4562, DOI 10.1016/j.vaccine.2005.08.022
   El-Bacha T, 2004, MOL CELL BIOCHEM, V266, P191, DOI 10.1023/B:MCBI.0000049154.17866.00
   El-Bacha T, 2007, BBA-MOL BASIS DIS, V1772, P1158, DOI 10.1016/j.bbadis.2007.08.003
   Eswar Narayanan, 2008, V426, P145, DOI 10.1007/978-1-60327-058-8_8
   Falconar AKI, 1997, ARCH VIROL, V142, P897, DOI 10.1007/s007050050127
   Falconar AKI, 2007, CLIN VACCINE IMMUNOL, V14, P493, DOI 10.1128/CVI.00371-06
   Fontaine KA, 2015, J VIROL, V89, P2358, DOI 10.1128/JVI.02309-14
   Gutsche I, 2011, P NATL ACAD SCI USA, V108, P8003, DOI 10.1073/pnas.1017338108
   Hwang NR, 2009, BIOCHEM J, V423, P253, DOI 10.1042/BJ20090854
   Ismail SA, 2005, ACTA CRYSTALLOGR D, V61, P1508, DOI 10.1107/S0907444905026740
   Kozakov D, 2006, PROTEINS, V65, P392, DOI 10.1002/prot.21117
   Kozakov D, 2013, PROTEINS, V81, P2159, DOI 10.1002/prot.24403
   Kurosu T, 2007, BIOCHEM BIOPH RES CO, V362, P1051, DOI 10.1016/j.bbrc.2007.08.137
   LASKOWSKI RA, 1993, J APPL CRYSTALLOGR, V26, P283, DOI 10.1107/S0021889892009944
   Lindenbach BD, 1997, J VIROL, V71, P9608, DOI 10.1128/JVI.71.12.9608-9617.1997
   Mackenzie JM, 1996, VIROLOGY, V220, P232, DOI 10.1006/viro.1996.0307
   McGuffin LJ, 2000, BIOINFORMATICS, V16, P404, DOI 10.1093/bioinformatics/16.4.404
   Muller DA, 2013, ANTIVIR RES, V98, P192, DOI 10.1016/j.antiviral.2013.03.008
   Muller DA, 2012, J GEN VIROL, V93, P771, DOI 10.1099/vir.0.039321-0
   Muylaert IR, 1996, VIROLOGY, V222, P159, DOI 10.1006/viro.1996.0406
   Ramiere C, 2014, J VIROL, V88, P3246, DOI 10.1128/JVI.02862-13
   SALI A, 1993, J MOL BIOL, V234, P779, DOI 10.1006/jmbi.1993.1626
   SCHLESINGER JJ, 1987, J GEN VIROL, V68, P853, DOI 10.1099/0022-1317-68-3-853
   Seidler NW, 2013, ADV EXP MED BIOL, V985, P61, DOI 10.1007/978-94-007-4716-6_3
   Shestov AA, 2014, ELIFE, V3, DOI 10.7554/eLife.03342
   Silva EM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057514
   Sirover MA, 1999, BBA-PROTEIN STRUCT M, V1432, P159, DOI 10.1016/S0167-4838(99)00119-3
   Westaway EG, 1997, J VIROL, V71, P6650, DOI 10.1128/JVI.71.9.6650-6661.1997
   Whitehead SS, 2007, NAT REV MICROBIOL, V5, P518, DOI 10.1038/nrmicro1690
   Wu SF, 2003, VACCINE, V21, P3919, DOI 10.1016/S0264-410X(03)00310-4
   Youn S, 2012, J VIROL, V86, P7360, DOI 10.1128/JVI.00157-12
   Young LB, 2013, J VIROL, V87, P9384, DOI 10.1128/JVI.01101-13
NR 45
TC 35
Z9 36
U1 0
U2 9
PU AMER SOC MICROBIOLOGY
PI WASHINGTON
PA 1752 N ST NW, WASHINGTON, DC 20036-2904 USA
SN 0022-538X
EI 1098-5514
J9 J VIROL
JI J. Virol.
PD DEC
PY 2015
VL 89
IS 23
BP 11871
EP 11883
DI 10.1128/JVI.01342-15
PG 13
WC Virology
SC Virology
GA CZ1WM
UT WOS:000366896600012
PM 26378175
OA Bronze, Green Published
DA 2020-12-17
ER

PT J
AU Cortines, JR
   Lima, LMTR
   Mohana-Borges, R
   Millen, TD
   Gaspar, LP
   Lanman, JK
   Prevelige, PE
   Silva, JL
AF Cortines, Juliana R.
   Lima, Luis Mauricio T. R.
   Mohana-Borges, Ronaldo
   Millen, Thiago de A.
   Gaspar, Luciane Pinto
   Lanman, Jason K.
   Prevelige, Peter E., Jr.
   Silva, Jerson L.
TI Structural insights into the stabilization of the human immunodeficiency
   virus type 1 capsid protein by the cyclophilin-binding domain and
   implications on the virus cycle
SO BIOCHIMICA ET BIOPHYSICA ACTA-PROTEINS AND PROTEOMICS
LA English
DT Article
DE Human immunodeficiency virus; Capsid protein; Cyclophilin; High
   hydrostatic pressure; SAXS
ID GAG PROTEIN; INTERSUBUNIT INTERACTIONS; DIMERIZATION DOMAIN; ASSEMBLY
   PROPERTIES; HIGH-RESOLUTION; CORE; MATURATION; IDENTIFICATION; ANTIBODY;
   REVEALS
AB During infection, human immunodeficiency virus type 1 (HIV-1) interacts with the cellular host factor cyclophilin A (CypA) through residues 85-93 of the N-terminal domain of HIV-1's capsid protein (CA). The role of the CA:CypA interaction is still unclear. Previous studies showed that a CypA-binding loop mutant, Delta 87-97, has increased ability to assemble in vitro. We used this mutant to infer whether the CypA-binding region has an overall effect on CA stability, as measured by pressure and chemical perturbation. We built a SAXS-based envelope model for the dimer of both WT and Delta 87-97. A new conformational arrangement of the dimers is described, showing the structural plasticity that CA can adopt. In protein folding studies, the deletion of the loop drastically reduces CA stability, as assayed by high hydrostatic pressure and urea. We hypothesize that the deletion promotes a rearrangement of helix 4, which may enhance the heterotypic interaction between the N- and C-terminal domains of CA dimers. In addition, we propose that the cyclophilin-binding loop may modulate capsid assembly during infection, either in the cytoplasm or near the nucleus by binding to the nuclear protein Nup385. (C) 2014 Published by Elsevier B.V.
C1 [Cortines, Juliana R.; Millen, Thiago de A.; Gaspar, Luciane Pinto; Silva, Jerson L.] Univ Fed Rio de Janeiro, Inst Nacl Biol Estrutural & Bioimagem, Inst Bioquim Med, BR-21941590 Rio De Janeiro, Brazil.
   [Lima, Luis Mauricio T. R.] Fed Univ Rio de Janeiro UFRJ, Sch Pharm, BR-21941590 Rio De Janeiro, Brazil.
   [Mohana-Borges, Ronaldo] Univ Fed Rio de Janeiro, Inst Biofis Carlos Chagas Filho, BR-21941902 Rio De Janeiro, Brazil.
   [Lanman, Jason K.; Prevelige, Peter E., Jr.] Univ Alabama Birmingham, Dept Microbiol, Birmingham, AL 35294 USA.
RP Silva, JL (corresponding author), Univ Fed Rio de Janeiro, Inst Nacl Biol Estrutural & Bioimagem, Inst Bioquim Med, BR-21941590 Rio De Janeiro, Brazil.
EM cortines@micro.ufrj.br; mauricio@pharma.ufrj.br; mohana@biof.ufrj.br;
   thiagomillen@yahoo.com.br; lgaspar@bio.fiocruz.br; jlanman@purdue.edu;
   prevelig@uab.edu; jerson@bioqmed.ufrj.br
RI Borges, Ronaldo S Mohana/C-5575-2013; Silva, Jerson/J-8984-2014;
   Cortines, Juliana/V-3997-2019
OI Silva, Jerson/0000-0001-9523-9441; Cortines, Juliana/0000-0003-2481-9267
FU CNPqNational Council for Scientific and Technological Development (CNPq)
   [AUX 573767/2008-4]; FAPERJCarlos Chagas Filho Foundation for Research
   Support of the State of Rio de Janeiro (FAPERJ) [CNE 102.208/2012];
   Ministerio da Saude (MS/DECIT); CAPESCAPES; FINEP of BrazilCiencia
   Tecnologia e Inovacao (FINEP); Brazilian Synchrotron Light Laboratory
FX This work was supported by grants from CNPq (AUX 573767/2008-4), FAPERJ
   (CNE 102.208/2012), Ministerio da Saude (MS/DECIT), CAPES, FINEP of
   Brazil and the Brazilian Synchrotron Light Laboratory. We thank Emerson
   Goncalves for technical support.
CR Akasaka K, 2013, ARCH BIOCHEM BIOPHYS, V531, P110, DOI 10.1016/j.abb.2012.11.016
   Arhel NJ, 2007, EMBO J, V26, P3025, DOI 10.1038/sj.emboj.7601740
   Berthet-Colominas C, 1999, EMBO J, V18, P1124, DOI 10.1093/emboj/18.5.1124
   Braaten D, 1996, J VIROL, V70, P3551, DOI 10.1128/JVI.70.6.3551-3560.1996
   Briggs JAG, 2004, NAT STRUCT MOL BIOL, V11, P672, DOI 10.1038/nsmb785
   Byeon IJL, 2009, CELL, V139, P780, DOI 10.1016/j.cell.2009.10.010
   Cortines JR, 2011, J MOL BIOL, V410, P641, DOI 10.1016/j.jmb.2011.03.052
   Datta SAK, 2007, J MOL BIOL, V365, P812, DOI 10.1016/j.jmb.2006.10.073
   Dellarole M, 2014, METHODS MOL BIOL, V1076, P53, DOI 10.1007/978-1-62703-649-8_4
   Deshmukh L, 2013, J AM CHEM SOC, V135, P16133, DOI 10.1021/ja406246z
   Di Nunzio F, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046037
   Du SC, 2011, J MOL BIOL, V406, P371, DOI 10.1016/j.jmb.2010.11.027
   Endrich MM, 1999, J BIOL CHEM, V274, P5326, DOI 10.1074/jbc.274.9.5326
   Fitzon T, 2000, VIROLOGY, V268, P294, DOI 10.1006/viro.1999.0178
   Forshey BM, 2002, J VIROL, V76, P5667, DOI 10.1128/JVI.76.11.5667-5677.2002
   Gamble TR, 1997, SCIENCE, V278, P849, DOI 10.1126/science.278.5339.849
   Ganser BK, 1999, SCIENCE, V283, P80, DOI 10.1126/science.283.5398.80
   Ganser-Pornillos BK, 2008, CURR OPIN STRUC BIOL, V18, P203, DOI 10.1016/j.sbi.2008.02.001
   Ganser-Pornillos BK, 2007, CELL, V131, P70, DOI 10.1016/j.cell.2007.08.018
   Ganser-Pornillos BK, 2004, J VIROL, V78, P2545, DOI 10.1128/JVI.78.5.2545-2552.2004
   Gitti RK, 1996, SCIENCE, V273, P231, DOI 10.1126/science.273.5272.231
   Grattinger M, 1999, VIROLOGY, V257, P247, DOI 10.1006/viro.1999.9668
   Gross I, 1998, J VIROL, V72, P4798, DOI 10.1128/JVI.72.6.4798-4810.1998
   Jiang JY, 2011, VIROLOGY, V421, P253, DOI 10.1016/j.virol.2011.09.012
   Kellermann G, 1997, J APPL CRYSTALLOGR, V30, P880, DOI 10.1107/S0021889897001829
   Kozin MB, 2001, J APPL CRYSTALLOGR, V34, P33, DOI 10.1107/S0021889800014126
   Lanman J, 2004, NAT STRUCT MOL BIOL, V11, P676, DOI 10.1038/nsmb790
   Lanman J, 2003, J MOL BIOL, V325, P759, DOI 10.1016/S0022-2836(02)01245-7
   Lanman J, 2002, J VIROL, V76, P6900, DOI 10.1128/JVI.76.14.6900-6908.2002
   Li S, 2000, NATURE, V407, P409, DOI 10.1038/35030177
   Lima LMTR, 2000, P NATL ACAD SCI USA, V97, P14289, DOI 10.1073/pnas.250352197
   LUBAN J, 1993, CELL, V73, P1067, DOI 10.1016/0092-8674(93)90637-6
   Monaco-Malbet S, 2000, STRUCTURE, V8, P1069, DOI 10.1016/S0969-2126(00)00507-4
   Monroe EB, 2010, STRUCTURE, V18, P1483, DOI 10.1016/j.str.2010.08.016
   MYERS JK, 1995, PROTEIN SCI, V4, P2138, DOI 10.1002/pro.5560041020
   PAULING L, 1951, P NATL ACAD SCI USA, V37, P205, DOI 10.1073/pnas.37.4.205
   Pornillos O, 2011, NATURE, V469, P424, DOI 10.1038/nature09640
   Pornillos O, 2009, CELL, V137, P1282, DOI 10.1016/j.cell.2009.04.063
   Sayah DM, 2004, NATURE, V430, P569, DOI 10.1038/nature02777
   Schaller T, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002439
   Shah VB, 2013, J VIROL, V87, P422, DOI 10.1128/JVI.07177-11
   Shin R, 2011, BIOCHEMISTRY-US, V50, P9457, DOI 10.1021/bi2011493
   Silva JL, 2014, CHEM REV, V114, P7239, DOI 10.1021/cr400204z
   Silva JL, 2002, BBA-PROTEIN STRUCT M, V1595, P250, DOI 10.1016/S0167-4838(01)00348-X
   Svergun DI, 1999, BIOPHYS J, V76, P2879, DOI 10.1016/S0006-3495(99)77443-6
   SVERGUN DI, 1992, J APPL CRYSTALLOGR, V25, P495, DOI 10.1107/S0021889892001663
   von Schwedler UK, 2003, J VIROL, V77, P5439, DOI 10.1128/JVI.77.9.5439-5450.2003
   von Schwedler UK, 1998, EMBO J, V17, P1555, DOI 10.1093/emboj/17.6.1555
   Wiegers K, 1999, VIROLOGY, V257, P261, DOI 10.1006/viro.1999.9669
   Winter R, 2005, PHILOS T R SOC A, V363, P537, DOI 10.1098/rsta.2004.1507
   Winter R, 2005, PHILOS T A, V363, P562
   Worthylake DK, 1999, ACTA CRYSTALLOGR D, V55, P85, DOI 10.1107/S0907444998007689
NR 52
TC 3
Z9 3
U1 0
U2 11
PU ELSEVIER
PI AMSTERDAM
PA RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS
SN 1570-9639
EI 1878-1454
J9 BBA-PROTEINS PROTEOM
JI BBA-Proteins Proteomics
PD MAY
PY 2015
VL 1854
IS 5
BP 341
EP 348
DI 10.1016/j.bbapap.2014.12.008
PG 8
WC Biochemistry & Molecular Biology; Biophysics
SC Biochemistry & Molecular Biology; Biophysics
GA CG2FF
UT WOS:000353089600004
PM 25526889
DA 2020-12-17
ER

PT J
AU Ventura, GT
   da Costa, ECB
   Capaccia, AM
   Mohana-Borges, R
AF Ventura, Gustavo Tavares
   Brasil da Costa, Emmerson Correa
   Capaccia, Anne Miranda
   Mohana-Borges, Ronaldo
TI pH-Dependent Conformational Changes in the HCV NS3 Protein Modulate Its
   ATPase and Helicase Activities
SO PLOS ONE
LA English
DT Article
ID HEPATITIS-C VIRUS; RNA HELICASE; CRYSTAL-STRUCTURE;
   ENZYMATIC-ACTIVITIES; PRIMASE INHIBITORS; SERINE-PROTEASE; DUPLEX RNA;
   DOMAIN; REPLICATION; BINDING
AB The hepatitis C virus (HCV) infects 170 to 200 million people worldwide and is, therefore, a major health problem. The lack of efficient treatments that specifically target the viral proteins or RNA and its high chronicity rate make hepatitis C the cause of many deaths and hepatic transplants annually. The NS3 protein is considered an important target for the development of anti-HCV drugs because it is composed of two domains (a serine protease in the N-terminal portion and an RNA helicase/NTPase in the C-terminal portion), which are essential for viral replication and proliferation. We expressed and purified both the NS3 helicase domain (NS3hel) and the full-length NS3 protein (NS3FL) and characterized pH-dependent structural changes associated with the increase in their ATPase and helicase activities at acidic pH. Using intrinsic fluorescence experiments, we have observed that NS3hel was less stable at pH 6.4 than at pH 7.2. Moreover, binding curves using an extrinsic fluorescent probe (bis-ANS) and ATPase assays performed under different pH conditions demonstrated that the hydrophobic clefts of NS3 are significantly more exposed to the aqueous medium at acidic pH. Using fluorescence spectroscopy and anisotropy assays, we have also observed more protein interaction with DNA upon pH acidification, which suggests that the hydrophobic clefts exposure on NS3 might be related to a loss of stability that could lead it to adopt a more open conformation. This conformational change at acidic pH would stimulate both its ATPase and helicase activities, as well as its ability to bind DNA. Taken together, our results indicate that the NS3 protein adopts a more open conformation due to acidification from pH 7.2 to 6.4, resulting in a more active form at a pH that is found near Golgi-derived membranes. This increased activity could better allow NS3 to carry out its functions during HCV replication.
C1 [Ventura, Gustavo Tavares; Brasil da Costa, Emmerson Correa; Capaccia, Anne Miranda; Mohana-Borges, Ronaldo] Univ Fed Rio de Janeiro, Inst Biofis Carlos Chagas Filho, Lab Genom Estrutural, Rio De Janeiro, Brazil.
RP Mohana-Borges, R (corresponding author), Univ Fed Rio de Janeiro, Inst Biofis Carlos Chagas Filho, Lab Genom Estrutural, Rio De Janeiro, Brazil.
EM mohana@biof.ufrj.br
RI Borges, Ronaldo S Mohana/C-5575-2013
FU Instituto Nacional de Ciencia e Tecnologia em Biologia Estrutural e
   Bioimagem (INCTINBEB); Coordenacao de Aperfeicoamento de Pessoal de
   Ensino Superior (CAPES)CAPES; Conselho Nacional de Desenvolvimento
   Cientifico e Tecnologico (CNPq)National Council for Scientific and
   Technological Development (CNPq); Fundacao de Amparo a Pesquisa do
   Estado do Rio de Janeiro (FAPERJ)Carlos Chagas Filho Foundation for
   Research Support of the State of Rio de Janeiro (FAPERJ)
FX This work was supported by the following Brazilian funding agencies:
   Instituto Nacional de Ciencia e Tecnologia em Biologia Estrutural e
   Bioimagem (INCTINBEB), Coordenacao de Aperfeicoamento de Pessoal de
   Ensino Superior (CAPES), Conselho Nacional de Desenvolvimento Cientifico
   e Tecnologico (CNPq), and Fundacao de Amparo a Pesquisa do Estado do Rio
   de Janeiro (FAPERJ). The funders had no role in study design, data
   collection and analysis, decision to publish, or preparation of the
   manuscript.
CR Abian O, 2010, BIOPHYS J, V99, P3811, DOI 10.1016/j.bpj.2010.10.037
   Alvisi G, 2011, RNA BIOL, V8, P258, DOI 10.4161/rna.8.2.15011
   Asselah T, 2011, LIVER INT, V31, P68, DOI 10.1111/j.1478-3231.2010.02411.x
   Aydin C, 2013, PROTEIN SCI, V22, P1786, DOI 10.1002/pro.2378
   Belon CA, 2009, FUTURE VIROL, V4, P277, DOI 10.2217/FVL.09.7
   Beran RKF, 2007, J BIOL CHEM, V282, P34913, DOI 10.1074/jbc.M707165200
   Cho HS, 1998, J BIOL CHEM, V273, P15045, DOI 10.1074/jbc.273.24.15045
   Crute JJ, 2002, NAT MED, V8, P386, DOI 10.1038/nm0402-386
   Dubuisson J, 2007, WORLD J GASTROENTERO, V13, P2406, DOI 10.3748/wjg.v13.i17.2406
   Fiske CH, 1927, SCIENCE, V65, P401, DOI 10.1126/science.65.1686.401
   Frick DN, 2007, CURR ISSUES MOL BIOL, V9, P1
   Frick DN, 2004, NUCLEIC ACIDS RES, V32, P5519, DOI 10.1093/nar/gkh891
   Frick DN, 2004, J BIOL CHEM, V279, P1269, DOI 10.1074/jbc.M310630200
   Fried MW, 2002, NEW ENGL J MED, V347, P975, DOI 10.1056/NEJMoa020047
   Gallinari P, 1998, J VIROL, V72, P6758, DOI 10.1128/JVI.72.8.6758-6769.1998
   Gwack Y, 1996, BIOCHEM BIOPH RES CO, V225, P654, DOI 10.1006/bbrc.1996.1225
   Hoofnagle JH, 2006, NEW ENGL J MED, V355, P2444, DOI 10.1056/NEJMct061675
   Kim JL, 1998, STRUCTURE, V6, P89, DOI 10.1016/S0969-2126(98)00010-0
   Kleymann G, 2002, NAT MED, V8, P392, DOI 10.1038/nm0402-392
   Kolykhalov AA, 2000, J VIROL, V74, P2046, DOI 10.1128/JVI.74.4.2046-2051.2000
   Kwong AD, 2011, NAT BIOTECHNOL, V29, P993, DOI 10.1038/nbt.2020
   Lam AMI, 2006, J VIROL, V80, P404, DOI 10.1128/JVI.80.1.404-411.2006
   Lam AMI, 2004, NUCLEIC ACIDS RES, V32, P4060, DOI 10.1093/nar/gkh743
   Lam AMI, 2003, J BIOL CHEM, V278, P44514, DOI 10.1074/jbc.M306444200
   Lam AMI, 2003, J VIROL, V77, P3950, DOI 10.1128/JVI.77.7.3950-3961.2003
   Lamarre D, 2003, NATURE, V426, P186, DOI 10.1038/nature02099
   Lim SR, 2012, ANTIMICROB AGENTS CH, V56, P271, DOI 10.1128/AAC.05636-11
   Liu WJ, 2002, J VIROL, V76, P10766, DOI 10.1128/JVI.76.21.10766-10775.2002
   Luo DH, 2008, EMBO J, V27, P3209, DOI 10.1038/emboj.2008.232
   Ma YH, 2008, J VIROL, V82, P7624, DOI 10.1128/JVI.00724-08
   Mackintosh SG, 2006, J BIOL CHEM, V281, P3528, DOI 10.1074/jbc.M512100200
   Matlock DL, 2010, BIOCHEMISTRY-US, V49, P2097, DOI 10.1021/bi901977k
   Moradpour D, 2007, NAT REV MICROBIOL, V5, P453, DOI 10.1038/nrmicro1645
   Pace CN, 2000, PROTEINS, P1
   Pang PS, 2002, EMBO J, V21, P1168, DOI 10.1093/emboj/21.5.1168
   Pawlotsky JM, 2014, SEMIN LIVER DIS, V34, P22, DOI 10.1055/s-0034-1371007
   Piccininni S, 2002, J BIOL CHEM, V277, P45670, DOI 10.1074/jbc.M204124200
   Sali DL, 1998, BIOCHEMISTRY-US, V37, P3392, DOI 10.1021/bi972010r
   Serafino A, 2003, J MED VIROL, V70, P31, DOI 10.1002/jmv.10367
   Serebrov V, 2009, J BIOL CHEM, V284, P2512, DOI 10.1074/jbc.M805460200
   Smith DB, 2014, HEPATOLOGY, V59, P318, DOI 10.1002/hep.26744
   Taremi SS, 1998, PROTEIN SCI, V7, P2143, DOI 10.1002/pro.5560071011
   Tsai WL, 2010, ONCOGENE, V29, P2309, DOI 10.1038/onc.2010.36
   Uhl P, 2014, INT J MOL SCI, V15, P7500, DOI 10.3390/ijms15057500
   Vaughan R, 2012, VIRUS RES, V169, P80, DOI 10.1016/j.virusres.2012.07.007
   Vega S, 2013, INT J MOL SCI, V14, P13282, DOI 10.3390/ijms140713282
   Venkatraman S, 2012, TRENDS PHARMACOL SCI, V33, P289, DOI 10.1016/j.tips.2012.03.012
   Wardell AD, 1999, J GEN VIROL, V80, P701, DOI 10.1099/0022-1317-80-3-701
   Wu MM, 2000, CHEM BIOL, V7, P197, DOI 10.1016/S1074-5521(00)00088-0
   Yao NH, 1999, STRUCTURE, V7, P1353, DOI 10.1016/S0969-2126(00)80025-8
   Yao NH, 1997, NAT STRUCT BIOL, V4, P463, DOI 10.1038/nsb0697-463
   Yau AHL, 2014, CAN J GASTROENTEROL, V28, P445, DOI 10.1155/2014/549624
NR 52
TC 5
Z9 5
U1 0
U2 11
PU PUBLIC LIBRARY SCIENCE
PI SAN FRANCISCO
PA 1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA
SN 1932-6203
J9 PLOS ONE
JI PLoS One
PD DEC 31
PY 2014
VL 9
IS 12
AR e115941
DI 10.1371/journal.pone.0115941
PG 24
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA AX7UC
UT WOS:000347119100079
PM 25551442
OA DOAJ Gold, Green Published
DA 2020-12-17
ER

PT J
AU Abrahim-Vieira, B
   da Costa, ECB
   Azevedo, PHRD
   Portela, AC
   Dias, LRS
   Pinheiro, S
   Tanuri, A
   Capaccia, AM
   Ventura, GT
   Mohana-Borges, R
   Rodrigues, CR
   de Souza, AMT
   Muri, EMF
AF Abrahim-Vieira, Barbara
   da Costa, Emmerson C. B.
   Azevedo, Pedro H. R. de A.
   Portela, Aline C.
   Dias, Luiza R. S.
   Pinheiro, Sergio
   Tanuri, Amilcar
   Capaccia, Anne M.
   Ventura, Gustavo T.
   Mohana-Borges, Ronaldo
   Rodrigues, Carlos R.
   de Souza, Alessandra M. T.
   Muri, Estela M. F.
TI Novel isomannide-based peptide mimetics containing a tartaric acid
   backbone as serine protease inhibitors
SO MEDICINAL CHEMISTRY RESEARCH
LA English
DT Article
DE Isomannide; Serine proteases; Tartaric acid; Inhibitor
ID VIRUS NS3 PROTEASE; POTENTIAL INHIBITORS; RESISTANCE; FLAVIVIRUSES;
   MECHANISM; CLEAVAGE
AB Hepatitis C viral infection is a cause of chronic liver disease, and current therapies are only effective in 50 % of patients. Serine proteases, which are present in both hepatitis C virus (HCV) and the dengue virus, are the most studied class of proteolytic enzymes and are the primary targets for drug development in this field. In this paper, we describe the synthesis of a novel class of isomannide-based peptide mimetic compounds based on a tartaric acid backbone. Our data showed that substitutions at position 168 (D168A) and 170 (V170A) conferred low-level resistance against compound 5a3, whereas substitutions at position 155 (R155K) and 156 (A156V) conferred no resistance. These data suggest that even though compound 5a3 is a noncompetitive inhibitor; it is able to interact with important residues located near the catalytic site. In addition, this novel compound class exhibits potent antiviral activity against variants carrying resistance mutations to boceprevir and telaprevir. Our docking studies showed important interactions, including hydrogen bonds and a pi-pi interaction, between compound 5a3 and residues of the allosteric site of NS3/4A. Biological and theoretical results indicate that 5a3 is a promising lead compound for the development of new drugs targeting HCV infection.
C1 [Abrahim-Vieira, Barbara; Rodrigues, Carlos R.; de Souza, Alessandra M. T.] Univ Fed Rio de Janeiro, ModMolQSAR, Fac Farm, Rio De Janeiro, Brazil.
   [da Costa, Emmerson C. B.; Tanuri, Amilcar] Univ Fed Rio de Janeiro, Inst Ciencias Biol, Lab Virol Mol, Rio De Janeiro, RJ, Brazil.
   [Azevedo, Pedro H. R. de A.; Portela, Aline C.; Dias, Luiza R. S.; Muri, Estela M. F.] Univ Fed Fluminense, Fac Farm, BR-24241000 Niteroi, RJ, Brazil.
   [Pinheiro, Sergio] Univ Fed Fluminense, Inst Quim, BR-24241000 Niteroi, RJ, Brazil.
   [Capaccia, Anne M.; Ventura, Gustavo T.; Mohana-Borges, Ronaldo] Univ Fed Rio de Janeiro, Inst Biofis Carlos Chagas Filho, Lab Genom Estrutural, BR-21941 Rio De Janeiro, RJ, Brazil.
RP Muri, EMF (corresponding author), Univ Fed Fluminense, Fac Farm, Rua Mario Viana 523 Santa Rosa, BR-24241000 Niteroi, RJ, Brazil.
EM estelamuri@yahoo.com.br
RI Pinheiro, Sergio/AAU-6419-2020; Muri, Estela/AAG-4930-2019; Rodrigues,
   Carlos Rangel/Q-2316-2019; Borges, Ronaldo S Mohana/C-5575-2013; Dias,
   Luiza R S/X-2847-2018; Souza, Alessandra M. T./R-5628-2016
OI Muri, Estela/0000-0001-8489-1848; Rodrigues, Carlos
   Rangel/0000-0001-8453-7654; Souza, Alessandra M. T./0000-0001-9986-405X;
   Dias, Luiza R. S./0000-0001-5809-5602
FU Coordination for the Improvement of Higher Education Personnel
   (Coordenacao de Aperfeicoamento de Pessoal de Nivel
   Superior-CAPES)CAPES; National Council for Scientific and Technological
   Development (Conselho Nacional de Desenvolvimento Cientifico e
   Tecnologico-CNPq)National Council for Scientific and Technological
   Development (CNPq); Carlos Chagas Filho Foundation
FX This work was supported by Coordination for the Improvement of Higher
   Education Personnel (Coordenacao de Aperfeicoamento de Pessoal de Nivel
   Superior-CAPES), National Council for Scientific and Technological
   Development (Conselho Nacional de Desenvolvimento Cientifico e
   Tecnologico-CNPq) and the Carlos Chagas Filho Foundation for Support of
   Research of the State of Rio de Janeiro (Fundacao Carlos Chagas Filho de
   Amparo a Pesquisa do Estado do Rio de Janeiro-FAPERJ).
CR Barros JC, 2006, LETT ORG CHEM, V3, P882, DOI 10.2174/157017806779468040
   Barros TG, 2012, LETT ORG CHEM, V9, P239, DOI 10.2174/157017812800233787
   Barros TG, 2010, AMINO ACIDS, V38, P701, DOI 10.1007/s00726-009-0273-4
   Barros TG, 2009, SYNTHESIS-STUTTGART, P620, DOI 10.1055/s-0028-1083332
   BAZAN JF, 1989, VIROLOGY, V171, P637, DOI 10.1016/0042-6822(89)90639-9
   Chee CF, 2010, TETRAHEDRON LETT, V51, P495, DOI 10.1016/j.tetlet.2009.11.030
   Cohen J, 1999, SCIENCE, V285, P26, DOI 10.1126/science.285.5424.26
   de Resende GO, 2007, LETT ORG CHEM, V4, P168, DOI 10.2174/157017807780737200
   Feld JJ, 2005, NATURE, V436, P967, DOI 10.1038/nature04082
   Frokjaer S, 2005, NAT REV DRUG DISCOV, V4, P298, DOI 10.1038/nrd1695
   Ghosh AK, 2007, BIOORGAN MED CHEM, V15, P7576, DOI 10.1016/j.bmc.2007.09.010
   GORBALENYA AE, 1989, NUCLEIC ACIDS RES, V17, P3889, DOI 10.1093/nar/17.10.3889
   Halfon P, 2011, J HEPATOL, V55, P192, DOI 10.1016/j.jhep.2011.01.011
   Ingallinella P, 1998, BIOCHEMISTRY-US, V37, P8906, DOI 10.1021/bi980314n
   Kumar M, 2011, J MOL MODEL, V17, P1173, DOI 10.1007/s00894-010-0821-6
   Lampa A, 2010, BIOORGAN MED CHEM, V18, P5413, DOI 10.1016/j.bmc.2010.05.027
   Lange C, 2002, HEPATITIS C NEW DRUG
   Lim SR, 2012, ANTIMICROB AGENTS CH, V56, P271, DOI 10.1128/AAC.05636-11
   Lin C, 2004, J BIOL CHEM, V279, P17508, DOI 10.1074/jbc.M313020200
   Lipinski Christopher A, 2004, Drug Discov Today Technol, V1, P337, DOI 10.1016/j.ddtec.2004.11.007
   Maryanoff BE, 2008, BIOORGAN MED CHEM, V16, P1562, DOI 10.1016/j.bmc.2007.11.015
   Melino S, 2007, FEBS J, V274, P2986, DOI 10.1111/j.1742-4658.2007.05831.x
   Muri EMF, 2005, AMINO ACIDS, V28, P413, DOI 10.1007/s00726-004-0146-9
   Muri EMF, 2004, AMINO ACIDS, V27, P153, DOI 10.1007/s00726-004-0121-5
   Ortqvist P, 2010, BIOORGAN MED CHEM, V18, P6512, DOI 10.1016/j.bmc.2010.06.101
   Pecanha Emerson P., 2003, Farmaco (Lausanne), V58, P149, DOI 10.1016/S0014-827X(02)00016-2
   Prongay AJ, 2007, J MED CHEM, V50, P2310, DOI 10.1021/jm060173k
   Sander T, 2009, J CHEM INF MODEL, V49, P232, DOI 10.1021/ci800305f
   Sarrazin C, 2010, GASTROENTEROLOGY, V138, P447, DOI 10.1053/j.gastro.2009.11.055
   Shiryaev SA, 2012, PLOS ONE, V7, DOI [10.1371/journal.pone.0035759, 10.1371/journal.pone.0040029]
   SHRINER RL, 1963, ORG SYNTH, V4, P242
   Sidique S, 2009, BIOORG MED CHEM LETT, V19, P5773, DOI 10.1016/j.bmcl.2009.07.150
   Tong X, 2006, ANTIVIR RES, V70, P28, DOI 10.1016/j.antiviral.2005.12.003
   Vermehren J, 2011, CLIN MICROBIOL INFEC, V17, P122, DOI 10.1111/j.1469-0691.2010.03430.x
   Westermann B, 2004, TETRAHEDRON LETT, V45, P5983, DOI 10.1016/j.tetlet.2004.06.051
   Wright M, 2001, ANTIVIR CHEM CHEMOTH, V12, P201, DOI 10.1177/095632020101200401
   Yusof R, 2000, J BIOL CHEM, V275, P9963, DOI 10.1074/jbc.275.14.9963
   Zhu ZW, 2010, HEPATOLOGY, V52, P1897, DOI 10.1002/hep.23921
NR 38
TC 5
Z9 5
U1 0
U2 25
PU SPRINGER BIRKHAUSER
PI NEW YORK
PA 233 SPRING STREET, 6TH FLOOR, NEW YORK, NY 10013 USA
SN 1054-2523
EI 1554-8120
J9 MED CHEM RES
JI Med. Chem. Res.
PD DEC
PY 2014
VL 23
IS 12
BP 5305
EP 5320
DI 10.1007/s00044-014-1058-1
PG 16
WC Chemistry, Medicinal
SC Pharmacology & Pharmacy
GA AS3GI
UT WOS:000344165100028
DA 2020-12-17
ER

PT J
AU Allonso, D
   Meneses, MDF
   Fernandes, CA
   Ferreira, DF
   Mohana-Borges, R
AF Allonso, Diego
   Meneses, Marcelo D. F.
   Fernandes, Carlos A.
   Ferreira, Davis F.
   Mohana-Borges, Ronaldo
TI Assessing Positivity and Circulating Levels of NS1 in Samples from a
   2012 Dengue Outbreak in Rio de Janeiro, Brazil
SO PLOS ONE
LA English
DT Article
ID LINKED IMMUNOSORBENT ASSAYS; PROTEIN NS1; PLASMA-LEVELS; SOLUBLE ST2;
   VIRUS; ANTIGEN; DIAGNOSIS; CORRELATE; DISEASE
AB Dengue virus (DENV) represents a major threat to public health worldwide. Early DENV diagnosis should not only detect the infection but also identify patients with a higher likelihood to develop severe cases. Previous studies have suggested the potential for NS1 to serve as a viral marker for dengue severity. However, further studies using different sera panels are required to confirm this hypothesis. In this context, we developed a lab-based ELISA to detect and quantitate NS1 protein from the four DENV serotypes and from primary and secondary cases. This approach was used to calculate the circulating NS1 concentration in positive samples. We also tested the NS1 positivity of DENV-positive samples according to the Platelia Dengue NS1 Ag assay. A total of 128 samples were positive for DENV infection and were classified according to the WHO guidelines. The overall NS1 positivity was 68% according to the Platelia assay, whereas all samples were NS1-positive when analyzed with our lab-based ELISA. Fifty-four samples were positive by PCR, revealing a co-circulation of DENV1 and DENV4, and the NS1 positivity for DENV4 samples was lower than that for DENV1. The circulating NS1 concentration ranged from 7 to 284 ng/mL. Our results support previous data indicating the low efficiency of the Platelia assay to detect DENV4 infection. Moreover, this work is the first to analyze NS1 antigenemia using retrospective samples from a Brazilian outbreak.
C1 [Allonso, Diego; Mohana-Borges, Ronaldo] Univ Fed Rio de Janeiro, Inst Biofis Carlos Chagas Filho, Rio De Janeiro, Brazil.
   [Meneses, Marcelo D. F.; Ferreira, Davis F.] Univ Fed Rio de Janeiro, Inst Microbiol Paulo Goes, Rio De Janeiro, Brazil.
   [Fernandes, Carlos A.] Lab Cent Noel Nutels LACEN, Rio De Janeiro, RJ, Brazil.
RP Mohana-Borges, R (corresponding author), Univ Fed Rio de Janeiro, Inst Biofis Carlos Chagas Filho, Rio De Janeiro, Brazil.
EM mohana@biof.ufrj.br
RI Allonso, Diego/Y-3446-2018; Ferreira, Davis/D-9356-2014; Borges, Ronaldo
   S Mohana/C-5575-2013
OI Allonso, Diego/0000-0002-1410-480X; 
FU Brazilian Funding Agency: Instituto Nacional de Ciencia e Tecnologia em
   Biologia Estrutural e Bioimagem (INCT-INBEB); Brazilian Funding Agency:
   Coordenacao de Aperfeicoamento de Pessoal de Ensino Superior (CAPES);
   Brazilian Funding Agency: Conselho Nacional de Desenvolvimento
   Cientifico e Tecnologico (CNPq)National Council for Scientific and
   Technological Development (CNPq); Brazilian Funding Agency: Fundacao de
   Amparo a Pesquisa do Estado do Rio de Janeiro (FAPERJ)Carlos Chagas
   Filho Foundation for Research Support of the State of Rio de Janeiro
   (FAPERJ)
FX The funders had no role in study design, data collection and analysis,
   decision to publish, or preparation of the manuscript. Brazilian Funding
   Agencies: Instituto Nacional de Ciencia e Tecnologia em Biologia
   Estrutural e Bioimagem (INCT-INBEB), Coordenacao de Aperfeicoamento de
   Pessoal de Ensino Superior (CAPES), Conselho Nacional de Desenvolvimento
   Cientifico e Tecnologico (CNPq) and Fundacao de Amparo a Pesquisa do
   Estado do Rio de Janeiro (FAPERJ).
CR Alcon S, 2002, J CLIN MICROBIOL, V40, P376, DOI 10.1128/JCM.40.02.376-381.2002
   Allonso D, 2013, AM J TROP MED HYG, V88, P506, DOI 10.4269/ajtmh.2012.12-0619
   Allonso D, 2012, J CLIN VIROL, V55, P214, DOI 10.1016/j.jcv.2012.07.010
   Allonso D, 2011, J VIROL METHODS, V175, P109, DOI 10.1016/j.jviromet.2011.04.029
   [Anonymous], 2008, EVALUATION 2 NEW COM, V2, pe280
   Avirutnan P, 2006, J INFECT DIS, V193, P1078, DOI 10.1086/500949
   Becerra A, 2008, CYTOKINE, V41, P114, DOI 10.1016/j.cyto.2007.11.001
   Bessoff K, 2008, CLIN VACCINE IMMUNOL, V15, P1513, DOI 10.1128/CVI.00140-08
   Blacksell SD, 2012, CLIN VACCINE IMMUNOL, V19, P804, DOI 10.1128/CVI.05717-11
   de la Cruz-Hernandez SI, 2013, AM J TROP MED HYG, V88, P446, DOI 10.4269/ajtmh.12-0023
   Dussart P, 2008, PLOS NEGLECT TROP D, V2, DOI 10.1371/journal.pntd.0000280
   Guerrero CD, 2013, CYTOKINE, V61, P766, DOI 10.1016/j.cyto.2012.12.024
   Guzman MG, 2010, NAT REV MICROBIOL, pS7, DOI 10.1038/nrmicro2460
   Hober D, 1996, MICROBIOL IMMUNOL, V40, P569, DOI 10.1111/j.1348-0421.1996.tb01110.x
   LANCIOTTI RS, 1992, J CLIN MICROBIOL, V30, P545, DOI 10.1128/JCM.30.3.545-551.1992
   Lee YR, 2006, J GEN VIROL, V87, P3623, DOI 10.1099/vir.0.82093-0
   Libraty DH, 2002, J INFECT DIS, V186, P1165, DOI 10.1086/343813
   Macedo GA, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0096314
   Mairuhu ATA, 2005, J MED VIROL, V76, P547, DOI 10.1002/jmv.20397
   Osorio L, 2010, VIROL J, V7, DOI 10.1186/1743-422X-7-361
   Lima MDQ, 2011, CLIN VACCINE IMMUNOL, V18, P1031, DOI 10.1128/CVI.00024-11
   Simmons CP, 2012, NEW ENGL J MED, V366, P1423, DOI 10.1056/NEJMra1110265
   Suvarna JC, 2009, TROP MED INT HEALTH, V14, P576, DOI 10.1111/j.1365-3156.2009.02261.x
   Tran NBC, 2010, PLOS NEGLECT TROP D, V4, DOI 10.1371/journal.pntd.0000657
   Watanabe S, 2012, J VIROL, V86, P5508, DOI 10.1128/JVI.07081-11
   WHO, 2009, WHO TECH REP SER, V958, P1
   Young PR, 2000, J CLIN MICROBIOL, V38, P1053, DOI 10.1128/JCM.38.3.1053-1057.2000
NR 27
TC 26
Z9 26
U1 0
U2 15
PU PUBLIC LIBRARY SCIENCE
PI SAN FRANCISCO
PA 1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA
SN 1932-6203
J9 PLOS ONE
JI PLoS One
PD NOV 20
PY 2014
VL 9
IS 11
AR e113634
DI 10.1371/journal.pone.0113634
PG 8
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA AT9ND
UT WOS:000345253000067
PM 25412084
OA DOAJ Gold, Green Published
DA 2020-12-17
ER

PT J
AU Ramirez, R
   Falcon, R
   Izquierdo, A
   Garcia, A
   Alvarez, M
   Perez, AB
   Soto, Y
   Mune, M
   da Silva, EM
   Ortega, O
   Mohana-Borges, R
   Guzman, MG
AF Ramirez, Rosa
   Falcon, Rosabel
   Izquierdo, Alienys
   Garcia, Angelica
   Alvarez, Mayling
   Beatriz Perez, Ana
   Soto, Yudira
   Mune, Mayra
   da Silva, Emiliana Mandarano
   Ortega, Oney
   Mohana-Borges, Ronaldo
   Guzman, Maria G.
TI Recombinant dengue 2 virus NS3 protein conserves structural antigenic
   and immunological properties relevant for dengue vaccine design
SO VIRUS GENES
LA English
DT Article
DE Dengue virus; NS3; Recombinant protein; Immunogenicity; Vaccine
ID T-CELL RESPONSES; NUCLEOCAPSID-LIKE PARTICLES; NEUTRALIZING ANTIBODIES;
   HEMORRHAGIC-FEVER; IMMUNE-RESPONSE; LYMPHOCYTE RESPONSES;
   MEDIATED-IMMUNITY; DISEASE SEVERITY; VIRAL CHALLENGE; 4 SEROTYPES
AB The NS3 protein is a multifunctional nonstructural protein of flaviviruses implicated in the polyprotein processing. The predominance of cytotoxic T cell lymphocytes epitopes on the NS3 protein suggests a protective role of this protein in limiting virus replication. In this work, we studied the antigenicity and immunogenicity of a recombinant NS3 protein of the Dengue virus 2. The full-length NS3 gene was cloned and expressed as a Histagged fusion protein in Escherichia coli. The pNS3 protein was purified by two chromatography steps. The recombinant NS3 protein was recognized by anti-protease NS3 polyclonal antibody and anti-DENV2 HMAF by Western Blot. This purified protein was able to stimulate the secretion of high levels of gamma interferon and low levels of interleukin-10 and tumor necrosis factor-alpha in mice splenocytes, suggesting a predominantly Th-1-type T cell response. Immunized BALB/ c mice with the purified NS3 protein showed a strong induction of anti-NS3 IgG antibodies, essentially IgG2b, as determined by ELISA. Immunized mice sera with recombinant NS3 protein showed specific recognition of native dengue protein by Western blotting and immunofluorescence techniques. The successfully purified recombinant protein was able to preserv the structural and antigenic determinants of the native dengue protein. The antigenicity shown by the recombinant NS3 protein suggests its possible inclusion into future DENV vaccine preparations.
C1 [Ramirez, Rosa; Falcon, Rosabel; Izquierdo, Alienys; Garcia, Angelica; Alvarez, Mayling; Beatriz Perez, Ana; Soto, Yudira; Mune, Mayra; Ortega, Oney; Guzman, Maria G.] IPK, PAHO WHO Collaborating Ctr Study Dengue & Its Vec, Inst Trop Med Pedro Kouri, Havana 17100, Cuba.
   [da Silva, Emiliana Mandarano; Mohana-Borges, Ronaldo] Univ Fed Rio de Janeiro, Inst Biofis Carlos Chagas Filho, Lab Genom Estrutural, BR-21949900 Rio De Janeiro, RJ, Brazil.
RP Guzman, MG (corresponding author), IPK, PAHO WHO Collaborating Ctr Study Dengue & Its Vec, Inst Trop Med Pedro Kouri, Autopista Novia Mediodia Km 6 1-2, Havana 17100, Cuba.
EM lupe@ipk.sld.cu
RI Borges, Ronaldo S Mohana/C-5575-2013
OI Falcon, Rosabel/0000-0003-1273-6835
FU International Society for Infectious Diseases (ISID); Cuban government;
   CAPES, agency from de Brazilian government
FX We would like to thank the International Society for Infectious Diseases
   (ISID) for providing financial support supports through an ISID Exchange
   Fellowship to Rosa Ramirez. We are grateful to technician Ramon Linares
   for his valuable help in the care and maintenance of the animals during
   the experiment. We also thank Melkis Alfonso, Osmel Fleitas and Tatiana
   Almaguer for the technical assistance. This study was also jointly
   supported by funds from the Cuban government, and CAPES, agency from de
   Brazilian government.
CR Amorim JH, 2010, J VIROL METHODS, V167, P186, DOI 10.1016/j.jviromet.2010.04.003
   Appanna R, 2007, CLIN VACCINE IMMUNOL, V14, P969, DOI 10.1128/CVI.00069-07
   Arakaki TL, 2002, PROTEIN EXPRES PURIF, V25, P241, DOI 10.1016/S1046-5928(02)00005-0
   Bartelma G, 2002, VIROLOGY, V299, P122, DOI 10.1006/viro.2002.1504
   Beaumier CM, 2008, J INFECT DIS, V197, P608, DOI 10.1086/526790
   Berrios V, 1996, IMMUNOL INVEST, V25, P231, DOI 10.3109/08820139609059305
   Bhatt S, 2013, NATURE, V496, P504, DOI 10.1038/nature12060
   BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3
   BRANDT WE, 1967, AM J TROP MED HYG, V16, P339, DOI 10.4269/ajtmh.1967.16.339
   CHAMBERS TJ, 1990, ANNU REV MICROBIOL, V44, P649, DOI 10.1146/annurev.mi.44.100190.003245
   Chaturvedi UC, 2000, FEMS IMMUNOL MED MIC, V28, P183, DOI 10.1111/j.1574-695X.2000.tb01474.x
   Chen RF, 2007, T ROY SOC TROP MED H, V101, P1106, DOI 10.1016/j.trstmh.2007.06.019
   Chen ZT, 2008, HYBRIDOMA, V27, P467, DOI 10.1089/hyb.2008.0048
   CHURDBOONCHART V, 1991, AM J TROP MED HYG, V44, P481, DOI 10.4269/ajtmh.1991.44.481
   Costa SM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025685
   De Paula SO, 2008, ARCH VIROL, V153, P2215, DOI 10.1007/s00705-008-0250-3
   Diamond MS, 2001, VIROLOGY, V289, P297, DOI 10.1006/viro.2001.1114
   Duangchinda T, 2010, P NATL ACAD SCI USA, V107, P16922, DOI 10.1073/pnas.1010867107
   Friberg H, 2011, IMMUNOL CELL BIOL, V89, P122, DOI 10.1038/icb.2010.61
   Gil L, 2012, J GEN VIROL, V93, P1204, DOI 10.1099/vir.0.037721-0
   Gil L, 2009, INT IMMUNOL, V21, P1175, DOI 10.1093/intimm/dxp082
   Gil L, 2009, VIRAL IMMUNOL, V22, P23, DOI 10.1089/vim.2008.0063
   Green S, 1999, J INFECT DIS, V179, P755, DOI 10.1086/314680
   Green S, 2006, CURR OPIN INFECT DIS, V19, P429, DOI 10.1097/01.qco.0000244047.31135.fa
   Guy B, 2008, VACCINE, V26, P5712, DOI 10.1016/j.vaccine.2008.08.019
   Guzman MG, 2013, ARCH VIROL, V158, P1445, DOI 10.1007/s00705-013-1645-3
   Guzman MG, 2003, AM J TROP MED HYG, V69, P129, DOI 10.4269/ajtmh.2003.69.129
   Halstead SB, 2013, VACCINE, V31, P4501, DOI 10.1016/j.vaccine.2013.06.079
   HENCHAL EA, 1982, AM J TROP MED HYG, V31, P830, DOI 10.4269/ajtmh.1982.31.830
   Hermida L, 2006, VACCINE, V24, P3165, DOI 10.1016/j.vaccine.2006.01.036
   Huang QW, 2011, PROTEIN EXPRES PURIF, V80, P169, DOI 10.1016/j.pep.2011.08.008
   Jayaratne S D, 2012, BMC Res Notes, V5, P645, DOI 10.1186/1756-0500-5-645
   Kochel TJ, 2000, VACCINE, V18, P3166, DOI 10.1016/S0264-410X(00)00105-5
   Kouri G, 1983, Bull Pan Am Health Organ, V17, P126
   KUNO G, 1985, B WORLD HEALTH ORGAN, V63, P279
   Kurane I, 1998, VIROLOGY, V240, P169, DOI 10.1006/viro.1997.8925
   Kurane Ichiro, 2011, Trop Med Health, V39, P45, DOI 10.2149/tmh.2011-S09
   Kyle JL, 2008, VIROLOGY, V380, P296, DOI 10.1016/j.virol.2008.08.008
   LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0
   Lazo L, 2007, VACCINE, V25, P1064, DOI 10.1016/j.vaccine.2006.09.068
   Li J, 2005, J BIOL CHEM, V280, P28766, DOI 10.1074/jbc.M500588200
   Libraty DH, 2002, J INFECT DIS, V185, P1213, DOI 10.1086/340365
   LIVINGSTON PG, 1995, J IMMUNOL, V154, P1287
   LOBIGS M, 1994, VIROLOGY, V202, P195, DOI 10.1006/viro.1994.1335
   Luo D, 2008, J VIROL, V82, P173, DOI 10.1128/JVI.01788-07
   Luo DH, 2008, EMBO J, V27, P3209, DOI 10.1038/emboj.2008.232
   Mangada MM, 2005, J IMMUNOL, V175, P2676, DOI 10.4049/jimmunol.175.4.2676
   Mangada MM, 2002, J INFECT DIS, V185, P1697, DOI 10.1086/340822
   Markine-Goriaynoff D, 2002, J VIROL, V76, P432, DOI 10.1128/JVI.76.1.432-435.2002
   Masaki H, 2009, VIRUS RES, V144, P188, DOI 10.1016/j.virusres.2009.04.024
   Mathew A, 1998, J VIROL, V72, P3999, DOI 10.1128/JVI.72.5.3999-4004.1998
   Mathew A, 1996, J CLIN INVEST, V98, P1684, DOI 10.1172/JCI118964
   Mladinich KM, 2012, IMMUNOGENETICS, V64, P111, DOI 10.1007/s00251-011-0566-0
   Mongkolsapaya J, 2003, NAT MED, V9, P921, DOI 10.1038/nm887
   Alvarez-Rodriguez LM, 2012, J TROP MED-US, V2012, DOI 10.1155/2012/956875
   Murphy BR, 2011, ANNU REV IMMUNOL, V29, P587, DOI 10.1146/annurev-immunol-031210-101315
   Nimmerjahn F, 2005, SCIENCE, V310, P1510, DOI 10.1126/science.1118948
   Perez AB, 2004, J MED VIROL, V73, P230, DOI 10.1002/jmv.20080
   Perez AB, 2010, HUM IMMUNOL, V71, P1135, DOI 10.1016/j.humimm.2010.08.004
   Raviprakash K, 2008, J VIROL, V82, P6927, DOI 10.1128/JVI.02724-07
   Rivino L, 2013, J VIROL, V87, P2693, DOI 10.1128/JVI.02675-12
   Rothman AL, 2001, VACCINE, V19, P4694, DOI 10.1016/S0264-410X(01)00236-5
   Rothman AL, 2011, NAT REV IMMUNOL, V11, P532, DOI 10.1038/nri3014
   Sallberg M, 1996, J GEN VIROL, V77, P2721, DOI 10.1099/0022-1317-77-11-2721
   Schexneider Katherine I, 2005, Curr Hematol Rep, V4, P145
   Simmons CP, 2005, J VIROL, V79, P5665, DOI 10.1128/JVI.79.9.5665-5675.2005
   Spaulding AC, 1999, J VIROL, V73, P398, DOI 10.1128/JVI.73.1.398-403.1999
   TOWBIN H, 1979, P NATL ACAD SCI USA, V76, P4350, DOI 10.1073/pnas.76.9.4350
   Valdes K, 2000, CLIN DIAGN LAB IMMUN, V7, P856, DOI 10.1128/CDLI.7.5.856-857.2000
   Williams KL, 2009, ANN NY ACAD SCI, V1171, pE12, DOI 10.1111/j.1749-6632.2009.05057.x
   Xu T, 2005, J VIROL, V79, P10278, DOI 10.1128/JVI.79.16.10278-10288.2005
   Yauch LE, 2010, J IMMUNOL, V185, P5405, DOI 10.4049/jimmunol.1001709
   Yauch LE, 2009, J IMMUNOL, V182, P4865, DOI 10.4049/jimmunol.0801974
   Zivna I, 2002, J IMMUNOL, V168, P5959, DOI 10.4049/jimmunol.168.11.5959
NR 74
TC 10
Z9 10
U1 0
U2 2
PU SPRINGER
PI DORDRECHT
PA VAN GODEWIJCKSTRAAT 30, 3311 GZ DORDRECHT, NETHERLANDS
SN 0920-8569
EI 1572-994X
J9 VIRUS GENES
JI Virus Genes
PD OCT
PY 2014
VL 49
IS 2
BP 185
EP 195
DI 10.1007/s11262-014-1087-3
PG 11
WC Genetics & Heredity; Virology
SC Genetics & Heredity; Virology
GA AT7CL
UT WOS:000345094000002
PM 24854144
DA 2020-12-17
ER

PT J
AU Faustino, AF
   Carvalho, FA
   Martins, IC
   Castanho, MARB
   Mohana-Borges, R
   Almeida, FCL
   Da Poian, AT
   Santos, NC
AF Faustino, Andre F.
   Carvalho, Filomena A.
   Martins, Ivo C.
   Castanho, Miguel A. R. B.
   Mohana-Borges, Ronaldo
   Almeida, Fabio C. L.
   Da Poian, Andrea T.
   Santos, Nuno C.
TI Dengue Virus Capsid Protein Interacts Specifically with Very Low-Density
   Lipoproteins
SO BIOPHYSICAL JOURNAL
LA English
DT Meeting Abstract
CT 58th Annual Meeting of the Biophysical-Society
CY FEB 15-19, 2014
CL San Francisco, CA
SP Biophys Soc
C1 [Faustino, Andre F.; Carvalho, Filomena A.; Martins, Ivo C.; Castanho, Miguel A. R. B.; Santos, Nuno C.] Univ Lisbon, Fac Med, Inst Mol Med, P-1699 Lisbon, Portugal.
   [Mohana-Borges, Ronaldo; Almeida, Fabio C. L.; Da Poian, Andrea T.] Univ Fed Rio de Janeiro, Rio De Janeiro, Brazil.
RI Borges, Ronaldo S Mohana/C-5575-2013
CR [Anonymous], 2012, Patent, Patent No. [WO/2012/15918, 201215918]
   Bartenschlager R, 2011, TRENDS MICROBIOL, V19, P95, DOI 10.1016/j.tim.2010.11.005
   Carvalho FA, 2012, IUBMB LIFE, V64, P465, DOI 10.1002/iub.1037
   Carvalho FA, 2012, J VIROL, V86, P2096, DOI 10.1128/JVI.06796-11
   Faustino, 2013, NANOMEDICIN IN PRESS
   Martins IC, 2012, BIOCHEM J, V444, P405, DOI 10.1042/BJ20112219
   Samsa MM, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000632
NR 7
TC 0
Z9 0
U1 0
U2 6
PU CELL PRESS
PI CAMBRIDGE
PA 50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA
SN 0006-3495
EI 1542-0086
J9 BIOPHYS J
JI Biophys. J.
PD JAN 28
PY 2014
VL 106
IS 2
SU 1
BP 388A
EP 388A
DI 10.1016/j.bpj.2013.11.2194
PG 1
WC Biophysics
SC Biophysics
GA AI6QE
UT WOS:000337000402195
OA Bronze
DA 2020-12-17
ER

PT J
AU Faustino, AF
   Carvalho, FA
   Martins, IC
   Castanho, MARB
   Mohana-Borges, R
   Almeida, FCL
   Da Poian, AT
   Santos, NC
AF Faustino, Andre F.
   Carvalho, Filomena A.
   Martins, Ivo C.
   Castanho, Miguel A. R. B.
   Mohana-Borges, Ronaldo
   Almeida, Fabio C. L.
   Da Poian, Andrea T.
   Santos, Nuno C.
TI Dengue virus capsid protein interacts specifically with very low-density
   lipoproteins
SO NANOMEDICINE-NANOTECHNOLOGY BIOLOGY AND MEDICINE
LA English
DT Article
DE Dengue virus capsid protein; Lipoproteins; Single-molecule studies;
   AFM-based force spectroscopy; Dynamic light scattering
ID HEPATITIS-C VIRUS; GLOBAL DISTRIBUTION; INTEGRAL-EQUATIONS; LIPID
   PROFILE; INFECTION; FEVER; VISUALIZATION; SPECTROSCOPY; FLAVIVIRIDAE;
   PREDICTOR
AB Dengue affects millions of people worldwide. No specific treatment is currently available, in part due to an incomplete understanding of the viral components' interactions with host cellular structures. We tested dengue virus (DENV) capsid protein (C) interaction with low-and very low-density lipoproteins (LDL and VLDL, respectively) using atomic force microscopy-based force spectroscopy, dynamic light scattering, NMR and computational analysis. Data reveal a specific DENV C interaction with VLDL, but not LDL. This binding is potassium-dependent and involves the DENV C N-terminal region, as previously observed for the DENV C-lipid droplets (LDs) interaction. A successful inhibition of DENV C-VLDL binding was achieved with a peptide drug lead. The similarities between LDs and VLDL, and between perilipin 3 (DENV C target on LDs) and ApoE, indicate ApoE as the molecular target on VLDL. We hypothesize that DENV may form lipoviroparticles, which would constitute a novel step on DENV life cycle.
   From the Clinical Editor: Using atomic force microscopy-based force spectroscopy, dynamic light scattering, NMR, and computational analysis, these authors demonstrate that dengue viral capsid proteins (DENV C) bind to very low density lipoprotein surfaces, but not to LDLs, in a potassium-dependent manner. This observation suggests the formation of lipo-viroparticles, which may be a novel step in its life cycle, and may offer potential therapeutic interventions directed to this step. (C) 2014 Elsevier Inc. All rights reserved.
C1 [Faustino, Andre F.; Carvalho, Filomena A.; Martins, Ivo C.; Castanho, Miguel A. R. B.; Santos, Nuno C.] Univ Lisbon, Fac Med, Inst Med Mol, P-1649028 Lisbon, Portugal.
   [Mohana-Borges, Ronaldo] Univ Fed Rio de Janeiro, Inst Biofis Carlos Chagas Filho, Rio De Janeiro, Brazil.
   [Almeida, Fabio C. L.; Da Poian, Andrea T.] Univ Fed Rio de Janeiro, Inst Bioquim Med, Rio De Janeiro, Brazil.
   [Almeida, Fabio C. L.] Univ Fed Rio de Janeiro, Ctr Nacl Ressonancia Magnet Nucl, Rio De Janeiro, Brazil.
   [Almeida, Fabio C. L.] Natl Inst Struct Biol & Bioimage, Rio De Janeiro, Brazil.
RP Santos, NC (corresponding author), Univ Lisbon, Fac Med, Inst Med Mol, Av Prof Egas Moniz, P-1649028 Lisbon, Portugal.
EM nsantos@fm.ul.pt
RI Martins, Ivo C/G-2534-2013; Almeida, Fabio/O-4989-2018; Borges, Ronaldo
   S Mohana/C-5575-2013; Da Poian, Andrea T./V-1699-2019; Santos,
   Nuno/N-7248-2013; Carvalho, Filomena/M-9202-2013
OI Martins, Ivo C/0000-0002-9284-8599; Almeida, Fabio/0000-0001-6046-7006;
   Da Poian, Andrea/0000-0002-3969-704X; Santos, Nuno/0000-0002-0580-0475;
   Castanho, Miguel/0000-0001-7891-7562; Carvalho,
   Filomena/0000-0001-6088-3894; Faustino, Andre F./0000-0002-7364-8524;
   FCCN, Bogus/0000-0003-1034-3552
FU Fundacao para a Ciencia e Tecnologia - Ministerio da Educacao e Ciencia
   (FCT-MEC, Portugal) [PTDC/QUI-BIQ/112929/2009,
   PTDC/SAU-ENB/117013/2010]; Calouste Gulenkian Foundation (Portugal);
   European UnionEuropean Union (EU); FCT-CAPESCAPESPortuguese Foundation
   for Science and Technology; CNPqNational Council for Scientific and
   Technological Development (CNPq); FAPERJCarlos Chagas Filho Foundation
   for Research Support of the State of Rio de Janeiro (FAPERJ);
   FINEPCiencia Tecnologia e Inovacao (FINEP); CAPESCAPES [PVE171/2012];
   INCT-Dengue; FCT-MEC [SFRH/BD/77609/2011, SFRH/BPD/74287/2010]
FX This work was supported by Fundacao para a Ciencia e Tecnologia -
   Ministerio da Educacao e Ciencia (FCT-MEC, Portugal, projects
   PTDC/QUI-BIQ/112929/2009 and PTDC/SAU-ENB/117013/2010), Calouste
   Gulenkian Foundation (Portugal), European Union FP7-IRSES project
   MEMPEPACROSS, FCT-CAPES Portugal-Brazil joint cooperation projects, and
   by the Brazilian Funding Agencies CNPq, FAPERJ, FINEP, CAPES
   (PVE171/2012) and INCT-Dengue. AFF and ICM acknowledge FCT-MEC for
   fellowships SFRH/BD/77609/2011 and SFRH/BPD/74287/2010, respectively.
CR Agnello V, 1999, P NATL ACAD SCI USA, V96, P12766, DOI 10.1073/pnas.96.22.12766
   Alves MJ, 2013, EUROSURVEILLANCE, V18, P20398
   Andre P, 2002, J VIROL, V76, P6919, DOI 10.1128/JVI.76.14.6919-6928.2002
   Bartenschlager R, 2011, TRENDS MICROBIOL, V19, P95, DOI 10.1016/j.tim.2010.11.005
   Berne B. J., 1990, DYNAMIC LIGHT SCATTE
   Bhatt S, 2013, NATURE, V496, P504, DOI 10.1038/nature12060
   Carvalho FA, 2012, IUBMB LIFE, V64, P465, DOI 10.1002/iub.1037
   Carvalho FA, 2012, J VIROL, V86, P2096, DOI 10.1128/JVI.06796-11
   Carvalho FA, 2010, ACS NANO, V4, P4609, DOI 10.1021/nn1009648
   Chenna R, 2003, NUCLEIC ACIDS RES, V31, P3497, DOI 10.1093/nar/gkg500
   Clark Kristina Bargeron, 2012, Yale Journal of Biology and Medicine, V85, P3
   Cushley RJ, 2002, ANNU REV BIOPH BIOM, V31, P177, DOI 10.1146/annurev.biophys.31.101101.140910
   DELAGLIO F, 1995, J BIOMOL NMR, V6, P277, DOI 10.1007/BF00197809
   Enserink M, 2010, SCIENCE, V329, P736, DOI 10.1126/science.329.5993.736
   Fujie H, 1999, J MED VIROL, V59, P141, DOI 10.1002/(SICI)1096-9071(199910)59:2&lt;141::AID-JMV3&gt;3.0.CO;2-5
   Gubler D. J., 1998, Annals Academy of Medicine Singapore, V27, P227
   Gubler Duane J., 2002, Trends in Microbiology, V10, P100, DOI 10.1016/S0966-842X(01)02288-0
   Guzman A, 2010, INT J ANTIMICROB AG, V36, pS40, DOI 10.1016/j.ijantimicag.2010.06.018
   Guzman MG, 2010, NAT REV MICROBIOL, pS7, DOI 10.1038/nrmicro2460
   Hickenbottom SJ, 2004, STRUCTURE, V12, P1199, DOI 10.1016/j.str.2004.04.021
   JOHNSON BA, 1994, J BIOMOL NMR, V4, P603, DOI 10.1007/BF00404272
   KAHLON TS, 1992, LIPIDS, V27, P1055, DOI 10.1007/BF02535588
   Lambrechts L, 2010, PLOS NEGLECT TROP D, V4, DOI 10.1371/journal.pntd.0000646
   Ma LX, 2004, P NATL ACAD SCI USA, V101, P3414, DOI 10.1073/pnas.0305892101
   Malvern Instruments Ltd, 2004, ZET NAN SER
   Martins I. C., 2012, International Patent Publication, Patent No. [WO/ 2012/ 159187, 2012159187]
   Martins IC, 2012, BIOCHEM J, V444, P405, DOI 10.1042/BJ20112219
   Mukhopadhyay S, 2005, NAT REV MICROBIOL, V3, P13, DOI 10.1038/nrmicro1067
   Nelson D. L, 2005, LEHNINGER PRINCIPLES
   Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084
   PROVENCHER SW, 1982, COMPUT PHYS COMMUN, V27, P229, DOI 10.1016/0010-4655(82)90174-6
   PROVENCHER SW, 1982, COMPUT PHYS COMMUN, V27, P213, DOI 10.1016/0010-4655(82)90173-4
   Quaresma JAS, 2007, T ROY SOC TROP MED H, V101, P161, DOI 10.1016/j.trstmh.2006.02.019
   Reiter P, 2010, EUROSURVEILLANCE, V15, P11
   Samsa MM, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000632
   Sanner MF, 1996, BIOPOLYMERS, V38, P305, DOI 10.1002/(SICI)1097-0282(199603)38:3<305::AID-BIP4>3.3.CO;2-8
   Santos NC, 1996, BIOPHYS J, V71, P1641, DOI 10.1016/S0006-3495(96)79369-4
   Schweitzer BK, 2009, LABMEDICINE, V40, P493, DOI 10.1309/LM5YWS85NJPCWESW
   Seneviratne SL, 2006, T ROY SOC TROP MED H, V100, P608, DOI 10.1016/j.trstmh.2005.10.007
   Sousa CA, 2012, EUROSURVEILLANCE, V17, P15
   Suvarna JC, 2009, TROP MED INT HEALTH, V14, P576, DOI 10.1111/j.1365-3156.2009.02261.x
   van Gorp ECM, 2002, CLIN INFECT DIS, V34, P1150, DOI 10.1086/339539
   Wood RJ, 2006, J NUTR, V136, P384
NR 43
TC 34
Z9 34
U1 1
U2 21
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 1549-9634
EI 1549-9642
J9 NANOMED-NANOTECHNOL
JI Nanomed.-Nanotechnol. Biol. Med.
PD JAN
PY 2014
VL 10
IS 1
BP 247
EP 255
DI 10.1016/j.nano.2013.06.004
PG 9
WC Nanoscience & Nanotechnology; Medicine, Research & Experimental
SC Science & Technology - Other Topics; Research & Experimental Medicine
GA 281LR
UT WOS:000329103500026
PM 23792329
DA 2020-12-17
ER

PT J
AU da Costa, ECB
   Amorim, R
   da Silva, FC
   Rocha, DR
   Papa, MP
   de Arruda, LB
   Mohana-Borges, R
   Ferreira, VF
   Tanuri, A
   da Costa, LJ
   Ferreira, SB
AF da Costa, Emmerson C. B.
   Amorim, Raquel
   da Silva, Fernando C.
   Rocha, David R.
   Papa, Michelle P.
   de Arruda, Luciana B.
   Mohana-Borges, Ronaldo
   Ferreira, Vitor F.
   Tanuri, Amilcar
   da Costa, Luciana J.
   Ferreira, Sabrina B.
TI Synthetic 1,4-Pyran Naphthoquinones Are Potent Inhibitors of Dengue
   Virus Replication
SO PLOS ONE
LA English
DT Article
ID BETA-LAPACHONE; TRYPANOSOMA-CRUZI; NS3 PROTEASE; HELICASE ACTIVITY; NS2B
   COFACTOR; RNA HELICASE; DERIVATIVES; TRIPHOSPHATASE; RECOMBINANT;
   1,4-NAPHTHOQUINONE
AB Dengue virus infection is a serious public health problem in endemic areas of he world where 2,5 billion people live. Clinical manifestations of the Dengue infection range from a mild fever to fatal cases of hemorrhagic fever. Although being the most rapidly spreading mosquito-borne viral infection in the world, until now no strategies are available for effective prevention or control of Dengue infection. In this scenario, the development of compounds that specifically inhibit viral replication with minimal effects to the human hosts will have a substantial effect in minimizing the symptoms of the disease and help to prevent viral transmission in the affected population. The aim of this study was to screen compounds with potential activity against dengue virus from a library of synthetic naphthoquinones Several 1,2- and 1,4-pyran naphthoquinones were synthesized by a three-component reaction of lawsone, aldehyde (formaldehyde or arylaldehydes) and different dienophiles adequately substituted. These compounds were tested for he ability to inhibit the ATPase activity of the viral NS3 enzyme in in vitro assays and the replication of dengue virus in cultured cells. We have identified two 1,4-pyran naphthoquinones, which inhibited dengue virus replication in mammal cells by 99.0% and three others that reduced the dengue virus ATPase activity of NS3 by two-fold in in vitro assays
C1 [da Costa, Emmerson C. B.; Mohana-Borges, Ronaldo] Univ Fed Rio de Janeiro, Inst Biofis Carlos Chagas Filho, Lab Genom Estrutural, Rio De Janeiro, Brazil.
   [Amorim, Raquel; Papa, Michelle P.; de Arruda, Luciana B.; da Costa, Luciana J.] Univ Fed Rio de Janeiro, Dept Virol, Inst Microbiol Paulo de Goes, Rio De Janeiro, Brazil.
   [da Silva, Fernando C.; Rocha, David R.; Ferreira, Vitor F.] Univ Fed Fluminense, Dept Quim Organ, Inst Quim, BR-24000 Niteroi, RJ, Brazil.
   [Tanuri, Amilcar] Univ Fed Rio de Janeiro, Inst Biol, Dept Genet, Rio De Janeiro, Brazil.
   [Ferreira, Sabrina B.] Univ Fed Rio de Janeiro, Dept Quim Organ, Inst Quim, Rio De Janeiro, Brazil.
RP da Costa, LJ (corresponding author), Univ Fed Rio de Janeiro, Dept Virol, Inst Microbiol Paulo de Goes, Rio De Janeiro, Brazil.
EM ljcosta@micro.ufrj.br; sabrinab@iq.ufrj.br
RI Amorim, Raquel/M-8161-2013; Arruda, Luciana B/N-9086-2013; de Carvalho
   da Silva, Fernando/E-3408-2014; Borges, Ronaldo S Mohana/C-5575-2013;
   ferreira, Vitor francisco/Y-4031-2019; da Rocha, David R/J-9912-2012;
   Costa, Luciana J/B-7878-2013; Arruda, Luciana/B-5806-2014; Ferreira,
   Sabrina Baptista/AAC-9368-2019
OI Amorim, Raquel/0000-0002-1605-0702; de Carvalho da Silva,
   Fernando/0000-0002-2042-3778; ferreira, Vitor
   francisco/0000-0002-2166-766X; da Rocha, David R/0000-0002-7928-8646;
   Ferreira, Sabrina Baptista/0000-0002-5363-0888
FU CNPq (Brazil)National Council for Scientific and Technological
   Development (CNPq); CAPES-FAPERJCAPESCarlos Chagas Filho Foundation for
   Research Support of the State of Rio de Janeiro (FAPERJ); CAPESCAPES;
   CNPqNational Council for Scientific and Technological Development (CNPq)
   [471588/2009-1]; FAPERJ-PRONEXCarlos Chagas Filho Foundation for
   Research Support of the State of Rio de Janeiro (FAPERJ) [110.574/2010];
   CNPq INCT-Dengue
FX Fellowships granted to VFF by CNPq (Brazil), DRR by CAPES-FAPERJ and SBF
   and RA by CAPES are gratefully acknowledged. This work was partially
   supported by CAPES; CNPq grant 471588/2009-1; FAPERJ-PRONEX grant number
   110.574/2010 and CNPq INCT-Dengue. The funders had no role in study
   design, data collection and analysis, decision to publish, or
   preparation of the manuscript.
CR ANDERSON RD, 1994, MUTAT RES-FUND MOL M, V309, P109, DOI 10.1016/0027-5107(94)90048-5
   Benarroch D, 2004, VIROLOGY, V328, P208, DOI 10.1016/j.virol.2004.07.004
   Boguszewska-Chachulska AM, 2004, FEBS LETT, V567, P253, DOI 10.1016/j.febslet.2004.04.072
   BOOTHMAN DA, 1989, CANCER RES, V49, P605
   Cui TA, 1998, VIROLOGY, V246, P409, DOI 10.1006/viro.1998.9213
   da Rocha DR, 2011, ORG BIOMOL CHEM, V9, P4315, DOI 10.1039/c1ob05209h
   da Silva AJM, 2009, J BRAZIL CHEM SOC, V20, P176, DOI 10.1590/S0103-50532009000100026
   da Silva EN, 2010, J MED CHEM, V53, P504, DOI 10.1021/jm900865m
   da Silva FD, 2009, J BRAZIL CHEM SOC, V20, P1478, DOI 10.1590/S0103-50532009000800014
   De Burghgraeve T, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037244
   DRISCOLL JS, 1974, CANCER CHEMOTH REP 2, V4, P3
   Ertl P, 1999, BIOORG MED CHEM LETT, V9, P2863, DOI 10.1016/S0960-894X(99)00489-8
   Eyong KO, 2008, BIOORG MED CHEM LETT, V18, P5387, DOI 10.1016/j.bmcl.2008.09.053
   FALGOUT B, 1995, J VIROL, V69, P7232, DOI 10.1128/JVI.69.11.7232-7243.1995
   Ferreira S, 2013, MEDCHEMCOMM UNPUB
   Ferreira SB, 2011, EUR J MED CHEM, V46, P3071, DOI 10.1016/j.ejmech.2011.03.012
   Ferreira VF, 2006, BIOORGAN MED CHEM, V14, P5459, DOI 10.1016/j.bmc.2006.04.046
   Ferreira VF, 2010, ORG BIOMOL CHEM, V8, P4793, DOI 10.1039/c0ob00277a
   Fiske CH, 1927, SCIENCE, V65, P401, DOI 10.1126/science.65.1686.401
   Francisco AI, 2010, J BRAZIL CHEM SOC, V21, P1293, DOI 10.1590/S0103-50532010000700017
   Gebhard LG, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036244
   GUIRAUD P, 1994, PLANTA MED, V60, P373, DOI 10.1055/s-2006-959504
   Guzman MG, 2010, NAT REV MICROBIOL, pS7, DOI 10.1038/nrmicro2460
   Halstead Scott B, 2005, Vaccine, V23, P849, DOI 10.1016/j.vaccine.2004.03.069
   Hussain H, 2007, ARKIVOC, P145, DOI 10.3998/ark.5550190.0008.204
   Johnson BW, 2005, J CLIN MICROBIOL, V43, P4977, DOI 10.1128/JCM.43.10.4977-4983.2005
   Jorqueira A, 2006, PARASITOL RES, V99, P429, DOI 10.1007/s00436-006-0153-8
   Kwong AD, 2005, NAT REV DRUG DISCOV, V4, P845, DOI 10.1038/nrd1853
   Leung D, 2001, J BIOL CHEM, V276, P45762, DOI 10.1074/jbc.M107360200
   Levin MK, 2003, J BIOL CHEM, V278, P23311, DOI 10.1074/jbc.M301283200
   Li HT, 1999, J VIROL, V73, P3108, DOI 10.1128/JVI.73.4.3108-3116.1999
   Lima NMF, 2004, MEM I OSWALDO CRUZ, V99, P757, DOI 10.1590/S0074-02762004000700017
   Lima NMF, 2002, J BRAZIL CHEM SOC, V13, P822, DOI 10.1590/S0103-50532002000600015
   Liu KKC, 2004, MINI-REV MED CHEM, V4, P1105
   LOPES JN, 1978, ANN TROP MED PARASIT, V72, P523, DOI 10.1080/00034983.1978.11719356
   Luo D, 2008, J VIROL, V82, P173, DOI 10.1128/JVI.01788-07
   Mastrangelo E, 2012, J ANTIMICROB CHEMOTH, V67, P1884, DOI 10.1093/jac/dks147
   Monks Terrence J, 2002, Curr Drug Metab, V3, P425, DOI 10.2174/1389200023337388
   Niyomrattanakit P, 2004, J VIROL, V78, P13708, DOI 10.1128/JVI.78.24.13708-13716.2004
   Perez-Sacau E, 2005, CHEM BIODIVERS, V2, P264, DOI 10.1002/cbdv.200590009
   Racloz V, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001648
   REED L. J., 1938, AMER JOUR HYG, V27, P493
   Sabchareon A, 2012, LANCET, V380, P1559, DOI 10.1016/S0140-6736(12)61428-7
   Sampath A, 2009, ANTIVIR RES, V81, P6, DOI 10.1016/j.antiviral.2008.08.004
   Silva TMS, 2005, BIOORGAN MED CHEM, V13, P193, DOI 10.1016/j.bmc.2004.09.043
   Teixeira MJ, 2005, INFECT IMMUN, V73, P1191, DOI 10.1128/IAI.73.2.1191-1195.2005
   WENGLER G, 1993, VIROLOGY, V197, P265, DOI 10.1006/viro.1993.1587
   WHO, 2009, DENG GUID DIAGN TREA
   *WHO, 2006, SCI WORK GROUP REP D
   Xu T, 2005, J VIROL, V79, P10278, DOI 10.1128/JVI.79.16.10278-10288.2005
NR 50
TC 20
Z9 20
U1 0
U2 21
PU PUBLIC LIBRARY SCIENCE
PI SAN FRANCISCO
PA 1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA
SN 1932-6203
J9 PLOS ONE
JI PLoS One
PD DEC 20
PY 2013
VL 8
IS 12
AR e82504
DI 10.1371/journal.pone.0082504
PG 11
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA 276IX
UT WOS:000328745100035
PM 24376541
OA DOAJ Gold, Green Published
DA 2020-12-17
ER

PT J
AU Freire, JM
   Veiga, AS
   Conceicao, TM
   Kowalczyk, W
   Mohana-Borges, R
   Andreu, D
   Santos, NC
   Da Poian, AT
   Castanho, MARB
AF Freire, Joao Miguel
   Veiga, Ana Salome
   Conceicao, Thais M.
   Kowalczyk, Wioleta
   Mohana-Borges, Ronaldo
   Andreu, David
   Santos, Nuno C.
   Da Poian, Andrea T.
   Castanho, Miguel A. R. B.
TI Intracellular Nucleic Acid Delivery by the Supercharged Dengue Virus
   Capsid Protein
SO PLOS ONE
LA English
DT Article
ID CELL-PENETRATING PEPTIDES; FUNCTIONAL PROTEINS; LIPID-COMPOSITION;
   DRUG-DELIVERY; IN-VITRO; EFFICACY; BINDING; VECTOR; DRIVEN; NMR
AB Supercharged proteins are a recently identified class of proteins that have the ability to efficiently deliver functional macromolecules into mammalian cells. They were first developed as bioengineering products, but were later found in the human proteome. In this work, we show that this class of proteins with unusually high net positive charge is frequently found among viral structural proteins, more specifically among capsid proteins. In particular, the capsid proteins of viruses from the Flaviviridae family have all a very high net charge to molecular weight ratio (> + 1.07/kDa), thus qualifying as supercharged proteins. This ubiquity raises the hypothesis that supercharged viral capsid proteins may have biological roles that arise from an intrinsic ability to penetrate cells. Dengue virus capsid protein was selected for a detailed experimental analysis. We showed that this protein is able to deliver functional nucleic acids into mammalian cells. The same result was obtained with two isolated domains of this protein, one of them being able to translocate lipid bilayers independently of endocytic routes. Nucleic acids such as siRNA and plasmids were delivered fully functional into cells. The results raise the possibility that the ability to penetrate cells is part of the native biological functions of some viral capsid proteins.
C1 [Freire, Joao Miguel; Veiga, Ana Salome; Santos, Nuno C.; Castanho, Miguel A. R. B.] Univ Lisbon, Inst Med Mol, Fac Med, P-1699 Lisbon, Portugal.
   [Conceicao, Thais M.; Da Poian, Andrea T.] Univ Fed Rio de Janeiro, Inst Bioquim Med, Rio De Janeiro, Brazil.
   [Kowalczyk, Wioleta; Andreu, David] Pompeu Fabra Univ, Dept Expt & Hlth Sci, Barcelona, Spain.
   [Mohana-Borges, Ronaldo] Univ Fed Rio de Janeiro, Inst Biofis Carlos Chagas Filho, BR-21941 Rio De Janeiro, Brazil.
RP Castanho, MARB (corresponding author), Univ Lisbon, Inst Med Mol, Fac Med, P-1699 Lisbon, Portugal.
EM macastanho@fm.ul.pt
RI Borges, Ronaldo S Mohana/C-5575-2013; Andreu, David/I-4359-2014;
   Kowalczyk, Wioleta/F-5904-2014; Da Poian, Andrea T./V-1699-2019; Santos,
   Nuno/N-7248-2013
OI Andreu, David/0000-0002-6317-6666; FCCN, Bogus/0000-0001-6282-8004;
   FCCN, Bogus/0000-0003-1034-3552; Castanho, Miguel/0000-0001-7891-7562;
   Da Poian, Andrea/0000-0002-3969-704X; Veiga, Ana
   Salome/0000-0002-9892-2243; Santos, Nuno/0000-0002-0580-0475
FU Fundacao para a Ciencia e Tecnologia - Ministerio da Educacao e Ciencia
   (FCT-MEC, Portugal) [PTDC/QUI-BIQ/112929/2009]; European UnionEuropean
   Union (EU) [FP7-HEALTH-F3-2008-223414]; Spanish Ministry of Economy and
   Competitiveness [SAF2011-24899]; Generalitat de CatalunyaGeneralitat de
   Catalunya [2009 SGR 492]; Brazilian Conselho Nacional de Desenvolvimento
   Cientifico e Tecnologico (CNPq)National Council for Scientific and
   Technological Development (CNPq); Fundacao Carlos Chagas Filho de Amparo
   a Pesquisa do Estado do Rio de Janeiro (FAPERJ)Carlos Chagas Filho
   Foundation for Research Support of the State of Rio de Janeiro (FAPERJ);
   National Institute of Science and Technology in Dengue (INCT-Dengue);
   FCT-MEC [SFRH/BD/70423/2010]
FX This work was supported by Fundacao para a Ciencia e Tecnologia -
   Ministerio da Educacao e Ciencia (FCT-MEC, Portugal)
   [PTDC/QUI-BIQ/112929/2009], by the European Union [projects FP7-PEOPLE
   IRSES (MEMPEPACROSS) and FP7-HEALTH-F3-2008-223414 (LEISHDRUG)], by the
   Spanish Ministry of Economy and Competitiveness (SAF2011-24899), the
   Generalitat de Catalunya (2009 SGR 492), by the Brazilian Conselho
   Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq), Fundacao
   Carlos Chagas Filho de Amparo a Pesquisa do Estado do Rio de Janeiro
   (FAPERJ), and the National Institute of Science and Technology in Dengue
   (INCT-Dengue). JMF also acknowledges FCT-MEC for Ph.D. fellowship
   SFRH/BD/70423/2010. WK is a fellow in the Juan de la Cierva Program of
   the Spanish Ministry of Science and Innovation. The funders had no role
   in study design, data collection and analysis, decision to publish, or
   preparation of the manuscript.
CR Abrescia NGA, 2012, ANNU REV BIOCHEM, V81, P795, DOI 10.1146/annurev-biochem-060910-095130
   Alves CS, 2010, J BIOL CHEM, V285, P27536, DOI 10.1074/jbc.M110.130955
   Bolhassani A, 2011, BBA-REV CANCER, V1816, P232, DOI 10.1016/j.bbcan.2011.07.006
   BRECKENRIDGE WC, 1972, BIOCHIM BIOPHYS ACTA, V266, P695, DOI 10.1016/0005-2736(72)90365-3
   Carvalho FA, 2012, J VIROL, V86, P2096, DOI 10.1128/JVI.06796-11
   Cronican JJ, 2011, CHEM BIOL, V18, P833, DOI 10.1016/j.chembiol.2011.07.003
   Cronican JJ, 2010, ACS CHEM BIOL, V5, P747, DOI 10.1021/cb1001153
   DeLano W.L., 2008, PYMOL MOL GRAPHICS S
   Doerr A, 2009, NAT METHODS, V6, P322, DOI 10.1038/nmeth0509-322
   Faustino AF, 2014, NANOMED-NANOTECHNOL, V10, P247, DOI 10.1016/j.nano.2013.06.004
   Ferre R, 2009, BIOPHYS J, V96, P1815, DOI [10.1016/j.bpj.2008.11.053, 10.1016/j.bpj.2008.11053]
   FIELDS GB, 1990, INT J PEPT PROT RES, V35, P161, DOI 10.1111/j.1399-3011.1990.tb00939.x
   Fischer R, 2005, CHEMBIOCHEM, V6, P2126, DOI 10.1002/cbic.200500044
   Fischer R, 2002, BBA-BIOMEMBRANES, V1564, P365, DOI 10.1016/S0005-2736(02)00471-6
   Freire JM, 2013, BIOPOLYMERS, V100, P325, DOI 10.1002/bip.22266
   Freire JM, 2013, J PEPT SCI, V19, P182, DOI 10.1002/psc.2477
   Gautam A, 2012, DATABASE-OXFORD, DOI 10.1093/database/bas015
   Gautier R, 2008, BIOINFORMATICS, V24, P2101, DOI 10.1093/bioinformatics/btn392
   GREEN M, 1989, CELL, V58, P215, DOI 10.1016/0092-8674(89)90417-0
   Hayashi Y, 2011, INT J PHARMACEUT, V419, P308, DOI 10.1016/j.ijpharm.2011.07.038
   Henriques ST, 2005, BIOCHEMISTRY-US, V44, P10189, DOI 10.1021/bi0502644
   HERTZ L, 1988, NEUROCHEM RES, V13, P605, DOI 10.1007/BF00973275
   Hubner W, 2009, SCIENCE, V323, P1743, DOI 10.1126/science.1167525
   Hulo C, 2011, NUCLEIC ACIDS RES, V39, pD576, DOI 10.1093/nar/gkq901
   Jarver P, 2010, TRENDS PHARMACOL SCI, V31, P528, DOI 10.1016/j.tips.2010.07.006
   Kasson PM, 2011, P NATL ACAD SCI USA, V108, P3827, DOI 10.1073/pnas.1101072108
   Kler S, 2012, J AM CHEM SOC, V134, P8823, DOI 10.1021/ja2110703
   Kobayashi Y, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040422
   Lawrence MS, 2007, J AM CHEM SOC, V129, P10110, DOI 10.1021/ja071641y
   Ma LX, 2004, P NATL ACAD SCI USA, V101, P3414, DOI 10.1073/pnas.0305892101
   Martins IC, 2012, BIOCHEM J, V444, P405, DOI 10.1042/BJ20112219
   McGuffin LJ, 2000, BIOINFORMATICS, V16, P404, DOI 10.1093/bioinformatics/16.4.404
   McNaughton BR, 2009, P NATL ACAD SCI USA, V106, P6111, DOI 10.1073/pnas.0807883106
   Melo MN, 2009, J MOL BIOL, V392, P736, DOI 10.1016/j.jmb.2009.07.035
   Menger FM, 2005, LANGMUIR, V21, P10336, DOI 10.1021/la0508691
   Milletti F, 2012, DRUG DISCOV TODAY, V17, P850, DOI 10.1016/j.drudis.2012.03.002
   Morris MC, 2001, NAT BIOTECHNOL, V19, P1173, DOI 10.1038/nbt1201-1173
   Morris MC, 1999, NUCLEIC ACIDS RES, V27, P3510, DOI 10.1093/nar/27.17.3510
   Morris MC, 1997, NUCLEIC ACIDS RES, V25, P2730, DOI 10.1093/nar/25.14.2730
   Mukhopadhyay S, 2005, NAT REV MICROBIOL, V3, P13, DOI 10.1038/nrmicro1067
   NORTON WT, 1975, J NEUROSCI RES, V1, P57, DOI 10.1002/jnr.490010106
   Ouzounis CA, 2000, GENOME RES, V10, P568, DOI 10.1101/gr.10.4.568
   Pierson TC, 2013, CURR OPIN VIROL, V3, P3, DOI 10.1016/j.coviro.2012.12.001
   Rodenhuis-Zybert IA, 2010, CELL MOL LIFE SCI, V67, P2773, DOI 10.1007/s00018-010-0357-z
   Roy A, 2010, NAT PROTOC, V5, P725, DOI 10.1038/nprot.2010.5
   Samsa MM, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000632
   Sangiambut S, 2008, J GEN VIROL, V89, P1254, DOI 10.1099/vir.0.83264-0
   Santos NC, 2002, QUIM NOVA, V25, P1181, DOI 10.1590/S0100-40422002000700019
   Schneider CA, 2012, NAT METHODS, V9, P671, DOI 10.1038/nmeth.2089
   Sliva K, 2010, VIROL J, V7, DOI 10.1186/1743-422X-7-248
   Smit JM, 2011, VIRUSES-BASEL, V3, P160, DOI 10.3390/v3020160
   STRUCK DK, 1981, BIOCHEMISTRY-US, V20, P4093, DOI 10.1021/bi00517a023
   Svensen N, 2012, TRENDS PHARMACOL SCI, V33, P186, DOI 10.1016/j.tips.2012.02.002
   Teixeira AP, 2008, NEUROCHEM INT, V52, P478, DOI 10.1016/j.neuint.2007.08.007
   Thompson DB, 2012, CHEM BIOL, V19, P831, DOI 10.1016/j.chembiol.2012.06.014
   Thompson DB, 2012, METHOD ENZYMOL, V503, P293, DOI 10.1016/B978-0-12-396962-0.00012-4
   Timko BP, 2011, ANNU REV MATER RES, V41, P1, DOI 10.1146/annurev-matsci-062910-100359
   Torchilin VP, 2008, BIOPOLYMERS, V90, P604, DOI 10.1002/bip.20989
   Torchilin VP, 2006, ANNU REV BIOMED ENG, V8, P343, DOI 10.1146/annurev.bioeng.8.061505.095735
   Wexler-Cohen Y, 2010, FASEB J, V24, P4196, DOI 10.1096/fj.09-151704
   Wilkins MR, 1999, METH MOL B, V112, P531
   Zaitseva E, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1001131
   Zhang Y, 2003, EMBO J, V22, P2604, DOI 10.1093/emboj/cdg270
NR 63
TC 23
Z9 23
U1 0
U2 12
PU PUBLIC LIBRARY SCIENCE
PI SAN FRANCISCO
PA 1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA
SN 1932-6203
J9 PLOS ONE
JI PLoS One
PD DEC 5
PY 2013
VL 8
IS 12
AR e81450
DI 10.1371/journal.pone.0081450
PG 10
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA 273WD
UT WOS:000328566100058
PM 24339931
OA DOAJ Gold, Green Published
DA 2020-12-17
ER

PT J
AU Belgrano, FS
   da Silva, ICD
   de Oliveira, FMB
   Fantappie, MR
   Mohana-Borges, R
AF Belgrano, Fabricio S.
   de Abreu da Silva, Isabel C.
   Bastos de Oliveira, Francisco M.
   Fantappie, Marcelo R.
   Mohana-Borges, Ronaldo
TI Role of the Acidic Tail of High Mobility Group Protein B1 (HMGB1) in
   Protein Stability and DNA Bending
SO PLOS ONE
LA English
DT Article
ID RESONANCE ENERGY-TRANSFER; GROUP BOX 1; CHROMATIN PROTEIN;
   CONFORMATIONAL-CHANGES; COOPERATIVE BINDING; CRYSTAL-STRUCTURE; LEXA
   REPRESSOR; TATA-BOX; DOMAINS; HMG-1
AB High mobility group box (HMGB) proteins are abundant nonhistone proteins found in all eukaryotic nuclei and are capable of binding/bending DNA. The human HMGB1 is composed of two binding motifs, known as Boxes A and B, are L-shaped alpha-helix structures, followed by a random-coil acidic tail that consists of 30 Asp and Glu residues. This work aimed at evaluating the role of the acidic tail of human HMGB1 in protein stability and DNA interactions. For this purpose, we cloned, expressed and purified HMGB1 and its tailless form, HMGB1 Delta C, in E. coli strain. Tryptophan fluorescence spectroscopy and circular dichroism (CD) experiments clearly showed an increase in protein stability promoted by the acidic tail under different conditions, such as the presence of the chemical denaturant guanidine hydrochloride (Gdn.HCl), high temperature and low pH. Folding intermediates found at low pH for both proteins were denatured only in the presence of chemical denaturant, thus showing a relatively high stability. The acidic tail did not alter the DNA-binding properties of the protein, although it enhanced the DNA bending capability from 76 degrees (HMGB1 Delta C) to 91 degrees (HMGB1), as measured using the fluorescence resonance energy transfer technique. A model of DNA bending in vivo was proposed, which might help to explain the interaction of HMGB1 with DNA and other proteins, i.e., histones, and the role of that protein in chromatin remodeling.
C1 [Belgrano, Fabricio S.; Mohana-Borges, Ronaldo] Univ Fed Rio de Janeiro, Inst Biofis Carlos Chages Filho, Lab Genom Estrutural, Rio De Janeiro, Brazil.
   [de Abreu da Silva, Isabel C.; Fantappie, Marcelo R.] Univ Fed Rio de Janeiro, Inst Bioquim Med, Lab Helmintol & Entomol Mol, Rio De Janeiro, Brazil.
   [Bastos de Oliveira, Francisco M.] Cornell Univ, Weill Inst Cell & Mol Biol, Ithaca, NY USA.
RP Mohana-Borges, R (corresponding author), Univ Fed Rio de Janeiro, Inst Biofis Carlos Chages Filho, Lab Genom Estrutural, Rio De Janeiro, Brazil.
EM mohana@biof.ufrj.br
RI Borges, Ronaldo S Mohana/C-5575-2013; de Oliveira, Francisco
   Bastos/I-3540-2013
OI de Oliveira, Francisco Bastos/0000-0003-3314-3940; Belgrano,
   Fabricio/0000-0002-0411-7244
FU Brazilian funding agency CAPESCAPES; Brazilian funding agency
   CNPqNational Council for Scientific and Technological Development
   (CNPq); Brazilian funding agency FAPERJCarlos Chagas Filho Foundation
   for Research Support of the State of Rio de Janeiro (FAPERJ); Brazilian
   funding agency IMBEBB; National Institutes of Science and Technology in
   Structural Biology and Bioimaging (INCT-INBEB)
FX This work was supported by grants from the following Brazilian funding
   agencies: CAPES, CNPq, FAPERJ, IMBEBB, and the National Institutes of
   Science and Technology in Structural Biology and Bioimaging
   (INCT-INBEB). The funders had no role in study design, data collection
   and analysis, decision to publish, or preparation of the manuscript.
CR AIZAWA S, 1994, BIOCHEMISTRY-US, V33, P14690, DOI 10.1021/bi00253a006
   Allonso D, 2012, J CLIN VIROL, V55, P214, DOI 10.1016/j.jcv.2012.07.010
   ANDERSON DE, 1990, BIOCHEMISTRY-US, V29, P2403, DOI 10.1021/bi00461a025
   BIANCHI ME, 1989, SCIENCE, V243, P1056, DOI 10.1126/science.2922595
   Bonaldi T, 2002, EMBO J, V21, P6865, DOI 10.1093/emboj/cdf692
   BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3
   Carpenter ML, 2001, DNA PROTEIN INTERACT, P491
   Cato L, 2008, J MOL BIOL, V384, P1262, DOI 10.1016/j.jmb.2008.10.001
   Dragan AI, 2004, J MOL BIOL, V343, P371, DOI 10.1016/j.jmb.2004.08.035
   Dragan AI, 2003, J MOL BIOL, V331, P795, DOI 10.1016/S0022-2836(03)00785-X
   Dragan AI, 2008, METHOD ENZYMOL, V450, P185, DOI 10.1016/S0076-6879(08)03409-5
   Elenkov I, 2011, INT J BIOL SCI, V7, P691, DOI 10.7150/ijbs.7.691
   Ellwood KB, 2000, MOL CELL BIOL, V20, P4359, DOI 10.1128/MCB.20.12.4359-4370.2000
   Gaillard Claire, 2000, BMC Biochemistry, V1, P1
   Gerlitz G, 2009, BIOCHEM CELL BIOL, V87, P127, DOI 10.1139/O08-110
   GOODWIN GH, 1973, EUR J BIOCHEM, V38, P14, DOI 10.1111/j.1432-1033.1973.tb03026.x
   HAMADA H, 1985, BIOCHEMISTRY-US, V24, P1428, DOI 10.1021/bi00327a022
   Hardman CH, 1995, BIOCHEMISTRY-US, V34, P16596, DOI 10.1021/bi00051a007
   Heyduk E, 1997, J BIOL CHEM, V272, P19763, DOI 10.1074/jbc.272.32.19763
   Hieb AR, 2007, J MOL BIOL, V372, P619, DOI 10.1016/j.jmb.2007.06.061
   KIM YC, 1993, NATURE, V365, P512, DOI 10.1038/365512a0
   Knapp S, 2004, BIOCHEMISTRY-US, V43, P11992, DOI 10.1021/bi049364k
   Kugel JF, 2008, BIOCHEM MOL BIOL EDU, V36, P341, DOI 10.1002/bmb.20202
   Lorenz M, 1999, BIOCHEMISTRY-US, V38, P12150, DOI 10.1021/bi990459+
   Masse JE, 2002, J MOL BIOL, V323, P263, DOI 10.1016/S0022-2836(02)00938-5
   Masters KM, 2003, J BIOL CHEM, V278, P31685, DOI 10.1074/jbc.M305201200
   McCauley M, 2005, BIOPHYS J, V89, P353, DOI 10.1529/biophysj.104.052068
   McCauley MJ, 2007, J MOL BIOL, V374, P993, DOI 10.1016/j.jmb.2007.09.073
   Mohana-Borges R, 2000, J BIOL CHEM, V275, P4708, DOI 10.1074/jbc.275.7.4708
   Muller S, 2004, J INTERN MED, V255, P332, DOI 10.1111/j.1365-2796.2003.01296.x
   Muller S, 2001, EMBO J, V20, P4337, DOI 10.1093/emboj/20.16.4337
   MYERS JK, 1995, PROTEIN SCI, V4, P2138, DOI 10.1002/pro.5560041020
   Pace CN, 2000, PROTEINS, P1
   Pasheva E, 2004, BIOCHEMISTRY-US, V43, P2935, DOI 10.1021/bi035615y
   Payet D, 1997, J MOL BIOL, V266, P66, DOI 10.1006/jmbi.1996.0782
   Phair RD, 2004, MOL CELL BIOL, V24, P6393, DOI 10.1128/MCB.24.14.6393-6402.2004
   Polyanichko AM, 2002, J BIOMOL STRUCT DYN, V19, P1053, DOI 10.1080/07391102.2002.10506808
   Rice PA, 1996, CELL, V87, P1295, DOI 10.1016/S0092-8674(00)81824-3
   Scaffidi P, 2002, NATURE, V418, P191, DOI 10.1038/nature00858
   Sessa L, 2007, GENE, V387, P133, DOI 10.1016/j.gene.2006.08.034
   SHEFLIN LG, 1993, BIOCHEMISTRY-US, V32, P3238, DOI 10.1021/bi00064a005
   Sousa FJR, 2006, J MOL BIOL, V359, P1059, DOI 10.1016/j.jmb.2006.03.069
   Stott K, 2010, J MOL BIOL, V403, P706, DOI 10.1016/j.jmb.2010.07.045
   Stros M, 1998, J BIOL CHEM, V273, P10355
   STROS M, 1994, NUCLEIC ACIDS RES, V22, P1044, DOI 10.1093/nar/22.6.1044
   Stros M, 2010, BBA-GENE REGUL MECH, V1799, P101, DOI 10.1016/j.bbagrm.2009.09.008
   TAKASHI R, 1977, P NATL ACAD SCI USA, V74, P2334, DOI 10.1073/pnas.74.6.2334
   Tang DL, 2010, BBA-GENE REGUL MECH, V1799, P131, DOI 10.1016/j.bbagrm.2009.11.014
   Thomas JO, 2001, BIOCHEM SOC T, V29, P395, DOI 10.1042/BST0290395
   Thomas JO, 2001, TRENDS BIOCHEM SCI, V26, P167, DOI 10.1016/S0968-0004(01)01801-1
   Travers AA, 2003, EMBO REP, V4, P131, DOI 10.1038/sj.embor.embor741
   Troseid M, 2010, AIDS, V24, P1733, DOI 10.1097/QAD.0b013e32833b254d
   Ueda T, 2004, BIOCHEMISTRY-US, V43, P9901, DOI 10.1021/bi035975l
   Wang Q, 2007, BIOCHEM BIOPH RES CO, V360, P14, DOI 10.1016/j.bbrc.2007.05.130
   Watson M, 2007, J MOL BIOL, V374, P1286, DOI 10.1016/j.jmb.2007.09.075
   Webb M, 2001, J MOL BIOL, V309, P79, DOI 10.1006/jmbi.2001.4667
   Weinberg RL, 2004, J MOL BIOL, V341, P1145, DOI 10.1016/j.jmb.2004.06.071
   WEIR HM, 1993, EMBO J, V12, P1311, DOI 10.1002/j.1460-2075.1993.tb05776.x
   WERNER MH, 1995, CELL, V81, P705, DOI 10.1016/0092-8674(95)90532-4
   Wu J, 2001, J BIOL CHEM, V276, P14614, DOI 10.1074/jbc.M004402200
   Zhang JY, 2009, NUCLEIC ACIDS RES, V37, P1107, DOI 10.1093/nar/gkn1011
   Zimmerman J, 2008, BIOCHEM BIOPH RES CO, V371, P79, DOI 10.1016/j.bbrc.2008.04.024
NR 62
TC 23
Z9 26
U1 0
U2 14
PU PUBLIC LIBRARY SCIENCE
PI SAN FRANCISCO
PA 1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA
SN 1932-6203
J9 PLOS ONE
JI PLoS One
PD NOV 8
PY 2013
VL 8
IS 11
AR e79572
DI 10.1371/journal.pone.0079572
PG 12
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA 255CG
UT WOS:000327216200075
PM 24255708
OA DOAJ Gold, Green Published
DA 2020-12-17
ER

PT J
AU Faustino, AF
   Carvalho, FA
   Martins, IC
   Castanho, MARB
   Mohana-Borges, R
   Almeida, FCL
   da Poian, AT
   Santos, NC
AF Faustino, A. F.
   Carvalho, F. A.
   Martins, I. C.
   Castanho, M. A. R. B.
   Mohana-Borges, R.
   Almeida, F. C. L.
   da Poian, A. T.
   Santos, N. C.
TI Dengue virus capsid protein interacts specifically with very low density
   lipoproteins
SO EUROPEAN BIOPHYSICS JOURNAL WITH BIOPHYSICS LETTERS
LA English
DT Meeting Abstract
CT 9th European-Biophysical-Societies-Association Congress
CY JUL 13-17, 2013
CL Lisbon, PORTUGAL
SP European Biophys Soc Assoc, Soc Portuguesa Biofisica
C1 [Faustino, A. F.; Carvalho, F. A.; Martins, I. C.; Castanho, M. A. R. B.; Santos, N. C.] Univ Nova Lisboa, Fac Med, Inst Med Mol, P-1200 Lisbon, Portugal.
   [Mohana-Borges, R.; Almeida, F. C. L.; da Poian, A. T.] Univ Fed Rio de Janeiro, Rio De Janeiro, Brazil.
RI Borges, Ronaldo S Mohana/C-5575-2013
NR 0
TC 0
Z9 0
U1 0
U2 1
PU SPRINGER
PI NEW YORK
PA 233 SPRING ST, NEW YORK, NY 10013 USA
SN 0175-7571
EI 1432-1017
J9 EUR BIOPHYS J BIOPHY
JI Eur. Biophys. J. Biophys. Lett.
PD JUL
PY 2013
VL 42
SU 1
BP S196
EP S196
PG 1
WC Biophysics
SC Biophysics
GA 296WE
UT WOS:000330215300610
DA 2020-12-17
ER

PT J
AU Freire, J
   Veiga, AS
   Conceicao, T
   Kowalczyk, W
   Mohana-Borges, R
   Andreu, D
   Santos, N
   da Poian, AT
   Castanho, M
AF Freire, J.
   Veiga, A. S.
   Conceicao, T.
   Kowalczyk, W.
   Mohana-Borges, R.
   Andreu, D.
   Santos, N.
   da Poian, A. T.
   Castanho, M.
TI Unraveling a new actor in dengue virus-cell fusion
SO EUROPEAN BIOPHYSICS JOURNAL WITH BIOPHYSICS LETTERS
LA English
DT Meeting Abstract
CT 9th European-Biophysical-Societies-Association Congress
CY JUL 13-17, 2013
CL Lisbon, PORTUGAL
SP European Biophys Soc Assoc, Soc Portuguesa Biofisica
C1 [Freire, J.; Veiga, A. S.; Santos, N.; Castanho, M.] Univ Lisbon, Inst Med Mol, Fac Med, P-1699 Lisbon, Portugal.
   [Conceicao, T.; da Poian, A. T.] Univ Fed Rio de Janeiro, Inst Bioquim Med, Rio de Janeiro, Brazil.
   [Kowalczyk, W.; Andreu, D.] Pompeu Fabra Univ, Dept Expt & Hlth Sci, Barcelona, Spain.
   [Mohana-Borges, R.] Univ Fed Rio de Janeiro, Inst Biofis Carlos Chagas Filho, Rio de Janeiro, Brazil.
RI Borges, Ronaldo S Mohana/C-5575-2013; Andreu, David/I-4359-2014
OI Andreu, David/0000-0002-6317-6666
NR 0
TC 0
Z9 0
U1 0
U2 0
PU SPRINGER
PI NEW YORK
PA 233 SPRING ST, NEW YORK, NY 10013 USA
SN 0175-7571
EI 1432-1017
J9 EUR BIOPHYS J BIOPHY
JI Eur. Biophys. J. Biophys. Lett.
PD JUL
PY 2013
VL 42
SU 1
BP S163
EP S163
PG 1
WC Biophysics
SC Biophysics
GA 296WE
UT WOS:000330215300488
DA 2020-12-17
ER

PT J
AU Silva, EM
   Conde, JN
   Allonso, D
   Nogueira, ML
   Mohana-Borges, R
AF Silva, Emiliana M.
   Conde, Jonas N.
   Allonso, Diego
   Nogueira, Mauricio L.
   Mohana-Borges, Ronaldo
TI Mapping the Interactions of Dengue Virus NS1 Protein with Human Liver
   Proteins Using a Yeast Two-Hybrid System: Identification of C1q as an
   Interacting Partner
SO PLOS ONE
LA English
DT Article
ID NONSTRUCTURAL GLYCOPROTEIN NS1; ANTIBODY-DEPENDENT ENHANCEMENT; HUMAN
   ENDOTHELIAL-CELLS; NECROSIS-FACTOR-ALPHA; WEST-NILE-VIRUS; NF-KAPPA-B;
   HEMORRHAGIC-FEVER; COMPLEMENT ACTIVATION; INFECTED PATIENTS;
   SERUM-LEVELS
AB Dengue constitutes a global health concern. The clinical manifestation of this disease varies from mild febrile illness to severe hemorrhage and/or fatal hypovolemic shock. Flavivirus nonstructural protein 1 (NS1) is a secreted glycoprotein that is displayed on the surface of infected cells but is absent in viral particles. NS1 accumulates at high levels in the plasma of dengue virus (DENV)-infected patients, and previous reports highlight its involvement in immune evasion, dengue severity, liver dysfunction and pathogenesis. In the present study, we performed a yeast two-hybrid screen to search for DENV2 NS1-interacting partners using a human liver cDNA library. We identified fifty genes, including human complement component 1 (C1q), which was confirmed by coimmunoprecipitation, ELISA and immunofluorescence assays, revealing for the first time the direct binding of this protein to NS1. Furthermore, the majority of the identified genes encode proteins that are secreted into the plasma of patients, and most of these proteins are classified as acute-phase proteins (APPs), such as plasminogen, haptoglobin, hemopexin, a-2-HS-glycoprotein, retinol binding protein 4, transferrin, and C4. The results presented here confirm the direct interaction of DENV NS1 with a key protein of the complement system and suggest a role for this complement protein in the pathogenesis of DENV infection.
C1 [Silva, Emiliana M.; Conde, Jonas N.; Allonso, Diego; Mohana-Borges, Ronaldo] Univ Fed Rio de Janeiro, Inst Biofis Carlos Chagas Filho, Lab Genom Estrutural, BR-21941 Rio De Janeiro, Brazil.
   [Nogueira, Mauricio L.] Fac Med Sao Jose do Rio Preto, Dept Doencas Dermatol Infecciosas & Parasitarias, Sao Paulo, Brazil.
RP Mohana-Borges, R (corresponding author), Univ Fed Rio de Janeiro, Inst Biofis Carlos Chagas Filho, Lab Genom Estrutural, BR-21941 Rio De Janeiro, Brazil.
EM mohana@biof.ufrj.br
RI Borges, Ronaldo S Mohana/C-5575-2013; Nascimento conde,
   Jonas/D-4481-2019; Nogueira, Mauricio L/B-7599-2012; Allonso,
   Diego/Y-3446-2018
OI Nogueira, Mauricio L/0000-0003-1102-2419; Allonso,
   Diego/0000-0002-1410-480X
FU Brazilian Health Ministry; CNPqNational Council for Scientific and
   Technological Development (CNPq); FAPERJCarlos Chagas Filho Foundation
   for Research Support of the State of Rio de Janeiro (FAPERJ); IMBEBB;
   FINEP (GENOPROT Dengue)Ciencia Tecnologia e Inovacao (FINEP); National
   Institutes of Science and Technology in Structural Biology and
   Bioimaging (INCT-INBEB)
FX This work was supported by the following funding agencies: the Brazilian
   Health Ministry, CNPq, FAPERJ, IMBEBB, FINEP (GENOPROT Dengue), and the
   National Institutes of Science and Technology in Structural Biology and
   Bioimaging (INCT-INBEB). The funders had no role in the study design,
   data collection and analysis, decision to publish, or preparation of the
   manuscript.
CR Alcon S, 2002, J CLIN MICROBIOL, V40, P376, DOI 10.1128/JCM.40.02.376-381.2002
   Alcon-LePoder S, 2005, J VIROL, V79, P11403, DOI 10.1128/JVI.79.17.11403-11411.2005
   Allonso D, 2012, J CLIN VIROL, V55, P214, DOI 10.1016/j.jcv.2012.07.010
   Allonso D, 2011, J VIROL METHODS, V175, P109, DOI 10.1016/j.jviromet.2011.04.029
   [Anonymous], 2009, DENG GUID DIAGN TREA
   Armbrust T, 1997, HEPATOLOGY, V26, P98
   Avirutnan P, 2006, J INFECT DIS, V193, P1078, DOI 10.1086/500949
   Avirutnan P, 1998, J IMMUNOL, V161, P6338
   Avirutnan P, 2008, VACCINE, V26, pI100, DOI 10.1016/j.vaccine.2008.11.061
   Avirutnan P, 2011, J IMMUNOL, V187, P424, DOI 10.4049/jimmunol.1100750
   Avirutnan P, 2010, J EXP MED, V207, P793, DOI 10.1084/jem.20092545
   BARTHOLOMEW RM, 1978, J EXP MED, V147, P844, DOI 10.1084/jem.147.3.844
   Black PH, 2003, BRAIN BEHAV IMMUN, V17, P350, DOI 10.1016/S0889-1591(03)00048-5
   BOKISCH VA, 1973, NEW ENGL J MED, V289, P996, DOI 10.1056/NEJM197311082891902
   Bozza FA, 2008, BMC INFECT DIS, V8, DOI 10.1186/1471-2334-8-86
   Cardier JE, 2005, CYTOKINE, V30, P359, DOI 10.1016/j.cyto.2005.01.021
   CHANG NS, 1994, J LEUKOCYTE BIOL, V55, P778
   Chua JJE, 2005, VIRUS RES, V112, P85, DOI 10.1016/j.virusres.2005.03.025
   Chung KM, 2006, P NATL ACAD SCI USA, V103, P19111, DOI 10.1073/pnas.0605668103
   DUNCAN AR, 1988, NATURE, V332, P738, DOI 10.1038/332738a0
   EBENBICHLER CF, 1991, J EXP MED, V174, P1417, DOI 10.1084/jem.174.6.1417
   Falconar AKI, 1997, ARCH VIROL, V142, P897, DOI 10.1007/s007050050127
   Falconar AKI, 2008, CLIN VACCINE IMMUNOL, V15, P549, DOI 10.1128/CVI.00351-07
   Flamand M, 1999, J VIROL, V73, P6104, DOI 10.1128/JVI.73.7.6104-6110.1999
   Gabay C, 1999, NEW ENGL J MED, V340, P448, DOI 10.1056/NEJM199902113400607
   Green S, 1999, J MED VIROL, V59, P329, DOI 10.1002/(SICI)1096-9071(199911)59:3&lt;329::AID-JMV12&gt;3.0.CO;2-G
   Gutsche I, 2011, P NATL ACAD SCI USA, V108, P8003, DOI 10.1073/pnas.1017338108
   Guzman MG, 2010, NAT REV MICROBIOL, pS7, DOI 10.1038/nrmicro2460
   Guzman MG, 2003, J CLIN VIROL, V27, P1, DOI 10.1016/S1386-6532(03)00010-6
   Halstead SB, 2003, ADV VIRUS RES, V60, P421, DOI 10.1016/S0065-3527(03)60011-4
   Halstead SB, 2007, LANCET, V370, P1644, DOI 10.1016/S0140-6736(07)61687-0
   He GB, 2011, CELL RES, V21, P159, DOI 10.1038/cr.2010.183
   HOBER D, 1993, AM J TROP MED HYG, V48, P324, DOI 10.4269/ajtmh.1993.48.324
   Huerta-Zepeda A, 2008, THROMB HAEMOSTASIS, V99, P936, DOI [10.1160/TH07-08-0483, 10.1160/TH07-08-0438]
   Idusogie EE, 2000, J IMMUNOL, V164, P4178, DOI 10.4049/jimmunol.164.8.4178
   Jacobs MG, 2000, FASEB J, V14, P1603, DOI 10.1096/fj.14.11.1603
   Juffrie M, 2001, AM J TROP MED HYG, V65, P70, DOI 10.4269/ajtmh.2001.65.70
   Kurosu T, 2007, BIOCHEM BIOPH RES CO, V362, P1051, DOI 10.1016/j.bbrc.2007.08.137
   Kyle JL, 2008, ANNU REV MICROBIOL, V62, P71, DOI 10.1146/annurev.micro.62.081307.163005
   Lambris JD, 2008, NAT REV MICROBIOL, V6, P132, DOI 10.1038/nrmicro1824
   Libraty DH, 2002, J INFECT DIS, V186, P1165, DOI 10.1086/343813
   Lin CF, 2005, J IMMUNOL, V174, P395, DOI 10.4049/jimmunol.174.1.395
   Loos M, 1989, Behring Inst Mitt, P32
   Mackenzie JM, 1996, VIROLOGY, V220, P232, DOI 10.1006/viro.1996.0307
   Mehlhop E, 2007, CELL HOST MICROBE, V2, P417, DOI 10.1016/j.chom.2007.09.015
   Mehlhop E, 2009, CELL HOST MICROBE, V6, P381, DOI 10.1016/j.chom.2009.09.003
   Nascimento EJM, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006782
   Noisakran S, 2008, J GEN VIROL, V89, P2492, DOI 10.1099/vir.0.83620-0
   Paes MV, 2009, LAB INVEST, V89, P1140, DOI 10.1038/labinvest.2009.83
   PRYOR MJ, 1994, J GEN VIROL, V75, P1183, DOI 10.1099/0022-1317-75-5-1183
   Restrepo BN, 2008, REV SOC BRAS MED TRO, V41, P6, DOI 10.1590/S0037-86822008000100002
   Rosen L, 1999, AM J TROP MED HYG, V61, P720, DOI 10.4269/ajtmh.1999.61.720
   SANGKAWIBHA N, 1984, AM J EPIDEMIOL, V120, P653, DOI 10.1093/oxfordjournals.aje.a113932
   Schouten M, 2008, J LEUKOCYTE BIOL, V83, P536, DOI 10.1189/jlb.0607373
   Silva BM, 2011, ARCH VIROL, V156, P1275, DOI 10.1007/s00705-011-0969-0
   SUSAL C, 1994, J IMMUNOL, V152, P6028
   Vaughn DW, 2000, J INFECT DIS, V181, P2, DOI 10.1086/315215
   Volanakis JE, 2002, CURR TOP MICROBIOL, V266, P41
   Wang WK, 2006, CLIN INFECT DIS, V43, P1023, DOI 10.1086/507635
   Wang WK, 2003, VIROLOGY, V305, P330, DOI 10.1006/viro.2002.1704
   Yamanaka A, 2008, J VIROL, V82, P927, DOI 10.1128/JVI.00992-07
   Young PR, 2000, J CLIN MICROBIOL, V38, P1053, DOI 10.1128/JCM.38.3.1053-1057.2000
NR 62
TC 26
Z9 30
U1 0
U2 16
PU PUBLIC LIBRARY SCIENCE
PI SAN FRANCISCO
PA 1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA
SN 1932-6203
J9 PLOS ONE
JI PLoS One
PD MAR 14
PY 2013
VL 8
IS 3
AR e57514
DI 10.1371/journal.pone.0057514
PG 9
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA 109YM
UT WOS:000316407400008
PM 23516407
OA DOAJ Gold, Green Published
DA 2020-12-17
ER

PT J
AU Allonso, D
   Vazquez, S
   Guzman, MG
   Mohana-Borges, R
AF Allonso, Diego
   Vazquez, Susana
   Guzman, Maria G.
   Mohana-Borges, Ronaldo
TI Short Report: High Mobility Group Box 1 Protein as an Auxiliary
   Biomarker for Dengue Diagnosis
SO AMERICAN JOURNAL OF TROPICAL MEDICINE AND HYGIENE
LA English
DT Article
ID CHROMATIN PROTEIN; DENDRITIC CELLS; HMGB1 PROTEIN; INFECTION; RELEASE;
   INFLAMMATION; CYTOKINE
AB Despite the availability of many methods for rapid and early diagnosis of dengue, there is still a need to develop new approaches that not only combine low cost, specificity, and sensitivity, but also are capable of accurately detecting secondary infection in the early stages of the disease. We report the potential of the high mobility group box 1 protein as an auxiliary biomarker for early dengue diagnosis. We tested a 205-sample serum panel that included negative and positive samples from primary and secondary dengue cases, as well as samples from patients with dengue-like symptoms. We observed that high mobility group box 1 protein was generally detected only in dengue-positive samples for persons with primary and secondary infections. These results highlight the possibility of using this endogenous molecule as an auxiliary biomarker to aid in dengue detection and improve current methods for early diagnosis of dengue.
C1 [Allonso, Diego; Mohana-Borges, Ronaldo] Univ Fed Rio de Janeiro, Inst Biofis Carlos Chagas Filho, Lab Genom Estrutural, BR-21941902 Rio De Janeiro, Brazil.
   [Vazquez, Susana; Guzman, Maria G.] Pedro Kouri Trop Med Inst, WHO Collaborating Ctr Study Dengue & Vector, Pan Amer Hlth Org, Dept Virol, Havana, Cuba.
RP Mohana-Borges, R (corresponding author), Univ Fed Rio de Janeiro, Inst Biofis Carlos Chagas Filho, Lab Genom Estrutural, Edificio Ctr Ciencias Saude,Bloco C Sala 36 Sub S, BR-21941902 Rio De Janeiro, Brazil.
EM diegoars@biof.ufrj.br; svazquez@ipk.sld.cu; lupe@ipk.sld.cu;
   mohana@biof.ufrj.br
RI Borges, Ronaldo S Mohana/C-5575-2013; Allonso, Diego/Y-3446-2018
OI Allonso, Diego/0000-0002-1410-480X
FU CAPESCAPES; CNPqNational Council for Scientific and Technological
   Development (CNPq); FAPERJCarlos Chagas Filho Foundation for Research
   Support of the State of Rio de Janeiro (FAPERJ); IMBEBB; National
   Institutes of Science and Technology in Structural Biology and
   Bioimaging (INCT-INBEB)
FX This work was supported by CAPES, CNPq, FAPERJ, IMBEBB, and the National
   Institutes of Science and Technology in Structural Biology and
   Bioimaging (INCT-INBEB).
CR Allonso D, 2012, J CLIN VIROL, V55, P214, DOI 10.1016/j.jcv.2012.07.010
   Andersson U, 2011, ANNU REV IMMUNOL, V29, P139, DOI 10.1146/annurev-immunol-030409-101323
   Bianchi ME, 2007, IMMUNOL REV, V220, P35, DOI 10.1111/j.1600-065X.2007.00574.x
   Chen LC, 2008, J INFECTION, V56, P143, DOI 10.1016/j.jinf.2007.10.008
   Dumitriu IE, 2005, J IMMUNOL, V174, P7506, DOI 10.4049/jimmunol.174.12.7506
   Guzman MG, 2010, NAT REV MICROBIOL, pS7, DOI 10.1038/nrmicro2460
   Huang WC, 2010, CYTOKINE, V51, P119, DOI 10.1016/j.cyto.2010.02.021
   Ito Y, 2011, CYTOKINE, V56, P180, DOI 10.1016/j.cyto.2011.07.016
   Kamau E, 2009, J GEN VIROL, V90, P1827, DOI 10.1099/vir.0.009027-0
   Muller S, 2001, EMBO J, V20, P4337, DOI 10.1093/emboj/20.16.4337
   Nowak P, 2007, AIDS, V21, P869, DOI 10.1097/QAD.0b013e3280b079b6
   Peeling RW, 2010, NAT REV MICROBIOL, pS30, DOI 10.1038/nrmicro2459
   Scaffidi P, 2002, NATURE, V418, P191, DOI 10.1038/nature00858
   Simmons CP, 2012, NEW ENGL J MED, V366, P1423, DOI 10.1056/NEJMra1110265
   Wang HC, 1999, SCIENCE, V285, P248, DOI 10.1126/science.285.5425.248
NR 15
TC 6
Z9 7
U1 0
U2 3
PU AMER SOC TROP MED & HYGIENE
PI MCLEAN
PA 8000 WESTPARK DR, STE 130, MCLEAN, VA 22101 USA
SN 0002-9637
J9 AM J TROP MED HYG
JI Am. J. Trop. Med. Hyg.
PD MAR
PY 2013
VL 88
IS 3
BP 506
EP 509
DI 10.4269/ajtmh.2012.12-0619
PG 4
WC Public, Environmental & Occupational Health; Tropical Medicine
SC Public, Environmental & Occupational Health; Tropical Medicine
GA 106QC
UT WOS:000316158800018
PM 23269659
OA Green Published, Bronze
DA 2020-12-17
ER

PT J
AU Carvalho, FA
   Martins, IC
   Carneiro, FA
   Assuncao-Miranda, I
   Faustino, AF
   Castanho, M
   Mohana-Borges, R
   Almeida, FCL
   Da Poian, AT
   Santos, NC
AF Carvalho, Filomena A.
   Martins, Ivo C.
   Carneiro, Fabiana A.
   Assuncao-Miranda, Iranaia
   Faustino, Andre F.
   Castanho, Miguel
   Mohana-Borges, Ronaldo
   Almeida, Fabio C. L.
   Da Poian, Andrea T.
   Santos, Nuno C.
TI Dengue Virus Capsid Protein Binding to Lipid Droplets and its
   Inhibition. towards a New Drug Target
SO BIOPHYSICAL JOURNAL
LA English
DT Meeting Abstract
CT 57th Annual Meeting of the Biophysical-Society
CY FEB 02-06, 2013
CL Philadelphia, PA
SP Biophys Soc
C1 [Carvalho, Filomena A.; Martins, Ivo C.; Faustino, Andre F.; Castanho, Miguel; Santos, Nuno C.] Univ Lisbon, Fac Med, Inst Mol Med, P-1699 Lisbon, Portugal.
   [Carneiro, Fabiana A.; Assuncao-Miranda, Iranaia; Mohana-Borges, Ronaldo; Almeida, Fabio C. L.; Da Poian, Andrea T.] Univ Fed Rio de Janeiro, Rio De Janeiro, Brazil.
RI Carvalho, Filomena A./M-9202-2013; Santos, Nuno/N-7248-2013; Martins,
   Ivo C/G-2534-2013; CARNEIRO, FABIANA A/S-4525-2018; Borges, Ronaldo S
   Mohana/C-5575-2013
OI Carvalho, Filomena A./0000-0001-6088-3894; Santos,
   Nuno/0000-0002-0580-0475; Martins, Ivo C/0000-0002-9284-8599; 
CR Carvalho FA, 2012, J VIROL, V86, P2096, DOI 10.1128/JVI.06796-11
   Martins IC, 2012, BIOCHEM J, V444, P405, DOI 10.1042/BJ20112219
NR 2
TC 0
Z9 0
U1 0
U2 7
PU CELL PRESS
PI CAMBRIDGE
PA 50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA
SN 0006-3495
EI 1542-0086
J9 BIOPHYS J
JI Biophys. J.
PD JAN 29
PY 2013
VL 104
IS 2
SU 1
BP 415A
EP 415A
DI 10.1016/j.bpj.2012.11.2313
PG 1
WC Biophysics
SC Biophysics
GA 105MI
UT WOS:000316074304114
OA Bronze
DA 2020-12-17
ER

PT J
AU Allonso, D
   Belgrano, FS
   Calzada, N
   Guzman, MG
   Vazquez, S
   Mohana-Borges, R
AF Allonso, Diego
   Belgrano, Fabricio S.
   Calzada, Naifi
   Guzman, Maria G.
   Vazquez, Susana
   Mohana-Borges, Ronaldo
TI Elevated serum levels of high mobility group box 1 (HMGB1) protein in
   dengue-infected patients are associated with disease symptoms and
   secondary infection
SO JOURNAL OF CLINICAL VIROLOGY
LA English
DT Article
DE Dengue virus; HMGB1; Dengue pathogenesis
ID ORIGINAL ANTIGENIC SIN; VIRUS-INFECTION; HIV-1 INFECTION; DENDRITIC
   CELLS; PLASMA-LEVELS; ANTIBODY; PATHOGENESIS; INFLAMMATION; CYTOKINE;
   RELEASE
AB Background: Dengue virus (DENV) is described as the most prevalent arbovirus, infecting at least 50 million people worldwide. During infection, an intricate network of cytokines, a group of substances closely related to disease severity, is released. Recently, it was observed that both DENV-infected epithelial cells undergoing necrosis and dendritic cells (DCs) are able to release a non-classical pro-inflammatory cytokine called high mobility group box 1 (HMGB1).
   Objectives: The aim of this study was to evaluate whether HMGB1 levels were altered in DENV-infected patients' sera and whether this augment correlated with disease pathogenesis.
   Study design: Samples from DENV-infected patients were collected from different days after the onset of symptoms and from patients experiencing primary or secondary infection. The circulating HMGB1 concentration was measured in healthy blood donors as well as in donors with primary and secondary cases of DENV infection by a quantitative capture ELISA assay.
   Results: We observed that the HMGB1 concentration in DENV-infected patients was significantly higher than in healthy patients. HMGB1 levels reached the highest concentration in the first day after the onset of symptoms and decreased throughout the course of the infection. Moreover, we observed that the HMGB1 concentration was augmented during secondary infection as well.
   Conclusion: We hypothesize that HMGB1 levels correlate with disease pathogenesis, specifically with the clinical symptoms and secondary infection, implicating a pro-inflammatory cytokine role for HMGB1 in DENV infection. This is the first report assessing the circulating levels of HMGB1 during DENV infection. (C) 2012 Published by Elsevier B.V.
C1 [Allonso, Diego; Belgrano, Fabricio S.; Mohana-Borges, Ronaldo] Univ Fed Rio de Janeiro, Biophys Inst Carlos Chagas Filho, Lab Struct Genom, BR-21941 Rio De Janeiro, Brazil.
   [Calzada, Naifi; Guzman, Maria G.; Vazquez, Susana] Pedro Kouri Trop Med Inst Havana, PAHO WHO Collaborating Ctr Study Dengue & Its Vec, Dept Virol, Havana, Cuba.
RP Mohana-Borges, R (corresponding author), Inst Biofis Carlos Chagas Filho UFRJ, Lab Genom Estrutural, Ilha Fundao, Edificio Ctr Ciencias Saude,Bloco C Sala 36 Sub S, BR-21941902 Rio De Janeiro, RJ, Brazil.
EM svazquez@ipk.sld.cu; mohana@biof.ufrj.br
RI Borges, Ronaldo S Mohana/C-5575-2013; Allonso, Diego/Y-3446-2018
OI Allonso, Diego/0000-0002-1410-480X; Mohana Borges,
   Ronaldo/0000-0002-1796-475X; Belgrano, Fabricio/0000-0002-0411-7244
FU CAPESCAPES; CNPqNational Council for Scientific and Technological
   Development (CNPq); FAPERJCarlos Chagas Filho Foundation for Research
   Support of the State of Rio de Janeiro (FAPERJ); IMBEBB; National
   Institutes of Science and Technology in Structural Biology and
   Bioimaging (INCT-INBEB)
FX This work was supported by the following funding agencies: CAPES, CNPq,
   FAPERJ, IMBEBB, and the National Institutes of Science and Technology in
   Structural Biology and Bioimaging (INCT-INBEB). The funding agencies had
   no role in the study design, data collection and analysis, decision to
   publish or preparation of the manuscript.
CR Allonso D, 2011, J VIROL METHODS, V175, P109, DOI 10.1016/j.jviromet.2011.04.029
   [Anonymous], 2009, DENG GUID DIAGN TREA
   Bianchi ME, 2005, CURR OPIN GENET DEV, V15, P496, DOI 10.1016/j.gde.2005.08.007
   Borde C, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016145
   Chen LC, 2008, J INFECTION, V56, P143, DOI 10.1016/j.jinf.2007.10.008
   Chu JJH, 2003, J GEN VIROL, V84, P3305, DOI 10.1099/vir.0.19447-0
   Craig DGN, 2011, LIVER INT, V31, P1127, DOI 10.1111/j.1478-3231.2011.02528.x
   Dumitriu IE, 2005, J IMMUNOL, V174, P7506, DOI 10.4049/jimmunol.174.12.7506
   Gubler DJ, 2011, EXPERT REV VACCINES, V10, P563, DOI [10.1586/ERV.11.35, 10.1586/erv.11.35]
   Guzman MG, 2010, NAT REV MICROBIOL, pS7, DOI 10.1038/nrmicro2460
   Guzman MG, 2002, LANCET INFECT DIS, V2, P33, DOI 10.1016/S1473-3099(01)00171-2
   HALSTEAD SB, 1977, NATURE, V265, P739, DOI 10.1038/265739a0
   HALSTEAD SB, 1977, J EXP MED, V146, P201, DOI 10.1084/jem.146.1.201
   Harris E, 2000, AM J TROP MED HYG, V63, P5, DOI 10.4269/ajtmh.2000.63.5
   Ito Y, 2011, CYTOKINE, V56, P180, DOI 10.1016/j.cyto.2011.07.016
   Kamau E, 2009, J GEN VIROL, V90, P1827, DOI 10.1099/vir.0.009027-0
   Moh A, 2007, LAB INVEST, V87, P1018, DOI 10.1038/labinvest.3700630
   Mongkolsapaya J, 2003, NAT MED, V9, P921, DOI 10.1038/nm887
   Nowak P, 2007, AIDS, V21, P869, DOI 10.1097/QAD.0b013e3280b079b6
   Oppenheim JJ, 2007, ADV EXP MED BIOL, V601, P185
   Park JS, 2006, AM J PHYSIOL-CELL PH, V290, pC917, DOI 10.1152/ajpcell.00401.2005
   Roche RR, 2000, J CLIN MICROBIOL, V38, P3508, DOI 10.1128/JCM.38.9.3508-3510.2000
   Rosario D, 1998, Rev Panam Salud Publica, V4, P1
   Rothman AL, 2011, NAT REV IMMUNOL, V11, P532, DOI 10.1038/nri3014
   Scaffidi P, 2002, NATURE, V418, P191, DOI 10.1038/nature00858
   Sims GP, 2010, ANNU REV IMMUNOL, V28, P367, DOI 10.1146/annurev.immunol.021908.132603
   Srikiatkhachorn A, 2010, CURR TOP MICROBIOL, V338, P67, DOI 10.1007/978-3-642-02215-9_6
   Stros M, 2010, BBA-GENE REGUL MECH, V1799, P101, DOI 10.1016/j.bbagrm.2009.09.008
   Sunden-Cullberg J, 2005, CRIT CARE MED, V33, P564, DOI 10.1097/01.ccm.0000155991.88802.4D
   Taniguchi N, 2003, ARTHRITIS RHEUM, V48, P971, DOI 10.1002/art.10859
   Troseid M, 2010, AIDS, V24, P1733, DOI 10.1097/QAD.0b013e32833b254d
   Urbonaviciute V, 2008, J EXP MED, V205, P3007, DOI 10.1084/jem.20081165
   Vazquez S, 2005, J CLIN VIROL, V33, P132, DOI 10.1016/j.jcv.2004.10.013
   Vazquez Y, 2009, MABS-AUSTIN, V1, P157, DOI 10.4161/mabs.1.2.7908
   Yang H, 2010, BBA-GENE REGUL MECH, V1799, P149, DOI 10.1016/j.bbagrm.2009.11.019
   Yang RK, 2006, MOL MED, V12, P105, DOI 10.2119/2006-00010.Yang
   Zhou RR, 2011, BMC GASTROENTEROL, V11, DOI 10.1186/1471-230X-11-21
NR 37
TC 28
Z9 30
U1 0
U2 4
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 1386-6532
J9 J CLIN VIROL
JI J. Clin. Virol.
PD NOV
PY 2012
VL 55
IS 3
BP 214
EP 219
DI 10.1016/j.jcv.2012.07.010
PG 6
WC Virology
SC Virology
GA 010RY
UT WOS:000309113000005
PM 22884669
DA 2020-12-17
ER

PT J
AU Carvalho, FA
   Carneiro, FA
   Martins, IC
   Assuncao-Miranda, I
   Faustino, AF
   Castanho, M
   Mohana-Borges, R
   Da Poian, AT
   Santos, NC
AF Carvalho, F. A.
   Carneiro, F. A.
   Martins, I. C.
   Assuncao-Miranda, I.
   Faustino, A. F.
   Castanho, M.
   Mohana-Borges, R.
   Da Poian, A. T.
   Santos, N. C.
TI AFM-based force spectroscopy probing of dengue virus capsid protein
   binding to lipid droplets-towards a new drug target
SO FEBS JOURNAL
LA English
DT Meeting Abstract
CT 22nd International-Union-of-Biochemistry-and-Molecular-Biology (IUBMB)
   Congress/37th Federation-of-European-Biochemical-Societies (FEBS)
   Congress
CY SEP 04-09, 2012
CL Seville, SPAIN
SP Int Union Biochem & Mol Biol (IUBMB), Federat European Biochem Soc (FEBS)
C1 [Carvalho, F. A.; Martins, I. C.; Faustino, A. F.; Castanho, M.; Santos, N. C.] Univ Lisbon, Fac Med, Inst Mol Med, P-1699 Lisbon, Portugal.
   [Carneiro, F. A.; Assuncao-Miranda, I.; Mohana-Borges, R.; Da Poian, A. T.] Univ Fed Rio de Janeiro, Rio De Janeiro, Brazil.
RI Borges, Ronaldo S Mohana/C-5575-2013; Carvalho, Filomena A./M-9202-2013;
   CARNEIRO, FABIANA A/S-4525-2018; Martins, Ivo C/G-2534-2013; Santos,
   Nuno/N-7248-2013
OI Carvalho, Filomena A./0000-0001-6088-3894; Martins, Ivo
   C/0000-0002-9284-8599; Santos, Nuno/0000-0002-0580-0475
CR Carvalho FA, 2012, J VIROL, V86, P2096, DOI 10.1128/JVI.06796-11
   Martins, 2012, BIOCH J IN PRESS
NR 2
TC 1
Z9 1
U1 0
U2 7
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 1742-464X
EI 1742-4658
J9 FEBS J
JI FEBS J.
PD SEP
PY 2012
VL 279
SU 1
SI SI
BP 10
EP 11
PG 2
WC Biochemistry & Molecular Biology
SC Biochemistry & Molecular Biology
GA 996XR
UT WOS:000308128600039
DA 2020-12-17
ER

PT J
AU Faustino, AF
   Carvalho, FA
   Martins, IC
   Castanho, MARB
   Mohana-Borges, R
   Da Poian, AT
   Santos, NC
AF Faustino, A. F.
   Carvalho, F. A.
   Martins, I. C.
   Castanho, M. A. R. B.
   Mohana-Borges, R.
   Da Poian, A. T.
   Santos, N. C.
TI Dengue virus capsid protein interacts specifically with very low density
   lipoproteins
SO FEBS JOURNAL
LA English
DT Meeting Abstract
CT 22nd International-Union-of-Biochemistry-and-Molecular-Biology (IUBMB)
   Congress/37th Federation-of-European-Biochemical-Societies (FEBS)
   Congress
CY SEP 04-09, 2012
CL Seville, SPAIN
SP Int Union Biochem & Mol Biol (IUBMB), Federat European Biochem Soc (FEBS)
C1 [Faustino, A. F.; Carvalho, F. A.; Martins, I. C.; Castanho, M. A. R. B.; Santos, N. C.] Univ Lisbon, Inst Mol Med, Fac Med, P-1699 Lisbon, Portugal.
   [Mohana-Borges, R.; Da Poian, A. T.] Univ Fed Rio de Janeiro, Rio De Janeiro, Brazil.
RI Santos, Nuno/N-7248-2013; Martins, Ivo C/G-2534-2013; Borges, Ronaldo S
   Mohana/C-5575-2013; Carvalho, Filomena A./M-9202-2013
OI Santos, Nuno/0000-0002-0580-0475; Martins, Ivo C/0000-0002-9284-8599;
   Carvalho, Filomena A./0000-0001-6088-3894
CR Carvalho FA, 2012, J VIROL, V86, P2096, DOI 10.1128/JVI.06796-11
   Martins IC, 2012, BIOCHEM J, V444, P405, DOI 10.1042/BJ20112219
NR 2
TC 0
Z9 0
U1 0
U2 7
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 1742-464X
EI 1742-4658
J9 FEBS J
JI FEBS J.
PD SEP
PY 2012
VL 279
SU 1
SI SI
BP 319
EP 319
PG 1
WC Biochemistry & Molecular Biology
SC Biochemistry & Molecular Biology
GA 996XR
UT WOS:000308128602058
DA 2020-12-17
ER

PT J
AU Martins, IC
   Gomes-Neto, F
   Faustino, A
   Carvalho, F
   Carneiro, F
   Bozza, P
   Mohana-Borges, R
   Castanho, M
   Almeida, F
   Santos, N
   Da Poian, A
AF Martins, I. C.
   Gomes-Neto, F.
   Faustino, A.
   Carvalho, F.
   Carneiro, F.
   Bozza, P.
   Mohana-Borges, R.
   Castanho, M.
   Almeida, F.
   Santos, N.
   Da Poian, A.
TI The disordered N-terminal region of dengue virus capsid protein contains
   a drug targetable lipid droplet-binding motif
SO FEBS JOURNAL
LA English
DT Meeting Abstract
CT 22nd IUBMB Congress/37th FEBS Congress
CY SEP 04-09, 2012
CL Seville, SPAIN
SP IUBMB, FEBS
C1 [Martins, I. C.; Faustino, A.; Carvalho, F.; Castanho, M.; Santos, N.] FMUL, IMM, Lisbon, Portugal.
   [Gomes-Neto, F.; Carneiro, F.; Mohana-Borges, R.; Almeida, F.; Da Poian, A.] Univ Fed Rio de Janeiro, Rio De Janeiro, Brazil.
   [Bozza, P.] Fundacao Oswaldo Cruz, Inst Oswaldo Cruz, Rio De Janeiro, Brazil.
RI Martins, Ivo C/G-2534-2013; CARNEIRO, FABIANA A/S-4525-2018; Borges,
   Ronaldo S Mohana/C-5575-2013
OI Martins, Ivo C/0000-0002-9284-8599; 
NR 0
TC 0
Z9 0
U1 0
U2 4
PU WILEY-BLACKWELL
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 1742-464X
J9 FEBS J
JI FEBS J.
PD SEP
PY 2012
VL 279
SU 1
SI SI
BP 432
EP 432
PG 1
WC Biochemistry & Molecular Biology
SC Biochemistry & Molecular Biology
GA 996XR
UT WOS:000308128602411
DA 2020-12-17
ER

PT J
AU Ribeiro, FS
   da Silva, ICD
   Carneiro, VC
   Belgrano, FD
   Mohana-Borges, R
   Rosa, ID
   Benchimol, M
   Souza, NRQ
   Mesquita, RD
   Sorgine, MHF
   Gazos-Lopes, F
   Vicentino, ARR
   Wu, WJ
   Maciel, RD
   da Silva-Neto, MAC
   Fantappie, MR
AF Ribeiro, Fabio Schneider
   de Abreu da Silva, Isabel Caetano
   Carneiro, Vitor Coutinho
   Belgrano, Fabricio dos Santos
   Mohana-Borges, Ronaldo
   Rosa, Ivone de Andrade
   Benchimol, Marlene
   Quintino Souza, Nathalia Rocha
   Mesquita, Rafael Dias
   Ferreira Sorgine, Marcos Henrique
   Gazos-Lopes, Felipe
   Revoredo Vicentino, Amanda Roberta
   Wu, Wenjie
   Maciel, Renata de Moraes
   Cardoso da Silva-Neto, Mario Alberto
   Fantappie, Marcelo Rosado
TI The Dengue Vector Aedes aegypti Contains a Functional High Mobility
   Group Box 1 (HMGB1) Protein with a Unique Regulatory C-Terminus
SO PLOS ONE
LA English
DT Article
ID DNA-BINDING PROPERTIES; ACIDIC TAIL; CHROMATIN PROTEIN; IN-VITRO; DSP1;
   DOMAINS; GENE; RECEPTORS; COMPLEXES; INTERACT
AB The mosquito Aedes aegypti can spread the dengue, chikungunya and yellow fever viruses. Thus, the search for key molecules involved in the mosquito survival represents today a promising vector control strategy. High Mobility Group Box (HMGB) proteins are essential nuclear factors that maintain the high-order structure of chromatin, keeping eukaryotic cells viable. Outside the nucleus, secreted HMGB proteins could alert the innate immune system to foreign antigens and trigger the initiation of host defenses. In this work, we cloned and functionally characterized the HMGB1 protein from Aedes aegypti (AaHMGB1). The AaHMGB1 protein typically consists of two HMG-box DNA binding domains and an acidic C-terminus. Interestingly, AaHMGB1 contains a unique alanine/glutamine-rich (AQ-rich) C-terminal region that seems to be exclusive of dipteran HMGB proteins. AaHMGB1 is localized to the cell nucleus, mainly associated with heterochromatin. Circular dichroism analyses of AaHMGB1 or the C-terminal truncated proteins revealed a-helical structures. We showed that AaHMGB1 can effectively bind and change the topology of DNA, and that the AQ-rich and the C-terminal acidic regions can modulate its ability to promote DNA supercoiling, as well as its preference to bind supercoiled DNA. AaHMGB1 is phosphorylated by PKA and PKC, but not by CK2. Importantly, phosphorylation of AaHMGB1 by PKA or PKC completely abolishes its DNA bending activity. Thus, our study shows that a functional HMGB1 protein occurs in Aedes aegypt and we provide the first description of a HMGB1 protein containing an AQ-rich regulatory C-terminus.
C1 [Ribeiro, Fabio Schneider; de Abreu da Silva, Isabel Caetano; Carneiro, Vitor Coutinho; Gazos-Lopes, Felipe; Revoredo Vicentino, Amanda Roberta; Maciel, Renata de Moraes; Cardoso da Silva-Neto, Mario Alberto; Fantappie, Marcelo Rosado] Univ Fed Rio de Janeiro, Inst Bioquim Med, Programa Biol Mol & Biotecnol, Rio De Janeiro, Brazil.
   [Belgrano, Fabricio dos Santos; Mohana-Borges, Ronaldo; Rosa, Ivone de Andrade] Univ Fed Rio de Janeiro, Inst Biofis Carlos Chagas Filho, BR-21941 Rio De Janeiro, Brazil.
   [Quintino Souza, Nathalia Rocha; Mesquita, Rafael Dias] Univ Fed Rio de Janeiro, Inst Quim, Dept Bioquim, Rio De Janeiro, Brazil.
   [Quintino Souza, Nathalia Rocha; Mesquita, Rafael Dias; Ferreira Sorgine, Marcos Henrique; Cardoso da Silva-Neto, Mario Alberto; Fantappie, Marcelo Rosado] Univ Fed Rio de Janeiro, Inst Nacl Ciencia & Tecnol Entomol Mol, Rio De Janeiro, Brazil.
   [Rosa, Ivone de Andrade; Benchimol, Marlene] Univ Santa Ursula, Rio De Janeiro, Brazil.
   [Wu, Wenjie] Roswell Pk Canc Inst, Dept Urol, Buffalo, NY 14263 USA.
RP Ribeiro, FS (corresponding author), Univ Fed Rio de Janeiro, Inst Bioquim Med, Programa Biol Mol & Biotecnol, Rio De Janeiro, Brazil.
EM fantappie@bioqmed.ufrj.br
RI Silva-Neto, Mario A C/C-1211-2013; Borges, Ronaldo S Mohana/C-5575-2013;
   de Moraes Maciel, Renata/E-1426-2014
OI Silva-Neto, Mario A C/0000-0003-2273-194X; Mesquita, Rafael
   D/0000-0002-2882-3362; Belgrano, Fabricio/0000-0002-0411-7244; Carneiro,
   Vitor/0000-0003-1518-7667
FU INCT-EM; CNPqNational Council for Scientific and Technological
   Development (CNPq); FaperjCarlos Chagas Filho Foundation for Research
   Support of the State of Rio de Janeiro (FAPERJ)
FX This work was supported by INCT-EM (http://www.inctem.bioqmed.ufrj.br/),
   CNPq (http://www.cnpq.br/), and Faperj (http://www.faperj.br/). The
   funders had no role in study design, data collection and analysis,
   decision to publish, or preparation of the manuscript.
CR Abhyankar MM, 2008, EUKARYOT CELL, V7, P1565, DOI 10.1128/EC.00123-08
   Aleporou-Marinou V, 2003, BIOCHEM GENET, V41, P291, DOI 10.1023/B:BIGI.0000006030.05308.04
   de Oliveira FMB, 2006, GENE, V377, P33, DOI 10.1016/j.gene.2006.03.001
   Bianchi ME, 2007, IMMUNOL REV, V220, P35, DOI 10.1111/j.1600-065X.2007.00574.x
   Bianchi ME, 2005, CURR OPIN GENET DEV, V15, P496, DOI 10.1016/j.gde.2005.08.007
   Bonaldi T, 2003, EMBO J, V22, P5551, DOI 10.1093/emboj/cdg516
   Boonyaratanakornkit V, 1998, MOL CELL BIOL, V18, P4471, DOI 10.1128/MCB.18.8.4471
   Briquet S, 2006, EUKARYOT CELL, V5, P672, DOI 10.1128/EC.5.4.672-682.2006
   Camacho C, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-421
   Celona B, 2011, PLOS BIOL, V9, DOI 10.1371/journal.pbio.1001086
   Chen YH, 2011, MOL IMMUNOL, V48, P793, DOI 10.1016/j.molimm.2010.11.020
   da Silva ICD, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023572
   Finn RD, 2010, NUCLEIC ACIDS RES, V38, pD211, DOI 10.1093/nar/gkp985
   Gentile C, 2005, MEM I OSWALDO CRUZ, V100, P645
   Groth A, 2007, CELL, V128, P721, DOI 10.1016/j.cell.2007.01.030
   Hagedorn HH, 1989, PHYSL ROLES HEMOLYMP
   Kiilerich B, 2008, GENE, V407, P86, DOI 10.1016/j.gene.2007.09.025
   Kirov NC, 1996, EMBO J, V15, P7079, DOI 10.1002/j.1460-2075.1996.tb01099.x
   Lamiable O, 2010, GENESIS, V48, P244, DOI 10.1002/dvg.20609
   Lee KB, 2000, J MOL BIOL, V304, P135, DOI 10.1006/jmbi.2000.4206
   Lehming N, 1998, P NATL ACAD SCI USA, V95, P7322, DOI 10.1073/pnas.95.13.7322
   LEHMING N, 1994, NATURE, V371, P175, DOI 10.1038/371175a0
   Li B, 2007, CELL, V128, P707, DOI 10.1016/j.cell.2007.01.015
   Lotze MT, 2005, NAT REV IMMUNOL, V5, P331, DOI 10.1038/nri1594
   Martin D, 2003, J BIOCHEM, V134, P583, DOI 10.1093/jb/mvg177
   Mosrin-Huaman C, 1998, DEV GENET, V23, P324
   Muller S, 2001, EMBO J, V20, P4337, DOI 10.1093/emboj/20.16.4337
   NER SS, 1993, NUCLEIC ACIDS RES, V21, P4369, DOI 10.1093/nar/21.18.4369
   Oh YJ, 2009, J IMMUNOL, V182, P5800, DOI 10.4049/jimmunol.0801873
   Pasheva E, 2004, BIOCHEMISTRY-US, V43, P2935, DOI 10.1021/bi035615y
   PAULL TT, 1993, GENE DEV, V7, P1521, DOI 10.1101/gad.7.8.1521
   Payet D, 1997, J MOL BIOL, V266, P66, DOI 10.1006/jmbi.1996.0782
   Pfaffl MW, 2001, APMIS, V109, P345, DOI 10.1034/j.1600-0463.2001.090503.x
   Raikhel AS, 2002, INSECT BIOCHEM MOLEC, V32, P1275, DOI 10.1016/S0965-1748(02)00090-5
   Retief J D, 2000, Methods Mol Biol, V132, P243
   Roemer SC, 2008, NUCLEIC ACIDS RES, V36, P3655, DOI 10.1093/nar/gkn249
   Salvaing J, 2006, BMC BIOL, V4, DOI 10.1186/1741-7007-4-9
   Seabra-Junior E. S., 2011, FAT FUNCTIONAL ANAL
   Stott K, 2010, J MOL BIOL, V403, P706, DOI 10.1016/j.jmb.2010.07.045
   Stros M, 1998, EUR J BIOCHEM, V251, P427, DOI 10.1046/j.1432-1327.1998.2510427.x
   Stros M, 1998, J BIOL CHEM, V273, P10355
   Stros M, 2004, BIOCHEMISTRY-US, V43, P7215, DOI 10.1021/bi049928k
   STROS M, 1994, NUCLEIC ACIDS RES, V22, P1044, DOI 10.1093/nar/22.6.1044
   Stros M, 2010, BBA-GENE REGUL MECH, V1799, P101, DOI 10.1016/j.bbagrm.2009.09.008
   Thomas JO, 2001, TRENDS BIOCHEM SCI, V26, P167, DOI 10.1016/S0968-0004(01)01801-1
   Thompson Julie D, 2002, Curr Protoc Bioinformatics, VChapter 2, DOI 10.1002/0471250953.bi0203s00
   Thomsen MS, 2004, BIOCHEMISTRY-US, V43, P8029, DOI 10.1021/bi0499009
   WAGNER CR, 1992, MOL CELL BIOL, V12, P1915, DOI 10.1128/MCB.12.5.1915
   Wang SF, 1998, J BIOL CHEM, V273, P27531, DOI 10.1074/jbc.273.42.27531
   WARD LD, 1985, METHOD ENZYMOL, V117, P400
   WISNIEWSKI JR, 1992, J BIOL CHEM, V267, P17170
   WISNIEWSKI JR, 1994, J BIOL CHEM, V269, P10713
   WISNIEWSKI JR, 1994, EUR J BIOCHEM, V225, P687, DOI 10.1111/j.1432-1033.1994.00687.x
   Youn JH, 2006, J IMMUNOL, V177, P7889, DOI 10.4049/jimmunol.177.11.7889
   Zhang XH, 2008, J IMMUNOL, V181, P5015, DOI 10.4049/jimmunol.181.7.5015
NR 55
TC 12
Z9 12
U1 0
U2 5
PU PUBLIC LIBRARY SCIENCE
PI SAN FRANCISCO
PA 1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA
SN 1932-6203
J9 PLOS ONE
JI PLoS One
PD JUL 3
PY 2012
VL 7
IS 7
AR e40192
DI 10.1371/journal.pone.0040192
PG 13
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA 971EQ
UT WOS:000306186900029
PM 22802955
OA DOAJ Gold, Green Published
DA 2020-12-17
ER

PT J
AU Martins, IC
   Gomes-Neto, F
   Faustino, AF
   Carvalho, FA
   Carneiro, FA
   Bozza, PT
   Mohana-Borges, R
   Castanho, MARB
   Almeida, FCL
   Santos, NC
   Da Poian, AT
AF Martins, Ivo C.
   Gomes-Neto, Francisco
   Faustino, Andre F.
   Carvalho, Filomena A.
   Carneiro, Fabiana A.
   Bozza, Patricia T.
   Mohana-Borges, Ronaldo
   Castanho, Miguel A. R. B.
   Almeida, Fabio C. L.
   Santos, Nuno C.
   Da Poian, Andrea T.
TI The disordered N-terminal region of dengue virus capsid protein contains
   a lipid-droplet-binding motif
SO BIOCHEMICAL JOURNAL
LA English
DT Article
DE atomic force microscopy (AFM); capsid protein; conformational selection;
   dengue virus (DENV); intrinsically disordered protein; lipid droplet;
   NMR
ID HEPATITIS-C VIRUS; CORE PROTEIN; CONFORMATIONAL DIVERSITY; INTRINSIC
   DISORDER; VISUALIZATION; SPECTROSCOPY; FLEXIBILITY; INHIBITOR;
   ALIGNMENT; SYSTEM
AB Dengue is the major arthropod-borne human viral disease, for which no vaccine or specific treatment is available. We used NMR, zeta potential measurements and atomic force microscopy to study the structural features of the interaction between dengue virus C (capsid) protein and LDs (lipid droplets), organelles crucial for infectious particle formation. C protein-binding sites to LD were mapped, revealing a new function for a conserved segment in the N-terminal disordered region and indicating that conformational selection is involved in recognition. The results suggest that the positively charged N-terminal region of C protein prompts the interaction with negatively charged LDs, after which a conformational rearrangement enables the access of the central hydrophobic patch to the LD surface. Taken together, the results allowed the design of a peptide with inhibitory activity of C protein LD binding, paving the way for new drug development approaches against dengue.
C1 [Martins, Ivo C.; Gomes-Neto, Francisco; Almeida, Fabio C. L.; Da Poian, Andrea T.] Univ Fed Rio de Janeiro, Inst Bioquim Med, BR-21941902 Rio De Janeiro, RJ, Brazil.
   [Martins, Ivo C.; Faustino, Andre F.; Carvalho, Filomena A.; Castanho, Miguel A. R. B.; Santos, Nuno C.] Univ Lisbon, Fac Med, Inst Med Mol, P-1649028 Lisbon, Portugal.
   [Gomes-Neto, Francisco; Almeida, Fabio C. L.] Univ Fed Rio de Janeiro, Ctr Nacl Ressonancia Magnet Nucl, BR-21941902 Rio De Janeiro, RJ, Brazil.
   [Gomes-Neto, Francisco; Almeida, Fabio C. L.] Natl Inst Struct Biol & Bioimage, BR-21941902 Rio De Janeiro, RJ, Brazil.
   [Carneiro, Fabiana A.] Univ Fed Rio de Janeiro, BR-25245390 Duque De Caxias, RJ, Brazil.
   [Bozza, Patricia T.] Fundacao Oswaldo Cruz, Inst Oswaldo Cruz, BR-21040360 Rio De Janeiro, RJ, Brazil.
   [Mohana-Borges, Ronaldo] Univ Fed Rio de Janeiro, Inst Biofis Carlos Chagas Filho, Lab Genom Estrutural, BR-21941902 Rio De Janeiro, RJ, Brazil.
RP Da Poian, AT (corresponding author), Univ Fed Rio de Janeiro, Inst Bioquim Med, BR-21941902 Rio De Janeiro, RJ, Brazil.
EM dapoian@bioqmed.ufrj.br
RI Martins, Ivo C/G-2534-2013; Almeida, Fabio/O-4989-2018; CARNEIRO,
   FABIANA A/S-4525-2018; Da Poian, Andrea T./V-1699-2019; Carvalho,
   Filomena A./M-9202-2013; Borges, Ronaldo S Mohana/C-5575-2013; Santos,
   Nuno/N-7248-2013
OI Martins, Ivo C/0000-0002-9284-8599; Almeida, Fabio/0000-0001-6046-7006;
   Carvalho, Filomena A./0000-0001-6088-3894; Santos,
   Nuno/0000-0002-0580-0475; Mohana Borges, Ronaldo/0000-0002-1796-475X;
   Faustino, Andre F./0000-0002-7364-8524; Castanho,
   Miguel/0000-0001-7891-7562; Bozza, Patricia/0000-0001-8349-9529; Da
   Poian, Andrea/0000-0002-3969-704X; Carneiro,
   Fabiana/0000-0002-6584-4875; FCCN, Bogus/0000-0001-6282-8004; FCCN,
   Bogus/0000-0003-1034-3552
FU European UnionEuropean Union (EU); National Institute of Science and
   Technology in Dengue (INCTD, Brazil); Conselho Nacional de
   Desenvolvimento Cientifico e Tecnologico (CNPq, Brazil)National Council
   for Scientific and Technological Development (CNPq); Fundagao Carlos
   Chagas Filho de Amparo a Pesquisa do Estado do Rio de Janeiro (FAPERJ,
   Brazil)Carlos Chagas Filho Foundation for Research Support of the State
   of Rio de Janeiro (FAPERJ); Fundacao para a Ciencia e a Tecnologia
   (FCT)-Ministerio da Educacao e Ciencia (MEC) (Portugal)
   [PTDC/QUI-BIQ/112929/20091]; Fundacao Calouste Gulbenkian (Portugal);
   FCT-Fundacao Coordenacao de Aperfeicoamento do Pessoal de Nivel Superior
   (CAPES) Portugal-Brazil joint co-operation project; Marie Curie
   International Outgoing FellowshipEuropean Union (EU) [MC-10F237373]; FCT
   postdoctoral fellowship [SFRH/BPD/46324/2008, SFRH/BPD/74287/2010]
FX This work was supported by the European Union 7th Framework Programme
   PEOPLE IRSES (International Research Staff Exchange Scheme) project
   MEMPEPACROSS, the National Institute of Science and Technology in Dengue
   (INCTD, Brazil), the Conselho Nacional de Desenvolvimento Cientifico e
   Tecnologico (CNPq, Brazil), the Fundagao Carlos Chagas Filho de Amparo a
   Pesquisa do Estado do Rio de Janeiro (FAPERJ, Brazil), the Fundacao para
   a Ciencia e a Tecnologia (FCT)-Ministerio da Educacao e Ciencia (MEC)
   (Portugal) [grant number PTDC/QUI-BIQ/112929/20091, the Fundacao
   Calouste Gulbenkian (Portugal), and FCT-Fundacao Coordenacao de
   Aperfeicoamento do Pessoal de Nivel Superior (CAPES) Portugal-Brazil
   joint co-operation projects. I.C.M. is the recipient of consecutive
   postdoctoral funding from a Marie Curie International Outgoing
   Fellowship [grant number MC-10F237373) and FCT postdoctoral fellowships
   [grant numbers SFRH/BPD/46324/2008 and SFRH/BPD/74287/2010].
CR ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2
   Assuncao-Miranda I, 2010, FASEB J, V24, P218, DOI 10.1096/fj.09-139469
   Berjanskii MV, 2005, J AM CHEM SOC, V127, P14970, DOI 10.1021/ja054842f
   Carvalho FA, 2012, J VIROL, V86, P2096, DOI 10.1128/JVI.06796-11
   Carvalho FA, 2010, ACS NANO, V4, P4609, DOI 10.1021/nn1009648
   Chenna R, 2003, NUCLEIC ACIDS RES, V31, P3497, DOI 10.1093/nar/gkg500
   de Paula VS, 2011, STRUCTURE, V19, P26, DOI 10.1016/j.str.2010.11.011
   DELAGLIO F, 1995, J BIOMOL NMR, V6, P277, DOI 10.1007/BF00197809
   Dokland T, 2004, STRUCTURE, V12, P1157, DOI 10.1016/j.str.2004.04.024
   Domingues MM, 2008, J PEPT SCI, V14, P394, DOI 10.1002/psc.1007
   Dunker AK, 2008, CURR OPIN STRUC BIOL, V18, P756, DOI 10.1016/j.sbi.2008.10.002
   Guex N, 1997, ELECTROPHORESIS, V18, P2714, DOI 10.1002/elps.1150181505
   Heaton NS, 2010, P NATL ACAD SCI USA, V107, P17345, DOI 10.1073/pnas.1010811107
   Henzler-Wildman K, 2007, NATURE, V450, P964, DOI 10.1038/nature06522
   Ivanyi-Nagy R, 2008, NUCLEIC ACIDS RES, V36, P712, DOI 10.1093/nar/gkm1051
   Ivanyi-Nagy R, 2010, PROTEIN PEPTIDE LETT, V17, P1019, DOI 10.2174/092986610791498911
   James LC, 2003, TRENDS BIOCHEM SCI, V28, P361, DOI 10.1016/S0968-0004(03)00135-X
   JOHNSON BA, 1994, J BIOMOL NMR, V4, P603, DOI 10.1007/BF00404272
   Jones CT, 2003, J VIROL, V77, P7143, DOI 10.1128/JVI.77.12.7143-7149.2003
   Khromykh AA, 1996, ARCH VIROL, V141, P685, DOI 10.1007/BF01718326
   Kofler RM, 2002, J VIROL, V76, P3534, DOI 10.1128/JVI.76.7.3534-3543.2002
   Kuhn RJ, 2002, CELL, V108, P717, DOI 10.1016/S0092-8674(02)00660-8
   Kunkel M, 2001, J VIROL, V75, P2119, DOI 10.1128/JVI.75.5.2119-2129.2001
   Lalezari JP, 2003, NEW ENGL J MED, V348, P2175, DOI 10.1056/NEJMoa035026
   Ma LX, 2004, P NATL ACAD SCI USA, V101, P3414, DOI 10.1073/pnas.0305892101
   Maecker HT, 2001, J IMMUNOL METHODS, V255, P27, DOI 10.1016/S0022-1759(01)00416-1
   Majeau N, 2004, J GEN VIROL, V85, P971, DOI 10.1099/vir.0.79775-0
   Markoff L, 1997, VIROLOGY, V233, P105, DOI 10.1006/viro.1997.8608
   McLauchlan J, 2000, J VIRAL HEPATITIS, V7, P2
   Mukhopadhyay S, 2005, NAT REV MICROBIOL, V3, P13, DOI 10.1038/nrmicro1067
   Netsawang J, 2010, VIRUS RES, V147, P275, DOI 10.1016/j.virusres.2009.11.012
   Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084
   PIOTTO M, 1992, J BIOMOL NMR, V2, P661, DOI 10.1007/BF02192855
   Poordad F, 2011, NEW ENGL J MED, V364, P1195, DOI 10.1056/NEJMoa1010494
   Puttikhunt C, 2009, ARCH VIROL, V154, P1211, DOI 10.1007/s00705-009-0426-5
   Samsa MM, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000632
   Sangiambut S, 2008, J GEN VIROL, V89, P1254, DOI 10.1099/vir.0.83264-0
   Schlick P, 2009, J VIROL, V83, P5581, DOI 10.1128/JVI.02653-08
   Schoelm G, 2008, J VIROL, V82, P3192, DOI 10.1128/JVI.02393-07
   Shen Y, 2009, J BIOMOL NMR, V44, P213, DOI 10.1007/s10858-009-9333-z
   Shi ST, 2002, VIROLOGY, V292, P198, DOI 10.1006/viro.2001.1225
   Stratmann D, 2011, PROTEINS, V79, P2662, DOI 10.1002/prot.23090
   Tokuriki N, 2009, TRENDS BIOCHEM SCI, V34, P53, DOI 10.1016/j.tibs.2008.10.009
   Turoverov KK, 2010, PROG BIOPHYS MOL BIO, V102, P73, DOI 10.1016/j.pbiomolbio.2010.01.003
   Valente AP, 2006, CURR MED CHEM, V13, P3697, DOI 10.2174/092986706779026147
   WAGNER G, 1986, EUR J BIOCHEM, V157, P275, DOI 10.1111/j.1432-1033.1986.tb09666.x
   Welch BD, 2010, J VIROL, V84, P11235, DOI 10.1128/JVI.01339-10
   Wilder-Smith Annelies, 2010, Curr Infect Dis Rep, V12, P157, DOI 10.1007/s11908-010-0102-7
   Wu E, 2004, TRENDS MICROBIOL, V12, P162, DOI 10.1016/j.tim.2004.02.005
   Xue B, 2010, PROTEIN PEPTIDE LETT, V17, P932, DOI 10.2174/092986610791498984
NR 50
TC 57
Z9 57
U1 0
U2 25
PU PORTLAND PRESS LTD
PI LONDON
PA CHARLES DARWIN HOUSE, 12 ROGER STREET, LONDON WC1N 2JU, ENGLAND
SN 0264-6021
EI 1470-8728
J9 BIOCHEM J
JI Biochem. J.
PD JUN 15
PY 2012
VL 444
BP 405
EP 415
DI 10.1042/BJ20112219
PN 3
PG 11
WC Biochemistry & Molecular Biology
SC Biochemistry & Molecular Biology
GA 962KZ
UT WOS:000305545300005
PM 22428600
DA 2020-12-17
ER

PT J
AU Barros, TG
   Zorzanelli, BC
   Pinheiro, S
   de Brito, MA
   Tanuri, A
   da Costa, ECB
   Mohana-Borges, RS
   Rodrigues, CR
   Souza, ATM
   Ferreira, VF
   Muri, EMF
AF Barros, Thalita G.
   Zorzanelli, Bruna C.
   Pinheiro, Sergio
   de Brito, Monique A.
   Tanuri, Amilcar
   da Costa, Emmerson C. B.
   Mohana-Borges, Ronaldo S.
   Rodrigues, Carlos R.
   Souza, Alessandra T. M.
   Ferreira, Vitor F.
   Muri, Estela M. F.
TI Novel Peptide Mimetics Based on N-protected Amino Acids Derived from
   Isomannide as Potential Inhibitors of NS3 Serine Protease of Hepatitis C
   Virus
SO LETTERS IN ORGANIC CHEMISTRY
LA English
DT Article
DE HCV; isomannide; peptide mimetic; serine protease
ID DENGUE VIRUS; FLAVIVIRUSES; DISCOVERY; BILN-2061; DESIGN; DOMAIN
AB Hepatitis C virus (HCV) is among the most important flaviviruses. It has a serine protease which is important for viral replication and this enzyme constitutes a suitable target for new anti-retroviral drugs. Herein we disclose a series of amide and ester peptide mimetic inhibitors of serine proteases, all of them obtained via coupling reactions of isomannide derivatives with N-protected amino acids. The arginine derivative 19 showed 45% of inhibition of NS3/4A serine protease at 100 mu M and molecular modeling studies had shown that 19 interacted with the active site of this enzyme.
C1 [Muri, Estela M. F.] Univ Fed Fluminense, Fac Farm, Dept Tecnol Farmaceut, MTC, BR-24241000 Niteroi, RJ, Brazil.
   [Barros, Thalita G.; Zorzanelli, Bruna C.; Pinheiro, Sergio; Souza, Alessandra T. M.; Ferreira, Vitor F.] Univ Fed Fluminense, Inst Quim, BR-24241000 Niteroi, RJ, Brazil.
   [Tanuri, Amilcar] Univ Fed Rio de Janeiro, Dept Genet, Inst Biol, Lab Virol Mol, Rio De Janeiro, RJ, Brazil.
   [da Costa, Emmerson C. B.; Mohana-Borges, Ronaldo S.] Univ Fed Rio de Janeiro, Inst Biofis Carlos Chagas Filho, Lab Genom Estrutural, BR-21941 Rio De Janeiro, RJ, Brazil.
   [Rodrigues, Carlos R.; Souza, Alessandra T. M.] Univ Fed Rio de Janeiro, Fac Farm, ModMolQSAR, Rio De Janeiro, RJ, Brazil.
RP Muri, EMF (corresponding author), Univ Fed Fluminense, Fac Farm, Dept Tecnol Farmaceut, MTC, Rua Mario Viana 523, BR-24241000 Niteroi, RJ, Brazil.
EM estelamuri@yahoo.com.br
RI ferreira, Vitor francisco/Y-4031-2019; Pinheiro, Sergio/AAU-6419-2020;
   Borges, Ronaldo S Mohana/C-5575-2013; Rodrigues, Carlos
   Rangel/Q-2316-2019; Souza, Alessandra M. T./R-5628-2016; Muri,
   Estela/AAG-4930-2019
OI ferreira, Vitor francisco/0000-0002-2166-766X; Rodrigues, Carlos
   Rangel/0000-0001-8453-7654; Souza, Alessandra M. T./0000-0001-9986-405X;
   Muri, Estela/0000-0001-8489-1848
FU CNPqNational Council for Scientific and Technological Development
   (CNPq); CAPESCAPES; FAPERJCarlos Chagas Filho Foundation for Research
   Support of the State of Rio de Janeiro (FAPERJ); FINEPCiencia Tecnologia
   e Inovacao (FINEP)
FX Authors thank to CNPq, CAPES, FAPERJ and FINEP for the financial support
   and for individual research fellowship. We thank to John S. Williamson
   and Paulo Carvalho (University of Mississippi) for HRMS.
CR Alongi M, 2005, TETRAHEDRON LETT, V46, P7069, DOI 10.1016/j.tetlet.2005.07.155
   Arosio D, 2006, TETRAHEDRON LETT, V47, P3697, DOI 10.1016/j.tetlet.2006.03.149
   Asselah T, 2004, J HEPATOL, V41, P178, DOI 10.1016/j.jhep.2004.05.004
   Barros TG, 2010, AMINO ACIDS, V38, P701, DOI 10.1007/s00726-009-0273-4
   Barros TG, 2009, SYNTHESIS-STUTTGART, P620, DOI 10.1055/s-0028-1083332
   BAZAN JF, 1989, VIROLOGY, V171, P637, DOI 10.1016/0042-6822(89)90639-9
   BAZAN JF, 1990, SEMIN VIROL, V1, P311
   Chappell KJ, 2008, CURR MED CHEM, V15, P2771, DOI 10.2174/092986708786242804
   Chary A, 2010, REV RECENT CLIN TRIA, V5, P158, DOI 10.2174/157488710792007293
   Chiappe C, 2003, J ORG CHEM, V68, P6710, DOI 10.1021/jo026838h
   Cohen J, 1999, SCIENCE, V285, P26, DOI 10.1126/science.285.5424.26
   Dahl G, 2009, BIOCHEMISTRY-US, V48, P11592, DOI 10.1021/bi9016928
   Feld JJ, 2005, NATURE, V436, P967, DOI 10.1038/nature04082
   Frokjaer S, 2005, NAT REV DRUG DISCOV, V4, P298, DOI 10.1038/nrd1695
   Gao YJ, 2010, BIOORGAN MED CHEM, V18, P1331, DOI 10.1016/j.bmc.2009.12.026
   Ghosh AK, 2007, BIOORGAN MED CHEM, V15, P7576, DOI 10.1016/j.bmc.2007.09.010
   GOODSELL DS, 1990, PROTEINS, V8, P195, DOI 10.1002/prot.340080302
   GORBALENYA AE, 1989, NUCLEIC ACIDS RES, V17, P3889, DOI 10.1093/nar/17.10.3889
   Han SY, 2004, TETRAHEDRON, V60, P2447, DOI 10.1016/j.tet.2004.01.020
   Hanessian S, 1997, TETRAHEDRON, V53, P12789, DOI 10.1016/S0040-4020(97)00476-6
   Hosseini M, 2007, ORG BIOMOL CHEM, V5, P3486, DOI 10.1039/b711349h
   Kumar S, 2005, TETRAHEDRON, V61, P4141, DOI 10.1016/j.tet.2005.02.010
   Lampa A, 2010, BIOORGAN MED CHEM, V18, P5413, DOI 10.1016/j.bmc.2010.05.027
   Lescar J, 2008, ANTIVIR RES, V80, P94, DOI 10.1016/j.antiviral.2008.07.001
   Lin C, 2004, J BIOL CHEM, V279, P17508, DOI 10.1074/jbc.M313020200
   Llewellyn DB, 2005, TETRAHEDRON-ASYMMETR, V16, P1789, DOI 10.1016/j.tetasy.2005.04.004
   Loupy A, 1996, TETRAHEDRON LETT, V37, P7023, DOI 10.1016/0040-4039(96)01539-0
   Melino S, 2007, FEBS J, V274, P2986, DOI 10.1111/j.1742-4658.2007.05831.x
   Moitessier N, 2005, TETRAHEDRON LETT, V46, P6191, DOI 10.1016/j.tetlet.2005.07.081
   Muri EMF, 2005, AMINO ACIDS, V28, P413, DOI 10.1007/s00726-004-0146-9
   Muri EMF, 2004, AMINO ACIDS, V27, P153, DOI 10.1007/s00726-004-0121-5
   Nair LG, 2010, BIOORG MED CHEM LETT, V20, P1689, DOI 10.1016/j.bmcl.2010.01.037
   Nair LG, 2010, BIOORG MED CHEM LETT, V20, P567, DOI 10.1016/j.bmcl.2009.11.094
   Ortqvist P, 2010, BIOORGAN MED CHEM, V18, P6512, DOI 10.1016/j.bmc.2010.06.101
   Pompei M, 2010, BIOORG MED CHEM LETT, V20, P168, DOI 10.1016/j.bmcl.2009.11.005
   Prongay AJ, 2007, J MED CHEM, V50, P2310, DOI 10.1021/jm060173k
   Rosales-Leon L, 2007, J MOL GRAPH MODEL, V25, P585, DOI 10.1016/j.jmgm.2006.04.001
   Seo J, 2006, TETRAHEDRON LETT, V47, P4069, DOI 10.1016/j.tetlet.2006.03.190
   TAMION R, 1993, TETRAHEDRON-ASYMMETR, V4, P1879, DOI 10.1016/S0957-4166(00)80428-0
   Venkatraman S, 2010, BIOORG MED CHEM LETT, V20, P2151, DOI 10.1016/j.bmcl.2010.02.051
   Westermann B, 2004, TETRAHEDRON LETT, V45, P5983, DOI 10.1016/j.tetlet.2004.06.051
   Wright M, 2001, ANTIVIR CHEM CHEMOTH, V12, P201, DOI 10.1177/095632020101200401
   Yin Z, 2006, BIOORG MED CHEM LETT, V16, P36, DOI 10.1016/j.bmcl.2005.09.062
   Yin Z, 2006, BIOORG MED CHEM LETT, V16, P40, DOI 10.1016/j.bmcl.2005.09.049
NR 44
TC 9
Z9 9
U1 0
U2 7
PU BENTHAM SCIENCE PUBL LTD
PI SHARJAH
PA EXECUTIVE STE Y-2, PO BOX 7917, SAIF ZONE, 1200 BR SHARJAH, U ARAB
   EMIRATES
SN 1570-1786
EI 1875-6255
J9 LETT ORG CHEM
JI Lett. Org. Chem.
PD MAY
PY 2012
VL 9
IS 4
BP 239
EP 249
DI 10.2174/157017812800233787
PG 11
WC Chemistry, Organic
SC Chemistry
GA 931ZA
UT WOS:000303256700002
DA 2020-12-17
ER

PT J
AU Carvalho, FA
   Carneiro, FA
   Martins, IC
   Assuncao-Miranda, I
   Faustino, AF
   Pereira, RM
   Bozza, PT
   Castanho, MARB
   Mohana-Borges, R
   Da Poian, AT
   Santos, NC
AF Carvalho, Filomena A.
   Carneiro, Fabiana A.
   Martins, Ivo C.
   Assuncao-Miranda, Iranaia
   Faustino, Andre F.
   Pereira, Renata M.
   Bozza, Patricia T.
   Castanho, Miguel A. R. B.
   Mohana-Borges, Ronaldo
   Da Poian, Andrea T.
   Santos, Nuno C.
TI Dengue Virus Capsid Protein Binding to Hepatic Lipid Droplets (LD) Is
   Potassium Ion Dependent and Is Mediated by LD Surface Proteins
SO JOURNAL OF VIROLOGY
LA English
DT Article
ID ATOMIC-FORCE MICROSCOPY; C VIRUS; CORE PROTEIN; GOLD NANOPARTICLES;
   ASSOCIATION; REVEALS; CHANNEL; DOMAIN; FORMS; AFM
AB Dengue virus (DENY) affects millions of people, causing more than 20,000 deaths annually. No effective treatment for the disease caused by DENV infection is currently available, partially due to the lack of knowledge on the basic aspects of the viral life cycle, including the molecular basis of the interaction between viral components and cellular compartments. Here, we characterized the properties of the interaction between the DEW capsid (C) protein and hepatic lipid droplets (LDs), which was recently shown to be essential for the virus replication cycle. Zeta potential analysis revealed a negative surface charge of LDs, with an average surface charge of -19 mV. The titration of LDs with C protein led to an increase of the surface charge, which reached a plateau at +13.7 mV, suggesting that the viral protein-LD interaction exposes the protein cationic surface to the aqueous environment. Atomic force microscopy (AFM)-based force spectroscopy measurements were performed by using C proteinfunctionalized AFM tips. The C protein-LD interaction was found to be strong, with a single (un)binding force of 33.6 pN. This binding was dependent on high intracellular concentrations of potassium ions but not sodium. The inhibition of Na+/K+-ATPase in DEW-infected cells resulted in the dissociation of C protein from LDs and a 50-fold inhibition of infectious virus production but not of RNA replication, indicating a biological relevance for the potassium-dependent interaction. Limited proteolysis of the LD surface impaired the C protein-LD interaction, and force measurements in the presence of specific antibodies indicated that perilipin 3 (TIP47) is the major DEW C protein ligand on the surface of LDs.
C1 [Carvalho, Filomena A.; Martins, Ivo C.; Faustino, Andre F.; Castanho, Miguel A. R. B.; Santos, Nuno C.] Univ Lisbon, Inst Mol Med, Fac Med, P-1200 Lisbon, Portugal.
   [Carneiro, Fabiana A.; Da Poian, Andrea T.] Univ Fed Rio de Janeiro, Inst Bioquim Med, Rio De Janeiro, Brazil.
   [Carneiro, Fabiana A.] Univ Fed Rio de Janeiro, Duque De Caxias, Brazil.
   [Assuncao-Miranda, Iranaia] Univ Fed Rio de Janeiro, Inst Microbiol Prof Paulo Goes, Rio De Janeiro, Brazil.
   [Pereira, Renata M.; Mohana-Borges, Ronaldo] Univ Fed Rio de Janeiro, Inst Biofis Carlos Chagas Filho, Rio De Janeiro, Brazil.
   [Bozza, Patricia T.] Fundacao Oswaldo Cruz, Inst Oswaldo Cruz, Rio De Janeiro, Brazil.
RP Santos, NC (corresponding author), Univ Lisbon, Inst Mol Med, Fac Med, P-1200 Lisbon, Portugal.
EM nsantos@fm.ul.pt
RI Borges, Ronaldo S Mohana/C-5575-2013; CARNEIRO, FABIANA A/S-4525-2018;
   Santos, Nuno/N-7248-2013; Da Poian, Andrea T./V-1699-2019; Martins, Ivo
   C/G-2534-2013; Carvalho, Filomena A./M-9202-2013
OI Santos, Nuno/0000-0002-0580-0475; Martins, Ivo C/0000-0002-9284-8599;
   Carvalho, Filomena A./0000-0001-6088-3894; Castanho,
   Miguel/0000-0001-7891-7562; Carneiro, Fabiana/0000-0002-6584-4875; FCCN,
   Bogus/0000-0001-6282-8004; Da Poian, Andrea/0000-0002-3969-704X; FCCN,
   Bogus/0000-0003-1034-3552; Faustino, Andre F./0000-0002-7364-8524;
   Bozza, Patricia/0000-0001-8349-9529
FU European UnionEuropean Union (EU); Fundacao para a Ciencia e a
   Tecnologia-Ministerio da Educacao e Ciencia (FCT-MEC, Portugal)
   [PTDC/QUI-BIQ/112929/2009, PTDC/QUI/69937/2006]; Fundacao Calouste
   Gulbenkian (Portugal); FCT-CAPES Portugal-Brazil; Conselho Nacional de
   Desenvolvimento Cientifico e TecnolOgico (CNPq)National Council for
   Scientific and Technological Development (CNPq); Fundacao Carlos Chagas
   Filho de Anwar a Pesquisa do Estado do Rio de Janeiro (FAPERJ)Carlos
   Chagas Filho Foundation for Research Support of the State of Rio de
   Janeiro (FAPERJ); Financiadora de Estudos e Projetos (FINEP)Ciencia
   Tecnologia e Inovacao (FINEP); National Institute of Science and
   Technology in Dengue (INCT-Dengue); Marie Curie International Outgoing
   FellowshipEuropean Union (EU) [MC-IOE-237373]; FCT-MEC
   [SFRH/BPD/46324/2008, SFRH/BPD/74287/2010]
FX This work was supported by FP7-PEOPLE IRSES (International Research
   Staff Exchange Scheme) project MEMPEPACROSS (European Union), by the
   Fundacao para a Ciencia e a Tecnologia-Ministerio da Educacao e Ciencia
   (FCT-MEC, Portugal) (projects PTDC/QUI-BIQ/112929/2009 and
   PTDC/QUI/69937/2006), by Fundacao Calouste Gulbenkian (Portugal), by the
   FCT-CAPES Portugal-Brazil joint cooperation projects, and by the
   Brazilian funding agencies Conselho Nacional de Desenvolvimento
   Cientifico e TecnolOgico (CNPq), Fundacao Carlos Chagas Filho de Anwar a
   Pesquisa do Estado do Rio de Janeiro (FAPERJ), Financiadora de Estudos e
   Projetos (FINEP), and National Institute of Science and Technology in
   Dengue (INCT-Dengue). I. C. Martins also acknowledges consecutive
   postdoctoral funding from a Marie Curie International Outgoing
   Fellowship (MC-IOE-237373) and FCT-MEC postdoctoral fellowships
   (SFRH/BPD/46324/2008 and SFRH/BPD/74287/2010). The funders had no role
   in study design, data collection and analysis, decision to publish, or
   preparation of the manuscript.
CR Alves CS, 2010, J BIOL CHEM, V285, P27536, DOI 10.1074/jbc.M110.130955
   Assuncao-Miranda I, 2010, FASEB J, V24, P218, DOI 10.1096/fj.09-139469
   Barba G, 1997, P NATL ACAD SCI USA, V94, P1200, DOI 10.1073/pnas.94.4.1200
   Boulant S, 2007, J GEN VIROL, V88, P2204, DOI 10.1099/vir.0.82898-0
   Boulant S, 2006, J BIOL CHEM, V281, P22236, DOI 10.1074/jbc.M601031200
   Bozza PT, 2009, BBA-MOL CELL BIOL L, V1791, P540, DOI 10.1016/j.bbalip.2009.01.005
   Brasaemle DL, 1997, J LIPID RES, V38, P2249
   Brewer SH, 2005, LANGMUIR, V21, P9303, DOI 10.1021/la050588t
   Carvalho FA, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018167
   Carvalho FA, 2010, ACS NANO, V4, P4609, DOI 10.1021/nn1009648
   Conceicao TM, 2010, J VIROL METHODS, V163, P1, DOI 10.1016/j.jviromet.2009.10.001
   Conceicao TM, 2010, J INFECTION, V60, P65, DOI 10.1016/j.jinf.2009.10.003
   Desmeules P, 2002, BIOPHYS J, V82, P3343, DOI 10.1016/S0006-3495(02)75674-9
   Digel M, 2010, FEBS LETT, V584, P2168, DOI 10.1016/j.febslet.2010.03.035
   Dokland T, 2004, STRUCTURE, V12, P1157, DOI 10.1016/j.str.2004.04.024
   Domingues MM, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008385
   Francius G, 2009, NAT PROTOC, V4, P939, DOI 10.1038/nprot.2009.65
   Griffin SDC, 2003, FEBS LETT, V535, P34, DOI 10.1016/S0014-5793(02)03851-6
   Guzman A, 2010, INT J ANTIMICROB AG, V36, pS40, DOI 10.1016/j.ijantimicag.2010.06.018
   Hodges BDM, 2010, J LIPID RES, V51, P262, DOI 10.1194/jlr.R003582
   Hope RG, 2000, J GEN VIROL, V81, P1913, DOI 10.1099/0022-1317-81-8-1913
   Jones CT, 2003, J VIROL, V77, P7143, DOI 10.1128/JVI.77.12.7143-7149.2003
   Kaufman ED, 2007, LANGMUIR, V23, P6053, DOI 10.1021/la063725a
   Kimmel AR, 2010, J LIPID RES, V51, P468, DOI 10.1194/jlr.R000034
   Kuhn RJ, 2002, CELL, V108, P717, DOI 10.1016/S0092-8674(02)00660-8
   Lee CK, 2007, MICRON, V38, P446, DOI 10.1016/j.micron.2006.06.014
   Ma LX, 2004, P NATL ACAD SCI USA, V101, P3414, DOI 10.1073/pnas.0305892101
   Mankouri J, 2009, P NATL ACAD SCI USA, V106, P15903, DOI 10.1073/pnas.0906798106
   Markoff L, 1997, VIROLOGY, V233, P105, DOI 10.1006/viro.1997.8608
   Martin S, 2006, NAT REV MOL CELL BIO, V7, P373, DOI 10.1038/nrm1912
   McLauchlan J, 2009, BBA-MOL CELL BIOL L, V1791, P552, DOI 10.1016/j.bbalip.2008.12.012
   Miller S, 2008, NAT REV MICROBIOL, V6, P363, DOI 10.1038/nrmicro1890
   Mukhopadhyay S, 2005, NAT REV MICROBIOL, V3, P13, DOI 10.1038/nrmicro1067
   Muller DJ, 2008, BIOCHEMISTRY-US, V47, P7986, DOI 10.1021/bi800753x
   Olofsson SO, 2009, BBA-MOL CELL BIOL L, V1791, P448, DOI 10.1016/j.bbalip.2008.08.001
   Piramowicz MD, 2006, ACTA BIOCHIM POL, V53, P93
   Premkumar A, 2005, J MEMBRANE BIOL, V204, P33, DOI 10.1007/s00232-005-0744-9
   Ratto TV, 2006, LANGMUIR, V22, P1749, DOI 10.1021/la052087d
   Samsa MM, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000632
   Santos NC, 2004, BIOPHYS CHEM, V107, P133, DOI 10.1016/j.bpc.2003.09.001
   Sha BD, 1997, NAT STRUCT BIOL, V4, P239, DOI 10.1038/nsb0397-239
   Shavinskaya A, 2007, J BIOL CHEM, V282, P37158, DOI 10.1074/jbc.M707329200
   Thiele C, 2008, CURR OPIN CELL BIOL, V20, P378, DOI 10.1016/j.ceb.2008.05.009
   Tsapikouni TS, 2010, COLLOID SURFACE B, V75, P252, DOI 10.1016/j.colsurfb.2009.08.041
   Walther TC, 2009, BBA-MOL CELL BIOL L, V1791, P459, DOI 10.1016/j.bbalip.2008.10.009
   Wang K, 2011, BBA-BIOMEMBRANES, V1808, P510, DOI 10.1016/j.bbamem.2010.05.006
   Welsch S, 2009, CELL HOST MICROBE, V5, P365, DOI 10.1016/j.chom.2009.03.007
   Willemsen OH, 2000, BIOPHYS J, V79, P3267, DOI 10.1016/S0006-3495(00)76559-3
   Wolins NE, 2001, J BIOL CHEM, V276, P5101, DOI 10.1074/jbc.M006775200
   Xu ZW, 2010, BIOL PHARM BULL, V33, P743, DOI 10.1248/bpb.33.743
NR 50
TC 79
Z9 79
U1 0
U2 24
PU AMER SOC MICROBIOLOGY
PI WASHINGTON
PA 1752 N ST NW, WASHINGTON, DC 20036-2904 USA
SN 0022-538X
EI 1098-5514
J9 J VIROL
JI J. Virol.
PD FEB
PY 2012
VL 86
IS 4
BP 2096
EP 2108
DI 10.1128/JVI.06796-11
PG 13
WC Virology
SC Virology
GA 886OA
UT WOS:000299862500019
PM 22130547
OA Bronze, Green Published
DA 2020-12-17
ER

PT J
AU Costa, SM
   Yorio, AP
   Goncalves, AJS
   Vidale, MM
   Costa, ECB
   Mohana-Borges, R
   Motta, MA
   Freire, MS
   Alves, AMB
AF Costa, Simone M.
   Yorio, Anna Paula
   Goncalves, Antonio J. S.
   Vidale, Mariana M.
   Costa, Emmerson C. B.
   Mohana-Borges, Ronaldo
   Motta, Marcia A.
   Freire, Marcos S.
   Alves, Ada M. B.
TI Induction of a Protective Response in Mice by the Dengue Virus NS3
   Protein Using DNA Vaccines
SO PLOS ONE
LA English
DT Article
ID T-CELL RESPONSES; ACTIVATOR SIGNAL SEQUENCE; HEMORRHAGIC-FEVER;
   NONSTRUCTURAL PROTEIN-3; MONOCLONAL-ANTIBODIES; JAPANESE ENCEPHALITIS;
   IMMUNE-RESPONSES; DRUG DESIGN; TYPE-2; IMMUNIZATION
AB The dengue non-structural 3 (NS3) is a multifunctional protein, containing a serino-protease domain, located at the N-terminal portion, and helicase, NTPase and RTPase domains present in the C-terminal region. This protein is considered the main target for CD4+ and CD8+ T cell responses during dengue infection, which may be involved in protection. However, few studies have been undertaken evaluating the use of this protein as a protective antigen against dengue, as well as other flavivirus. In the present work, we investigate the protective efficacy of DNA vaccines based on the NS3 protein from DENV2. Different recombinant plasmids were constructed, encoding either the full-length NS3 protein or only its functional domains (protease and helicase), fused or not to a signal peptide (t-PA). The recombinant proteins were successfully expressed in transfected BHK-21 cells, and only plasmids encoding the t-PA signal sequence mediated protein secretion. Balb/c mice were immunized with the different DNA vaccines and challenged with a lethal dose of DENV2. Most animals immunized with plasmids encoding the full-length NS3 or the helicase domain survived challenge, regardless of the presence of the t-PA. However, some mice presented clinical signs of infection with high morbidity (hind leg paralysis and hunched posture), mainly in animal groups immunized with the DNA vaccines based on the helicase domain. On the other hand, inoculation with plasmids encoding the protease domain did not induce any protection, since mortality and morbidity rates in these mouse groups were similar to those detected in the control animals. The cellular immune response was analyzed by ELISPOT with a specific-CD8+ T cell NS3 peptide. Results revealed that the DNA vaccines based on the full-length protein induced the production of INF-gamma, thus suggesting the involvement of this branch of the immune system in the protection.
C1 [Costa, Simone M.; Yorio, Anna Paula; Goncalves, Antonio J. S.; Vidale, Mariana M.; Alves, Ada M. B.] Fundacao Oswaldo Cruz, Inst Oswaldo Cruz, Lab Biotecnol & Fisiol Infeccoes Virais, Rio De Janeiro, Brazil.
   [Costa, Emmerson C. B.; Mohana-Borges, Ronaldo] Univ Fed Rio de Janeiro, Inst Biofis Carlos Chagas Filho, Lab Genom Estrutural, BR-21941 Rio De Janeiro, Brazil.
   [Motta, Marcia A.; Freire, Marcos S.] Fundacao Oswaldo Cruz Fdn, Inst Tecnol Imunobiol, Lab Tecnol Virol, Rio De Janeiro, Brazil.
RP Costa, SM (corresponding author), Fundacao Oswaldo Cruz, Inst Oswaldo Cruz, Lab Biotecnol & Fisiol Infeccoes Virais, Rio De Janeiro, Brazil.
EM ada@ioc.fiocruz.br
RI Borges, Ronaldo S Mohana/C-5575-2013
OI Mohana Borges, Ronaldo/0000-0002-1796-475X
FU Fundacao Oswaldo Cruz (FIOCRUZ); Instituto Oswaldo Cruz (IOC)/FIOCRUZ;
   Fundacao de Amparo a Pesquisa do Estado do Rio de Janeiro (FAPERJ)Carlos
   Chagas Filho Foundation for Research Support of the State of Rio de
   Janeiro (FAPERJ); Conselho Nacional de Desenvolvimento Cientifico e
   Tecnologico (CNPq)National Council for Scientific and Technological
   Development (CNPq); CNPq/FAPERJNational Council for Scientific and
   Technological Development (CNPq)Carlos Chagas Filho Foundation for
   Research Support of the State of Rio de Janeiro (FAPERJ)
FX Funding: This work was supported by Programa de Desenvolvimento
   Tecnologico em Insumos para Saude (PDTIS)/Fundacao Oswaldo Cruz
   (FIOCRUZ), Instituto Oswaldo Cruz (IOC)/FIOCRUZ, Fundacao de Amparo a
   Pesquisa do Estado do Rio de Janeiro (FAPERJ), Conselho Nacional de
   Desenvolvimento Cientifico e Tecnologico (CNPq) and Programa de apoio a
   Nucleos de Excelencia (PRONEX)-CNPq/FAPERJ grants. The funders had no
   role in study design, data collection and analysis, decision to publish,
   or preparation of the manuscript.
CR Alves AMB, 1999, BRAZ J MED BIOL RES, V32, P223, DOI 10.1590/S0100-879X1999000200011
   Appanna R, 2007, CLIN VACCINE IMMUNOL, V14, P969, DOI 10.1128/CVI.00069-07
   AZEVEDO AS, 2011, PLOS ONE IN PRESS
   Balsitis SJ, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000790
   Bartelma G, 2002, VIROLOGY, V299, P122, DOI 10.1006/viro.2002.1504
   Beaumier CM, 2008, J INFECT DIS, V197, P608, DOI 10.1086/526790
   Bollati M, 2010, ANTIVIR RES, V87, P125, DOI 10.1016/j.antiviral.2009.11.009
   Brinton MA, 1998, CLIN DIAGN VIROL, V10, P129, DOI 10.1016/S0928-0197(98)00039-7
   CHAMBERS TJ, 1990, ANNU REV MICROBIOL, V44, P649, DOI 10.1146/annurev.mi.44.100190.003245
   Cheng HJ, 2009, MOL IMMUNOL, V47, P398, DOI 10.1016/j.molimm.2009.08.033
   Costa SM, 2007, VIROLOGY, V358, P413, DOI 10.1016/j.virol.2006.08.052
   Costa SM, 2006, VACCINE, V24, P195, DOI 10.1016/j.vaccine.2005.07.059
   Cui TA, 1998, VIROLOGY, V246, P409, DOI 10.1006/viro.1998.9213
   Dmitriev IP, 1996, J BIOTECHNOL, V44, P97, DOI 10.1016/0168-1656(95)00141-7
   Duangchinda T, 2010, P NATL ACAD SCI USA, V107, P16922, DOI 10.1073/pnas.1010867107
   ERHARDT W, 1984, RES EXP MED, V184, P159, DOI 10.1007/BF01852390
   Falconar AKI, 2007, CLIN VACCINE IMMUNOL, V14, P493, DOI 10.1128/CVI.00371-06
   FALGOUT B, 1993, J VIROL, V67, P2034, DOI 10.1128/JVI.67.4.2034-2042.1993
   FALGOUT B, 1991, J VIROL, V65, P2467, DOI 10.1128/JVI.65.5.2467-2475.1991
   FALGOUT B, 1990, J VIROL, V64, P4356, DOI 10.1128/JVI.64.9.4356-4363.1990
   Gubler DJ, 1998, CLIN MICROBIOL REV, V11, P480, DOI 10.1128/CMR.11.3.480
   Guzman MG, 2000, AM J EPIDEMIOL, V152, P793, DOI 10.1093/aje/152.9.793
   GUZMAN MG, 1990, AM J TROP MED HYG, V42, P179, DOI 10.4269/ajtmh.1990.42.179
   HALSTEAD SB, 1970, YALE J BIOL MED, V42, P276
   HALSTEAD SB, 1977, NATURE, V265, P739, DOI 10.1038/265739a0
   Hu DM, 2011, VIROL J, V8, DOI 10.1186/1743-422X-8-47
   IRIE K, 1989, GENE, V75, P197, DOI 10.1016/0378-1119(89)90266-7
   KAUFMAN BM, 1987, AM J TROP MED HYG, V36, P427, DOI 10.4269/ajtmh.1987.36.427
   Konishi E, 2003, VACCINE, V21, P3675, DOI 10.1016/S0264-410X(03)00382-7
   Kurane I, 2007, COMP IMMUNOL MICROB, V30, P329, DOI 10.1016/j.cimid.2007.05.010
   Lazaro-Olan L, 2008, VECTOR-BORNE ZOONOT, V8, P69, DOI 10.1089/vbz.2007.0117
   Li HT, 1999, J VIROL, V73, P3108, DOI 10.1128/JVI.73.4.3108-3116.1999
   Lin CF, 2008, LAB INVEST, V88, P1079, DOI 10.1038/labinvest.2008.70
   Linderbach BD, 2001, FIELDS VIROLOGY, P991
   Luo DH, 2008, EMBO J, V27, P3209, DOI 10.1038/emboj.2008.232
   Luo MC, 2008, J VIROL METHODS, V154, P121, DOI 10.1016/j.jviromet.2008.08.011
   Mackenzie JS, 2004, NAT MED, V10, pS98, DOI 10.1038/nm1144
   Malavige GN, 2004, POSTGRAD MED J, V80, P588, DOI 10.1136/pgmj.2004.019638
   Mangada MM, 2005, J IMMUNOL, V175, P2676, DOI 10.4049/jimmunol.175.4.2676
   Mathew A, 2008, IMMUNOL REV, V225, P300, DOI 10.1111/j.1600-065X.2008.00678.x
   Mongkolsapaya J, 2003, NAT MED, V9, P921, DOI 10.1038/nm887
   Morozova OV, 1999, VIRAL IMMUNOL, V12, P277, DOI 10.1089/vim.1999.12.277
   Murrell S, 2011, BIOTECHNOL ADV, V29, P239, DOI 10.1016/j.biotechadv.2010.11.008
   Niyomrattanakit P, 2004, J VIROL, V78, P13708, DOI 10.1128/JVI.78.24.13708-13716.2004
   Qi RF, 2008, ACTA BIOCH BIOPH SIN, V40, P91, DOI 10.1111/j.1745-7270.2008.00382.x
   Rau H, 2006, VET RES, V37, P155, DOI 10.1051/vetres:2005049
   Rothman AL, 2004, J CLIN INVEST, V113, P946, DOI 10.1172/JCI21512
   Rothman AL, 1996, J VIROL, V70, P6540, DOI 10.1128/JVI.70.10.6540-6546.1996
   Sambrook J, 1989, MOL CLONING LAB MANU
   Sampath A, 2006, J VIROL, V80, P6686, DOI 10.1128/JVI.02215-05
   SCHLESINGER JJ, 1993, VIROLOGY, V192, P132, DOI 10.1006/viro.1993.1015
   SCHLESINGER JJ, 1987, J GEN VIROL, V68, P853, DOI 10.1099/0022-1317-68-3-853
   Shrestha B, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000823
   TAN CHC, 1990, J GEN VIROL, V71, P745, DOI 10.1099/0022-1317-71-3-745
   Valdes K, 2000, CLIN DIAGN LAB IMMUN, V7, P856, DOI 10.1128/CDLI.7.5.856-857.2000
   Valle RPC, 1998, J VIROL, V72, P624, DOI 10.1128/JVI.72.1.624-632.1998
   Weaver SC, 2009, INFECT GENET EVOL, V9, P523, DOI 10.1016/j.meegid.2009.02.003
   Webster DP, 2009, LANCET INFECT DIS, V9, P678, DOI 10.1016/S1473-3099(09)70254-3
   Whitehead SS, 2007, NAT REV MICROBIOL, V5, P518, DOI 10.1038/nrmicro1690
   WHO/TDR, 2009, DENG GUID DIAGN TREA
   Xu T, 2005, J VIROL, V79, P10278, DOI 10.1128/JVI.79.16.10278-10288.2005
   Yauch LE, 2009, J IMMUNOL, V182, P4865, DOI 10.4049/jimmunol.0801974
   Young NJ, 2005, PREV VET MED, V72, P115, DOI 10.1016/j.prevetmed.2005.08.013
   Zivna I, 2002, J IMMUNOL, V168, P5959, DOI 10.4049/jimmunol.168.11.5959
NR 64
TC 29
Z9 29
U1 0
U2 1
PU PUBLIC LIBRARY SCIENCE
PI SAN FRANCISCO
PA 185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA
SN 1932-6203
J9 PLOS ONE
JI PLoS One
PD OCT 21
PY 2011
VL 6
IS 10
AR e25685
DI 10.1371/journal.pone.0025685
PG 10
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA 841LG
UT WOS:000296513200006
PM 22031819
OA DOAJ Gold, Green Published
DA 2020-12-17
ER

PT J
AU Andrade, ID
   Vianez, JL
   Goulart, CL
   Homble, F
   Ruysschaert, JM
   von Kruger, WMA
   Bisch, PM
   de Souza, W
   Mohana-Borges, R
   Motta, MCM
AF Andrade, Iamara da Silva
   Vianez-Junior, Joao Lidio
   Goulart, Carolina Lage
   Homble, Fabrice
   Ruysschaert, Jean-Marie
   von Krueger, Wanda Maria Almeida
   Bisch, Paulo Mascarello
   de Souza, Wanderley
   Mohana-Borges, Ronaldo
   Machado Motta, Maria Cristina
TI Characterization of a porin channel in the endosymbiont of the
   trypanosomatid protozoan Crithidia deanei
SO MICROBIOLOGY-SGM
LA English
DT Article
ID OUTER-MEMBRANE; PROTEIN; MITOCHONDRIAL; EVOLUTION; BACTERIA; VDAC;
   BIOSYNTHESIS; PERMEABILITY; EUKARYOTES; PREDICTION
AB Crithidia deanei is a trypanosomatid protozoan that harbours a symbiotic bacterium. The partners maintain a mutualistic relationship, thus constituting an excellent model for studying metabolic exchanges between the host and the symbiont, the origin of organelles and cellular evolution. According to molecular analysis, symbionts of different trypanosomatid species share high identity and descend from a common ancestor, a beta-proteobacterium of the genus Bordetella. The endosymbiont is surrounded by two membranes, like Gram-negative bacteria, but its envelope presents special features, since phosphatidylcholine is a major membrane component and the peptidoglycan layer is highly reduced, as described in other obligate intracellular bacteria. Like the process that generated mitochondria and plastids, the endosymbiosis in trypanosomatids depends on pathways that facilitate the intensive metabolic exchanges between the bacterium and the host protozoan. A search of the annotated symbiont genome database identified one sequence with identity to porin-encoding genes of the genus Bordetella. Considering that the symbiont outer membrane has a great accessibility to cytoplasm host factors, it was important to characterize this single porin-like protein using biochemical, molecular, computational and ultrastructural approaches. Antiserum against the recombinant porin-like molecule revealed that it is mainly located in the symbiont envelope. Secondary structure analysis and comparative modelling predicted the protein 3D structure as an 18-domain beta-barrel, which is consistent with porin channels. Electrophysiological measurements showed that the porin displays a slight preference for cations over anions. Taken together, the data presented herein suggest that the C. deanei endosymbiont porin is phylogenetically and structurally similar to those described in Gram-negative bacteria, representing a diffusion channel that might contribute to the exchange of nutrients and metabolic precursors between the symbiont and its host cell.
C1 [Andrade, Iamara da Silva; Mohana-Borges, Ronaldo] Univ Fed Rio de Janeiro, Inst Biofis Carlos Chagas Filho, Lab Genom Estrutural, BR-21941590 Rio De Janeiro, Brazil.
   [Andrade, Iamara da Silva; de Souza, Wanderley; Machado Motta, Maria Cristina] Univ Fed Rio de Janeiro, Inst Biofis Carlos Chagas Filho, Lab Ultraestrutura Celular Hertha Meyer, BR-21941590 Rio De Janeiro, Brazil.
   [Andrade, Iamara da Silva; Goulart, Carolina Lage; von Krueger, Wanda Maria Almeida; Bisch, Paulo Mascarello; de Souza, Wanderley; Mohana-Borges, Ronaldo; Machado Motta, Maria Cristina] Univ Fed Rio de Janeiro, Inst Nacl Ciencia & Tecnol Bioimagens & Biol Estr, Ctr Ciencias Saude, BR-21941590 Rio De Janeiro, Brazil.
   [Vianez-Junior, Joao Lidio; Bisch, Paulo Mascarello] Univ Fed Rio de Janeiro, Inst Biofis Carlos Chagas Filho, Lab Fis Biol, BR-21941590 Rio De Janeiro, Brazil.
   [Goulart, Carolina Lage; von Krueger, Wanda Maria Almeida; Bisch, Paulo Mascarello] Univ Fed Rio de Janeiro, Inst Biofis Carlos Chagas Filho, Unidade Multidisciplinar Genom, BR-21941590 Rio De Janeiro, Brazil.
   [Goulart, Carolina Lage; Homble, Fabrice; Ruysschaert, Jean-Marie] Univ Libre Bruxelles, Lab Struct & Fonct Membranes Biol SFMB, B-1050 Brussels, Belgium.
   [de Souza, Wanderley] Inst Nacl Metrol Normalizacao & Qualidade Ind, Rio De Janeiro, Brazil.
RP Mohana-Borges, R (corresponding author), Univ Fed Rio de Janeiro, Inst Biofis Carlos Chagas Filho, Lab Genom Estrutural, BR-21941590 Rio De Janeiro, Brazil.
EM mohana@biof.ufrj.br; motta@biot.ufrj.br
RI VON KRUGER, WANDA M A/G-9612-2014; Borges, Ronaldo S Mohana/C-5575-2013;
   Homble, Fabrice/AAH-3780-2020; Vianez Junior, Joao Lidio/I-9547-2016
OI Homble, Fabrice/0000-0001-6031-136X; Motta, Maria
   Cristina/0000-0002-0947-4830; Vianez Junior, Joao
   Lidio/0000-0001-6226-9441
FU Conselho Nacional de Desenvolvimento Cientifico e Tecnologico
   (CNPq)National Council for Scientific and Technological Development
   (CNPq); Instituto Nacional de Ciencia e Tecnologia em Bioimagens e
   Biologia Estrutural (INCT-BBE); Fundacao Carlos Chagas Filho de Amparo a
   Pesquisa do Estado do Rio de Janeiro (FAPERJ)Carlos Chagas Filho
   Foundation for Research Support of the State of Rio de Janeiro (FAPERJ);
   Fonds de la Recherche Scientifique (FRS-FNRS) (Belgium)Fonds de la
   Recherche Scientifique - FNRS
FX We would like to thank Christian Probst and Marco Aurelio Krieger for
   providing the porin gene sequence. We would also like to thank Francisco
   J. R. Souza and Paulo Roberto Junior for their technical assistance.
   This investigation received financial support from Conselho Nacional de
   Desenvolvimento Cientifico e Tecnologico (CNPq), Instituto Nacional de
   Ciencia e Tecnologia em Bioimagens e Biologia Estrutural (INCT-BBE) and
   Fundacao Carlos Chagas Filho de Amparo a Pesquisa do Estado do Rio de
   Janeiro (FAPERJ). F. H. is a Research Director from the Fonds de la
   Recherche Scientifique (FRS-FNRS) (Belgium).
CR ALFIERI SC, 1982, EXP PARASITOL, V53, P371, DOI 10.1016/0014-4894(82)90080-7
   ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2
   Bendtsen JD, 2004, J MOL BIOL, V340, P783, DOI 10.1016/j.jmb.2004.05.028
   Berman HM, 2000, NUCLEIC ACIDS RES, V28, P235, DOI 10.1093/nar/28.1.235
   Bolter B, 2001, EMBO J, V20, P935, DOI 10.1093/emboj/20.5.935
   Burghardt T, 2007, MOL MICROBIOL, V63, P166, DOI 10.1111/j.1365-2958.2006.05509.x
   CAMARGO EP, 1977, NATURE, V270, P52, DOI 10.1038/270052a0
   Colombini M, 2004, MOL CELL BIOCHEM, V256, P107, DOI 10.1023/B:MCBI.0000009862.17396.8d
   Corsaro D, 1999, CRIT REV MICROBIOL, V25, P39, DOI 10.1080/10408419991299167
   Dolezal P, 2006, SCIENCE, V313, P314, DOI 10.1126/science.1127895
   DU YB, 1994, J BACTERIOL, V176, P3081, DOI 10.1128/JB.176.10.3081-3084.1994
   Duy D, 2007, BIOL CHEM, V388, P879, DOI 10.1515/BC.2007.120
   Efron B, 1996, P NATL ACAD SCI USA, V93, P13429, DOI 10.1073/pnas.93.23.13429
   Webb Benjamin, 2016, Curr Protoc Protein Sci, V86, DOI [10.1002/0471250953.bi0506s15, 10.1002/cpbi.3, 10.1002/0471140864.ps0209s50, 10.1002/cpps.20]
   Fajardo DA, 1998, J BACTERIOL, V180, P4452, DOI 10.1128/JB.180.17.4452-4459.1998
   Ferguson AD, 2002, SCIENCE, V295, P1715, DOI 10.1126/science.1067313
   Finn RD, 2008, NUCLEIC ACIDS RES, V36, pD281, DOI 10.1093/nar/gkm960
   Frossard ML, 2006, BIOCHEM BIOPH RES CO, V343, P443, DOI 10.1016/j.bbrc.2006.02.168
   Goebel W, 2001, TRENDS MICROBIOL, V9, P267, DOI 10.1016/S0966-842X(01)02040-6
   Gross J, 2009, NAT REV GENET, V10, P495, DOI 10.1038/nrg2610
   Guex N, 1997, ELECTROPHORESIS, V18, P2714, DOI 10.1002/elps.1150181505
   Hewitt V, 2011, BBA-BIOMEMBRANES, V1808, P947, DOI 10.1016/j.bbamem.2010.07.019
   Hille B, 1992, IONIC CHANNEL EXCITA
   Homble F., 2010, MEMBRANE ACTIVE PEPT, V9, P281
   Jones DT, 1999, J MOL BIOL, V292, P195, DOI 10.1006/jmbi.1999.3091
   Klebba PE, 1998, CURR OPIN MICROBIOL, V1, P238, DOI 10.1016/S1369-5274(98)80017-9
   Koebnik R, 2000, MOL MICROBIOL, V37, P239, DOI 10.1046/j.1365-2958.2000.01983.x
   Kumar S, 2008, BRIEF BIOINFORM, V9, P299, DOI 10.1093/bib/bbn017
   LASKOWSKI RA, 1993, J APPL CRYSTALLOGR, V26, P283, DOI 10.1107/S0021889892009944
   Lemasters JJ, 2006, BBA-MOL BASIS DIS, V1762, P181, DOI 10.1016/j.bbadis.2005.10.006
   LIU MY, 1992, BIOCHIM BIOPHYS ACTA, V1098, P255, DOI 10.1016/S0005-2728(05)80344-5
   LIU MY, 1991, AM J PHYSIOL, V260, pC371
   Lopez-Lara IM, 2001, J BIOTECHNOL, V91, P211, DOI 10.1016/S0168-1656(01)00331-5
   MANNELLA CA, 1992, TRENDS BIOCHEM SCI, V17, P315, DOI 10.1016/0968-0004(92)90444-E
   Marjanovic Z, 2005, PLANTA, V222, P258, DOI 10.1007/s00425-005-1539-z
   Motta Maria Cristina M., 2010, Open Parasitology Journal, V4, P139
   Motta Maria Cristina Machado, 1991, Microscopia Electronica y Biologia Celular, V15, P131
   Motta MCM, 1997, J EUKARYOT MICROBIOL, V44, P492, DOI 10.1111/j.1550-7408.1997.tb05729.x
   Motta MCM, 1997, EUR J CELL BIOL, V72, P370
   NIKAIDO H, 1981, J GEN PHYSIOL, V77, P121, DOI 10.1085/jgp.77.2.121
   NIKAIDO H, 1992, MOL MICROBIOL, V6, P435, DOI 10.1111/j.1365-2958.1992.tb01487.x
   Nikaido H, 2003, MICROBIOL MOL BIOL R, V67, P593, DOI 10.1128/MMBR.67.4.593-656.2003
   NIKAIDO H, 1993, J BIOENERG BIOMEMBR, V25, P581
   NOVAK E, 1988, J PROTOZOOL, V35, P375, DOI 10.1111/j.1550-7408.1988.tb04110.x
   Palmie-Peixoto IV, 2006, FEMS MICROBIOL LETT, V255, P33, DOI 10.1111/j.1574-6968.2005.00056.x
   Pei JM, 2007, BIOINFORMATICS, V23, P802, DOI 10.1093/bioinformatics/btm017
   Pohorille A, 2005, ASTROBIOLOGY, V5, P1, DOI 10.1089/ast.2005.5.1
   Pruitt KD, 2007, NUCLEIC ACIDS RES, V35, pD61, DOI 10.1093/nar/gkl842
   PUGSLEY AP, 1993, MICROBIOL REV, V57, P50, DOI 10.1128/MMBR.57.1.50-108.1993
   Rachel Reinhard, 2002, Archaea, V1, P9, DOI 10.1155/2002/307480
   Reumann S, 1996, BIOCHEM SOC T, V24, P754, DOI 10.1042/bst0240754
   Ruiz N, 2006, NAT REV MICROBIOL, V4, P57, DOI 10.1038/nrmicro1322
   SAITOU N, 1987, MOL BIOL EVOL, V4, P406, DOI 10.1093/oxfordjournals.molbev.a040454
   SALZMAN TA, 1985, INT J BIOCHEM, V17, P1343, DOI 10.1016/0020-711X(85)90058-8
   SOARES MJ, 1987, J PROTOZOOL, V34, P199, DOI 10.1111/j.1550-7408.1987.tb03160.x
   Tamura K, 2004, P NATL ACAD SCI USA, V101, P11030, DOI 10.1073/pnas.0404206101
   Tatusov RL, 2001, NUCLEIC ACIDS RES, V29, P22, DOI 10.1093/nar/29.1.22
   von Heijne G, 1990, CURR OPIN CELL BIOL, V2, P604, DOI 10.1016/0955-0674(90)90100-S
   WARREN LG, 1960, J PARASITOL, V46, P529, DOI 10.2307/3274932
   Zachariae U, 2006, J BIOL CHEM, V281, P7413, DOI 10.1074/jbc.M510939200
   Zeth K, 2010, BIOCHEM J, V431, P13, DOI 10.1042/BJ20100371
   Zientz E, 2004, MICROBIOL MOL BIOL R, V68, P745, DOI 10.1128/MMBR.68.4.745-770.2004
NR 62
TC 5
Z9 5
U1 0
U2 8
PU MICROBIOLOGY SOC
PI LONDON
PA CHARLES DARWIN HOUSE, 12 ROGER ST, LONDON WC1N 2JU, ERKS, ENGLAND
SN 1350-0872
EI 1465-2080
J9 MICROBIOL-SGM
JI Microbiology-(UK)
PD OCT
PY 2011
VL 157
BP 2818
EP 2830
DI 10.1099/mic.0.049247-0
PN 10
PG 13
WC Microbiology
SC Microbiology
GA 837FU
UT WOS:000296177300008
PM 21757490
OA Bronze
DA 2020-12-17
ER

PT J
AU Allonso, D
   Rosa, MD
   Coelho, DR
   da Costa, SM
   Nogueira, RMR
   Bozza, FA
   Dos Santos, FB
   Alves, AMD
   Mohana-Borges, R
AF Allonso, Diego
   Rosa, Marcela da Silva
   Coelho, Diego Rodrigues
   da Costa, Simone Morais
   Ribeiro Nogueira, Rita Maria
   Bozza, Fernando Augusto
   Dos Santos, Flavia Barreto
   de Barcelos Alves, Ada Maria
   Mohana-Borges, Ronaldo
TI Polyclonal antibodies against properly folded Dengue virus NS1 protein
   expressed in E-coli enable sensitive and early dengue diagnosis
SO JOURNAL OF VIROLOGICAL METHODS
LA English
DT Article
DE Dengue virus; NS1 protein; Dengue diagnosis; E. coli
ID NONSTRUCTURAL GLYCOPROTEIN NS1; SECONDARY STRUCTURE ANALYSES; ANTIGEN
   CAPTURE IMMUNOASSAY; LINKED-IMMUNOSORBENT-ASSAY; MONOCLONAL-ANTIBODIES;
   SIGNAL SEQUENCE; DNA VACCINE; TYPE-1; INFECTIONS; CELLS
AB The non-structural 1 (NS1) protein plays an important role in dengue diagnosis because it has been detected as a soluble serum antigen in both primary and secondary infections. The NS1 protein was expressed in Escherichia coli cells, and the efficiency of four different refolding protocols was tested. All of the protocols generated dimeric NS1 in a conformation similar to that of the protein expressed by eukaryotic cells. A polyclonal antibody produced from the properly folded E. coli recombinant NS1 (rNS1) protein proved to be a useful tool for the diagnosis of Dengue virus because it detected 100% of the Dengue virus 2 (DENV2) in infected patients' sera and 60% of the DENV IgM-positive sera not detected by commercial NS1-based diagnostic kits. These data suggest a high-efficiency method for correctly folding rNS1 that maintains its structural and immunogenic properties. In addition, a detection method using the polyclonal antibody against correctly folded rNS1 seemed to be more sensitive and efficient for NS1 detection in serum, highlighting its usefulness for developing a high-sensitivity diagnostic kit. (C) 2011 Elsevier B.V. All rights reserved.
C1 [Allonso, Diego; Rosa, Marcela da Silva; Coelho, Diego Rodrigues; Mohana-Borges, Ronaldo] Univ Fed Rio de Janeiro, Inst Biofis Carlos Chagas Filho, Lab Genom Estruct, BR-21941590 Rio De Janeiro, Brazil.
   [da Costa, Simone Morais; de Barcelos Alves, Ada Maria] Fundacao Oswaldo Cruz, Inst Oswaldo Cruz, Lab Biotecnol & Fisiol Infeccoes Virais, Rio De Janeiro, Brazil.
   [Ribeiro Nogueira, Rita Maria; Dos Santos, Flavia Barreto] Fundacao Oswaldo Cruz, Inst Oswaldo Cruz, Lab Flavivirus, Rio De Janeiro, Brazil.
   [Bozza, Fernando Augusto] Fundacao Oswaldo Cruz, Inst Pesquisas Clin Evandro Chagas, Unidade Terapia Intens, Rio De Janeiro, Brazil.
RP Mohana-Borges, R (corresponding author), Univ Fed Rio de Janeiro, Inst Biofis Carlos Chagas Filho, Lab Genom Estruct, Edificio Ctr Ciencias Saude,Bloco C,Sala 36 Sub S, BR-21941902 Rio de Janeiro, Brazil.
EM mohana@biof.ufrj.br
RI Bozza, Fernando A/A-2618-2013; Borges, Ronaldo S Mohana/C-5575-2013;
   Allonso, Diego/Y-3446-2018
OI Bozza, Fernando A/0000-0003-4878-0256; Allonso,
   Diego/0000-0002-1410-480X; Mohana Borges, Ronaldo/0000-0002-1796-475X
FU CNPqNational Council for Scientific and Technological Development
   (CNPq); FAPERJCarlos Chagas Filho Foundation for Research Support of the
   State of Rio de Janeiro (FAPERJ); IMBEBB; FINEP (GENOPROT Dengue)Ciencia
   Tecnologia e Inovacao (FINEP); National Institutes of Science and
   Technology in Structural Biology and Bioimaging (INCT-INBEB);
   Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)CAPES
FX This work was supported by the following funding agencies: CNPq, FAPERJ,
   IMBEBB, and FINEP (GENOPROT Dengue), the National Institutes of Science
   and Technology in Structural Biology and Bioimaging (INCT-INBEB). The
   funders had no role in study design, data collection and analysis,
   decision to publish, or preparation of the manuscript. We thank M.Sc.
   Iamara Andrade for her help with fluorescence microscopy and Ana
   Carolina Fonseca-Guimaraes for her technical assistance. Diego Allonso
   holds a Ph.D. fellowship from Coordenacao de Aperfeicoamento de Pessoal
   de Nivel Superior (CAPES). We would also like to thank the Genomic
   Platform for DNA sequencing of PDTIS/FIOCRUZ.
CR Alcon S, 2002, J CLIN MICROBIOL, V40, P376, DOI 10.1128/JCM.40.02.376-381.2002
   Amorim JH, 2010, J VIROL METHODS, V167, P186, DOI 10.1016/j.jviromet.2010.04.003
   Costa SM, 2006, VACCINE, V24, P4562, DOI 10.1016/j.vaccine.2005.08.022
   Costa SM, 2006, VACCINE, V24, P195, DOI 10.1016/j.vaccine.2005.07.059
   Das D, 2009, PROTEIN EXPRES PURIF, V66, P66, DOI 10.1016/j.pep.2009.02.003
   Dos Santos FB, 2004, AM J TROP MED HYG, V71, P144, DOI 10.4269/ajtmh.2004.71.144
   Dos Santos FB, 2007, CLIN VACCINE IMMUNOL, V14, P641, DOI 10.1128/CVI.00474-06
   Falconar AKI, 1997, ARCH VIROL, V142, P897, DOI 10.1007/s007050050127
   FALCONAR AKI, 1991, J GEN VIROL, V72, P961, DOI 10.1099/0022-1317-72-4-961
   FALGOUT B, 1989, J VIROL, V63, P1852, DOI 10.1128/JVI.63.5.1852-1860.1989
   FALGOUT B, 1995, J VIROL, V69, P7232, DOI 10.1128/JVI.69.11.7232-7243.1995
   Flamand M, 1999, J VIROL, V73, P6104, DOI 10.1128/JVI.73.7.6104-6110.1999
   Kao CL, 2001, J CLIN MICROBIOL, V39, P3672, DOI 10.1128/JCM.39.10.3672-3677.2001
   Lemes EMB, 2005, J CLIN VIROL, V32, P305, DOI 10.1016/j.jcv.2004.08.015
   Mackenzie JM, 1996, VIROLOGY, V220, P232, DOI 10.1006/viro.1996.0307
   MASON PW, 1990, J GEN VIROL, V71, P2107, DOI 10.1099/0022-1317-71-9-2107
   Melo MN, 2009, J MOL BIOL, V392, P736, DOI 10.1016/j.jmb.2009.07.035
   PRYOR MJ, 1994, J GEN VIROL, V75, P1183, DOI 10.1099/0022-1317-75-5-1183
   PRYOR MJ, 1993, VIROLOGY, V194, P769, DOI 10.1006/viro.1993.1318
   Qiu LW, 2009, CLIN VACCINE IMMUNOL, V16, P88, DOI 10.1128/CVI.00212-08
   Lima MDQ, 2010, PLOS NEGLECT TROP D, V4, DOI 10.1371/journal.pntd.0000738
   Ramirez AH, 2009, DIAGN MICR INFEC DIS, V65, P247, DOI 10.1016/j.diagmicrobio.2009.07.022
   RICE CM, 1985, SCIENCE, V229, P726, DOI 10.1126/science.4023707
   SCHLESINGER JJ, 1987, J GEN VIROL, V68, P853, DOI 10.1099/0022-1317-68-3-853
   SMITH GW, 1985, J GEN VIROL, V66, P559, DOI 10.1099/0022-1317-66-3-559
   Wallis TP, 2004, J BIOL CHEM, V279, P20729, DOI 10.1074/jbc.M312907200
   Whitmore L, 2004, NUCLEIC ACIDS RES, V32, pW668, DOI 10.1093/nar/gkh371
   Whitmore L, 2008, BIOPOLYMERS, V89, P392, DOI 10.1002/bip.20853
   WINKLER G, 1988, VIROLOGY, V162, P187, DOI 10.1016/0042-6822(88)90408-4
   WINKLER G, 1989, VIROLOGY, V171, P302, DOI 10.1016/0042-6822(89)90544-8
   Wu SF, 2003, VACCINE, V21, P3919, DOI 10.1016/S0264-410X(03)00310-4
   Xu H, 2006, J CLIN MICROBIOL, V44, P2872, DOI 10.1128/JCM.00777-06
   ZHAO B, 1987, J VIROL, V61, P4019, DOI 10.1128/JVI.61.12.4019-4022.1987
   Zhou JM, 2006, VIRUS GENES, V33, P27, DOI 10.1007/s11262-005-0036-6
NR 34
TC 16
Z9 17
U1 0
U2 7
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 0166-0934
EI 1879-0984
J9 J VIROL METHODS
JI J. Virol. Methods
PD JUL
PY 2011
VL 175
IS 1
BP 109
EP 116
DI 10.1016/j.jviromet.2011.04.029
PG 8
WC Biochemical Research Methods; Biotechnology & Applied Microbiology;
   Virology
SC Biochemistry & Molecular Biology; Biotechnology & Applied Microbiology;
   Virology
GA 791LG
UT WOS:000292666100016
PM 21569796
OA Green Published
DA 2020-12-17
ER

PT J
AU Martins, IC
   Carneiro, FA
   Mohana-Borges, R
   Faustino, A
   Pereira, RM
   Carvalho, FA
   Castanho, MA
   Almeida, F
   Santos, NC
   DaPoian, AT
AF Martins, Ivo C.
   Carneiro, Fabiana A.
   Mohana-Borges, Ronaldo
   Faustino, Andre
   Pereira, Renata M.
   Carvalho, Filomena A.
   Castanho, Miguel A.
   Almeida, Fabio
   Santos, Nuno C.
   DaPoian, Andrea T.
TI Characterization of the Interaction of the Dengue Virus Capsid Protein
   with Lipid Droplets
SO BIOPHYSICAL JOURNAL
LA English
DT Meeting Abstract
CT 55th Annual Meeting of the Biophysical-Society
CY MAR 05-09, 2011
CL Baltimore, MD
SP Biophys Soc
RI Santos, Nuno/N-7248-2013; Borges, Ronaldo S Mohana/C-5575-2013; Martins,
   Ivo C/G-2534-2013; CARNEIRO, FABIANA A/S-4525-2018
OI Santos, Nuno/0000-0002-0580-0475; Martins, Ivo C/0000-0002-9284-8599; 
NR 0
TC 1
Z9 1
U1 0
U2 5
PU CELL PRESS
PI CAMBRIDGE
PA 600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA
SN 0006-3495
J9 BIOPHYS J
JI Biophys. J.
PD FEB 2
PY 2011
VL 100
IS 3
SU 1
BP 403
EP 404
PG 2
WC Biophysics
SC Biophysics
GA 972PF
UT WOS:000306288603324
DA 2020-12-17
ER

PT J
AU Diaz, A
   Fontana, EC
   Todeschini, AR
   Soule, S
   Gonzalez, H
   Casaravilla, C
   Portela, M
   Mohana-Borges, R
   Mendonca-Previato, L
   Previato, JO
   Ferreira, F
AF Diaz, Alvaro
   Carolina Fontana, E.
   Todeschini, Adriane R.
   Soule, Silvia
   Gonzalez, Humberto
   Casaravilla, Cecilia
   Portela, Magdalena
   Mohana-Borges, Ronaldo
   Mendonca-Previato, Lucia
   Previato, Jose O.
   Ferreira, Fernando
TI The Major Surface Carbohydrates of the Echinococcus granulosus Cyst:
   Mucin-Type O-Glycans Decorated by Novel Galactose-Based Structures
SO BIOCHEMISTRY
LA English
DT Article
ID LAMINATED-LAYER; MYOINOSITOL HEXAKISPHOSPHATE; LIQUID-CHROMATOGRAPHY;
   MULTILOCULARIS; ANTIGEN; MEMBRANE; METACESTODES; EXPRESSION; INFECTION;
   COMPONENT
AB The cestodes constitute important but understudied human and veterinary parasites. Their surfaces are rich in carbohydrates, on which very little structural information is available. The tissue-dwelling larva (hydatid cyst) of the cestode Echinococcus granulosus is outwardly protected by a massive layer of carbohydrate-rich extracellular matrix, termed the laminated layer. The monosaccharide composition of this layer suggests that its major carbohydrate components are exclusively mucin-type O-glycans. We have purified these glycans after their release from the crude laminated layer and obtained by MS and NMR the complete structure of 10 of the most abundant components. The structures, between two and six residues in length, encompass a limited number of biosynthetic motifs. The mucin cores I and 2 are either nondecorated or elongated by a chain of Galp beta 1-3 residues. This chain can be capped by a single Galp alpha 1-4 residue, such capping becoming more dominant with increasing chain size. In addition, the core 2 N-acetylglucosamine residue is in cases substituted with the disaccharide Galp alpha 1-4Galp beta 1-4, giving rise to the blood P-1-antigen motif. Larger, also related, glycans exist, reaching at least 18 residues in size. The glycans described are related but larger than those previously described from an Echinococcus multilocularis mucin [Hulsmeier, A. J., et al. (2002) J. Biol. Chem. 277, 5742-5748]. Our results reveal that the E. granulosus cyst exposes to the host only a few different major carbohydrate motifs. These motifs are composed essentially of galactose units and include the elongation by (Galp beta 1-3)(n) and the capping by Galp alpha 1-4, novel in animal mucin-type O-glycans.
C1 [Diaz, Alvaro; Casaravilla, Cecilia] UdelaR, Catedra Inmunol, Dept Biociencias, Fac Quim, Montevideo, Uruguay.
   [Diaz, Alvaro; Casaravilla, Cecilia] UdelaR, Inst Quim Biol, Fac Ciencias, Montevideo, Uruguay.
   [Carolina Fontana, E.; Soule, Silvia; Gonzalez, Humberto; Ferreira, Fernando] UdelaR, Lab Carbohidratos & Glicoconjugados, Dept Quim Organ, Fac Quim,Fac Ciencias,Fac Med, Montevideo, Uruguay.
   [Portela, Magdalena] UdelaR, Unidad Prote & Bioquim Analit, Inst Pasteur, Montevideo, Uruguay.
   [Todeschini, Adriane R.; Mohana-Borges, Ronaldo; Mendonca-Previato, Lucia; Previato, Jose O.] Univ Fed Rio de Janeiro, Inst Biofis Carlos Chagas Filho, BR-21949900 Rio De Janeiro, Brazil.
RP Diaz, A (corresponding author), UdelaR, Catedra Inmunol, Dept Biociencias, Fac Quim, Montevideo, Uruguay.
EM adiaz@fq.edu.uy
RI Todeschini, Adriane Regina/ABC-9165-2020; Diaz, Alvaro/C-2805-2009;
   Borges, Ronaldo S Mohana/C-5575-2013; Todeschini, Adriane/AAG-8128-2020
OI Todeschini, Adriane Regina/0000-0002-6049-2751; Diaz,
   Alvaro/0000-0001-5375-6766; Fontana, Carolina/0000-0002-7362-2180;
   Previato, Jose Osvaldo/0000-0002-9233-9954; Mohana Borges,
   Ronaldo/0000-0002-1796-475X; Mendonca Previato,
   Lucia/0000-0003-3927-3244
FU Universidad de la Republica [250/2002, 404/2009]; Ministry of Education
   of Uruguay [PDT 54/078]; AMSUD-Pasteur travel grant
FX This work was supported by grants from the Universidad de la Republica
   (CSIC I + D no. 250/2002 and 404/2009) and from the Ministry of
   Education of Uruguay (PDT 54/078) and by an AMSUD-Pasteur travel grant
   to A.D.
CR Andrade MA, 2004, NITRIC OXIDE-BIOL CH, V10, P150, DOI 10.1016/j.niox.2004.03.002
   Baz A, 1999, PARASITE IMMUNOL, V21, P141, DOI 10.1046/j.1365-3024.1999.00212.x
   CAMERON GL, 1957, NATURE, V179, P147, DOI 10.1038/179147a0
   Casaravilla C, 2006, FEBS J, V273, P3192, DOI 10.1111/j.1742-4658.2006.05328.x
   Dai WJ, 2001, INFECT IMMUN, V69, P6074, DOI 10.1128/IAI.69.10.6074-6083.2001
   DAVIES M, 1992, J CHROMATOGR, V609, P125, DOI 10.1016/0021-9673(92)80155-N
   DENNIS RD, 1993, PARASITE IMMUNOL, V15, P669, DOI 10.1111/j.1365-3024.1993.tb00582.x
   DEPLAZES P, 1991, PARASITOLOGY, V103, P41, DOI 10.1017/S0031182000059278
   Diaz A, 1997, J IMMUNOL, V158, P3779
   Diaz A, 2000, MOL MED, V6, P648, DOI 10.1007/BF03402045
   Diaz A, 2007, EUR J IMMUNOL, V37, P3319, DOI 10.1002/eji.200737765
   DOMON B, 1988, GLYCOCONJUGATE J, V5, P397, DOI 10.1007/BF01049915
   Errico DA, 2001, EXP PARASITOL, V98, P100, DOI 10.1006/exper.2001.4620
   Ferreira AM, 2000, PARASITOL TODAY, V16, P168, DOI 10.1016/S0169-4758(99)01625-7
   Freire T, 2004, BIOCHEM J, V382, P501, DOI 10.1042/BJ20031877
   Gottstein B, 2008, EXP PARASITOL, V119, P447, DOI 10.1016/j.exppara.2008.03.002
   Gutierrez ALS, 2007, GLYCOBIOLOGY, V17, p1C, DOI 10.1093/glycob/cwm030
   Hokke CH, 2007, EXP PARASITOL, V117, P275, DOI 10.1016/j.exppara.2007.06.003
   Hulsmeier AJ, 2002, J BIOL CHEM, V277, P5742, DOI 10.1074/jbc.M107161200
   Ingold K, 2001, J PARASITOL, V87, P55, DOI 10.1645/0022-3395(2001)087[0055:COTLLO]2.0.CO;2
   Ingold K, 2000, INT J PARASITOL, V30, P207, DOI 10.1016/S0020-7519(99)00177-0
   Irigoin F, 2008, PARASITE IMMUNOL, V30, P354, DOI 10.1111/j.1365-3024.2008.01034.x
   Irigoin F, 2004, J CELL BIOCHEM, V93, P1272, DOI 10.1002/jcb.20262
   Irigoin F, 2002, BIOCHEM J, V362, P297, DOI 10.1042/0264-6021:3620297
   Jansson P.E., 1976, CHEM COMMUN U STOCKH, V8, P1
   Jones C, 2004, BIOCHEMISTRY-US, V43, P11889, DOI 10.1021/bi048942u
   Khoo KH, 1997, MOL BIOCHEM PARASIT, V86, P237, DOI 10.1016/S0166-6851(97)00036-4
   KILEJIAN A, 1962, EXP PARASITOL, V12, P377, DOI 10.1016/0014-4894(62)90049-8
   KILEJIAN A, 1971, COMP BIOCHEM PHYSIOL, V40, P25, DOI 10.1016/0305-0491(71)90058-7
   KING MJ, 1994, BBA-REV BIOMEMBRANES, V1197, P15, DOI 10.1016/0304-4157(94)90017-5
   KORC I, 1967, EXP PARASITOL, V20, P219, DOI 10.1016/0014-4894(67)90041-0
   MAKNI S, 1992, ANN TROP MED PARASIT, V86, P87, DOI 10.1080/00034983.1992.11812635
   Morelle W, 2007, NAT PROTOC, V2, P1585, DOI 10.1038/nprot.2007.227
   PERSAT F, 1992, J BIOL CHEM, V267, P8764
   RICHARDS KS, 1983, PARASITOLOGY, V86, P399, DOI 10.1017/S0031182000050599
   RUSSI S, 1974, J IMMUNOL, V112, P1061
   Steers NJR, 2001, PARASITE IMMUNOL, V23, P411, DOI 10.1046/j.1365-3024.2001.00385.x
   Sterla S, 1999, PARASITE IMMUNOL, V21, P27, DOI 10.1046/j.1365-3024.1999.00197.x
   SWEELEY CC, 1963, J AM CHEM SOC, V85, P2497, DOI 10.1021/ja00899a032
   Terrazas LI, 2008, CURR TOP MED CHEM, V8, P383, DOI 10.2174/156802608783790848
   Thompson Robin, 1995, V1, P1
   Thornalley PJ, 1999, BIOCHEM J, V344, P109, DOI 10.1042/0264-6021:3440109
   Van de Vijver KK, 2006, GLYCOBIOLOGY, V16, P237, DOI 10.1093/glycob/cwj058
   VARCLADIAZ VM, 1973, J PARASITOL, V59, P484
   Walker M, 2004, INFECT IMMUN, V72, P527, DOI 10.1128/IAI.72.1.527-536.2004
   WIERUSZESKI JM, 1987, J BIOL CHEM, V262, P6650
   WUHRER M, 2006, GLYCOCONJUGATE STRUC, P408
   Yu LG, 2007, GLYCOCONJUGATE J, V24, P411, DOI 10.1007/s10719-007-9034-3
   Zaccone P, 2006, PARASITE IMMUNOL, V28, P515, DOI 10.1111/j.1365-3024.2006.00879.x
NR 49
TC 23
Z9 23
U1 0
U2 3
PU AMER CHEMICAL SOC
PI WASHINGTON
PA 1155 16TH ST, NW, WASHINGTON, DC 20036 USA
SN 0006-2960
J9 BIOCHEMISTRY-US
JI Biochemistry
PD DEC 15
PY 2009
VL 48
IS 49
BP 11678
EP 11691
DI 10.1021/bi901112q
PG 14
WC Biochemistry & Molecular Biology
SC Biochemistry & Molecular Biology
GA 527UT
UT WOS:000272394000010
PM 19877716
DA 2020-12-17
ER

PT J
AU Melo, MN
   Sousa, FJR
   Carneiro, FA
   Castanho, MARB
   Valente, AP
   Almeida, FCL
   Da Poian, AT
   Mohana-Borges, R
AF Melo, Manuel Nuno
   Sousa, Francisco J. R.
   Carneiro, Fabiana A.
   Castanho, Miguel A. R. B.
   Valente, Ana Paula
   Almeida, Fabio C. L.
   Da Poian, Andrea T.
   Mohana-Borges, Ronaldo
TI Interaction of the Dengue Virus Fusion Peptide with Membranes Assessed
   by NMR: The Essential Role of the Envelope Protein Trp101 for Membrane
   Fusion
SO JOURNAL OF MOLECULAR BIOLOGY
LA English
DT Article
DE dengue virus; fusion peptide; membrane fusion; NMR; transfer NOE
ID IMMUNODEFICIENCY-VIRUS; RICH REGION; WEST-NILE; GLYCOPROTEIN;
   TRYPTOPHAN; BINDING; ENTRY; IMMUNOPATHOGENESIS; FLAVIVIRUSES;
   ENCEPHALITIS
AB Dengue virus (DV) infection depends on a step of membrane fusion, which occurs in the acidic environment of the endosome. This process is mediated by virus surface envelope glycoprotein, in which the loop between residues D98-G112 is considered to be crucial, acting as a fusion peptide. Here, we have characterized functionally and structurally the interaction between the DV fusion peptide and different model membranes by fluorescence and NMR. Its interaction was strongest in dodecylphosphocholine (DPC) micelles. and anionic phosphatidylcholine/phosphatidylglycerol vesicles, the only vesicle that was fused by DV fusion peptide. The three-dimensional structure of DV fusion peptide bound to DPC micelles was solved by solution homonuclear NMR with an r.m.s.d. of 0.98 angstrom. The most striking result obtained from the solution structure was the hydrophobic triad formed by residues W101, L107, and F108, pointing toward the same direction, keeping the segment between G102 and G106 in a loop conformation. The interaction of DV fusion peptide with phosphatidylcholine/phosphatidylglycerol vesicles was also mapped by transfer-nuclear Overhauser enhancement (NOE) experiments, in which the majority of the NOE cross-peaks were from the hydrophobic triad, corroborating the DPC-bound structure. Substitution of the residue W101 by an alanine residue completely abolished membrane binding and, thus, fusion by the peptide and its NOE cross-peaks. In conclusion, the 15-residue DV fusion peptide has intrinsic ability to promote membrane fusion, most likely due to the hydrophobic interaction among the residues W101, L107, and F108, which maintains its loop in the correct spatial conformation. (C) 2009 Elsevier Ltd. All rights reserved.
C1 [Melo, Manuel Nuno; Sousa, Francisco J. R.; Mohana-Borges, Ronaldo] Univ Fed Rio de Janeiro, Lab Genom Estrut, Inst Biofis Carlos Chagas Filho, BR-21941590 Rio De Janeiro, Brazil.
   [Melo, Manuel Nuno; Carneiro, Fabiana A.; Valente, Ana Paula; Almeida, Fabio C. L.; Da Poian, Andrea T.] Univ Fed Rio de Janeiro, Inst Bioquim Med, BR-21941590 Rio De Janeiro, Brazil.
   [Melo, Manuel Nuno; Castanho, Miguel A. R. B.] Univ Lisbon, Inst Mol Med, Fac Med, P-1649028 Lisbon, Portugal.
   [Valente, Ana Paula; Almeida, Fabio C. L.; Mohana-Borges, Ronaldo] Ctr Nacl Ressonancia Magnet Nucl Macromol, BR-21941590 Rio De Janeiro, Brazil.
RP Mohana-Borges, R (corresponding author), Univ Fed Rio de Janeiro, Lab Genom Estrut, Inst Biofis Carlos Chagas Filho, Edificio Ctr Ciencias Saude,Bloco C Sala 36 Sub S, BR-21941902 Rio De Janeiro, Brazil.
EM mohana@biof.ufrj.br
RI CARNEIRO, FABIANA A/S-4525-2018; Valente, Ana Paula/J-3010-2017; Da
   Poian, Andrea T./V-1699-2019; Almeida, Fabio/O-4989-2018; Borges,
   Ronaldo S Mohana/C-5575-2013
OI Valente, Ana Paula/0000-0001-7219-1123; Almeida,
   Fabio/0000-0001-6046-7006; Da Poian, Andrea/0000-0002-3969-704X;
   Carneiro, Fabiana/0000-0002-6584-4875; Mohana Borges,
   Ronaldo/0000-0002-1796-475X; FCCN, Bogus/0000-0003-1034-3552; FCCN,
   Bogus/0000-0001-6282-8004; Melo, Manuel Nuno/0000-0001-6567-0513;
   Castanho, Miguel/0000-0001-7891-7562
FU WHO/TDRWorld Health Organization; CNPqNational Council for Scientific
   and Technological Development (CNPq); FAPERJCarlos Chagas Filho
   Foundation for Research Support of the State of Rio de Janeiro (FAPERJ);
   TWASTurkiye Bilimsel ve Teknolojik Arastirma Kurumu (TUBITAK); IMBEBB;
   PRONEX-FAPERJCarlos Chagas Filho Foundation for Research Support of the
   State of Rio de Janeiro (FAPERJ); FINEP (GENOPROT Dengue)Ciencia
   Tecnologia e Inovacao (FINEP); National Institutes of Science and
   Technology in Dengue (INCTD-engue) and in Structural Biology and
   Bioimaging (INCT-INBEB); FCT (Portugal)Portuguese Foundation for Science
   and Technology; CAPES/GRICES (Brazil, Portugal)CAPES; FCTPortuguese
   Foundation for Science and Technology [PTDC/QUI/69937/2006]; CNPq
   (Brazil)National Council for Scientific and Technological Development
   (CNPq)
FX We thank Drs. Ana Carolina Zeri and Mauricio Sfor a of the National
   Laboratory of Synchrotron Light (LNLS) for help with the acquisitions on
   the Varian spectrometer. We also thank Dr. Jerson Lima Silva of the
   Medical Biochemistry Institute (Universidade Federal do Rio de Janeiro)
   and Dr. Roberto De Guzman of the University of Kansas for helpful
   insights in this project, and Dr. Martha Sorenson (Medical Biochemistry
   Institute, Universidade Federal do Rio de Janeiro) for proofreading the
   manuscript. This work was supported by the following funding agencies:
   WHO/TDR, CNPq, FAPERJ, TWAS, IMBEBB, PRONEX-FAPERJ, and FINEP (GENOPROT
   Dengue), the National Institutes of Science and Technology in Dengue
   (INCTD-engue) and in Structural Biology and Bioimaging (INCT-INBEB). The
   authors acknowledge a grant from FCT (Portugal) to M.N.M. and funding
   from CAPES/GRICES (Brazil, Portugal) and FCT project
   PTDC/QUI/69937/2006. F.J.R.S. holds a Ph.D. fellowship from CNPq
   (Brazil).
CR Allison SL, 2001, J VIROL, V75, P4268, DOI 10.1128/JVI.75.9.4268-4275.2001
   BAX A, 1985, J MAGN RESON, V65, P355, DOI 10.1016/0022-2364(85)90018-6
   Bressanelli S, 2004, EMBO J, V23, P728, DOI 10.1038/sj.emboj.7600064
   Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254
   Chan DC, 1998, CELL, V93, P681, DOI 10.1016/S0092-8674(00)81430-0
   Cruzeiro-Silva C, 2007, BBA-BIOMEMBRANES, V1768, P3182, DOI 10.1016/j.bbamem.2007.08.022
   DAPOIAN AT, 2009, STRUCTURE FUNCTION M, pCH19
   de Planque MRR, 2003, BIOCHEMISTRY-US, V42, P5341, DOI 10.1021/bi027000r
   DELAGLIO F, 1995, J BIOMOL NMR, V6, P277, DOI 10.1007/BF00197809
   Giannecchini S, 2004, VIROLOGY, V320, P156, DOI 10.1016/j.virol.2003.12.001
   Guillen J, 2008, BIOCHEMISTRY-US, V47, P8214, DOI 10.1021/bi800814q
   Han X, 2001, NAT STRUCT BIOL, V8, P715, DOI 10.1038/90434
   Johnson Bruce A, 2004, Methods Mol Biol, V278, P313
   Kanai R, 2006, J VIROL, V80, P11000, DOI 10.1128/JVI.01735-06
   Kilby JM, 1998, NAT MED, V4, P1302, DOI 10.1038/3293
   Killian JA, 2000, TRENDS BIOCHEM SCI, V25, P429, DOI 10.1016/S0968-0004(00)01626-1
   Koradi R, 1996, J MOL GRAPHICS, V14, P51, DOI 10.1016/0263-7855(96)00009-4
   Lakowicz J.R., 1999, PRINCIPLES FLUORESCE
   Laskowski RA, 1996, J BIOMOL NMR, V8, P477, DOI 10.1007/BF00228148
   Lei HY, 2001, J BIOMED SCI, V8, P377, DOI 10.1007/BF02255946
   Li L, 2008, SCIENCE, V319, P1830, DOI 10.1126/science.1153263
   Li YL, 2007, BIOPHYS J, V93, P876, DOI 10.1529/biophysj.106.102335
   Li Z, 2008, J MED CHEM, V51, P4660, DOI 10.1021/jm800412d
   Lindenbach BD, 2007, FIELDS VIROLOGY, P1101
   Liu W, 2006, BIOCHEMISTRY-US, V45, P11713, DOI 10.1021/bi0608414
   Lu YN, 2008, BIOCHEM BIOPH RES CO, V371, P356, DOI 10.1016/j.bbrc.2008.04.044
   Mackenzie JS, 2004, NAT MED, V10, pS98, DOI 10.1038/nm1144
   MAYER LD, 1986, BIOCHIM BIOPHYS ACTA, V858, P161, DOI 10.1016/0005-2736(86)90302-0
   Michael NL, 1999, NAT MED, V5, P740, DOI 10.1038/10462
   Modis Y, 2003, P NATL ACAD SCI USA, V100, P6986, DOI 10.1073/pnas.0832193100
   Modis Y, 2004, NATURE, V427, P313, DOI 10.1038/nature02165
   Nemec KN, 2006, BIOCHEMISTRY-US, V45, P12448, DOI 10.1021/bi061440r
   Pang T, 2007, IMMUNOL CELL BIOL, V85, P43, DOI 10.1038/sj.icb.7100008
   Perera R, 2008, ANTIVIR RES, V80, P11, DOI 10.1016/j.antiviral.2008.05.004
   PIOTTO M, 1992, J BIOMOL NMR, V2, P661, DOI 10.1007/BF02192855
   Post CB, 2003, CURR OPIN STRUC BIOL, V13, P581, DOI 10.1016/j.sbi.2003.09.012
   REY FA, 1995, NATURE, V375, P291, DOI 10.1038/375291a0
   Santos NC, 2003, BBA-BIOMEMBRANES, V1612, P123, DOI 10.1016/S0005-2736(03)00112-3
   SKLENAR V, 1993, J MAGN RESON SER A, V102, P241, DOI 10.1006/jmra.1993.1098
   Stauffer F, 2008, MOL MEMBR BIOL, V25, P128, DOI 10.1080/09687680701633091
   STRUCK DK, 1981, BIOCHEMISTRY-US, V20, P4093, DOI 10.1021/bi00517a023
   Thomas Stephen J, 2003, Adv Virus Res, V61, P235, DOI 10.1016/S0065-3527(03)61006-7
   Valente AP, 2006, CURR MED CHEM, V13, P3697, DOI 10.2174/092986706779026147
   Vaynberg J, 2006, TRENDS BIOTECHNOL, V24, P22, DOI 10.1016/j.tibtech.2005.09.006
   Wimley WC, 1996, NAT STRUCT BIOL, V3, P842, DOI 10.1038/nsb1096-842
NR 45
TC 34
Z9 34
U1 0
U2 21
PU ACADEMIC PRESS LTD- ELSEVIER SCIENCE LTD
PI LONDON
PA 24-28 OVAL RD, LONDON NW1 7DX, ENGLAND
SN 0022-2836
EI 1089-8638
J9 J MOL BIOL
JI J. Mol. Biol.
PD SEP 25
PY 2009
VL 392
IS 3
BP 736
EP 746
DI 10.1016/j.jmb.2009.07.035
PG 11
WC Biochemistry & Molecular Biology
SC Biochemistry & Molecular Biology
GA 500QE
UT WOS:000270317700015
PM 19619560
OA Green Published
DA 2020-12-17
ER

PT J
AU Portugal, MI
   Todeschini, AR
   de Lima, CS
   Silva, CAM
   Mohana-Borges, R
   Ottenhoff, THM
   Mendonca-Previato, L
   Previato, JO
   Pessolani, MCV
AF Portugal, Michelle I.
   Todeschini, Adriane R.
   de Lima, Cristiana S.
   Silva, Carlos A. M.
   Mohana-Borges, Ronaldo
   Ottenhoff, Tom H. M.
   Mendonca-Previato, Lucia
   Previato, Jose O.
   Pessolani, Maria C. V.
TI Characterization of two heparan sulphate-binding sites in the
   mycobacterial adhesin Hlp
SO BMC MICROBIOLOGY
LA English
DT Article
ID PROTEIN INTERACTIONS; LAMININ-BINDING; HEMAGGLUTININ; LEPRAE;
   IDENTIFICATION; TUBERCULOSIS; BACTERIAL; RESIDUES; LEPROSY; NMR
AB Background: The histone-like Hlp protein is emerging as a key component in mycobacterial pathogenesis, being involved in the initial events of host colonization by interacting with laminin and glycosaminoglycans (GAGs). In the present study, nuclear magnetic resonance (NMR) was used to map the binding site(s) of Hlp to heparan sulfate and identify the nature of the amino acid residues directly involved in this interaction.
   Results: The capacity of a panel of 30 mer synthetic peptides covering the full length of Hlp to bind to heparin/heparan sulfate was analyzed by solid phase assays, NMR, and affinity chromatography. An additional active region between the residues Gly46 and Ala60 was defined at the N-terminal domain of Hlp, expanding the previously defined heparin-binding site between Thr31 and Phe50. Additionally, the C-terminus, rich in Lys residues, was confirmed as another heparan sulfate binding region. The amino acids in Hlp identified as mediators in the interaction with heparan sulfate were Arg, Val, Ile, Lys, Phe, and Thr.
   Conclusion: Our data indicate that Hlp interacts with heparan sulfate through two distinct regions of the protein. Both heparan sulfate-binding regions here defined are preserved in all mycobacterial Hlp homologues that have been sequenced, suggesting important but possibly divergent roles for this surface-exposed protein in both pathogenic and saprophic species.
C1 [Portugal, Michelle I.; de Lima, Cristiana S.; Silva, Carlos A. M.; Pessolani, Maria C. V.] Fiocruz MS, Lab Microbiol Celular, Inst Oswaldo Cruz, BR-21045900 Rio De Janeiro, Brazil.
   [Todeschini, Adriane R.; Mendonca-Previato, Lucia; Previato, Jose O.] Univ Fed Rio de Janeiro, Inst Biofis Carlos Chagas Filho, Lab Glicobiol, BR-21949900 Rio De Janeiro, Brazil.
   [Mohana-Borges, Ronaldo] Univ Fed Rio de Janeiro, Inst Biofis Carlos Chagas Filho, Lab Genom Estrutural, BR-21949900 Rio De Janeiro, Brazil.
   [Ottenhoff, Tom H. M.] Leiden Univ, Med Ctr, Dept Immunohematol & Blood Transfus, NL-2300 RC Leiden, Netherlands.
RP Pessolani, MCV (corresponding author), Fiocruz MS, Lab Microbiol Celular, Inst Oswaldo Cruz, Av Brasil 4365 Manguinhos, BR-21045900 Rio De Janeiro, Brazil.
EM michelleip@ig.com.br; adrianet@biof.ufrj.br; crislima@ioc.fiocruz.br;
   adrianoc5@hotmail.com; mohana@biof.ufrj.br; T.H.M.Ottenhoff@lumc.nl;
   luciamp@biof.ufrj.br; previato@biof.ufrj.br; cpessola@ioc.fiocruz.br
RI Silva, Carlos Adriano M./D-3383-2015; Todeschini, Adriane/AAG-8128-2020;
   Todeschini, Adriane Regina/ABC-9165-2020; Borges, Ronaldo S
   Mohana/C-5575-2013
OI Silva, Carlos Adriano M./0000-0003-0441-7703; Todeschini, Adriane
   Regina/0000-0002-6049-2751; Mohana Borges, Ronaldo/0000-0002-1796-475X;
   Previato, Jose Osvaldo/0000-0002-9233-9954; Mendonca Previato,
   Lucia/0000-0003-3927-3244
CR Antia N H, 1982, Lepr India, V54, P599
   Aoki K, 2004, J BIOL CHEM, V279, P39798, DOI 10.1074/jbc.M402677200
   BAX A, 1985, J MAGN RESON, V65, P355, DOI 10.1016/0022-2364(85)90018-6
   Capila I, 2002, ANGEW CHEM INT EDIT, V41, P391
   Clamp M, 2004, BIOINFORMATICS, V20, P426, DOI 10.1093/bioinformatics/btg430
   de Lima CS, 2005, MICROBES INFECT, V7, P1097, DOI 10.1016/j.micinf.2005.02.013
   Delogu G, 1999, J BACTERIOL, V181, P7464, DOI 10.1128/JB.181.24.7464-7469.1999
   Fine PEM, 1996, INT J LEPROSY, V64, pS44
   Furugen M, 2001, MICROB PATHOGENESIS, V30, P129, DOI 10.1006/mpat.2000.0416
   GRIESINGER C, 1988, J AM CHEM SOC, V110, P7870, DOI 10.1021/ja00231a044
   Hileman RE, 1998, BIOESSAYS, V20, P156, DOI 10.1002/(SICI)1521-1878(199802)20:2<156::AID-BIES8>3.3.CO;2-#
   Marques MAD, 2000, MICROBES INFECT, V2, P1407
   Mayer M, 2001, J AM CHEM SOC, V123, P6108, DOI 10.1021/ja0100120
   MAYO KH, 1995, BIOCHEM J, V312, P357, DOI 10.1042/bj3120357
   Menozzi FD, 1996, J EXP MED, V184, P993, DOI 10.1084/jem.184.3.993
   Ng V, 2000, CELL, V103, P511, DOI 10.1016/S0092-8674(00)00142-2
   Ofek I, 2003, FEMS IMMUNOL MED MIC, V38, P181, DOI 10.1016/S0928-8244(03)00228-1
   Pessolani MCV, 2003, MICROBES INFECT, V5, P677, DOI 10.1016/S1286-4579(03)00098-4
   Pethe K, 2001, MOL MICROBIOL, V39, P89, DOI 10.1046/j.1365-2958.2001.02206.x
   Pethe K, 2000, J BIOL CHEM, V275, P14273, DOI 10.1074/jbc.275.19.14273
   Prabhakar S., 1998, Tubercle and Lung Disease, V79, P43, DOI 10.1054/tuld.1998.0004
   Shimoji Y, 1999, P NATL ACAD SCI USA, V96, P9857, DOI 10.1073/pnas.96.17.9857
   Todeschini AR, 2004, J BIOL CHEM, V279, P5323, DOI 10.1074/jbc.M310663200
   WILSON M, 2002, BACTERIAL DIS MECH, P353
NR 24
TC 7
Z9 8
U1 0
U2 2
PU BMC
PI LONDON
PA CAMPUS, 4 CRINAN ST, LONDON N1 9XW, ENGLAND
SN 1471-2180
J9 BMC MICROBIOL
JI BMC Microbiol.
PD MAY 15
PY 2008
VL 8
AR 75
DI 10.1186/1471-2180-8-75
PG 10
WC Microbiology
SC Microbiology
GA 312GP
UT WOS:000256657500001
PM 18482453
OA DOAJ Gold, Green Published
DA 2020-12-17
ER

PT J
AU Schwarzinger, S
   Mohana-Borges, R
   Kroon, GJA
   Dyson, HJ
   Wright, PE
AF Schwarzinger, Stephan
   Mohana-Borges, Ronaldo
   Kroon, Gerard J. A.
   Dyson, H. Jane
   Wright, Peter E.
TI Structural characterization of partially folded intermediates of
   apomyoglobin H64F
SO PROTEIN SCIENCE
LA English
DT Article
DE protein folding; protein stability; hydrophobic interaction; chain
   dynamics; NMR spectroscopy; myoglobin; molten globule
ID QUENCH-FLOW EXPERIMENTS; MOLTEN GLOBULE STATE; FOLDING PATHWAY; DYNAMIC
   CHARACTERIZATION; NMR-SPECTROSCOPY; PROTEIN; MYOGLOBIN; EVENTS
AB We present a detailed investigation of unfolded and partially folded states of a mutant apomyoglobin (apoMb) where the distal histidine has been replaced by phenylalanine (H64F). Previous studies have shown that substitution of His64, located in the E helix of the native protein, stabilizes the equilibrium molten globule and native states and leads to an increase in folding rate and a change in the folding pathway. Analysis of changes in chemical shift and in backbone flexibility, detected via [H-1]-N-15 heteronuclear nuclear Overhauser effect measurements, indicates that the phenylalanine substitution has only minor effects on the conformational ensemble in the acid- and urea-unfolded states, but has a substantial effect on the structure, dynamics, and stability of the equilibrium molten globule intermediate formed near pH 4. In H64F apomyoglobin, additional regions of the polypeptide chain are recruited into the compact core of the molten globule. Since the phenylalanine substitution has negligible effect on the unfolded ensemble, its influence on folding rate and stability comes entirely from interactions within the compact folded or partly folded states. Replacement of His64 with Phe leads to favorable hydrophobic packing between the helix E region and the molten globule core and leads to stabilization of helix E secondary structure and overall thermodynamic stabilization of the molten globule. The secondary structure of the equilibrium molten globule parallels that of the burst phase kinetic intermediate; both intermediates contain significant helical structure in regions of the polypeptide that comprise the A, B, E, G, and H helices of the fully folded protein.
C1 [Schwarzinger, Stephan; Mohana-Borges, Ronaldo; Kroon, Gerard J. A.; Dyson, H. Jane; Wright, Peter E.] Scripps Res Inst, Dept Mol Biol, La Jolla, CA 92037 USA.
   [Schwarzinger, Stephan; Mohana-Borges, Ronaldo; Kroon, Gerard J. A.; Dyson, H. Jane; Wright, Peter E.] Skaggs Inst Chem Biol, La Jolla, CA 92037 USA.
RP Wright, PE (corresponding author), Scripps Res Inst, Dept Mol Biol, 10550 N Torrey Pines Rd,MB 2, La Jolla, CA 92037 USA.
EM wright@scripps.edu
RI Schwarzinger, Stephan/O-4318-2014; Borges, Ronaldo S Mohana/C-5575-2013;
   Dyson, Helen Jane/D-4160-2011
OI Wright, Peter/0000-0002-1368-0223; Schwarzinger,
   Stephan/0000-0002-0894-5290; Mohana Borges, Ronaldo/0000-0002-1796-475X;
   Dyson, Helen Jane/0000-0001-6855-3398
FU NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASESUnited
   States Department of Health & Human ServicesNational Institutes of
   Health (NIH) - USANIH National Institute of Diabetes & Digestive &
   Kidney Diseases (NIDDK) [R37DK034909, R37DK034909, R01DK034909,
   R01DK034909, R01DK034909, R01DK034909, R01DK034909, R01DK034909,
   R01DK034909, R37DK034909, R37DK034909, R01DK034909, R01DK034909,
   R01DK034909, R01DK034909, R01DK034909, R01DK034909, R37DK034909,
   R37DK034909, R37DK034909, R01DK034909, R01DK034909, R01DK034909,
   R01DK034909, R01DK034909, R01DK034909, R01DK034909, R37DK034909] Funding
   Source: NIH RePORTER; NIDDK NIH HHSUnited States Department of Health &
   Human ServicesNational Institutes of Health (NIH) - USANIH National
   Institute of Diabetes & Digestive & Kidney Diseases (NIDDK) [DK34909,
   R01 DK034909, R37 DK034909] Funding Source: Medline
CR BAX A, 1991, Journal of Biomolecular NMR, V1, P99, DOI 10.1007/BF01874573
   Cavagnero S, 2001, BIOCHEMISTRY-US, V40, P14459, DOI 10.1021/bi011500n
   DELAGLIO F, 1995, J BIOMOL NMR, V6, P277, DOI 10.1007/BF00197809
   Dyson HJ, 2006, P NATL ACAD SCI USA, V103, P13057, DOI 10.1073/pnas.0605504103
   EDELHOCH H, 1967, BIOCHEMISTRY-US, V6, P1948, DOI 10.1021/bi00859a010
   Eliezer D, 2000, BIOCHEMISTRY-US, V39, P2894, DOI 10.1021/bi992545f
   Eliezer D, 1998, NAT STRUCT BIOL, V5, P148
   Eliezer D, 1997, FEBS LETT, V417, P92, DOI 10.1016/S0014-5793(97)01256-8
   Eliezer D, 1996, J MOL BIOL, V263, P531, DOI 10.1006/jmbi.1996.0596
   Garcia C, 2000, BIOCHEMISTRY-US, V39, P11227, DOI 10.1021/bi0010266
   Geierstanger B, 1998, BIOCHEMISTRY-US, V37, P4254, DOI 10.1021/bi972516+
   JENNINGS PA, 1995, J BIOMOL NMR, V6, P271
   JENNINGS PA, 1993, SCIENCE, V262, P892, DOI 10.1126/science.8235610
   JOHNSON BA, 1994, J BIOMOL NMR, V4, P604
   KAY LE, 1990, J MAGN RESON, V89, P496, DOI 10.1016/0022-2364(90)90333-5
   Koradi R, 1996, J MOL GRAPHICS, V14, P51, DOI 10.1016/0263-7855(96)00009-4
   Kuhlman B, 2003, SCIENCE, V302, P1364, DOI 10.1126/science.1089427
   KURIYAN J, 1986, J MOL BIOL, V192, P133, DOI 10.1016/0022-2836(86)90470-5
   Lecomte JTJ, 1996, PROTEINS, V25, P267, DOI 10.1002/(SICI)1097-0134(199607)25:3<267::AID-PROT1>3.3.CO;2-8
   Lietzow MA, 2002, J MOL BIOL, V322, P655, DOI 10.1016/S0022-2836(02)00847-1
   MUNOZ V, 1994, NAT STRUCT BIOL, V1, P399, DOI 10.1038/nsb0694-399
   Nishimura C, 2006, J MOL BIOL, V355, P139, DOI 10.1016/j.jmb.2005.10.047
   Nishimura C, 2005, J MOL BIOL, V351, P383, DOI 10.1016/j.jmb.2005.06.017
   Nishimura C, 2005, P NATL ACAD SCI USA, V102, P4765, DOI 10.1073/pnas.0409538102
   Nishimura C, 2003, J MOL BIOL, V334, P293, DOI 10.1016/j.jmb.2003.09.042
   Nishimura C, 2002, J MOL BIOL, V322, P483, DOI 10.1016/S0022-2836(02)00810-0
   Reymond MT, 1997, PROTEIN SCI, V6, P706
   ROSE GD, 1985, SCIENCE, V229, P834, DOI 10.1126/science.4023714
   Schwarzinger S, 2002, BIOCHEMISTRY-US, V41, P12681, DOI 10.1021/bi020381o
   Schwarzinger S, 2001, J AM CHEM SOC, V123, P2970, DOI 10.1021/ja003760i
   Tsui V, 1999, PROTEIN SCI, V8, P45, DOI 10.1110/ps.8.1.45
   VANGEET AL, 1968, ANAL CHEM, V40, P2227, DOI 10.1021/ac50158a064
   WITTCHEN HU, 1993, INT J METHOD PSYCH, V3, P101
   Yao J, 2001, BIOCHEMISTRY-US, V40, P3561, DOI 10.1021/bi002776i
NR 34
TC 14
Z9 14
U1 0
U2 4
PU COLD SPRING HARBOR LAB PRESS, PUBLICATIONS DEPT
PI WOODBURY
PA 500 SUNNYSIDE BLVD, WOODBURY, NY 11797-2924 USA
SN 0961-8368
J9 PROTEIN SCI
JI Protein Sci.
PD FEB
PY 2008
VL 17
IS 2
BP 313
EP 321
DI 10.1110/ps.073187208
PG 9
WC Biochemistry & Molecular Biology
SC Biochemistry & Molecular Biology
GA 256IB
UT WOS:000252720700013
PM 18227434
OA Green Published
DA 2020-12-17
ER

PT J
AU Simon, SM
   Sousa, FJR
   Mohana-Borges, R
   Walkers, GC
AF Simon, S. M.
   Sousa, F. J. R.
   Mohana-Borges, R.
   Walkers, G. C.
TI Regulation of Escherichia coli SOS mutagenesis by dimeric intrinsically
   disordered umuD gene products
SO PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF
   AMERICA
LA English
DT Article
DE natively unfolded; SOS response; unstructured; denatured; DNA repair
ID RECA-MEDIATED CLEAVAGE; DNA-POLYMERASE; UNSTRUCTURED PROTEINS; BINDING;
   IDENTIFICATION; TRANSITIONS; INTERACT; SEQUENCE; MODEL; ACTS
AB Products of the umuD gene in Escherichia coli play key roles in coordinating the switch from accurate DNA repair to mutagenic translesion DNA synthesis (TLS) during the SOS response to DNA damage. Homodimeric UmuD(2) is up-regulated 10-fold immediately after damage, after which slow autocleavage removes the N-terminal 24 amino acids of each UmuD. The remaining fragment, UmuD'(2), is required for mutagenic TLS. The small proteins UmuD(2) and UmuD'(2) make a large number of specific protein-protein contacts, including three of the five known E. coli DNA polymerases, parts of the replication machinery, and RecA recombinase. We show that, despite forming stable homodimers, UmuD(2) and UmuD'(2) have circular dichroism (CD) spectra with almost no alpha-helix or beta-sheet signal at physiological concentrations in vitro. High protein concentrations, osmolytic crowding agents, and specific interactions with a partner protein can produce CD spectra that resemble the expected beta-sheet signature. A lack of secondary structure in vitro is characteristic of intrinsically disordered proteins (IDPs), many of which act as regulators. A stable homodinner that lacks significant secondary structure is unusual but not unprecedented. Furthermore, previous single-cysteine cross-linking studies of UmuD(2) and UmuD'(2) show that they have a nonrandom structure at physiologically relevant concentrations in vitro. Our results offer insights into structural characteristics of relatively poorly understood IDPs and provide a model for how the umuD gene products can regulate diverse aspects of the bacterial SOS response.
C1 [Simon, S. M.] MIT, Dept Biol, Cambridge, MA 02139 USA.
   [Sousa, F. J. R.; Mohana-Borges, R.] Univ Fed Rio de Janeiro, Inst Biofis Carlos Chagas Filho, Lab Genom Estruct, BR-21941902 Rio De Janeiro, Brazil.
RP Walkers, GC (corresponding author), MIT, Dept Biol, 77 Massachusetts Ave, Cambridge, MA 02139 USA.
EM gwalker@mit.edu
RI Borges, Ronaldo S Mohana/C-5575-2013
OI /0000-0001-7243-8261
FU NATIONAL CANCER INSTITUTEUnited States Department of Health & Human
   ServicesNational Institutes of Health (NIH) - USANIH National Cancer
   Institute (NCI) [R01CA021615, R01CA021615, R01CA021615, R01CA021615,
   R01CA021615, R01CA021615, R01CA021615, R01CA021615, R01CA021615,
   R01CA021615, R01CA021615, R01CA021615, R01CA021615, R01CA021615,
   R01CA021615, R01CA021615, R01CA021615, R01CA021615, R01CA021615,
   R01CA021615, R01CA021615, R01CA021615, R01CA021615, R01CA021615,
   R01CA021615, R01CA021615, R01CA021615, R01CA021615, R01CA021615,
   R01CA021615, R01CA021615, R01CA021615, R01CA021615, R01CA021615] Funding
   Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH
   SCIENCESUnited States Department of Health & Human ServicesNational
   Institutes of Health (NIH) - USANIH National Institute of Environmental
   Health Sciences (NIEHS) [P30ES002109, P30ES002109, P30ES002109,
   P30ES002109, P30ES002109, P30ES002109, P30ES002109, P30ES002109,
   P30ES002109, P30ES002109, P30ES002109, P30ES002109, P30ES002109,
   P30ES002109, P30ES002109, P30ES002109, P30ES002109, P30ES002109,
   P30ES002109, P30ES002109, P30ES002109, P30ES002109, P30ES002109,
   P30ES002109, P30ES002109, P30ES002109, P30ES002109, P30ES002109,
   P30ES002109, P30ES002109, P30ES002109, P30ES002109, P30ES002109,
   P30ES002109, P30ES002109, P30ES002109, P30ES002109, P30ES002109,
   P30ES002109, P30ES002109, P30ES002109, P30ES002109, P30ES002109,
   P30ES002109, P30ES002109, P30ES002109, P30ES002109, P30ES002109,
   P30ES002109, P30ES002109, P30ES002109, P30ES002109, P30ES002109,
   P30ES002109, P30ES002109, P30ES002109, P30ES002109, P30ES002109,
   P30ES002109, P30ES002109, P30ES002109, P30ES002109, P30ES002109,
   P30ES002109, P30ES002109, P30ES002109, P30ES002109, P30ES002109,
   P30ES002109, P30ES002109, P30ES002109, P30ES002109, P30ES002109,
   P30ES002109, P30ES002109, P30ES002109, P30ES002109, P30ES002109,
   P30ES002109, P30ES002109, P30ES002109, P30ES002109, P30ES002109,
   P30ES002109, P30ES002109, P30ES002109, P30ES002109, P30ES002109,
   P30ES002109, P30ES002109, P30ES002109, P30ES002109, P30ES002109,
   P30ES002109, P30ES002109, P30ES002109, P30ES002109, P30ES002109,
   P30ES002109, P30ES002109, P30ES002109, P30ES002109, P30ES002109,
   P30ES002109, P30ES002109, P30ES002109, P30ES002109, P30ES002109,
   P30ES002109, P30ES002109, P30ES002109, P30ES002109, P30ES002109,
   P30ES002109, P30ES002109, P30ES002109, P30ES002109, P30ES002109,
   P30ES002109, P30ES002109, P30ES002109, P30ES002109, P30ES002109,
   P30ES002109, P30ES002109, P30ES002109, P30ES002109, P30ES002109,
   P30ES002109, P30ES002109, P30ES002109, P30ES002109, P30ES002109,
   P30ES002109, P30ES002109, P30ES002109, P30ES002109, P30ES002109,
   P30ES002109, P30ES002109, P30ES002109, P30ES002109, P30ES002109,
   P30ES002109, P30ES002109, P30ES002109, P30ES002109, P30ES002109,
   P30ES002109, P30ES002109, P30ES002109, P30ES002109, P30ES002109,
   P30ES002109, P30ES002109, P30ES002109, P30ES002109, P30ES002109,
   P30ES002109, P30ES002109, P30ES002109, P30ES002109, P30ES002109,
   P30ES002109, P30ES002109, P30ES002109, P30ES002109, P30ES002109,
   P30ES002109, P30ES002109, P30ES002109, P30ES002109, P30ES002109,
   P30ES002109, P30ES002109, P30ES002109, P30ES002109, P30ES002109,
   P30ES002109, P30ES002109, P30ES002109, P30ES002109, P30ES002109,
   P30ES002109, P30ES002109, P30ES002109, P30ES002109, P30ES002109,
   P30ES002109, P30ES002109, P30ES002109, P30ES002109, P30ES002109,
   P30ES002109, P30ES002109, P30ES002109, P30ES002109, P30ES002109,
   P30ES002109, P30ES002109, P30ES002109, P30ES002109, P30ES002109,
   P30ES002109, P30ES002109, P30ES002109, P30ES002109, P30ES002109,
   P30ES002109, P30ES002109, P30ES002109, P30ES002109, P30ES002109,
   P30ES002109, P30ES002109, P30ES002109, P30ES002109, P30ES002109,
   P30ES002109, P30ES002109, P30ES002109, P30ES002109, P30ES002109,
   P30ES002109, P30ES002109, P30ES002109, P30ES002109, P30ES002109,
   P30ES002109, P30ES002109, P30ES002109, P30ES002109, P30ES002109,
   P30ES002109, P30ES002109, P30ES002109, P30ES002109, P30ES002109,
   P30ES002109, P30ES002109, P30ES002109, P30ES002109, P30ES002109,
   P30ES002109, P30ES002109, P30ES002109, P30ES002109, P30ES002109,
   P30ES002109, P30ES002109, P30ES002109, P30ES002109, P30ES002109,
   P30ES002109, P30ES002109, P30ES002109, P30ES002109, P30ES002109,
   P30ES002109, P30ES002109, P30ES002109, P30ES002109, P30ES002109,
   P30ES002109, P30ES002109, P30ES002109, P30ES002109, P30ES002109,
   P30ES002109, P30ES002109, P30ES002109, P30ES002109, P30ES002109,
   P30ES002109, P30ES002109, P30ES002109, P30ES002109] Funding Source: NIH
   RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCESUnited States
   Department of Health & Human ServicesNational Institutes of Health (NIH)
   - USANIH National Institute of General Medical Sciences (NIGMS)
   [P50GM068762, P50GM068762, P50GM068762, P50GM068762, P50GM068762,
   P50GM068762, P50GM068762, P50GM068762, P50GM068762, P50GM068762,
   P50GM068762, P50GM068762, P50GM068762, P50GM068762, P50GM068762,
   P50GM068762, P50GM068762, P50GM068762, P50GM068762, P50GM068762,
   P50GM068762, P50GM068762, P50GM068762, P50GM068762, P50GM068762,
   P50GM068762, P50GM068762, P50GM068762, P50GM068762, P50GM068762,
   P50GM068762, P50GM068762, P50GM068762, P50GM068762, P50GM068762,
   P50GM068762, P50GM068762, P50GM068762, P50GM068762, P50GM068762,
   P50GM068762, P50GM068762, P50GM068762, P50GM068762, P50GM068762,
   P50GM068762, P50GM068762, P50GM068762, P50GM068762, P50GM068762,
   P50GM068762, P50GM068762, P50GM068762, P50GM068762, P50GM068762,
   P50GM068762, P50GM068762, P50GM068762, P50GM068762, P50GM068762,
   P50GM068762, P50GM068762, P50GM068762, P50GM068762, P50GM068762,
   P50GM068762, P50GM068762, P50GM068762, P50GM068762, P50GM068762,
   P50GM068762, P50GM068762, P50GM068762, P50GM068762, P50GM068762,
   P50GM068762, P50GM068762, P50GM068762, P50GM068762, P50GM068762,
   P50GM068762, P50GM068762, P50GM068762, P50GM068762, P50GM068762,
   P50GM068762, P50GM068762, P50GM068762, P50GM068762, P50GM068762,
   P50GM068762, P50GM068762, P50GM068762, P50GM068762, P50GM068762,
   P50GM068762, P50GM068762, P50GM068762, P50GM068762, P50GM068762,
   P50GM068762, P50GM068762, P50GM068762, P50GM068762, P50GM068762,
   P50GM068762, P50GM068762, P50GM068762, P50GM068762, P50GM068762,
   P50GM068762, P50GM068762, P50GM068762, P50GM068762, P50GM068762,
   P50GM068762, P50GM068762, P50GM068762, P50GM068762] Funding Source: NIH
   RePORTER; NCI NIH HHSUnited States Department of Health & Human
   ServicesNational Institutes of Health (NIH) - USANIH National Cancer
   Institute (NCI) [R01 CA021615, CA21615-27] Funding Source: Medline;
   NIEHS NIH HHSUnited States Department of Health & Human ServicesNational
   Institutes of Health (NIH) - USANIH National Institute of Environmental
   Health Sciences (NIEHS) [P30 ES002109] Funding Source: Medline; NIGMS
   NIH HHSUnited States Department of Health & Human ServicesNational
   Institutes of Health (NIH) - USANIH National Institute of General
   Medical Sciences (NIGMS) [P50 GM068762, GM68762] Funding Source: Medline
CR Alonso LG, 2002, BIOCHEMISTRY-US, V41, P10510, DOI 10.1021/bi025579n
   Beuning PJ, 2006, METHOD ENZYMOL, V408, P318, DOI 10.1016/S0076-6879(06)08020-7
   Beuning PJ, 2006, J BIOL CHEM, V281, P9633, DOI 10.1074/jbc.M511101200
   Dosztanyi Z, 2006, J PROTEOME RES, V5, P2985, DOI 10.1021/pr060171o
   Dunker AK, 2005, FEBS J, V272, P5129, DOI 10.1111/j.1742-4658.2005.04948.x
   Dunker AK, 2002, ADV PROTEIN CHEM, V62, P25
   Dyson HJ, 2005, NAT REV MOL CELL BIO, V6, P197, DOI 10.1038/nrm1589
   Dyson HJ, 2002, CURR OPIN STRUC BIOL, V12, P54, DOI 10.1016/S0959-440X(02)00289-0
   Ferentz AE, 2001, EMBO J, V20, P4287, DOI 10.1093/emboj/20.15.4287
   Fink AL, 2005, CURR OPIN STRUC BIOL, V15, P35, DOI 10.1016/j.sbi.2005.01.002
   Frank EG, 1996, P NATL ACAD SCI USA, V93, P10291, DOI 10.1073/pnas.93.19.10291
   Friedberg E.C., 2006, DNA REPAIR MUTAGENES
   GALLAGHER SR, 1995, CURRENT PROTOCOLS PR
   Gerlach VL, 1999, P NATL ACAD SCI USA, V96, P11922, DOI 10.1073/pnas.96.21.11922
   Godoy VG, 2007, MOL CELL, V28, P1058, DOI 10.1016/j.molcel.2007.10.025
   Gonzalez M, 1998, GENE DEV, V12, P3889, DOI 10.1101/gad.12.24.3889
   Gunasekaran K, 2007, J MOL BIOL, V365, P257, DOI 10.1016/j.jmb.2006.09.062
   Guzzo A, 1996, J BACTERIOL, V178, P7295, DOI 10.1128/jb.178.24.7295-7303.1996
   Koradi R, 1996, J MOL GRAPHICS, V14, P51, DOI 10.1016/0263-7855(96)00009-4
   Lah J, 2005, J BIOL CHEM, V280, P17397, DOI 10.1074/jbc.M501128200
   Le Gall T, 2007, J BIOMOL STRUCT DYN, V24, P325
   Lee MH, 1996, J BACTERIOL, V178, P7285, DOI 10.1128/jb.178.24.7285-7294.1996
   Lee MH, 1996, J BACTERIOL, V178, P7304, DOI 10.1128/jb.178.24.7304-7307.1996
   LEE MH, 1994, J BACTERIOL, V176, P4825, DOI 10.1128/jb.176.16.4825-4837.1994
   Liu JG, 2006, BIOCHEMISTRY-US, V45, P6873, DOI 10.1021/bi0602718
   LIU YF, 1995, BIOCHEMISTRY-US, V34, P12884, DOI 10.1021/bi00039a051
   Mohana-Borges R, 2000, J BIOL CHEM, V275, P4708, DOI 10.1074/jbc.275.7.4708
   Neher SB, 2003, P NATL ACAD SCI USA, V100, P13219, DOI 10.1073/pnas.2235804100
   NOHMI T, 1988, P NATL ACAD SCI USA, V85, P1816, DOI 10.1073/pnas.85.6.1816
   Opperman T, 1999, P NATL ACAD SCI USA, V96, P9218, DOI 10.1073/pnas.96.16.9218
   Patil A, 2006, FEBS LETT, V580, P2041, DOI 10.1016/j.febslet.2006.03.003
   Peat TS, 1996, NATURE, V380, P727, DOI 10.1038/380727a0
   PERRY KL, 1985, P NATL ACAD SCI USA, V82, P4331, DOI 10.1073/pnas.82.13.4331
   Receveur-Brechot V, 2006, PROTEINS, V62, P24, DOI 10.1002/prot.20750
   Reuven NB, 1999, J BIOL CHEM, V274, P31763, DOI 10.1074/jbc.274.45.31763
   Romero Pedro, 2004, Appl Bioinformatics, V3, P105, DOI 10.2165/00822942-200403020-00005
   Schlacher K, 2006, NATURE, V442, P883, DOI 10.1038/nature05042
   Sickmeier M, 2007, NUCLEIC ACIDS RES, V35, pD786, DOI 10.1093/nar/gkl893
   Sigalov AB, 2007, BIOCHIMIE, V89, P419, DOI 10.1016/j.biochi.2006.11.003
   Singh GP, 2007, PROTEINS, V66, P761, DOI 10.1002/prot.21281
   Sutton MD, 1999, P NATL ACAD SCI USA, V96, P12373, DOI 10.1073/pnas.96.22.12373
   Sutton MD, 2002, DNA REPAIR, V1, P77, DOI 10.1016/S1568-7864(01)00006-4
   Sutton MD, 2002, P NATL ACAD SCI USA, V99, P5307, DOI 10.1073/pnas.082322099
   Tang MJ, 1999, P NATL ACAD SCI USA, V96, P8919, DOI 10.1073/pnas.96.16.8919
   Tennyson RB, 1997, BIOCHEMISTRY-US, V36, P6107, DOI 10.1021/bi970152f
   Tompa P, 2005, FEBS LETT, V579, P3346, DOI 10.1016/j.febslet.2005.03.072
   UVERSKY VN, 1993, BIOCHEMISTRY-US, V32, P13288, DOI 10.1021/bi00211a042
   Uversky VN, 2002, PROTEIN SCI, V11, P739, DOI 10.1110/ps.4210102
   Uversky VN, 2005, J MOL RECOGNIT, V18, P343, DOI 10.1002/jmr.747
   WOODGATE R, 1989, P NATL ACAD SCI USA, V86, P7301, DOI 10.1073/pnas.86.19.7301
   Wright PE, 1999, J MOL BIOL, V293, P321, DOI 10.1006/jmbi.1999.3110
NR 51
TC 44
Z9 46
U1 0
U2 6
PU NATL ACAD SCIENCES
PI WASHINGTON
PA 2101 CONSTITUTION AVE NW, WASHINGTON, DC 20418 USA
SN 0027-8424
J9 P NATL ACAD SCI USA
JI Proc. Natl. Acad. Sci. U. S. A.
PD JAN 29
PY 2008
VL 105
IS 4
BP 1152
EP 1157
DI 10.1073/pnas.0706067105
PG 6
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA 258NF
UT WOS:000252873900014
PM 18216271
OA Green Published, Bronze
DA 2020-12-17
ER

PT J
AU Stauffer, F
   Melo, MN
   Carneiro, FA
   Sousa, FJR
   Juliano, MA
   Juliano, L
   Mohana-Borges, R
   Da Poian, AT
   Castanho, MARB
AF Stauffer, Fausto
   Melo, Manuel Nuno
   Carneiro, Fabiana A.
   Sousa, Francisco J. R.
   Juliano, Maria A.
   Juliano, Luiz
   Mohana-Borges, Ronaldo
   Da Poian, Andrea T.
   Castanho, Miguel A. R. B.
TI Interaction between dengue virus fusion peptide and lipid bilayers
   depends on peptide clustering
SO MOLECULAR MEMBRANE BIOLOGY
LA English
DT Article
DE dengue virus fusion peptide; oligomerization; partition; membrane
   fusion; lipid membrane
ID ENVELOPE PROTEIN; MEMBRANE-FUSION; MODEL SYSTEMS; FLUORESCENCE;
   GLYCOPROTEIN; INFECTIVITY; DYNAMICS; SULFATE; BINDING; REGION
AB Dengue fever is one of the most widespread tropical diseases in the world. The disease is caused by a virus member of the Flaviviridae family, a group of enveloped positive sense single-stranded RNA viruses. Dengue virus infection is mediated by virus glycoprotein E, which binds to the cell surface. After uptake by endocytosis, this protein induces the fusion between viral envelope and endosomal membrane at the acidic environment of the endosomal compartment. In this work, we evaluated by steady-state and time-resolved fluorescence spectroscopy the interaction between the peptide believed to be the dengue virus fusion peptide and large unilamellar vesicles, studying the extent of partition, fusion capacity and depth of insertion in membranes. The roles of the bilayer composition (neutral and anionic phospholipids), ionic strength and pH of the medium were also studied. Our results indicate that dengue virus fusion peptide has a high affinity to vesicles composed of anionic lipids and that the interaction is mainly electrostatic. Both partition coefficient and fusion index are enhanced by negatively charged phospholipids. The location determined by differential fluorescence quenching using lipophilic probes demonstrated that the peptide is in an intermediate depth in the hemilayers, in-between the bilayer core and its surface. Ultimately, these data provide novel insights on the interaction between dengue virus fusion peptide and its target membranes, namely, the role of oligomerization and specific types of membranes.
C1 [Stauffer, Fausto; Melo, Manuel Nuno; Castanho, Miguel A. R. B.] UL, Fac Ciencias, Ctr Quim Bioquim, P-1749016 Lisbon, Portugal.
   [Stauffer, Fausto; Carneiro, Fabiana A.; Da Poian, Andrea T.] Univ Fed Rio de Janeiro, Inst Bioquim Med, Rio De Janeiro, Brazil.
   [Sousa, Francisco J. R.; Mohana-Borges, Ronaldo] Univ Fed Rio de Janeiro, Inst Biofis Carlos Chagas Filho, Lab Genom Estrut, BR-21941 Rio De Janeiro, Brazil.
   [Juliano, Maria A.; Juliano, Luiz] Univ Fed Sao Paulo, Escola Paulista Med, Dept Biofis, Sao Paulo, Brazil.
RP Castanho, MARB (corresponding author), UL, Fac Ciencias, Ctr Quim Bioquim, Campo Grande,C8, P-1749016 Lisbon, Portugal.
EM castanho@fc.ul.pt
RI Da Poian, Andrea T./V-1699-2019; Complexos, INCT Fluidos/H-9172-2013;
   Borges, Ronaldo S Mohana/C-5575-2013; Juliano, Luiz/D-7204-2012;
   CARNEIRO, FABIANA A/S-4525-2018
OI Juliano, Luiz/0000-0002-5589-2822; Da Poian, Andrea/0000-0002-3969-704X;
   FCCN, Bogus/0000-0003-1034-3552; Mohana Borges,
   Ronaldo/0000-0002-1796-475X; Melo, Manuel Nuno/0000-0001-6567-0513;
   Carneiro, Fabiana/0000-0002-6584-4875; FCCN, Bogus/0000-0001-6282-8004;
   Castanho, Miguel/0000-0001-7891-7562
CR Allison SL, 2001, J VIROL, V75, P4268, DOI 10.1128/JVI.75.9.4268-4275.2001
   Basanez G, 2002, CELL MOL LIFE SCI, V59, P1478, DOI 10.1007/s00018-002-8523-6
   Caputo GA, 2003, BIOCHEMISTRY-US, V42, P3275, DOI 10.1021/bi026697d
   Chang DK, 2000, J BIOL CHEM, V275, P19150, DOI 10.1074/jbc.M907148199
   CHATTOPADHYAY A, 1987, BIOCHEMISTRY-US, V26, P39, DOI 10.1021/bi00375a006
   Chen YP, 1997, NAT MED, V3, P866, DOI 10.1038/nm0897-866
   Cheng SF, 2004, EUR J BIOCHEM, V271, P4725, DOI 10.1111/j.1432-1033.2004.04436.x
   Chiu SW, 1999, BIOPHYS J, V77, P2462, DOI 10.1016/S0006-3495(99)77082-7
   COUTINHO A, 1993, J CHEM EDUC, V70, P425, DOI 10.1021/ed070p425
   Crill WD, 2001, J VIROL, V75, P7769, DOI 10.1128/JVI.75.16.7769-7773.2001
   Feldman SA, 2000, J VIROL, V74, P6442, DOI 10.1128/JVI.74.14.6442-6447.2000
   Fernandes MX, 2002, ANAL BIOCHEM, V307, P1, DOI 10.1016/S0003-2697(02)00024-6
   Fry EE, 1999, EMBO J, V18, P543, DOI 10.1093/emboj/18.3.543
   Gibbons DL, 2004, NATURE, V427, P320, DOI 10.1038/nature02239
   Haugland R.P., 2002, HDB FLUORESCENT PROB
   Kuhn RJ, 2002, CELL, V108, P717, DOI 10.1016/S0092-8674(02)00660-8
   Lakowicz J.R., 1999, PRINCIPLES FLUORESCE
   Linderbach BD, 2001, FIELDS VIROLOGY, P991
   Ludtke S, 1995, BIOCHEMISTRY-US, V34, P16764, DOI 10.1021/bi00051a026
   Magzoub M, 2004, Q REV BIOPHYS, V37, P147, DOI 10.1017/S0033583505004014
   Maier O, 2002, CHEM PHYS LIPIDS, V116, P3, DOI 10.1016/S0009-3084(02)00017-8
   MAYER LD, 1986, BIOCHIM BIOPHYS ACTA, V858, P161, DOI 10.1016/0005-2736(86)90302-0
   Melo MN, 2007, BBA-BIOMEMBRANES, V1768, P1277, DOI 10.1016/j.bbamem.2007.02.005
   Modis Y, 2003, P NATL ACAD SCI USA, V100, P6986, DOI 10.1073/pnas.0832193100
   Modis Y, 2004, NATURE, V427, P313, DOI 10.1038/nature02165
   Murray D, 2002, CURR TOP MEMBR, V52, P277
   Pecheur EI, 1999, J MEMBRANE BIOL, V167, P1, DOI 10.1007/s002329900466
   Pecheur EI, 1998, BIOCHEMISTRY-US, V37, P2361, DOI 10.1021/bi972697f
   Santos NC, 1998, BIOCHEMISTRY-US, V37, P8674, DOI 10.1021/bi9803933
   Santos NC, 2002, TR APPL SPECT, V4, P113
   Santos NC, 2003, BBA-BIOMEMBRANES, V1612, P123, DOI 10.1016/S0005-2736(03)00112-3
   Shukla D, 1999, CELL, V99, P13, DOI 10.1016/S0092-8674(00)80058-6
   WARDLAW JR, 1987, FEBS LETT, V223, P20, DOI 10.1016/0014-5793(87)80502-1
   Wieprecht T, 2002, BIOPHYS CHEM, V96, P191, DOI 10.1016/S0301-4622(02)00025-X
NR 34
TC 18
Z9 18
U1 0
U2 17
PU TAYLOR & FRANCIS LTD
PI ABINGDON
PA 2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND
SN 0968-7688
EI 1464-5203
J9 MOL MEMBR BIOL
JI Mol. Membr. Biol.
PY 2008
VL 25
IS 2
BP 128
EP 138
DI 10.1080/09687680701633091
PG 11
WC Biochemistry & Molecular Biology; Cell Biology
SC Biochemistry & Molecular Biology; Cell Biology
GA 269NV
UT WOS:000253656800004
PM 18307100
DA 2020-12-17
ER

PT J
AU Gutierrez, ALS
   Farage, L
   Melo, MN
   Mohana-Borges, RS
   Guerardel, Y
   Coddeville, B
   Wieruszeski, JM
   Mendonca-Previato, L
   Previato, JO
AF Gutierrez, Ana L. S.
   Farage, Layla
   Melo, Manuel N.
   Mohana-Borges, Ronaldo S.
   Guerardel, Yann
   Coddeville, Bernadete
   Wieruszeski, Jean-Michel
   Mendonca-Previato, Lucia
   Previato, Jose O.
TI Characterization of glycoinositolphosphoryl ceramide structure mutant
   strains of Cryptococcus neoformans
SO GLYCOBIOLOGY
LA English
DT Article
DE Cryptococcus neoformans; Cryptococcus mutants; glycoinositolphosphoryl
   ceramide; mass spectrometry; NMR spectroscopy; UDP-Xyl
ID PHOSPHOINOSITOL-CONTAINING SPHINGOLIPIDS; INOSITOL PHOSPHORYLCERAMIDE
   SYNTHASE; YEAST HISTOPLASMA-CAPSULATUM; SACCHAROMYCES-CEREVISIAE;
   SPOROTHRIX-SCHENCKII; FORMS; CHROMATOGRAPHY; BIOSYNTHESIS; AUREOBASIDIN;
   VIRULENCE
AB In fungi, glycoinositolphosphoryl ceramide (GIPC) biosynthetic pathway produces essential molecules for growth, viability, and virulence. In previous studies, we demonstrated that the opportunistic fungus Cryptococcus neoformans synthesizes a complex family of xylose-(Xyl) branched GIPCs, all of which have not been previously reported in fungi. As an effort to understand the biosynthesis of these sphingolipids, we have now characterized the structures of GIPCs from C. neoformans wild-type (KN99 alpha) and mutant strains that lack UDP-Xyl, by disruption of either UDP-glucose dehydrogenase (NE321) or UDP-glucuronic acid decarboxylase (NE178). The structures of GIPCs were determined by a combination of nuclear magnetic resonance (NMR) spectroscopy, tandem mass spectrometry (MS), and gas chromatography-MS. The main and largest GIPC from wild-type strain was identified as an alpha-Manp(1 -> 6)alpha-Manp(1 -> 3)alpha-Manp [beta-Xylp(1 -> 2)]alpha-Manp(1 -> 4)beta-Galp(1 -> 6)alpha-Manp(1-2) Ins-1-P-Ceramide, whereas the most abundant GIPC from both mutant strains was found to be an alpha-Manp(1 -> 3)alpha-anp(1 -> 4)beta-Galp(1 -> 6) alpha-Manp(1 ->)Ins-1-P-Ceramide. The ceramide moieties of C. neoformans wild-type and mutant strains were composed of a C-18 phytosphingosine, which was N-acylated with 2-hydroxy tetra-, or hexacosanoic acid, and 2,3-dihydroxy-tetracosanoic acid. Our structural analysis results indicate that the C. neoformans mutant strains are unable to complete the assembly of the GIPC-oligosaccharide moiety due the absence of Xyl side chain.
C1 Univ Fed Rio de Janeiro, Inst Biofis Carlos Chagas Filho, BR-21944979 Rio De Janeiro, Brazil.
   Univ Sci & Technol, Unite Glycobiol Struct & Fonct, F-59655 Villeneuve Dascq, France.
RP Mendonca-Previato, L (corresponding author), Univ Fed Rio de Janeiro, Inst Biofis Carlos Chagas Filho, Cidade Univ, BR-21944979 Rio De Janeiro, Brazil.
EM luciamp@biof.ufrj.br
RI Borges, Ronaldo S Mohana/C-5575-2013
OI Guerardel, Yann/0000-0003-4967-9512; Mendonca Previato,
   Lucia/0000-0003-3927-3244; Melo, Manuel Nuno/0000-0001-6567-0513
CR BARR K, 1984, BIOCHEMISTRY-US, V23, P5589, DOI 10.1021/bi00318a032
   BARR K, 1984, BIOCHEMISTRY-US, V23, P5581, DOI 10.1021/bi00318a031
   Bennion B, 2003, J LIPID RES, V44, P2073, DOI 10.1194/jlr.M300184-JLR200
   CARTER HE, 1967, BIOCHEM BIOPH RES CO, V29, P886, DOI 10.1016/0006-291X(67)90304-X
   CIUCANU I, 1984, CARBOHYD RES, V131, P403
   Dickson RC, 2002, BBA-MOL CELL BIOL L, V1583, P13, DOI 10.1016/S1388-1981(02)00210-X
   Guerardel Y, 2002, J BIOL CHEM, V277, P30635, DOI 10.1074/jbc.M204398200
   Heise N, 2002, GLYCOBIOLOGY, V12, P409, DOI 10.1093/glycob/cwf053
   HUMBEL R, 1975, CLIN CHIM ACTA, V60, P143, DOI 10.1016/0009-8981(75)90119-9
   JANSSON PE, 1994, CARBOHYD RES, V257, P163, DOI 10.1016/0008-6215(94)80033-2
   Klutts JS, 2006, FEMS YEAST RES, V6, P499, DOI 10.1111/j.1567-1364.2006.00054.x
   Levery SB, 1998, BIOCHEMISTRY-US, V37, P8764, DOI 10.1021/bi9730083
   Mandala SM, 1998, J BIOL CHEM, V273, P14942, DOI 10.1074/jbc.273.24.14942
   Mandala SM, 1997, J BIOL CHEM, V272, P32709, DOI 10.1074/jbc.272.51.32709
   Mille C, 2004, J BIOL CHEM, V279, P47952, DOI 10.1074/jbc.M405534200
   MITCHELL TG, 1995, CLIN MICROBIOL REV, V8, P515, DOI 10.1128/CMR.8.4.515
   Moyrand F, 2004, EUKARYOT CELL, V3, P1601, DOI 10.1128/EC.3.6.1601-1608.2004
   Moyrand F, 2002, MOL MICROBIOL, V45, P837, DOI 10.1046/j.1365-2958.2002.03059.x
   Nagiec MM, 1997, J BIOL CHEM, V272, P9809, DOI 10.1074/jbc.272.15.9809
   Nielsen K, 2003, INFECT IMMUN, V71, P4831, DOI 10.1128/IAI.71.9.4831-4841.2003
   Penha CVL, 2000, GLYCOBIOLOGY, V10, P1125
   Penhal CVLY, 2001, EUR J BIOCHEM, V268, P4243, DOI 10.1046/j.1432-1327.2001.02339.x
   SHERMAN F, 1992, METHOD ENZYMOL, V194, P3
   SMITH SW, 1974, J BIOL CHEM, V249, P3395
   Sommer U, 2003, J BIOL CHEM, V278, P47724, DOI 10.1074/jbc.M307223200
   SWEELEY CC, 1963, J AM CHEM SOC, V85, P2497, DOI 10.1021/ja00899a032
   TAKESAKO K, 1993, J ANTIBIOT, V46, P1414, DOI 10.7164/antibiotics.46.1414
   Thevissen K, 2000, P NATL ACAD SCI USA, V97, P9531, DOI 10.1073/pnas.160077797
   Vaishnav VV, 1998, CARBOHYD RES, V306, P315, DOI 10.1016/S0008-6215(97)10058-1
   WIDER G, 1993, J MAGN RESON SER B, V102, P239, DOI 10.1006/jmrb.1993.1092
   Zhong WY, 2000, ANTIMICROB AGENTS CH, V44, P651, DOI 10.1128/AAC.44.3.651-653.2000
   Zink S, 2005, EUKARYOT CELL, V4, P879, DOI 10.1128/EC.4.5.879-889.2005
NR 32
TC 17
Z9 18
U1 0
U2 9
PU OXFORD UNIV PRESS INC
PI CARY
PA JOURNALS DEPT, 2001 EVANS RD, CARY, NC 27513 USA
SN 0959-6658
J9 GLYCOBIOLOGY
JI Glycobiology
PD JUN
PY 2007
VL 17
IS 6
BP 1C
EP 11C
DI 10.1093/glycob/cwm030
PG 11
WC Biochemistry & Molecular Biology
SC Biochemistry & Molecular Biology
GA 184YO
UT WOS:000247678700003
PM 17369287
OA Bronze
DA 2020-12-17
ER

PT J
AU Sousa, FJR
   Lima, LMTR
   Pacheco, ABF
   Oliveira, CLP
   Torriani, I
   Almeida, DF
   Foguel, D
   Silva, JL
   Mohana-Borges, R
AF Sousa, Francisco J. R.
   Lima, Luis M. T. R.
   Pacheco, Ana B. F.
   Oliveira, Cristiano L. P.
   Torriani, Iris
   Almeida, Darcy F.
   Foguel, Debora
   Silva, Jerson L.
   Mohana-Borges, Ronaldo
TI Tetramerization of the LexA repressor in solution: Implications for gene
   regulation of the E-coli SOS system at acidic pH
SO JOURNAL OF MOLECULAR BIOLOGY
LA English
DT Article
DE LexA repressor; SOS repair system; E. coli; protein-DNA interaction;
   partially folded protein
ID SMALL-ANGLE SCATTERING; X-RAY-SCATTERING; HYDROSTATIC-PRESSURE;
   STAPHYLOCOCCAL NUCLEASE; CONFORMATIONAL DRIFT; UNFOLDED PROTEINS;
   CRYSTAL-STRUCTURE; BINDING-SITES; DNA; STABILITY
AB Structural changes on LexA repressor promoted by acidic pH have been investigated. Intense protein aggregation occurred around pH 4.0 but was not detected at pH values lower than pH 3.5. The center of spectral mass of the Trp increased 400 cm(-1) at pH 2.5 relatively to pH 7.2, an indication that LexA has undergone structural reorganization but not denaturation. The Trp fluorescence polarization of LexA at pH 2.5 indicated that its hydrodynamic volume was larger than its dimer at pH 7.2. 4,4'-Dianilino-1,1'-binaphthyl-5,5-disulfonic acid (bis-ANS) experiments suggested that the residues in the hydrophobic clefts already present at the LexA structure at neutral pH had higher affinity to it at pH 2.5. A 100 kDa band corresponding to a tetramer was obtained when LexA was subject to pore-limiting native polyacrylamide gel electrophoresis at this pH. The existence of this tetrameric state was also confirmed by small angle X-ray scattering (SAXS) analysis at pH 2.5. 1D H-1 NMR experiments suggested that it was composed of a mixture of folded and unfolded regions. Although 14,000-fold less stable than the dimeric LexA, it showed a tetramer-monomer dissociation at pH 2.5 from the hydrostatic pressure and urea curves. Albeit with half of the affinity obtained at pH 7.2 (K-aff of 170 nM), tetrameric LexA remained capable of binding recA operator sequence at pH 2.5. Moreover, different from the absence of binding to the negative control polyGC at neutral pH, LexA bound to this sequence with a Kaff value of 1415 nM at pH 2.5. A binding stoichiometry experiment at both pH 7.2 and pH 2.5 showed a [monomeric LexA]/[recA operator] ratio of 2:1. These results are discussed in relation to the activation of the Escherichia coli SOS regulon in response to environmental conditions resulting in acidic intracellular pH. Furthermore, oligomerization of LexA is proposed to be a possible regulation mechanism of this regulon. (c) 2006 Elsevier Ltd. All rights reserved.
C1 Univ Fed Rio de Janeiro, Lab Genom Estrutural, Inst Biofis Carlos Chagas Filho, BR-21941590 Rio De Janeiro, Brazil.
   Univ Fed Rio de Janeiro, Inst Bioquim Med, Ctr Nacl Ressonancia Magent Nucl Macromol Jiri Jo, BR-21941590 Rio De Janeiro, Brazil.
   Univ Fed Rio de Janeiro, Fac Farm, BR-21941590 Rio De Janeiro, Brazil.
   Univ Fed Rio de Janeiro, Unidade Multidisciplinar Genom, Inst Biofis Carlos Chagas Filho, BR-21941590 Rio De Janeiro, Brazil.
   Lab Nacl Luz Sincrotron, BR-13084971 Campinas, SP, Brazil.
RP Mohana-Borges, R (corresponding author), Univ Fed Rio de Janeiro, Lab Genom Estrutural, Inst Biofis Carlos Chagas Filho, BR-21941590 Rio De Janeiro, Brazil.
EM mohana@biof.ufrj.br
RI Pacheco, Ana Beatriz Furlanetto/J-2617-2013; Oliveira, Cristiano L
   P/B-4403-2008; Silva, Jerson/J-8984-2014; Borges, Ronaldo S
   Mohana/C-5575-2013; Torriani, Iris L/E-5686-2010
OI Pacheco, Ana Beatriz Furlanetto/0000-0002-7899-9657; Oliveira, Cristiano
   L P/0000-0002-3426-6507; Silva, Jerson/0000-0001-9523-9441; Torriani,
   Iris/0000-0002-7847-5108; Foguel, Debora/0000-0001-7312-7115; Mohana
   Borges, Ronaldo/0000-0002-1796-475X
CR Bell CE, 2000, CELL, V101, P801, DOI 10.1016/S0092-8674(00)80891-0
   BERG OG, 1988, NUCLEIC ACIDS RES, V16, P5089, DOI 10.1093/nar/16.11.5089
   Botelho MG, 2003, J BIOL CHEM, V278, P34259, DOI 10.1074/jbc.M303189200
   BRENOWITZ M, 1990, BIOCHEMISTRY-US, V29, P3374, DOI 10.1021/bi00465a033
   BRENT R, 1981, P NATL ACAD SCI-BIOL, V78, P4204, DOI 10.1073/pnas.78.7.4204
   Cavalcanti LP, 2004, REV SCI INSTRUM, V75, P4541, DOI 10.1063/1.1804956
   CHAKERIAN AE, 1992, MOL MICROBIOL, V6, P963, DOI 10.1111/j.1365-2958.1992.tb02162.x
   Datta AB, 2005, J MOL BIOL, V345, P315, DOI 10.1016/j.jmb.2004.09.098
   DELAGLIO F, 1995, J BIOMOL NMR, V6, P277, DOI 10.1007/BF00197809
   DRI AM, 1994, MOL MICROBIOL, V12, P621, DOI 10.1111/j.1365-2958.1994.tb01049.x
   Dyson HJ, 2004, CHEM REV, V104, P3607, DOI 10.1021/cr030403s
   Fernandez de Henestrosa AR, 2000, MOL MICROBIOL, V35, P1560, DOI 10.1046/j.1365-2958.2000.01826.x
   Ferrao-Gonzales AD, 2000, P NATL ACAD SCI USA, V97, P6445, DOI 10.1073/pnas.97.12.6445
   Ferreiro DU, 2000, BIOCHEMISTRY-US, V39, P14692, DOI 10.1021/bi001694r
   FINK AL, 1993, PROTEIN SCI, V2, P1155, DOI 10.1002/pro.5560020710
   FOGH RH, 1994, EMBO J, V13, P3936, DOI 10.1002/j.1460-2075.1994.tb06709.x
   Foster JW, 2004, NAT REV MICROBIOL, V2, P898, DOI 10.1038/nrmicro1021
   GORDEN J, 1993, INFECT IMMUN, V61, P364, DOI 10.1128/IAI.61.1.364-367.1993
   GRANGERSCHNARR M, 1986, FEBS LETT, V198, P61, DOI 10.1016/0014-5793(86)81185-1
   Hahn K, 1999, MOL MICROBIOL, V31, P1489, DOI 10.1046/j.1365-2958.1999.01292.x
   Higurashi T, 2003, J MOL BIOL, V333, P605, DOI 10.1016/j.jmb.2003.08.056
   JENG MF, 1990, BIOCHEMISTRY-US, V29, P10433, DOI 10.1021/bi00498a001
   Kellermann G, 1997, J APPL CRYSTALLOGR, V30, P880, DOI 10.1107/S0021889897001829
   KERSTEN S, 1995, P NATL ACAD SCI USA, V92, P8645, DOI 10.1073/pnas.92.19.8645
   KIM B, 1992, SCIENCE, V255, P203, DOI 10.1126/science.1553548
   KING L, 1986, BIOCHEMISTRY-US, V25, P3632, DOI 10.1021/bi00360a023
   Koch MHJ, 2003, Q REV BIOPHYS, V36, P147, DOI 10.1017/S0033583503003871
   Kohn JE, 2004, P NATL ACAD SCI USA, V101, P12491, DOI 10.1073/pnas.0403643101
   LEWIS LK, 1994, J MOL BIOL, V241, P507, DOI 10.1006/jmbi.1994.1528
   LICHTNER R, 1979, BIOCHEM J, V181, P759, DOI 10.1042/bj1810759
   Lietzow MA, 2002, J MOL BIOL, V322, P655, DOI 10.1016/S0022-2836(02)00847-1
   LITTLE JW, 1984, P NATL ACAD SCI-BIOL, V81, P1375, DOI 10.1073/pnas.81.5.1375
   LITTLE JW, 1983, J MOL BIOL, V167, P791, DOI 10.1016/S0022-2836(83)80111-9
   LITTLE JW, 1994, METHOD ENZYMOL, V244, P266
   LITTLE JW, 1981, P NATL ACAD SCI-BIOL, V78, P4199, DOI 10.1073/pnas.78.7.4199
   LITTLE JW, 1982, CELL, V29, P11, DOI 10.1016/0092-8674(82)90085-X
   Luo Y, 2001, CELL, V106, P585, DOI 10.1016/S0092-8674(01)00479-2
   Martins SM, 2003, J BIOL CHEM, V278, P50449, DOI 10.1074/jbc.M307354200
   Matic I, 2004, RES MICROBIOL, V155, P337, DOI 10.1016/j.resmic.2004.01.010
   Mohana-Borges R, 2004, J MOL BIOL, V340, P1131, DOI 10.1016/j.jmb.2004.05.022
   Mohana-Borges R, 2000, J BIOL CHEM, V275, P4708, DOI 10.1074/jbc.275.7.4708
   Oliveira C. L. P., 2003, TRAT1D COMPUTER PROG
   PALADINI AA, 1981, BIOCHEMISTRY-US, V20, P2587, DOI 10.1021/bi00512a034
   Relan NK, 1997, BIOCHEMISTRY-US, V36, P1077, DOI 10.1021/bi9618427
   Richard H, 2004, J BACTERIOL, V186, P6032, DOI 10.1128/jb.186.18.6032-6041.2004
   ROYER CA, 1993, BIOCHEMISTRY-US, V32, P5222, DOI 10.1021/bi00070a034
   ROYER CA, 1990, BIOCHEMISTRY-US, V29, P4959, DOI 10.1021/bi00472a028
   RUAN K, 1989, BIOCHEMISTRY-US, V28, P2144, DOI 10.1021/bi00431a028
   SCHNARR M, 1985, BIOCHEMISTRY-US, V24, P2812, DOI 10.1021/bi00332a032
   SCHULDINER S, 1986, J BACTERIOL, V168, P936, DOI 10.1128/jb.168.2.936-939.1986
   SEMENYUK AV, 1991, J APPL CRYSTALLOGR, V24, P537, DOI 10.1107/S002188989100081X
   SILVA JL, 1992, J VIROL, V66, P2111, DOI 10.1128/JVI.66.4.2111-2117.1992
   SILVA JL, 1993, ANNU REV PHYS CHEM, V44, P89, DOI 10.1146/annurev.physchem.44.1.89
   Silva JL, 2001, TRENDS BIOCHEM SCI, V26, P612, DOI 10.1016/S0968-0004(01)01949-1
   SILVA JL, 1992, J MOL BIOL, V223, P545, DOI 10.1016/0022-2836(92)90669-B
   Sirangelo I, 1998, BBA-PROTEIN STRUCT M, V1385, P69, DOI 10.1016/S0167-4838(98)00038-7
   SLILATY SN, 1987, P NATL ACAD SCI USA, V84, P3987, DOI 10.1073/pnas.84.12.3987
   SMALL P, 1994, J BACTERIOL, V176, P1729, DOI 10.1128/jb.176.6.1729-1737.1994
   STUDIER FW, 1990, METHOD ENZYMOL, V185, P60
   Svergun DI, 2002, CURR OPIN STRUC BIOL, V12, P654, DOI 10.1016/S0959-440X(02)00363-9
   THLIVERIS AT, 1991, BIOCHIMIE, V73, P449, DOI 10.1016/0300-9084(91)90112-E
   Walker GC, 2000, BACTERIAL STRESS RESPONSES, P131
   WALKER GC, 1984, MICROBIOL REV, V48, P60, DOI 10.1128/MMBR.48.1.60-93.1984
   WEBER G, 1983, Q REV BIOPHYS, V16, P89, DOI 10.1017/S0033583500004935
   Weber G, 1992, PROTEIN INTERACTIONS
   WERTMAN KF, 1985, J BACTERIOL, V163, P376, DOI 10.1128/JB.163.1.376-384.1985
   WISHART DS, 1995, J BIOMOL NMR, V6, P135, DOI 10.1007/BF00211777
   Wright PE, 1999, J MOL BIOL, V293, P321, DOI 10.1006/jmbi.1999.3110
   Yao J, 2001, BIOCHEMISTRY-US, V40, P3561, DOI 10.1021/bi002776i
NR 69
TC 19
Z9 21
U1 0
U2 5
PU ACADEMIC PRESS LTD- ELSEVIER SCIENCE LTD
PI LONDON
PA 24-28 OVAL RD, LONDON NW1 7DX, ENGLAND
SN 0022-2836
EI 1089-8638
J9 J MOL BIOL
JI J. Mol. Biol.
PD JUN 16
PY 2006
VL 359
IS 4
BP 1059
EP 1074
DI 10.1016/j.jmb.2006.03.069
PG 16
WC Biochemistry & Molecular Biology
SC Biochemistry & Molecular Biology
GA 058RR
UT WOS:000238682800019
PM 16701697
DA 2020-12-17
ER

PT J
AU Faber-Barata, J
   Mohana-Borges, R
   Lima, LMTR
AF Faber-Barata, J
   Mohana-Borges, R
   Lima, LMTR
TI Specificity in DNA recognition by a peptide from papillomavirus E2
   protein
SO FEBS LETTERS
LA English
DT Article
DE peptide; DNA; molecular recognition; papillomavirus; E2 protein
ID BINDING DOMAIN; SEQUENCE; DISCRIMINATION; COMPLEXES; READOUT; SITES
AB The E2 proteins of papillomavirus specifically bind to double-stranded DNA containing the consensus sequence ACCG-N-4-CGGT, where N is any nucleotide. Here, we show the binding and recognition of dissimilar DNA sequences by an 18 amino-acid peptide (alpha 1E2), which corresponds to the DNA-recognition helix, alpha-helix-1. Isothermal DNA binding assays performed with the DNA consensus sequence show saturable curves with alpha 1E2 peptide, and the alpha 1E2 peptide is converted to an ordered conformation upon complexation. Measurements performed with non-specific DNA sequence fail to saturate, a behavior characteristic of non-specific binding. Binding of the alpha 1E2 peptide to these DNA sequences display a different counter-ion dependence, indicating a dissimilar, sequence-dependent mechanism of interaction. Quantitative stoichiometric measurements revealed the specificity in a1E2 peptide recognition of the ACCG half-site, demonstrating capacity for discrimination of nucleic acid bases sequences without the need of a whole protein architecture. (c) 2006 Federation of European Biochemical Societies. Published by Elsevier B.V. All rights reserved.
C1 Univ Fed Rio de Janeiro, CCS, Fac Farm, BR-21941590 Rio De Janeiro, Brazil.
   Univ Fed Rio de Janeiro, Inst Bioquim Med, Fac Farm, BR-21941590 Rio De Janeiro, Brazil.
   Univ Fed Rio de Janeiro, Inst Biofis Carlos Chagas Filho, BR-21941590 Rio De Janeiro, Brazil.
RP Lima, LMTR (corresponding author), Univ Fed Rio de Janeiro, CCS, Fac Farm, Sala Bss-34,Ilha Fundao, BR-21941590 Rio De Janeiro, Brazil.
EM Mauricio@pharma.ufrj.br
RI Borges, Ronaldo S Mohana/C-5575-2013
OI Mohana Borges, Ronaldo/0000-0002-1796-475X
CR CANTOR CR, 1980, BIOPHYS J
   CANTOR CR, 1980, BIOPHYSICAL CYHEM 3
   Dell G, 2003, J MOL BIOL, V334, P979, DOI 10.1016/j.jmb.2003.10.009
   Djuranovic D, 2004, J MOL BIOL, V339, P785, DOI 10.1016/j.jmb.2004.03.078
   Fasman G.D., 1996, CIRCULAR DICHROISM C
   Ferreiro DU, 2005, J BIOL CHEM, V280, P32480, DOI 10.1074/jbc.M505706200
   Ferreiro DU, 2000, BIOCHEMISTRY-US, V39, P14692, DOI 10.1021/bi001694r
   Ferreiro DU, 2003, J MOL BIOL, V331, P89, DOI 10.1016/S0022-2836(03)00720-4
   GAUTHIER JM, 1991, NUCLEIC ACIDS RES, V19, P7073, DOI 10.1093/nar/19.25.7073
   Hegde RS, 2002, ANNU REV BIOPH BIOM, V31, P343, DOI 10.1146/annurev.biophys.31.100901.142129
   HEGDE RS, 1992, NATURE, V359, P205
   Hines CS, 1998, J MOL BIOL, V276, P809, DOI 10.1006/jmbi.1997.1578
   Kim SS, 2000, J BIOL CHEM, V275, P31245, DOI 10.1074/jbc.M004541200
   Lewis H, 1999, J MOL BIOL, V294, P885, DOI 10.1006/jmbi.1999.3314
   Liang H, 1996, BIOCHEMISTRY-US, V35, P2095, DOI 10.1021/bi951932w
   Lima LMTR, 2000, P NATL ACAD SCI USA, V97, P14289, DOI 10.1073/pnas.250352197
   Lima LMTR, 2004, J BIOL CHEM, V279, P47968, DOI 10.1074/jbc.M407696200
   Luscombe NM, 2001, NUCLEIC ACIDS RES, V29, P2860, DOI 10.1093/nar/29.13.2860
   MANDELGUTFREUND Y, 1995, J MOL BIOL, V253, P370, DOI 10.1006/jmbi.1995.0559
   Mauricio L, 1997, J BIOL CHEM, V272, P19295, DOI 10.1074/jbc.272.31.19295
   MCBRIDE AA, 1991, J BIOL CHEM, V266, P18411
   Mohana-Borges R, 2000, J BIOL CHEM, V275, P4708, DOI 10.1074/jbc.275.7.4708
   Penrose KJ, 2004, J BIOL CHEM, V279, P22430, DOI 10.1074/jbc.M314340200
   RECORD MT, 1976, J MOL BIOL, V107, P145, DOI 10.1016/S0022-2836(76)80023-X
   SANDERS CM, 1994, NUCLEIC ACIDS RES, V22, P4890, DOI 10.1093/nar/22.23.4890
   SEEMAN NC, 1976, P NATL ACAD SCI USA, V73, P804, DOI 10.1073/pnas.73.3.804
   Thain A, 1997, J BIOL CHEM, V272, P8236, DOI 10.1074/jbc.272.13.8236
   Vamosi G, 1996, BIOPHYS J, V71, P972, DOI 10.1016/S0006-3495(96)79300-1
   Weinberg RL, 2004, J MOL BIOL, V341, P1145, DOI 10.1016/j.jmb.2004.06.071
   Zhang YL, 2004, P NATL ACAD SCI USA, V101, P8337, DOI 10.1073/pnas.0402319101
   Zimmerman JM, 2003, NUCLEIC ACIDS RES, V31, P5134, DOI 10.1093/nar/gkg697
NR 31
TC 6
Z9 6
U1 0
U2 0
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 1873-3468
J9 FEBS LETT
JI FEBS Lett.
PD APR 3
PY 2006
VL 580
IS 8
BP 1919
EP 1924
DI 10.1016/j.febslet.2006.02.047
PG 6
WC Biochemistry & Molecular Biology; Biophysics; Cell Biology
SC Biochemistry & Molecular Biology; Biophysics; Cell Biology
GA 029OW
UT WOS:000236574000002
PM 16542651
OA Bronze
DA 2020-12-17
ER

PT J
AU Rosa, NDA
   Einicker-Lamas, M
   Bernardo, RR
   Previatto, LM
   Mohana-Borges, R
   Morgado-Diaz, JA
   Benchimol, M
AF Rosa, NDA
   Einicker-Lamas, M
   Bernardo, RR
   Previatto, LM
   Mohana-Borges, R
   Morgado-Diaz, JA
   Benchimol, M
TI Cardiolipin in hydrogenosomes: Evidence of symbiotic origin
SO EUKARYOTIC CELL
LA English
DT Article
ID TRICHOMONAS-VAGINALIS; TRITRICHOMONAS-FETUS; MITOCHONDRIA; ORGANELLE;
   PROTEIN; EUKARYOTES; BIOGENESIS; METABOLISM; EVOLUTION
AB Hydrogenosomes are found in organisms that lack typical mitochondria. Cardiolipin is a phospholipid located exclusively in bacterial membranes and the inner membrane of mitochondria. Here we show, by cell fractionation, thin-layer chromatography, high-pressure liquid chromatography, and matrix-assisted laser desorption ionization-time of flight mass spectrometry that hydrogenosomes of Tritrichomonas foetus, a cattle vaginal parasite, contain cardiolipin, which is strong evidence for its endosymbiotic origin.
C1 Univ Santa Ursula, Lab Ultraestrutura Celular, Rio De Janeiro, Brazil.
   Univ Fed Rio de Janeiro, Inst Biofis Carlos Chagas Filho, BR-21941 Rio De Janeiro, Brazil.
   Univ Estacio Sa, Fac Farm, Rio De Janeiro, Brazil.
   Inst Nacl Canc, Div Biol Celular, INCA, Grp Biol Estrutural, Rio De Janeiro, Brazil.
RP Benchimol, M (corresponding author), Rua Jornalista Orlando Dantas 59, BR-22231010 Rio De Janeiro, Brazil.
EM marleneben@uol.com.br
RI bernardo, robson roney/C-6163-2018; Morgado-Diaz, Jose A./A-9649-2010;
   Borges, Ronaldo S Mohana/C-5575-2013
OI bernardo, robson roney/0000-0002-0035-5149; Mohana Borges,
   Ronaldo/0000-0002-1796-475X
CR Akhmanova A, 1998, NATURE, V396, P527, DOI 10.1038/25023
   BENCHIMOL M, 1983, J PROTOZOOL, V30, P422, DOI 10.1111/j.1550-7408.1983.tb02942.x
   Benchimol M, 1996, BIOL CELL, V87, P197, DOI 10.1016/S0248-4900(97)89276-3
   Bradley PJ, 1997, EMBO J, V16, P3484, DOI 10.1093/emboj/16.12.3484
   CERKASOVOVA A, 1976, Folia Parasitologica (Ceske Budejovice), V23, P33
   Clemens DL, 2000, MOL BIOCHEM PARASIT, V106, P307, DOI 10.1016/S0166-6851(99)00220-0
   Diaz JAM, 1997, EUR J CELL BIOL, V74, P85
   Dolezal P, 2005, P NATL ACAD SCI USA, V102, P10924, DOI 10.1073/pnas.0500349102
   Dyall SD, 2000, CURR OPIN MICROBIOL, V3, P404, DOI 10.1016/S1369-5274(00)00112-0
   Dyall SD, 2000, MOL CELL BIOL, V20, P2488, DOI 10.1128/MCB.20.7.2488-2497.2000
   Embley TM, 2003, IUBMB LIFE, V55, P387, DOI 10.1080/15216540310001592834
   Embley TM, 2003, PHILOS T R SOC B, V358, P191, DOI 10.1098/rstb.2002.1190
   GALLET PF, 1995, EUR J BIOCHEM, V228, P113, DOI 10.1111/j.1432-1033.1995.0113o.x
   Germot A, 1996, P NATL ACAD SCI USA, V93, P14614, DOI 10.1073/pnas.93.25.14614
   HORWITZ J, 1987, METHOD ENZYMOL, V141, P169
   JOHNSON PJ, 1993, J PARASITOL, V79, P664, DOI 10.2307/3283598
   Koshkin V, 2002, BIOCHEM J, V364, P317, DOI 10.1042/bj3640317
   LINDMARK DG, 1973, J BIOL CHEM, V248, P7724
   Martin W, 2001, BIOL CHEM, V382, P1521, DOI 10.1515/BC.2001.187
   Muller M, 1990, TRICHOMONADS PARASIT, P36
   PALTAUF F, 1982, J PARASITOL, V68, P949, DOI 10.2307/3281012
   Sutak R, 2004, P NATL ACAD SCI USA, V101, P10368, DOI 10.1073/pnas.0401319101
   Wright MM, 2004, BIOCHEM CELL BIOL, V82, P18, DOI 10.1139/o03-092
NR 23
TC 21
Z9 22
U1 1
U2 4
PU AMER SOC MICROBIOLOGY
PI WASHINGTON
PA 1752 N ST NW, WASHINGTON, DC 20036-2904 USA
SN 1535-9778
EI 1535-9786
J9 EUKARYOT CELL
JI Eukaryot. Cell
PD APR
PY 2006
VL 5
IS 4
BP 784
EP 787
DI 10.1128/EC.5.4.784-787.2006
PG 4
WC Microbiology; Mycology
SC Microbiology; Mycology
GA 037YP
UT WOS:000237184300019
PM 16607026
OA Bronze, Green Published
DA 2020-12-17
ER

PT J
AU Mohana-Borges, R
   Goto, NK
   Kroon, GJA
   Dyson, HJ
   Wright, PE
AF Mohana-Borges, R
   Goto, NK
   Kroon, GJA
   Dyson, HJ
   Wright, PE
TI Structural characterization of unfolded states of apomyoglobin using
   residual dipolar couplings
SO JOURNAL OF MOLECULAR BIOLOGY
LA English
DT Article
DE apomyoglobin; unfolded protein; NMR; residual dipolar; coupling;
   conformational ensemble
ID 8 M UREA; INTRINSICALLY UNSTRUCTURED PROTEINS; LONG-RANGE STRUCTURE;
   DENATURED STATE; STAPHYLOCOCCAL NUCLEASE; DYNAMIC CHARACTERIZATION;
   POLYACRYLAMIDE GELS; CHEMICAL-SHIFTS; POLYPROLINE-II; FOLDING
   INTERMEDIATE
AB The conformational propensities of unfolded states of apomyoglobin have been investigated by measurement of residual dipolar couplings between (15)N and (1)H in backbone amide groups. Weak alignment of apomyoglobin in acid and urea-unfolded states was induced with both stretched and compressed polyacrylamide gels. In 8 M urea solution at pH 2.3, conditions under which apomyoglobin contains no detectable secondary or tertiary structure, significant residual dipolar couplings of uniform sign were observed for all residues. At pH 2.3 in the absence of urea, a change in the magnitude and/or sign of the residual dipolar couplings occurs in local regions of the polypeptide where there is a high propensity for helical secondary structure. These results are interpreted on the basis of the statistical properties of the unfolded polypeptide chain, viewed as a polymer of statistical segments. For a folded protein, the magnitude and sign of the residual dipolar couplings depend on the orientation of each bond vector relative to the alignment tensor of the entire molecule, which reorients as a single entity. For unfolded proteins, there is no global alignment tensor; instead, residual dipolar couplings are attributed to alignment of the statistical segments or of transient elements of secondary structure. For apomyoglobin in 8 M urea, the backbone is highly extended, with phi and psi dihedral angles favoring the beta or P(II) regions. Each statistical segment has a highly anisotropic shape, with the N-H bond vectors approximately perpendicular to the long axis, and becomes weakly aligned in the anisotropic environment of the strained acrylamide gels. Local regions of enhanced flexibility or chain compaction are characterized by a decrease in the magnitude of the residual dipolar couplings. The formation of a small population of helical structure in the acid-denatured state of apomyoglobin leads to a change in sign of the residual dipolar couplings in local regions of the polypeptide; the population of helix estimated from the residual dipolar couplings is in excellent agreement with that determined from chemical shifts. The alignment model described here for apomyoglobin can also explain the pattern of residual dipolar couplings reported previously for denatured states of staphylococcal nuclease and other proteins. In conjunction with other NMR experiments, residual dipolar couplings can provide valuable insights into the dynamic conformational propensities of unfolded and partly folded states of proteins and thereby help to chart the upper reaches of the folding landscape. (C) 2004 Elsevier Ltd. All rights reserved.
C1 Scripps Res Inst, Dept Biol Mol, La Jolla, CA 92037 USA.
   Scripps Res Inst, Skaggs Inst Chem Biol, La Jolla, CA 92037 USA.
RP Wright, PE (corresponding author), Scripps Res Inst, Dept Biol Mol, 10550 N Pines Rd, La Jolla, CA 92037 USA.
EM wright@scripps.edu
RI Goto, Natalie/AAO-7979-2020; Borges, Ronaldo S Mohana/C-5575-2013;
   Dyson, Helen Jane/D-4160-2011
OI Goto, Natalie/0000-0003-4877-4884; Dyson, Helen
   Jane/0000-0001-6855-3398; Wright, Peter/0000-0002-1368-0223; Mohana
   Borges, Ronaldo/0000-0002-1796-475X
FU NIDDK NIH HHSUnited States Department of Health & Human ServicesNational
   Institutes of Health (NIH) - USANIH National Institute of Diabetes &
   Digestive & Kidney Diseases (NIDDK) [DK34909] Funding Source: Medline;
   NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASESUnited
   States Department of Health & Human ServicesNational Institutes of
   Health (NIH) - USANIH National Institute of Diabetes & Digestive &
   Kidney Diseases (NIDDK) [R01DK034909, R01DK034909, R37DK034909,
   R01DK034909, R01DK034909, R01DK034909, R37DK034909, R01DK034909,
   R01DK034909, R37DK034909, R01DK034909, R01DK034909, R01DK034909,
   R37DK034909, R01DK034909, R01DK034909, R01DK034909, R01DK034909,
   R37DK034909, R01DK034909, R01DK034909, R01DK034909, R37DK034909,
   R01DK034909, R37DK034909, R37DK034909, R01DK034909, R01DK034909] Funding
   Source: NIH RePORTER
CR Ackerman MS, 2002, BIOCHEMISTRY-US, V41, P13791, DOI 10.1021/bi020511t
   Ackerman MS, 2002, BIOCHEMISTRY-US, V41, P3089, DOI 10.1021/bi0120796
   Alexandrescu AT, 2003, PROTEIN SCI, V12, P2132, DOI 10.1110/ps.03164403
   ALEXANDRESCU AT, 1994, BIOCHEMISTRY-US, V33, P1063, DOI 10.1021/bi00171a004
   Bax A, 2003, PROTEIN SCI, V12, P1, DOI 10.1110/ps.0233303
   BRYNGELSON JD, 1995, PROTEINS, V21, P167, DOI 10.1002/prot.340210302
   Cantor C.R., 1980, BIOPHYSICAL CHEM
   Chou JJ, 2001, J BIOMOL NMR, V21, P377, DOI 10.1023/A:1013336502594
   DAMASCHUN G, 1993, BIOCHEMISTRY-US, V32, P7739, DOI 10.1021/bi00081a019
   DELAGLIO F, 1995, J BIOMOL NMR, V6, P277, DOI 10.1007/BF00197809
   Dyson HJ, 2002, ADV PROTEIN CHEM, V62, P311
   Dyson HJ, 1996, ANNU REV PHYS CHEM, V47, P369, DOI 10.1146/annurev.physchem.47.1.369
   DYSON HJ, 1991, ANNU REV BIOPHYS BIO, V20, P519
   Dyson HJ, 2002, CURR OPIN STRUC BIOL, V12, P54, DOI 10.1016/S0959-440X(02)00289-0
   EDELHOCH H, 1967, BIOCHEMISTRY-US, V6, P1948, DOI 10.1021/bi00859a010
   Eker F, 2004, BIOCHEMISTRY-US, V43, P613, DOI 10.1021/bi035740+
   Eliezer D, 1998, NAT STRUCT BIOL, V5, P148
   ELIEZER D, 1995, SCIENCE, V270, P487, DOI 10.1126/science.270.5235.487
   Eliezer D, 1996, J MOL BIOL, V263, P531, DOI 10.1006/jmbi.1996.0596
   Fieber W, 2004, J MOL BIOL, V339, P1191, DOI 10.1016/j.jmb.2004.04.037
   FLORY PJ, 1969, STAT MECH CHAIN MOL
   FRANK MK, 1995, PROTEIN SCI, V4, P2605, DOI 10.1002/pro.5560041218
   GARRETT DS, 1991, J MAGN RESON, V95, P214, DOI 10.1016/0022-2364(91)90341-P
   Gillespie JR, 1997, J MOL BIOL, V268, P158, DOI 10.1006/jmbi.1997.0954
   Goto NK, 2001, J MOL BIOL, V308, P745, DOI 10.1006/jmbi.2001.4614
   GRIKO YV, 1988, J MOL BIOL, V202, P127, DOI 10.1016/0022-2836(88)90525-6
   GRIKO YV, 1994, J MOL BIOL, V235, P1318, DOI 10.1006/jmbi.1994.1085
   Gulotta M, 2001, BIOCHEMISTRY-US, V40, P5137, DOI 10.1021/bi002256n
   Haber C, 2000, P NATL ACAD SCI USA, V97, P10792, DOI 10.1073/pnas.190320097
   Hansen MR, 1998, NAT STRUCT BIOL, V5, P1065, DOI 10.1038/4176
   Iakoucheva LM, 2002, J MOL BIOL, V323, P573, DOI 10.1016/S0022-2836(02)00969-5
   Ishii Y, 2001, J BIOMOL NMR, V21, P141, DOI 10.1023/A:1012417721455
   Jamin M, 1998, J MOL BIOL, V276, P491, DOI 10.1006/jmbi.1997.1543
   JENNINGS PA, 1994, NATO ADV SCI INST SE, V325, P7
   JOHNSON BA, 1994, J BIOMOL NMR, V4, P604
   Kelly JW, 2002, NAT STRUCT BIOL, V9, P323, DOI 10.1038/nsb0502-323
   Kuhn W, 1934, KOLLOID Z, V68, P2, DOI 10.1007/BF01451681
   Lecomte JTJ, 1999, PROTEIN SCI, V8, P1484, DOI 10.1110/ps.8.7.1484
   Lietzow MA, 2002, J MOL BIOL, V322, P655, DOI 10.1016/S0022-2836(02)00847-1
   Louhivuori M, 2003, J AM CHEM SOC, V125, P15647, DOI 10.1021/ja035427v
   Meekhof AE, 1999, J MOL BIOL, V286, P579, DOI 10.1006/jmbi.1998.2479
   Ohnishi S, 2003, PROTEINS, V50, P546, DOI 10.1002/prot.10327
   Ohnishi S, 2004, BIOCHEMISTRY-US, V43, P4064, DOI 10.1021/bi049879b
   Ottiger M, 1998, J MAGN RESON, V131, P373, DOI 10.1006/jmre.1998.1361
   Pappu RV, 2000, P NATL ACAD SCI USA, V97, P12565, DOI 10.1073/pnas.97.23.12565
   Prestegard JH, 2000, Q REV BIOPHYS, V33, P371, DOI 10.1017/S0033583500003656
   Reymond MT, 1997, PROTEIN SCI, V6, P706
   Rucker AL, 2002, PROTEIN SCI, V11, P980, DOI 10.1110/ps.4550102
   Sass HJ, 2000, J BIOMOL NMR, V18, P303, DOI 10.1023/A:1026703605147
   Schwalbe H, 1997, BIOCHEMISTRY-US, V36, P8977, DOI 10.1021/bi970049q
   Schwarzinger S, 2000, J BIOMOL NMR, V18, P43, DOI 10.1023/A:1008386816521
   Schwarzinger S, 2002, BIOCHEMISTRY-US, V41, P12681, DOI 10.1021/bi020381o
   Schwarzinger S, 2001, J AM CHEM SOC, V123, P2970, DOI 10.1021/ja003760i
   Shi ZS, 2002, ADV PROTEIN CHEM, V62, P163
   Shortle D, 2001, SCIENCE, V293, P487, DOI 10.1126/science.1060438
   Teilum K, 2002, J MOL BIOL, V324, P349, DOI 10.1016/S0022-2836(02)01039-2
   Tjandra N, 1997, SCIENCE, V278, P1111, DOI 10.1126/science.278.5340.1111
   Tompa P, 2002, TRENDS BIOCHEM SCI, V27, P527, DOI 10.1016/S0968-0004(02)02169-2
   Tsui V, 1999, PROTEIN SCI, V8, P45, DOI 10.1110/ps.8.1.45
   Tycko R, 2000, J AM CHEM SOC, V122, P9340, DOI 10.1021/ja002133q
   WISHART DS, 1995, J BIOMOL NMR, V6, P135, DOI 10.1007/BF00211777
   WISHART DS, 1994, METHOD ENZYMOL, V239, P363
   WOLYNES PG, 1995, SCIENCE, V267, P1619, DOI 10.1126/science.7886447
   Wright PE, 1999, J MOL BIOL, V293, P321, DOI 10.1006/jmbi.1999.3110
   Yao J, 2001, BIOCHEMISTRY-US, V40, P3561, DOI 10.1021/bi002776i
   Yi Q, 2000, J MOL BIOL, V299, P1341, DOI 10.1006/jmbi.2000.3816
   ZHANG O, 1995, BIOCHEMISTRY-US, V34, P6784, DOI 10.1021/bi00020a025
NR 67
TC 152
Z9 155
U1 3
U2 21
PU ACADEMIC PRESS LTD- ELSEVIER SCIENCE LTD
PI LONDON
PA 24-28 OVAL RD, LONDON NW1 7DX, ENGLAND
SN 0022-2836
J9 J MOL BIOL
JI J. Mol. Biol.
PD JUL 23
PY 2004
VL 340
IS 5
BP 1131
EP 1142
DI 10.1016/j.jmb.2004.05.022
PG 12
WC Biochemistry & Molecular Biology
SC Biochemistry & Molecular Biology
GA 839CG
UT WOS:000222760300017
PM 15236972
OA Green Published
DA 2020-12-17
ER

PT J
AU Silva, JL
   Oliveira, AC
   Gomes, AMO
   Lima, LMTR
   Mohana-Borges, R
   Pacheco, ABF
   Foguel, D
AF Silva, JL
   Oliveira, AC
   Gomes, AMO
   Lima, LMTR
   Mohana-Borges, R
   Pacheco, ABF
   Foguel, D
TI Pressure induces folding intermediates that are crucial for protein-DNA
   recognition and virus assembly
SO BIOCHIMICA ET BIOPHYSICA ACTA-PROTEIN STRUCTURE AND MOLECULAR ENZYMOLOGY
LA English
DT Review
DE hydrostatic pressure; protein-nucleic acid interaction; protein
   misfolding; amyloidogenesis; human papillomavirus E2 protein; virus
   fusion; picornavirus
ID PAPILLOMAVIRUS E2 PROTEIN; HIGH HYDROSTATIC-PRESSURE;
   TOBACCO-MOSAIC-VIRUS; BINDING DOMAIN; CRYSTAL-STRUCTURE; STAPHYLOCOCCAL
   NUCLEASE; IMMUNODEFICIENCY-VIRUS; CONFORMATIONAL-CHANGES; HIGH
   IMMUNOGENICITY; COLD DENATURATION
AB Protein-nucleic acid interactions are crucial for a variety of fundamental biological processes such as replication, transcription, restriction, translation and virus assembly. The molecular basis of protein-DNA and protein-RNA recognition is deeply related to the thermodynamics of the systems. We review here how protein-nucleic acid interactions can be approached in the same way as protein-protein interactions involved in protein folding and protein assembly, using hydrostatic pressure as the primary tool and employing several spectroscopic techniques, especially fluorescence, circular dichroism and high-resolution nuclear magnetic resonance. High pressure has the unique property of stabilizing partially folded states or molten-globule states of a protein. The competition between correct folding and misfolding, which in many proteins leads to formation of insoluble aggregates is an important problem in the biotechnology industry and in human diseases such as amyloidosis, Alzheimer's, prion and tumor diseases. The pressure studies reveal that a gradient of partially folded (molten globule) conformations is present between the unfolded and fully folded structure of several bacteria, plant and mammalian viruses. Using pressure, we have detected the presence of a ribonucleoprotein intermediate, where the coat protein is partially unfolded but bound to RNA. These intermediates are potential targets for antiviral compounds. Pressure studies on viruses have direct biotechnological applications. The ability of pressure to inactivate viruses has been evaluated with a view toward the applications of vaccine development and virus sterilization. Recent studies demonstrate that pressure causes virus inactivation while preserving the immunogenic properties. There is substantial evidence that a high-pressure cycle traps a virus in the 'fusion intermediate state', not infectious but highly immunogenic. (C) 2002 Elsevier Science B.V. All rights reserved.
C1 Univ Fed Rio de Janeiro, Programa Biol Estrutural, Dept Bioquim Med, ICB,Ctr Nacl Ressonancia Magnet Nucl Macromol, BR-21941590 Rio De Janeiro, Brazil.
   Univ Fed Rio de Janeiro, Fac Farm, Dept Med, BR-21941590 Rio De Janeiro, Brazil.
   Univ Fed Rio de Janeiro, Inst Biofis Carlos Chagas Filho, BR-21941590 Rio De Janeiro, Brazil.
RP Silva, JL (corresponding author), Univ Fed Rio de Janeiro, Programa Biol Estrutural, Dept Bioquim Med, ICB,Ctr Nacl Ressonancia Magnet Nucl Macromol, BR-21941590 Rio De Janeiro, Brazil.
EM jerson@bioqmed.ufrj.br
RI Silva, Jerson/J-8984-2014; Borges, Ronaldo S Mohana/C-5575-2013;
   Pacheco, Ana Beatriz Furlanetto/J-2617-2013; Gomes, Andre/C-4009-2014
OI Silva, Jerson/0000-0001-9523-9441; Pacheco, Ana Beatriz
   Furlanetto/0000-0002-7899-9657; Gomes, Andre/0000-0003-1052-8004;
   Foguel, Debora/0000-0001-7312-7115
CR Bloom BR, 1996, SCIENCE, V272, P1888, DOI 10.1126/science.272.5270.1888
   Bonafe CFS, 1998, BIOCHEMISTRY-US, V37, P11097, DOI 10.1021/bi980349n
   Bondos SE, 2000, BBA-PROTEIN STRUCT M, V1480, P353, DOI 10.1016/S0167-4838(00)00088-1
   Bradley DW, 2000, TRANSFUSION, V40, P193, DOI 10.1046/j.1537-2995.2000.40020193.x
   BULLOUGH PA, 1994, NATURE, V371, P37, DOI 10.1038/371037a0
   CARR CM, 1993, CELL, V73, P823, DOI 10.1016/0092-8674(93)90260-W
   COOPER A, 1976, P NATL ACAD SCI USA, V73, P2740, DOI 10.1073/pnas.73.8.2740
   DaPoian AT, 1996, P NATL ACAD SCI USA, V93, P8268, DOI 10.1073/pnas.93.16.8268
   DAPOIAN AT, 1994, BIOCHEMISTRY-US, V33, P8339, DOI 10.1021/bi00193a022
   DAPOIAN AT, 1995, BIOCHEMISTRY-US, V34, P2672, DOI 10.1021/bi00008a034
   de Sousa PC, 1999, J MOL BIOL, V287, P527
   ERIKSSON AE, 1992, SCIENCE, V255, P178, DOI 10.1126/science.1553543
   Ferrao-Gonzales AD, 2000, P NATL ACAD SCI USA, V97, P6445, DOI 10.1073/pnas.97.12.6445
   FOGH RH, 1994, EMBO J, V13, P3936, DOI 10.1002/j.1460-2075.1994.tb06709.x
   Foguel D, 1999, BIOTECHNOL BIOENG, V63, P552, DOI 10.1002/(SICI)1097-0290(19990605)63:5<552::AID-BIT5>3.0.CO;2-8
   FOGUEL D, 1994, P NATL ACAD SCI USA, V91, P8244, DOI 10.1073/pnas.91.17.8244
   Foguel D, 1998, J BIOL CHEM, V273, P9050, DOI 10.1074/jbc.273.15.9050
   FOGUEL D, 1995, BIOCHEMISTRY-US, V34, P1120, DOI 10.1021/bi00004a003
   Frye KJ, 1998, PROTEIN SCI, V7, P2217, DOI 10.1002/pro.5560071020
   Frye KJ, 1997, PROTEIN SCI, V6, P789
   Gaspar LP, 1997, J MOL BIOL, V273, P456, DOI 10.1006/jmbi.1997.1299
   Gaspar LP, 2001, J BIOL CHEM, V276, P7415, DOI 10.1074/jbc.M010037200
   GASPAR LP, 2001, IN PRESS
   Gorovits BM, 1998, BIOCHEMISTRY-US, V37, P6132, DOI 10.1021/bi9730137
   Hall PA, 1997, CURR BIOL, V7, pR144, DOI 10.1016/S0960-9822(97)70074-5
   Hegde RS, 1998, J MOL BIOL, V284, P1479, DOI 10.1006/jmbi.1998.2260
   Hillson N, 1999, P NATL ACAD SCI USA, V96, P14848, DOI 10.1073/pnas.96.26.14848
   Holmbeck SMA, 1998, J MOL BIOL, V284, P533, DOI 10.1006/jmbi.1998.2207
   Hummer G, 1998, P NATL ACAD SCI USA, V95, P1552, DOI 10.1073/pnas.95.4.1552
   Inoue K, 2000, NAT STRUCT BIOL, V7, P547
   Johnson JE, 1996, P NATL ACAD SCI USA, V93, P27, DOI 10.1073/pnas.93.1.27
   JONAS J, 1994, ANNU REV BIOPH BIOM, V23, P287, DOI 10.1146/annurev.bb.23.060194.001443
   JURKIEWICZ E, 1995, P NATL ACAD SCI USA, V92, P6935, DOI 10.1073/pnas.92.15.6935
   KAUZMANN W, 1959, ADV PROTEIN CHEM, V14, P1, DOI 10.1016/S0065-3233(08)60608-7
   Kelly JW, 1998, CURR OPIN STRUC BIOL, V8, P101, DOI 10.1016/S0959-440X(98)80016-X
   Kitahara R, 2000, BIOCHEMISTRY-US, V39, P12789, DOI 10.1021/bi0009993
   Koo EH, 1999, P NATL ACAD SCI USA, V96, P9989, DOI 10.1073/pnas.96.18.9989
   KUNDROT CE, 1987, J MOL BIOL, V193, P157, DOI 10.1016/0022-2836(87)90634-6
   LaCasse RA, 1999, SCIENCE, V283, P357, DOI 10.1126/science.283.5400.357
   Lauffer MA, 1941, J BIOL CHEM, V140, P509
   Lee C, 2000, P NATL ACAD SCI USA, V97, P7727, DOI 10.1073/pnas.97.14.7727
   Leimkuhler M, 2000, J MOL BIOL, V296, P1295, DOI 10.1006/jmbi.2000.3538
   Lima LMTR, 2000, P NATL ACAD SCI USA, V97, P14289, DOI 10.1073/pnas.250352197
   LITTLE JW, 1994, METHOD ENZYMOL, V244, P266
   LUISI B, 1995, DNA PROTEIN STRUCTUR, P1
   Luo Y, 2001, CELL, V106, P585, DOI 10.1016/S0092-8674(01)00479-2
   Lynch TW, 2000, J BIOL CHEM, V275, P30561, DOI 10.1074/jbc.M000266200
   Macgregor RB, 1998, BIOPOLYMERS, V48, P253, DOI 10.1002/(SICI)1097-0282(1998)48:4<253::AID-BIP5>3.3.CO;2-6
   Mohana-Borges R, 1999, P NATL ACAD SCI USA, V96, P7888, DOI 10.1073/pnas.96.14.7888
   Mohana-Borges R, 2000, J BIOL CHEM, V275, P4708, DOI 10.1074/jbc.275.7.4708
   Mohana-Borges R, 1999, J BIOL CHEM, V274, P7732, DOI 10.1074/jbc.274.12.7732
   Mozhaev VV, 1996, PROTEINS, V24, P81, DOI 10.1002/(SICI)1097-0134(199601)24:1<81::AID-PROT6>3.0.CO;2-R
   Nakagami T, 1996, TRANSFUSION, V36, P475, DOI 10.1046/j.1537-2995.1996.36596282595.x
   Nash DP, 1997, BIOCHEMISTRY-US, V36, P14375, DOI 10.1021/bi970881v
   OLIVEIRA AC, 1994, J MOL BIOL, V240, P184, DOI 10.1006/jmbi.1994.1433
   Oliveira AC, 1999, BIOPHYS J, V76, P1270, DOI 10.1016/S0006-3495(99)77290-5
   Oliveira AC, 1999, NATO ADV SCI I E-APP, V358, P497
   Oliveira AC, 2000, J BIOL CHEM, V275, P16037, DOI 10.1074/jbc.M910145199
   PABO CO, 1992, ANNU REV BIOCHEM, V61, P1053, DOI 10.1146/annurev.bi.61.070192.005201
   PENG XD, 1994, BIOCHEMISTRY-US, V33, P8323, DOI 10.1021/bi00193a020
   PENG XD, 1993, P NATL ACAD SCI USA, V90, P1776, DOI 10.1073/pnas.90.5.1776
   Pontes L, 2001, J MOL BIOL, V307, P1171, DOI 10.1006/jmbi.2001.4512
   PREVELIGE PE, 1994, BIOPHYS J, V66, P1631, DOI 10.1016/S0006-3495(94)80955-5
   Radford SE, 1999, CELL, V97, P291, DOI 10.1016/S0092-8674(00)80739-4
   Rietveld AWM, 1996, BIOCHEMISTRY-US, V35, P7743, DOI 10.1021/bi952118b
   ROBINSON CR, 1995, P NATL ACAD SCI USA, V92, P3444, DOI 10.1073/pnas.92.8.3444
   ROSSMANN MG, 1994, PROTEIN SCI, V3, P1712, DOI 10.1002/pro.5560031010
   ROYER CA, 1990, BIOCHEMISTRY-US, V29, P4959, DOI 10.1021/bi00472a028
   Ruan KC, 1999, EUR J BIOCHEM, V265, P79, DOI 10.1046/j.1432-1327.1999.00665.x
   RUECKERT RR, FIELDS VIROLOGY, P609
   Saad-Nehme J, 2001, BBA-PROTEIN STRUCT M, V1546, P164, DOI 10.1016/S0167-4838(01)00137-6
   Silva CCM, 2001, VACCINE, V19, P1511, DOI 10.1016/S0264-410X(00)00361-3
   SILVA JL, 1992, J VIROL, V66, P2111, DOI 10.1128/JVI.66.4.2111-2117.1992
   Silva JL, 1996, CURR OPIN STRUC BIOL, V6, P166, DOI 10.1016/S0959-440X(96)80071-6
   SILVA JL, 1993, ANNU REV PHYS CHEM, V44, P89, DOI 10.1146/annurev.physchem.44.1.89
   Silva JL, 2001, TRENDS BIOCHEM SCI, V26, P612, DOI 10.1016/S0968-0004(01)01949-1
   SILVA JL, 1992, J MOL BIOL, V223, P545, DOI 10.1016/0022-2836(92)90669-B
   SILVA JL, 1993, PROTEIN SCI, V2, P945, DOI 10.1002/pro.5560020608
   Skehel JJ, 2000, ANNU REV BIOCHEM, V69, P531, DOI 10.1146/annurev.biochem.69.1.531
   Smeller L, 1999, BIOCHEMISTRY-US, V38, P3816, DOI 10.1021/bi981693n
   SPOLAR RS, 1994, SCIENCE, V263, P777, DOI 10.1126/science.8303294
   St John RJ, 1999, P NATL ACAD SCI USA, V96, P13029, DOI 10.1073/pnas.96.23.13029
   Suarez MC, 2001, BIOCHEMISTRY-US, V40, P1300, DOI 10.1021/bi0020978
   Tian SM, 2000, EUR J BIOCHEM, V267, P4486, DOI 10.1046/j.1432-1327.2000.01496.x
   TILTON RF, 1988, BIOCHEMISTRY-US, V27, P6574, DOI 10.1021/bi00417a057
   VIDUGIRIS GJA, 1995, BIOCHEMISTRY-US, V34, P4909, DOI 10.1021/bi00015a001
   VONHIPPEL PH, 1994, SCIENCE, V263, P769, DOI 10.1126/science.8303292
   Walker GC, 2001, MOL CELL, V8, P486, DOI 10.1016/S1097-2765(01)00337-9
   Webb JN, 2001, P NATL ACAD SCI USA, V98, P7259, DOI 10.1073/pnas.131194798
   WEBER G, 1993, J PHYS CHEM-US, V97, P7108, DOI 10.1021/j100129a031
   WEBER G, 1983, Q REV BIOPHYS, V16, P89, DOI 10.1017/S0033583500004935
   Weber G., 1992, PROTEIN INTERACTIONS
   Woenckhaus J, 2001, BIOPHYS J, V80, P1518, DOI 10.1016/S0006-3495(01)76124-3
   ZHANG J, 1995, BIOCHEMISTRY-US, V34, P8631, DOI 10.1021/bi00027a012
NR 94
TC 48
Z9 52
U1 0
U2 10
PU ELSEVIER
PI AMSTERDAM
PA RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS
SN 0167-4838
J9 BBA-PROTEIN STRUCT M
JI Biochim. Biophys. Acta-Protein Struct. Molec. Enzym.
PD MAR 25
PY 2002
VL 1595
IS 1-2
BP 250
EP 265
AR PII S0167-4838(01)00348-X
DI 10.1016/S0167-4838(01)00348-X
PG 16
WC Biochemistry & Molecular Biology; Biophysics
SC Biochemistry & Molecular Biology; Biophysics
GA 557FJ
UT WOS:000175897400019
PM 11983400
DA 2020-12-17
ER

PT J
AU Oliveira, AC
   Gomes, AMO
   Almeida, FCL
   Mohana-Borges, R
   Valente, AP
   Reddy, VS
   Johnson, JE
   Silva, JL
AF Oliveira, AC
   Gomes, AMO
   Almeida, FCL
   Mohana-Borges, R
   Valente, AP
   Reddy, VS
   Johnson, JE
   Silva, JL
TI Virus maturation targets the protein capsid to concerted disassembly and
   unfolding
SO JOURNAL OF BIOLOGICAL CHEMISTRY
LA English
DT Article
ID FLOCK-HOUSE VIRUS; INFLUENZA HEMAGGLUTININ; FUNCTIONAL IMPLICATIONS;
   3-DIMENSIONAL STRUCTURE; PRESSURE DENATURATION; MEMBRANE-FUSION; ARC
   REPRESSOR; MOSAIC-VIRUS; STABILITY; PICORNAVIRUSES
AB Many animal viruses undergo post-assembly proteolytic cleavage that is required for infectivity, The role of maturation cleavage on Flock House virus was evaluated by comparing wild type (wt) and cleavage-defective mutant (D75N) Flock House virus virus-like particles. A concerted dissociation and unfolding of the mature wt particle was observed under treatment by urea, whereas the cleavage-defective mutant dissociated to folded subunits as determined by steady-state and dynamic fluorescence spectroscopy, circular dichroism, and nuclear magnetic resonance. The folded D75N a subunit could reassemble into capsids, whereas the yield of reassembly from unfolded cleaved alpha subunits was very low. Overall, our results demonstrate that the maturation/cleavage process targets the particle for an "off pathway" disassembly, because dissociation is coupled to unfolding. The increased motions in the cleaved capsid, revealed by fluorescence and NMR, and the concerted nature of dissociation/unfolding may be crucial to make the mature particle infectious.
C1 Univ Fed Rio de Janeiro, Ctr Nacl Ressonancia Magnet Nucl Macromol, Inst Ciencias Biomed, Dept Bioquim Med, BR-21941590 Rio De Janeiro, Brazil.
   Scripps Res Inst, Dept Mol Biol, La Jolla, CA 92037 USA.
RP Silva, JL (corresponding author), Univ Fed Rio de Janeiro, Ctr Nacl Ressonancia Magnet Nucl Macromol, Inst Ciencias Biomed, Dept Bioquim Med, BR-21941590 Rio De Janeiro, Brazil.
RI Silva, Jerson/J-8984-2014; Almeida, Fabio/O-4989-2018; Borges, Ronaldo S
   Mohana/C-5575-2013; Gomes, Andre/C-4009-2014; Valente, Ana
   Paula/J-3010-2017
OI Silva, Jerson/0000-0001-9523-9441; Almeida, Fabio/0000-0001-6046-7006;
   Gomes, Andre/0000-0003-1052-8004; Valente, Ana Paula/0000-0001-7219-1123
CR ALCALA JR, 1985, ANAL INSTRUM, V14, P225
   Baker KA, 1999, MOL CELL, V3, P309, DOI 10.1016/S1097-2765(00)80458-X
   BAVASAPPA R, 1994, PROTEIN SCI, V3, P1651
   BEECHEM JM, 1991, TOPICS FLUORESCENCE, V2, P241
   Bong DT, 1999, CHEM BIOL, V6, P473, DOI 10.1016/S1074-5521(99)80065-9
   Bothner B, 1999, NAT STRUCT BIOL, V6, P114
   BULLOUGH PA, 1994, NATURE, V371, P37, DOI 10.1038/371037a0
   CARR CM, 1993, CELL, V73, P823, DOI 10.1016/0092-8674(93)90260-W
   Chan DC, 1997, CELL, V89, P263, DOI 10.1016/S0092-8674(00)80205-6
   CHENG RH, 1994, STRUCTURE, V2, P271
   COOPER A, 1976, P NATL ACAD SCI USA, V73, P2740, DOI 10.1073/pnas.73.8.2740
   DAPOIAN AT, 1995, BIOCHEMISTRY-US, V34, P2672, DOI 10.1021/bi00008a034
   Dimitrov DS, 1997, CELL, V91, P721, DOI 10.1016/S0092-8674(00)80460-2
   FOGUEL D, 1995, BIOCHEMISTRY-US, V34, P120
   GALLAGHER TM, 1988, J VIROL, V62, P3399, DOI 10.1128/JVI.62.9.3399-3406.1988
   Gaspar LP, 1997, J MOL BIOL, V273, P456, DOI 10.1006/jmbi.1997.1299
   GRATTON E, 1986, BIOCHEM SOC T, V14, P835, DOI 10.1042/bst0140835
   Harrison Stephen C., 1996, P59
   HOGLE JM, 1985, SCIENCE, V229, P1358, DOI 10.1126/science.2994218
   Janshoff A, 1999, BIOCHEMISTRY-US, V38, P5328, DOI 10.1021/bi982976i
   Johnson JE, 1996, P NATL ACAD SCI USA, V93, P27, DOI 10.1073/pnas.93.1.27
   LIANG H, 1993, P NATL ACAD SCI USA, V90, P7010, DOI 10.1073/pnas.90.15.7010
   Mohana-Borges R, 1999, J BIOL CHEM, V274, P7732, DOI 10.1074/jbc.274.12.7732
   Oliveira AC, 1999, BIOPHYS J, V76, P1270, DOI 10.1016/S0006-3495(99)77290-5
   PALADINI AA, 1981, BIOCHEMISTRY-US, V20, P2587, DOI 10.1021/bi00512a034
   PIOTTO M, 1992, J BIOMOL NMR, V2, P661, DOI 10.1007/BF02192855
   PREDKI PF, 1995, BIOCHEMISTRY-US, V34, P9834, DOI 10.1021/bi00031a003
   PREVELIGE PE, 1994, BIOPHYS J, V66, P1631, DOI 10.1016/S0006-3495(94)80955-5
   Robinson CR, 1996, BIOCHEMISTRY-US, V35, P13878, DOI 10.1021/bi961375t
   Robinson CR, 1995, METHOD ENZYMOL, V259, P395
   ROSSMANN MG, 1994, PROTEIN SCI, V3, P1712, DOI 10.1002/pro.5560031010
   ROSSMANN MG, 1985, NATURE, V317, P145, DOI 10.1038/317145a0
   ROSSMANN MG, 1989, ANNU REV BIOCHEM, V58, P533, DOI 10.1146/annurev.bi.58.070189.002533
   RUECKERT RR, 1996, FIELDS VIROLOGY, P609
   Schneemann A, 1998, ADV VIRUS RES, V50, P381, DOI 10.1016/S0065-3527(08)60812-X
   SCHNEEMANN A, 1994, J VIROL, V68, P4547, DOI 10.1128/JVI.68.7.4547-4556.1994
   SCHNEEMANN A, 1993, J VIROL, V67, P2756, DOI 10.1128/JVI.67.5.2756-2763.1993
   SILVA JL, 1988, J MOL BIOL, V199, P149, DOI 10.1016/0022-2836(88)90385-3
   Silva JL, 1996, CURR OPIN STRUC BIOL, V6, P166, DOI 10.1016/S0959-440X(96)80071-6
   SILVA JL, 1993, ANNU REV PHYS CHEM, V44, P89, DOI 10.1146/annurev.physchem.44.1.89
   SILVA JL, 1992, J MOL BIOL, V223, P545, DOI 10.1016/0022-2836(92)90669-B
   Smith TJ, 1999, ADV VIRUS RES, V52, P1, DOI 10.1016/S0065-3527(08)60297-3
   WERY JP, 1994, J MOL BIOL, V235, P565, DOI 10.1006/jmbi.1994.1014
   ZLOTNICK A, 1994, J BIOL CHEM, V269, P13680
NR 44
TC 26
Z9 27
U1 0
U2 3
PU AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC
PI BETHESDA
PA 9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA
SN 0021-9258
J9 J BIOL CHEM
JI J. Biol. Chem.
PD MAY 26
PY 2000
VL 275
IS 21
BP 16037
EP 16043
DI 10.1074/jbc.M910145199
PG 7
WC Biochemistry & Molecular Biology
SC Biochemistry & Molecular Biology
GA 318NX
UT WOS:000087291400059
PM 10748191
OA Bronze
DA 2020-12-17
ER

PT J
AU Mohana-Borges, R
   Pacheco, ABF
   Sousa, FJR
   Foguel, D
   Almeida, DF
   Silva, JL
AF Mohana-Borges, R
   Pacheco, ABF
   Sousa, FJR
   Foguel, D
   Almeida, DF
   Silva, JL
TI LexA repressor forms stable dimers in solution - The role of specific
   DNA in tightening protein-protein interactions
SO JOURNAL OF BIOLOGICAL CHEMISTRY
LA English
DT Article
ID ESCHERICHIA-COLI; HIGH-PRESSURE; BINDING DOMAIN; ARC REPRESSOR;
   DIMERIZATION; RECOGNITION; CLEAVAGE; DAMAGE; OLIGOMERIZATION;
   SPECTROSCOPY
AB Cooperativity in the interactions among proteins subunits and DNA is crucial for DNA recognition. LexA repressor was originally thought to bind DNA as a monomer, with cooperativity leading to tighter binding of the second monomer, The main support for this model was a high value of the dissociation constant for the LexA dimer (micromolar range). Here we show that the protein is a dimer at nanomolar concentrations under different conditions, The reversible dissociation of LexA dimer was investigated by the effects of hydrostatic pressure or urea, using fluorescence emission and polarization to monitor the dissociation process. The dissociation constant lies in the picomolar range (lower than 20 pM). LexA monomers associate with an unusual large volume change (340 ml/mol), indicating the burial of a large surface area upon dimerization, Whereas nonspecific DNA has no stabilizing effect, specific DNA induces tightening of the dimer and a 750-fold decrease in the K-d. In contrast to the previous model, a tight dimer rather than a monomer is the functional repressor. Accordingly, the LexA dimer only loses its ability to recognize a specific DNA sequence by RecA-induced autoproteolysis, Our work provides insights into the linkage between protein-protein interactions, DNA recognition, and DNA repair.
C1 Univ Fed Rio de Janeiro, Ctr Nacl Ressonancia Magnet Nucl Macromol, ICB, Dept Bioquim Med,Programa Biol Estrutural, BR-21941590 Rio De Janeiro, Brazil.
   Univ Fed Rio de Janeiro, Inst Biofis Carlos Chagas Filho, BR-21941590 Rio De Janeiro, Brazil.
RP Silva, JL (corresponding author), Univ Fed Rio de Janeiro, Ctr Nacl Ressonancia Magnet Nucl Macromol, ICB, Dept Bioquim Med,Programa Biol Estrutural, BR-21941590 Rio De Janeiro, Brazil.
RI Pacheco, Ana Beatriz Furlanetto/J-2617-2013; Silva, Jerson/J-8984-2014;
   Borges, Ronaldo S Mohana/C-5575-2013
OI Pacheco, Ana Beatriz Furlanetto/0000-0002-7899-9657; Silva,
   Jerson/0000-0001-9523-9441; Foguel, Debora/0000-0001-7312-7115
CR BEECHEM JM, 1991, TOPICS FLUORESCENCE, V2, P241
   Bitinaite J, 1998, P NATL ACAD SCI USA, V95, P10570, DOI 10.1073/pnas.95.18.10570
   BLANCHE PJ, 1981, BIOCHIM BIOPHYS ACTA, V665, P408, DOI 10.1016/0005-2760(81)90253-8
   Chen L, 1998, NATURE, V392, P42, DOI 10.1038/32100
   Cho S, 1998, BIOCHEMISTRY-US, V37, P11301, DOI 10.1021/bi972916x
   FOGH RH, 1994, EMBO J, V13, P3936, DOI 10.1002/j.1460-2075.1994.tb06709.x
   FOGUEL D, 1994, P NATL ACAD SCI USA, V91, P8244, DOI 10.1073/pnas.91.17.8244
   Foguel D, 1998, J BIOL CHEM, V273, P9050, DOI 10.1074/jbc.273.15.9050
   Grillo AO, 1999, J MOL BIOL, V287, P539, DOI 10.1006/jmbi.1999.2625
   Harrington W F, 1973, Methods Enzymol, V27, P306
   HEREMANS K, 1982, ANNU REV BIOPHYS BIO, V11, P1, DOI 10.1146/annurev.bb.11.060182.000245
   Holmbeck SMA, 1998, J MOL BIOL, V284, P533, DOI 10.1006/jmbi.1998.2207
   JONAS J, 1994, ANNU REV BIOPH BIOM, V23, P287, DOI 10.1146/annurev.bb.23.060194.001443
   JOSEPHS R, 1967, P NATL ACAD SCI USA, V58, P1587, DOI 10.1073/pnas.58.4.1587
   KIM B, 1992, SCIENCE, V255, P203, DOI 10.1126/science.1553548
   Kohler JJ, 1999, P NATL ACAD SCI USA, V96, P11735, DOI 10.1073/pnas.96.21.11735
   Konola JT, 1998, J MOL BIOL, V276, P405, DOI 10.1006/jmbi.1997.1531
   LEWIS LK, 1994, J MOL BIOL, V241, P507, DOI 10.1006/jmbi.1994.1528
   LITTLE JW, 1985, P NATL ACAD SCI USA, V82, P2301, DOI 10.1073/pnas.82.8.2301
   LITTLE JW, 1994, METHOD ENZYMOL, V244, P266
   LITTLE JW, 1982, CELL, V29, P11, DOI 10.1016/0092-8674(82)90085-X
   LUISI B, 1995, DNA PROTEIN STRUCTUR, P1
   LUISI BF, 1991, NATURE, V352, P497, DOI 10.1038/352497a0
   NEET KE, 1994, PROTEIN SCI, V3, P2167, DOI 10.1002/pro.5560031202
   PABO CO, 1992, ANNU REV BIOCHEM, V61, P1053, DOI 10.1146/annurev.bi.61.070192.005201
   Pace C N, 1986, Methods Enzymol, V131, P266
   PALADINI AA, 1981, BIOCHEMISTRY-US, V20, P2587, DOI 10.1021/bi00512a034
   Peat TS, 1996, NATURE, V380, P727, DOI 10.1038/380727a0
   Rentzeperis D, 1999, NAT STRUCT BIOL, V6, P569
   SCHLEIF R, 1988, SCIENCE, V241, P1182, DOI 10.1126/science.2842864
   SCHNARR M, 1985, BIOCHEMISTRY-US, V24, P2812, DOI 10.1021/bi00332a032
   Shaner SL, 1996, J MOL RECOGNIT, V9, P468, DOI 10.1002/(SICI)1099-1352(199634/12)9:5/6<468::AID-JMR284>3.0.CO;2-W
   Silva JL, 1996, CURR OPIN STRUC BIOL, V6, P166, DOI 10.1016/S0959-440X(96)80071-6
   SILVA JL, 1993, ANNU REV PHYS CHEM, V44, P89, DOI 10.1146/annurev.physchem.44.1.89
   SILVA JL, 1992, J MOL BIOL, V223, P545, DOI 10.1016/0022-2836(92)90669-B
   SILVA JL, 1993, PROTEIN SCI, V2, P945, DOI 10.1002/pro.5560020608
   SMITH TL, 1995, J MOL BIOL, V249, P729, DOI 10.1006/jmbi.1995.0332
   SPOLAR RS, 1994, SCIENCE, V263, P777, DOI 10.1126/science.8303294
   STEITZ TA, 1990, Q REV BIOPHYS, V23, P205, DOI 10.1017/S0033583500005552
   STUDIER FW, 1990, METHOD ENZYMOL, V185, P60
   VONHIPPEL PH, 1994, SCIENCE, V263, P769, DOI 10.1126/science.8303292
   WALKER GC, 1984, MICROBIOL REV, V48, P60, DOI 10.1128/MMBR.48.1.60-93.1984
   WEBER G, 1983, Q REV BIOPHYS, V16, P89, DOI 10.1017/S0033583500004935
   Weber G, 1992, PROTEIN INTERACTIONS
   WU JQ, 1993, BIOCHEMISTRY-US, V32, P12531, DOI 10.1021/bi00097a033
NR 45
TC 69
Z9 71
U1 0
U2 3
PU AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC
PI BETHESDA
PA 9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA
SN 0021-9258
J9 J BIOL CHEM
JI J. Biol. Chem.
PD FEB 18
PY 2000
VL 275
IS 7
BP 4708
EP 4712
DI 10.1074/jbc.275.7.4708
PG 5
WC Biochemistry & Molecular Biology
SC Biochemistry & Molecular Biology
GA 285FC
UT WOS:000085378200027
PM 10671501
OA Bronze
DA 2020-12-17
ER

PT J
AU Mohana-Borges, R
   Silva, JL
   Ruiz-Sanz, J
   de Prat-Gay, G
AF Mohana-Borges, R
   Silva, JL
   Ruiz-Sanz, J
   de Prat-Gay, G
TI Folding of a pressure-denatured model protein
SO PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF
   AMERICA
LA English
DT Article
ID BARLEY CHYMOTRYPSIN INHIBITOR-2; NUCLEATION-CONDENSATION MECHANISM; 2
   COMPLEMENTARY FRAGMENTS; TRANSITION-STATE; STRUCTURAL CHARACTERIZATION;
   STAPHYLOCOCCAL NUCLEASE; FUNNELS; ASSOCIATION; PATHWAYS; KINETICS
AB The noncovalent complex formed by the association of two fragments of chymotrypsin inhibitor-2 is reversibly denatured by pressure in the absence of chemical denaturants, On pressure release, the complex returned to its original conformation through a biphasic reaction, with first-order rate constants of 0.012 and 0.002 s(-1), respectively. The slowest phase arises from an interconversion of the pressure-denatured state, as revealed by double pressure-jump experiments. Below 5 mu M, the process was concentration dependent with a second-order rate constant of 1,700 s(-1) M-1. Fragment association at atmospheric pressure showed a similar break in the order of the reaction above 5 mu M, but both first- and second-order folding/association rates are 2.5 times faster than those for the refolding of the pressure-denatured state. Although the folding rates of the intact protein and the association of the fragments displayed nonlinear Eyring behavior for the temperature dependence, refolding of the pressure-denatured complex showed a linear response. The negligible heat capacity of activation reflects a balance of minimal change in the burial of residues from the pressure-denatured state to the transition state. If we add the higher energy barrier in the refolding of the pressure-denatured state, the rate differences must lie in the structure of this state, which has to undergo a structural rearrangement. This clearly differs from the conformational flexibility of the isolated fragments or the largely unfolded denatured state of the intact protein in acid and provides insight into denatured states of proteins under folding conditions.
C1 Univ Buenos Aires, Fdn Campomar, Inst Invest Bioquim, RA-1405 Buenos Aires, DF, Argentina.
   Univ Buenos Aires, Fac Ciencias Exactas & Nat, RA-1405 Buenos Aires, DF, Argentina.
   Univ Granada, Fac Ciencias, Dept Quim Fis, E-18071 Granada, Spain.
   Univ Granada, Fac Ciencias, Inst Biotechnol, E-18071 Granada, Spain.
   Univ Fed Rio de Janeiro, Dept Bioquim Med, BR-21741590 Rio De Janeiro, Brazil.
RP de Prat-Gay, G (corresponding author), Univ Buenos Aires, Fdn Campomar, Inst Invest Bioquim, Patricias Argentinas 435, RA-1405 Buenos Aires, DF, Argentina.
RI Silva, Jerson/J-8984-2014; Borges, Ronaldo S Mohana/C-5575-2013
OI Silva, Jerson/0000-0001-9523-9441; Ruiz Sanz,
   Javier/0000-0002-4336-1274; Prat Gay, Gonzalo/0000-0001-5748-6863
CR BRYNGELSON JD, 1995, PROTEINS, V21, P167, DOI 10.1002/prot.340210302
   CHEN BL, 1989, BIOCHEMISTRY-US, V28, P691, DOI 10.1021/bi00428a042
   Dill KA, 1997, NAT STRUCT BIOL, V4, P10, DOI 10.1038/nsb0197-10
   FERSHT AR, 1995, CURR OPIN STRUC BIOL, V5, P79, DOI 10.1016/0959-440X(95)80012-P
   Foguel D, 1998, J BIOL CHEM, V273, P9050, DOI 10.1074/jbc.273.15.9050
   GAY GD, 1994, BIOCHEMISTRY-US, V33, P7957, DOI 10.1021/bi00191a024
   GAY GD, 1995, J MOL BIOL, V254, P968, DOI 10.1006/jmbi.1995.0669
   GAY GD, 1994, P NATL ACAD SCI USA, V91, P10943, DOI 10.1073/pnas.91.23.10943
   GAY GD, 1994, BIOCHEMISTRY-US, V33, P7964, DOI 10.1021/bi00191a025
   GAY GD, 1996, PROTEIN ENG, V9, P843
   Glasstone S, 1941, THEORY RATE PROCESSE
   HEREMANS K, 1982, ANNU REV BIOPHYS BIO, V11, P1, DOI 10.1146/annurev.bb.11.060182.000245
   Hummer G, 1998, P NATL ACAD SCI USA, V95, P1552, DOI 10.1073/pnas.95.4.1552
   ITZHAKI LS, 1995, J MOL BIOL, V254, P260, DOI 10.1006/jmbi.1995.0616
   JACKSON SE, 1991, BIOCHEMISTRY-US, V30, P10436, DOI 10.1021/bi00107a011
   Laidler K.J., 1950, CHEM KINETICS, P1
   Li AJ, 1996, J MOL BIOL, V257, P412, DOI 10.1006/jmbi.1996.0172
   LIVINGSTONE JR, 1991, BIOCHEMISTRY-US, V30, P4237, DOI 10.1021/bi00231a019
   Mohana-Borges R, 1999, J BIOL CHEM, V274, P7732, DOI 10.1074/jbc.274.12.7732
   MYERS JK, 1995, PROTEIN SCI, V4, P2138, DOI 10.1002/pro.5560041020
   Neira JL, 1996, FOLD DES, V1, P189, DOI 10.1016/S1359-0278(96)00031-4
   Nymeyer H, 1998, P NATL ACAD SCI USA, V95, P5921, DOI 10.1073/pnas.95.11.5921
   OTZEN DE, 1994, P NATL ACAD SCI USA, V91, P10422, DOI 10.1073/pnas.91.22.10422
   PALADINI AA, 1981, REV SCI INSTRUM, V52, P419, DOI 10.1063/1.1136596
   Panick G, 1998, J MOL BIOL, V275, P389, DOI 10.1006/jmbi.1997.1454
   RUIZSANZ J, 1995, BIOCHEMISTRY-US, V34, P1695, DOI 10.1021/bi00005a026
   Shakhnovich E, 1996, NATURE, V379, P96, DOI 10.1038/379096a0
   Shoemaker BA, 1997, P NATL ACAD SCI USA, V94, P777, DOI 10.1073/pnas.94.3.777
   Silva JL, 1996, CURR OPIN STRUC BIOL, V6, P166, DOI 10.1016/S0959-440X(96)80071-6
   SILVA JL, 1993, ANNU REV PHYS CHEM, V44, P89, DOI 10.1146/annurev.physchem.44.1.89
   VIDUGIRIS GJA, 1995, BIOCHEMISTRY-US, V34, P4909, DOI 10.1021/bi00015a001
   Vidugiris GJA, 1996, BIOCHEMISTRY-US, V35, P3857, DOI 10.1021/bi952012g
   WEBER G, 1983, Q REV BIOPHYS, V16, P89, DOI 10.1017/S0033583500004935
   ZHANG J, 1995, BIOCHEMISTRY-US, V34, P8631, DOI 10.1021/bi00027a012
NR 34
TC 51
Z9 51
U1 0
U2 7
PU NATL ACAD SCIENCES
PI WASHINGTON
PA 2101 CONSTITUTION AVE NW, WASHINGTON, DC 20418 USA
SN 0027-8424
J9 P NATL ACAD SCI USA
JI Proc. Natl. Acad. Sci. U. S. A.
PD JUL 6
PY 1999
VL 96
IS 14
BP 7888
EP 7893
DI 10.1073/pnas.96.14.7888
PG 6
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA 214RV
UT WOS:000081342100054
PM 10393917
OA Green Published, Bronze
DA 2020-12-17
ER

PT J
AU Mohana-Borges, R
   Silva, JL
   de Prat-Gay, G
AF Mohana-Borges, R
   Silva, JL
   de Prat-Gay, G
TI Protein folding in the absence of chemical denaturants - Reversible
   pressure denaturation of the noncovalent complex formed by the
   association of two protein fragments
SO JOURNAL OF BIOLOGICAL CHEMISTRY
LA English
DT Article
ID BARLEY CHYMOTRYPSIN INHIBITOR-2; TRANSITION-STATE; HYDROPHOBIC CORE; ARC
   REPRESSOR; DISSOCIATION; FLUORESCENCE; SPECTROSCOPY; EQUILIBRIUM;
   STABILITY; NUCLEASE
AB Small monomeric proteins are the best models for studying protein folding, but they are often too stable for denaturation using pressure as the sole perturbant. In the present work we subject [CI-2(1-40).(41-64)], a noncovalent complex formed by the association of two complementary fragments of the chymotrypsin inhibitor-2, to high pressure to investigate the folding mechanism of a model protein. Pressures up to 3.5 kilobar do not affect the intact protein, but it can be unfolded reversibly by pressure in the presence of subdenaturing concentrations of guanidine chloride, with free energy and molar volume changes of 2.5 kcal mol(-1) and 42.5 ml mol(-1), respectively. In contrast, the complex can be reversibly denatured by high pressure without the addition of chemical denaturants. However, the process is clearly independent of the protein concentration, indicating lack of dissociation. We determined a change in the free energy of 1.4 kcal mol(-1) and a molar volume change of 35 ml mol(-1) for the pressure denaturation of the complex. A persistent quenching of the tryptophan adds further evidence for the presence of residual structure in the high pressure-denatured state. This state also appears to be compact as the small volume change indicates, compared with pressure denaturation of naturally occurring dimers, Based on observations of a number of pressure-denatured states and on characteristics of large CI-2 fragments with a solvent accessible core but maintaining tertiary interactions, the structure of the pressure-denatured state of the CI-2 complex could be explained by an ordered molten globule-like conformation.
C1 Fdn Campomar, Inst Invest Bioquim, RA-1405 Buenos Aires, DF, Argentina.
   Univ Fed Rio de Janeiro, Dept Bioquim Med, ICB, Ctr Nacl Ressonancia Magnet Nucl Macromol, BR-21941590 Rio De Janeiro, Brazil.
RP de Prat-Gay, G (corresponding author), Fdn Campomar, Inst Invest Bioquim, Av Patricias Argentinas 435, RA-1405 Buenos Aires, DF, Argentina.
EM pratgay@iris.iib.uba.ar
RI Borges, Ronaldo S Mohana/C-5575-2013; Silva, Jerson/J-8984-2014
OI Silva, Jerson/0000-0001-9523-9441; Prat Gay, Gonzalo/0000-0001-5748-6863
CR de Prat Gay G, 1994, Proc Natl Acad Sci U S A, V91, P10943
   DEPRATGAY G, 1996, ARCH BIOCHEM BIOPHYS, V334, P1
   EFTINK MR, 1991, BIOCHEMISTRY-US, V30, P1193, DOI 10.1021/bi00219a005
   Foguel D, 1998, J BIOL CHEM, V273, P9050, DOI 10.1074/jbc.273.15.9050
   GAY GD, 1994, BIOCHEMISTRY-US, V33, P7957, DOI 10.1021/bi00191a024
   GAY GD, 1995, P NATL ACAD SCI USA, V92, P3683, DOI 10.1073/pnas.92.9.3683
   GAY GD, 1995, J MOL BIOL, V254, P968, DOI 10.1006/jmbi.1995.0669
   GAY GD, 1994, PROTEIN ENG, V7, P103
   GAY GD, 1994, BIOCHEMISTRY-US, V33, P7964, DOI 10.1021/bi00191a025
   GROSS M, 1994, EUR J BIOCHEM, V221, P617, DOI 10.1111/j.1432-1033.1994.tb18774.x
   HEREMANS K, 1982, ANNU REV BIOPHYS BIO, V11, P1, DOI 10.1146/annurev.bb.11.060182.000245
   ITZHAKI LS, 1995, J MOL BIOL, V254, P260, DOI 10.1006/jmbi.1995.0616
   JACKSON SE, 1993, BIOCHEMISTRY-US, V32, P11270, DOI 10.1021/bi00093a002
   JACKSON SE, 1991, BIOCHEMISTRY-US, V30, P10428, DOI 10.1021/bi00107a010
   JACKSON SE, 1993, BIOCHEMISTRY-US, V32, P11259, DOI 10.1021/bi00093a001
   JONAS J, 1994, ANNU REV BIOPH BIOM, V23, P287, DOI 10.1146/annurev.bb.23.060194.001443
   LETILLY V, 1992, EUR J BIOCHEM, V205, P1061
   LI TM, 1976, BIOCHEMISTRY-US, V15, P5571, DOI 10.1021/bi00670a023
   LUDVIGSEN S, 1991, J MOL BIOL, V222, P621, DOI 10.1016/0022-2836(91)90500-6
   MCPHALEN CA, 1987, BIOCHEMISTRY-US, V26, P261, DOI 10.1021/bi00375a036
   Mok YK, 1996, PROTEIN SCI, V5, P310
   Mozhaev VV, 1996, PROTEINS, V24, P81, DOI 10.1002/(SICI)1097-0134(199601)24:1<81::AID-PROT6>3.0.CO;2-R
   Neira JL, 1996, FOLD DES, V1, P189, DOI 10.1016/S1359-0278(96)00031-4
   Neira JL, 1997, J MOL BIOL, V268, P185, DOI 10.1006/jmbi.1997.0932
   OTZEN DE, 1994, P NATL ACAD SCI USA, V91, P10422, DOI 10.1073/pnas.91.22.10422
   PALADINI AA, 1994, ANAL BIOCHEM, V218, P364, DOI 10.1006/abio.1994.1193
   PALADINI AA, 1981, REV SCI INSTRUM, V52, P419, DOI 10.1063/1.1136596
   Panick G, 1998, J MOL BIOL, V275, P389, DOI 10.1006/jmbi.1997.1454
   PENG XD, 1994, BIOCHEMISTRY-US, V33, P8323, DOI 10.1021/bi00193a020
   PREVELIGE PE, 1994, BIOPHYS J, V66, P1631, DOI 10.1016/S0006-3495(94)80955-5
   ROYER CA, 1993, BIOCHEMISTRY-US, V32, P5222, DOI 10.1021/bi00070a034
   Royer CA, 1995, METHOD ENZYMOL, V259, P357
   RUIZSANZ J, 1995, BIOCHEMISTRY-US, V34, P1695, DOI 10.1021/bi00005a026
   SAMARASINGHE SD, 1992, BIOCHEMISTRY-US, V31, P7773, DOI 10.1021/bi00149a005
   SCHELLMAN JA, 1978, BIOPOLYMERS, V17, P1305, DOI 10.1002/bip.1978.360170515
   Silva JL, 1996, CURR OPIN STRUC BIOL, V6, P166, DOI 10.1016/S0959-440X(96)80071-6
   SILVA JL, 1993, ANNU REV PHYS CHEM, V44, P89, DOI 10.1146/annurev.physchem.44.1.89
   SILVA JL, 1992, J MOL BIOL, V223, P545, DOI 10.1016/0022-2836(92)90669-B
   Weber G., 1992, PROTEIN INTERACTIONS
NR 39
TC 25
Z9 25
U1 0
U2 4
PU AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC
PI BETHESDA
PA 9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA
SN 0021-9258
EI 1083-351X
J9 J BIOL CHEM
JI J. Biol. Chem.
PD MAR 19
PY 1999
VL 274
IS 12
BP 7732
EP 7740
DI 10.1074/jbc.274.12.7732
PG 9
WC Biochemistry & Molecular Biology
SC Biochemistry & Molecular Biology
GA 178LU
UT WOS:000079268100022
PM 10075663
OA Bronze
DA 2020-12-17
ER

PT J
AU Mohana-Borges, R
   Silva, JL
   Gay, GP
AF Mohana-Borges, R
   Silva, JL
   Gay, GP
TI Folding mechanism of a complex formed by the association of two protein
   fragments from high pressure experiments.
SO BIOPHYSICAL JOURNAL
LA English
DT Meeting Abstract
C1 UFRJ, Dept Bioquim Med, BR-21941590 Rio De Janeiro, Brazil.
RI Silva, Jerson/J-8984-2014; Borges, Ronaldo S Mohana/C-5575-2013
OI Silva, Jerson/0000-0001-9523-9441; 
NR 0
TC 0
Z9 0
U1 0
U2 0
PU BIOPHYSICAL SOCIETY
PI BETHESDA
PA 9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA
SN 0006-3495
J9 BIOPHYS J
JI Biophys. J.
PD FEB
PY 1998
VL 74
IS 2
BP A170
EP A170
PN 2
PG 1
WC Biophysics
SC Biophysics
GA ZL549
UT WOS:000073445400980
DA 2020-12-17
ER

EF